<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-GB">
	<id>https://embryology.med.unsw.edu.au/embryology/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Z3416054</id>
	<title>Embryology - User contributions [en-gb]</title>
	<link rel="self" type="application/atom+xml" href="https://embryology.med.unsw.edu.au/embryology/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Z3416054"/>
	<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=Special:Contributions/Z3416054"/>
	<updated>2026-08-18T02:05:34Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.39.10</generator>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=File:Polycystic_rat_ovary.jpg&amp;diff=208419</id>
		<title>File:Polycystic rat ovary.jpg</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=File:Polycystic_rat_ovary.jpg&amp;diff=208419"/>
		<updated>2015-10-23T08:10:04Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Examples of cystic follicles found in the polycystic ovaries of a rat specimen.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Polycystic Rat Ovary==&lt;br /&gt;
An exampe of a polycystic follicle present in the ovary of a rat. Observe the absence of an ovum and the accumulation of fluid (antrum) in the polycystic follicle. This image displays only a single polycystic follicle, so as to draw a comparison between a regular follicle. However, the number of polycystic follicles present in this rat specimen would likely be vast, resulting in infertility.&lt;br /&gt;
&lt;br /&gt;
'''Reference'''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3395821&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Copyright'''&lt;br /&gt;
&lt;br /&gt;
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.&lt;br /&gt;
&lt;br /&gt;
{{Template:Student Image}}&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=File:Polycystic_rat_ovary.jpg&amp;diff=208417</id>
		<title>File:Polycystic rat ovary.jpg</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=File:Polycystic_rat_ovary.jpg&amp;diff=208417"/>
		<updated>2015-10-23T08:09:41Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Examples of cystic follicles found in the polycystic ovaries of a rat specimen.&lt;br /&gt;
&lt;br /&gt;
PMCID: PMC3395821&lt;br /&gt;
&lt;br /&gt;
==Polycystic Rat Ovary==&lt;br /&gt;
An exampe of a polycystic follicle present in the ovary of a rat. Observe the absence of an ovum and the accumulation of fluid (antrum) in the polycystic follicle. This image displays only a single polycystic follicle, so as to draw a comparison between a regular follicle. However, the number of polycystic follicles present in this rat specimen would likely be vast, resulting in infertility.&lt;br /&gt;
&lt;br /&gt;
'''Reference'''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3395821&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Copyright'''&lt;br /&gt;
&lt;br /&gt;
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.&lt;br /&gt;
&lt;br /&gt;
{{Template:Student Image}}&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_3&amp;diff=208407</id>
		<title>2015 Group Project 3</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_3&amp;diff=208407"/>
		<updated>2015-10-23T08:00:35Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015header}}&lt;br /&gt;
&lt;br /&gt;
=Polycystic Ovarian Syndrome=&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Polycystic Ovary juxtaposed with a Standard Ovary.png|700px|thumb|centre|PCOS Ovary vs. Non-PCOS Ovary. A standard PCOS patient will possess cysts on both ovaries, not one, as depicted above. The cysts are a series of fluid filled sacs that form due to irregular menstrual cycles and hormone fluctuations.]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Introduction&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
[[File:Prevalence of Primary Infertility in 2010.jpeg|400px|thumb|right|Prevalence of Primary Infertility in 2010 &amp;lt;ref name=weloverichie&amp;gt;&amp;lt;pubmed&amp;gt;23271957&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
{|&lt;br /&gt;
|-bgcolor=&amp;quot;DDCEF2&amp;quot; &lt;br /&gt;
|&lt;br /&gt;
* '''Polycystic Ovarian Syndrome (PCOS) is a common endocrine disorder, affecting up to 20% of reproductive aged women &amp;lt;ref name=hey&amp;gt;&amp;lt;pubmed&amp;gt;21896560&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. It is the most common cause of anovulatory infertility &amp;lt;ref name=one/&amp;gt; which refers to infertility caused by the the absence of ovulation.'''&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Female Infertility refers to the failure to conceive after one year of regular unprotected intercourse in females &amp;lt;ref name=one&amp;gt;&amp;lt;pubmed&amp;gt;26150870&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. In 2010, infertility affected 48.5 million couples world wide and the areas of highest prevalence included North Africa and Middle East, South Asia, Central/Eastern Europe and Central Asia and Sub-Saharan Africa, as shown by the graph on the right &amp;lt;ref name=weloverichie/&amp;gt;. As there are several causes of female infertility, we will be focusing on infertility that is caused by '''Polycystic Ovarian Syndrome''' (PCOS), the most common cause of infertility that is medically treatable &amp;lt;ref name=one/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
=Causes=&lt;br /&gt;
&lt;br /&gt;
PCOS is a disorder of heterogeneous origin with unknown aetiology &amp;lt;ref name=hey/&amp;gt;. Studies have shown that both genetic and environmental factors contribute to the development of PCOS in women however there is limited research into the actual interactions between these two factors &amp;lt;ref name=un&amp;gt;&amp;lt;pubmed&amp;gt;17185788&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Genetic Factors&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
Despite the lack of information regarding its aetiology, there is increasing evidence for a genetic involvement in the endocrine disorder. Studies have shown that genes play an important role in contributing towards the clinical and biochemical features of the disease. This evidence includes the family clustering of cases, greater unanimity between monozygotic twins than heterozygotic twins and the ability to inherit endocrine and  metabolic features of PCOS &amp;lt;ref name=hey/&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
In one study, 115 sisters of women with PCOS were examined and results showed that half of these sisters had high testosterone levels, suggesting that hyperandrogenemia is a common trait with a dominant pattern of inheritance. These results strongly supported the idea of the familial clustering of biochemical features such as hyperandrogenism in first degree relatives &amp;lt;ref name=deux&amp;gt;&amp;lt;pubmed&amp;gt;9843997&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Several genes have been considered to play an important role in the development of PCOS such as CYP11A, the insulin gene, the follistatin gene and a region near the insulin receptor gene. Yet, the evidence supporting most of these genes has been refuted by larger studies, except for the region near the insulin receptor gene &amp;lt;ref name=deux/&amp;gt;. Among these, the gene CYP11a is the one that is strongly associated with hyperandrogenism in women with PCOS. &amp;lt;ref name=cinq&amp;gt;&amp;lt;pubmed&amp;gt;9147642&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; While it doesn't isolate this gene as the sole cause of PCOS, variation of the genotype at this locus contributes to production of excess androgen &amp;lt;ref name=h4&amp;gt;&amp;lt;pubmed&amp;gt;7962289&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Studies have also shown that there is strong evidence for linkage between the alleles at the Variable Number Tandem Repeats (VNTR) which is situated 5' to the insulin gene and PCOS. The data from the study suggests that it is a very susceptible region in PCOS and also may play a role in the development of hyperinsulinaemia &amp;lt;ref name=trois&amp;gt;&amp;lt;pubmed&amp;gt;9455828&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Environmental Factors&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
The prevalence of PCOS in populations where there has been a constant gene pool indicates that environmental factors play a significant role in the aetiology of PCOS &amp;lt;ref name=un/&amp;gt;. The role of environmental factors in PCOS has been extensively investigated through family studies, especially in sisters in order to minimise the effect of genotype on the PCOS phenotype &amp;lt;ref name=deux/&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
====&amp;lt;u&amp;gt;Obesity and Diet&amp;lt;/u&amp;gt;====&lt;br /&gt;
&lt;br /&gt;
[[File:Graph.jpg|600px|thumb|right|BMI for different PCOS phenotypes &amp;lt;ref name=deux/&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
Obesity is the major environmental factor driving the development of PCOS in susceptible individuals. The rising rates of PCOS have been paralleled by the widespread emergence of obesity and type 2 diabetes which are prevalent in developed countries,&amp;lt;ref name=un/&amp;gt;. Several family studies have shed light on the role of obesity in PCOS developpement, primarily one which studied the phenotypic characteristics among PCOS sisters &amp;lt;ref name=deux/&amp;gt;. It was found that sisters with hyperandrogenemia and irregular cycles had higher body weights than those with regular cycles and hyperandrogenemia. These findings were supported by another study which reported that affected sisters had higher body weights than unaffected ones &amp;lt;ref name=green&amp;gt;&amp;lt;pubmed&amp;gt;11994352&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The role of obesity in the intrauterine environment was also shown to be important after studies suggested that PCOS women with increased weight at birth were associated with overweight mothers &amp;lt;ref name=blue&amp;gt;&amp;lt;pubmed&amp;gt;9343501&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.  &lt;br /&gt;
&lt;br /&gt;
The risk of developing PCOS from obesity is compounded by  poor dietary choices and lack of physical activity which has begun to characterise the lifestyle in developed countries &amp;lt;ref name=deux/&amp;gt;. Energy dense food and larger sizes in portion act as major contributors towards the increasing incidence of obesity. The quality and type of nutrition can also have an effect on the PCOS phenotype while interacting with different genotypes &amp;lt;ref name=un/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
====&amp;lt;u&amp;gt;Medication&amp;lt;/u&amp;gt;====&lt;br /&gt;
&lt;br /&gt;
Studies have shown that valproic acid in medication used to treat epilepsy and bipolar disorders contributes to the development of PCOS. Women with these disorders  may develop the typical features of PCOS such as polycystic ovaries, anovulation, hyperandrogenism and obesity &amp;lt;ref name=quartre&amp;gt;&amp;lt;pubmed&amp;gt;8413434&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Recent studies also suggest that the weight gain from medication is significant as it can lead to the development of PCOS &amp;lt;ref name=deux/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
=Pathogenesis=&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Cyst Formation&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
The pathogenesis of polycystic ovarian syndrome is poorly understood, however it is believed that insulin resistance and excess androgens such as testosterone play a fundamental role. The below image details the various types of cysts that can form in the ovary and uterus. In PCOS patients, cysts arise due to irregular periods, and thus an imbalance of hormone levels. &amp;lt;ref name=coolsticks&amp;gt; Mayo Clinic Staff '''Ovarian Cysts Causes''' 13th August 2014 Date Retrieved: 22nd October 2015. http://www.mayoclinic.org/diseases-conditions/ovarian-cysts/basics/causes/con-20019937 &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Types of Cysts.jpg|700px|thumb|centre|Types of Ovarian Cysts &amp;lt;ref name=coolsticks/&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Underlying factors such as obesity and genetic predispositions likely contribute to the onset of polycystic ovarian syndrome through the development of a combination of hyperinsulinemia and hyperandrogenemia.&amp;lt;ref name=eleven&amp;gt;&amp;lt;pubmed&amp;gt;PMC4556908&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Hyperinsulinemia&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
Hyperinsulinemia is a term that defines the presence of excessive amounts of insulin in the blood relative to the amount of glucose. &amp;lt;ref name=fourteen&amp;gt;&amp;lt;pubmed&amp;gt;PMC4114053&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This phenomenon is typically associated with obesity and excess adipose tissue, both of which are associated with insulin resistance. In order to overcome this resistance, insulin secretion is increased in an attempt to normalise blood glucose levels, thereby leading to hyperinsulineamia. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2782313&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Excessive levels of insulin typically cause disruption to the hypothalamus-hypophysis-ovary axis whilst insulin resistance in ovarian tissues leads to decreased metabolic signalling. However, steroidogenic activity is largely unaffected by the impaired metabolic signalling, thereby paving the way androgens to become more effect and paving the way towards hyperandrogenemia. &amp;lt;ref name=coolbananas&amp;gt;&amp;lt;pubmed&amp;gt;PMC4334071&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
[[File:Patholophysiology of Polycystic Ovarian Syndrome.jpg|700px|thumb|left|The impact of hyperinsulinemia and hyperandrogenemia on the development of polycystic ovarian syndrome &amp;lt;ref name=coolbananas/&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Hyperandrogenemia&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
Hyperandrogenemia is a hallmark of the development of polycystic ovarian syndrome, with 80% of women presenting with excess androgen also having polycystic ovaries.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3872139&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The disruption of the hypothalamus hypophysis ovary axis as a result of hyperinsulinemia increases the release of GnRH and LH, leading to increased androgen production in the ovarian theca cells. Hyperandrogenemia decreases the feedback sensitivity of both estradiol and progesterone within gonadotropic hypothalmic cells. &amp;lt;ref name=coolbananas/&amp;gt; A deficiency of FSH is observed and correlates with the increased secretion of Gonadotrophin-releasing hormone (GnRH) and Luteinizing hormone (LH). As a result of this deficiency, graunlosa  cell aromatisation to oestrogens as well as follicle maturation and ovulation will be drastically impaired.  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3453528&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
As a consequence of the impairment of follicle maturation, small antral follicles will accumulate within the periphery of the ovary and develop a cystic morphology. Ovulation will be unable to occur due to the absence of mature follicles, culminating in infertility.  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC4562327&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Hyperandrogenism&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
====Animal Models====&lt;br /&gt;
&lt;br /&gt;
Studies conducted on female rhesus monkeys have supported evidence for the foetal origins of the clinical features of PCOS &amp;lt;ref name=h1&amp;gt;&amp;lt;pubmed&amp;gt;18406243&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.  It has been shown that in human females, an excess of androgen exposure at any stage from the development of the ovaries to the onset of puberty manifests as characteristic features of PCOS, such as resistance to insulin and LH hypersecretion. After exposure to levels of testosterone matching those of fetal males, in utero, female rhesus monkeys were found to display the clinical and biochemical features typical of PCOS such as hypersecretion of LH and abnormal insulin action. These results correlated to those of similar studies conducted on sheep, where the pregnant ewe was exposed to excessive levels of testosterone and LH secretion and abnormality in ovarian cycles were again prominent features &amp;lt;ref name=sheep&amp;gt;Padmanabhan V, Evans NP, Taylor JA, Robinson JE1997 '''Prenatal exposure to  androgens  leads  to  the  development  of  cystic  ovaries  in  the  sheep'''. Biol Reprod 56:194&amp;lt;/ref&amp;gt;. While these studies indicate that similar biochemical and clinical manifestations in humans originate from excess androgen exposure of the female fetus, it must be noted that it is very unlikely for any excess androgen production to be passed across the placenta from the mother to her daughter. This is because mechanisms such as androgen binding proteins and placental metabolism of androgen prevent excess androgen entering the circulation of the fetus &amp;lt;ref name=h2&amp;gt;&amp;lt;pubmed&amp;gt;12098657&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
====Cell Culture Models====&lt;br /&gt;
&lt;br /&gt;
While studies have shown that the adrenal could be a source of excess androgen such as the adrenal &amp;lt;ref name=h3&amp;gt;&amp;lt;pubmed&amp;gt;7962325&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;, they were followed by various studies using cell culture models which demonstrated that the ovary was the major source of excess androgen &amp;lt;ref name=h4/&amp;gt; &amp;lt;ref name=h5&amp;gt;&amp;lt;pubmed&amp;gt;9302378&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. ''In vitro'' studies have shown that the production of steroids is abnormal in theca cells &amp;lt;ref name=h3/&amp;gt;. In women affected by PCOS, stimulation by human chorionic gonadotrophin (hCG) is followed by an increase in thecal steroid production after suppression of LH by a GnRH analogue &amp;lt;ref name=h5/&amp;gt;. Theca cells cultured from polycystic ovaries produce 20 times as much androstenedione as those from normal ovaries &amp;lt;ref name=h4/&amp;gt; with increased expression of mRNA for enzymes responsible for making steroids also reported in following studies. &amp;lt;ref name=h6&amp;gt;&amp;lt;pubmed&amp;gt;10852468&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; These results have prompted many studies on genes encoding these steroidogeneic enzymes.&lt;br /&gt;
&lt;br /&gt;
[[File:Polycystic_rat_ovary.jpg|500px|thumb|right|An example of a polycystic and regular follicle present in the ovary of a rat specimen &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3395821&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; ]]&lt;br /&gt;
&lt;br /&gt;
=Signs and Symptoms=&lt;br /&gt;
&lt;br /&gt;
The symptoms of PCOS are different for each women. The three cardinal signs of PCOS are hyperandrogenism, polycystic ovaries and ovarian dysfunction &amp;lt;ref name=sign1&amp;gt;&amp;lt;pubmed&amp;gt;14688154&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Common clinical symptoms include &amp;lt;ref&amp;gt; Women's Heath, U.S. Department of Health and Human Services ,[ http://www.womenshealth.gov/publications/our-publications/fact-sheet/polycystic-ovary-syndrome.html#d ], 'Polycystic ovary syndrome (PCOS) fact sheet'&amp;lt;/ref&amp;gt; ;&lt;br /&gt;
&lt;br /&gt;
{|&lt;br /&gt;
|-bgcolor=&amp;quot;DDCEF2&amp;quot; &lt;br /&gt;
|&lt;br /&gt;
* Infertility- due to anovulation. &lt;br /&gt;
* Irregular Menstrual Cycles&lt;br /&gt;
* Hirsutism&lt;br /&gt;
* Ovarian Cysts&lt;br /&gt;
* Obesity&lt;br /&gt;
* Male Pattern Baldness&lt;br /&gt;
* Skin Tags&lt;br /&gt;
* Pelvic Pain&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
Along with obesity, PCOS is also associated with other metabolic issues such as insulin resistance, hyperinsulinemia and type 2 diabetes mellitus. It has also been associated with cardiovascular problems and cancers of the breast and endometrium &amp;lt;ref name=sign3&amp;gt;&amp;lt;pubmed&amp;gt;PMC4341818&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
=Diagnosis=&lt;br /&gt;
&lt;br /&gt;
A major diagnostic tool for PCOS is a pelvic ultrasound, but PCOS diagnosis cannot be completely dependent on just pelvic ultrasounds. A patient with PCOS may not necessarily have polycystic ovaries, and those with ovarian cysts may not necessarily have PCOS. A range of diagnostic assessments and associated symptoms have to be thoroughly investigated.&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Medical history and examination&amp;lt;/u&amp;gt;===&lt;br /&gt;
Clinical questions are asked or filled out in the form of a questionnaire to assess and assist in the diagnosis of PCOS. Studies show that those with a history:&lt;br /&gt;
*infrequent and irregular menstruation&lt;br /&gt;
*hirsutism (related to high levels of androgens in the blood – hyperandrogenism)&lt;br /&gt;
*obesity&lt;br /&gt;
*acne production &lt;br /&gt;
are at a higher predictive risk of PCOS. But questions regarding failed pregnancy attempts and history of nipple discharge proved no correlation in diagnosing PCOS. &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 17872783 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Ultrasound of Polycystic Ovaries .jpg|400px|thumb|right|Ultrasound of Polycystic Ovaries &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;18638401&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Blood Test&amp;lt;/u&amp;gt;===&lt;br /&gt;
A patient with elevated levels of androgens, a medical condition called hyperandrogenism, is very highly likely to have PCOS. &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 20591140 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;&lt;br /&gt;
Androgens, such as testosterone, and free androgen index (FAI) are the two tests best used in diagnosing hyperandrogenism.&lt;br /&gt;
Androgen excess in PCOS is a result from increased synthesis and release of ovarian androgens. Dehydroepiandrosterone sulfate (DHEA-S) levels are used as a biomarker for testing androgen levels, as it is made exclusively by the adrenal glands. DHEA-S levels of above 1890 micromol/L is extremely suggestive of hyperandrogenism. &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 18844715 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;&lt;br /&gt;
Free androgen index (FAI) is the ratio of total testosterone measurement to levels of sex hormone-binding globulin (SHBG). Those with PCOS will have high FAI, as this indicates a high ration of free testosterone in the body.&lt;br /&gt;
Other blood tests are also done to help exclude other predisposing factors such as levels of Thyroid Stimulating Hormone (TSH) and Follicle-stimulating hormone (FSH). An elevated ratio of LSH to FSH, of above 2:1 &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 14737959 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;, indicates a possibility, but not definitively, of PCOS.&lt;br /&gt;
The effect of insulin on blood can also be tested for insulin resistance. Insulin resistance enhances androgen production and increases free androgen levels by reducing SHBG. This can used as an indication marker for the possibility of PCOS&lt;br /&gt;
A study in 2014 showed that Anti-Müllerian hormone (AMH) is found to be elevated in patients with PCOS &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 24821925 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;, giving rise to its potential clinical implication in diagnosing PCOS. AMH is exclusively produced in ovarian follicles, with individual AMH concentration reflecting the quantity of remaining primordial follicles and measure of ovarian reserve.&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Gynecologic ultrasonography&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
Gynecologic ultrasonography is a pelvic ultrasound, specifically to the female pelvic region, with regards to the uterus, ovaries and the fallopian tube. The examination can be performed by transabdominal ultrasonography, with a full bladder, or transvaginal ultrasonography with a vaginal transducer. Typically transvaginal imaging shows a better and clearer image than transabdominal ultrasonography, as it uses higher frequency imaging, but is limited to areas it can reach. In the case of PCOS, both techniques can provide an image of the ovaries. Studies suggest that if more than 25 follicles are seen in an ovary, predominantly in the periphery, in women between 18-35 years, it is described to have a polycystic ovarian morphology. &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 24345633 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Magnetic Resonance Imaging&amp;lt;/u&amp;gt;===&lt;br /&gt;
Ovaries can also be seen on MRIs. On MRIs, PCOS is characterized by numberous peripheral cysts where the ovaries affected to be slightly larger than normal. Although MRI is seen to be effective in ovarian imaging, the finding of peripheral ovarian cysts in MRIsmay not be PCOS specific. &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 8888256 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt; But studies have seen that MR imaging in adolescence uncover distinct differences between young patients with and without PCOS &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 23292744 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;, with also great diagnostic sensitivity with patients between the age of 21-30 &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 19241321 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;, providing assistance of imagery in patients whom may be opposed to transvaginal ultrasounds.&lt;br /&gt;
&lt;br /&gt;
=Prevention and Treatment=&lt;br /&gt;
&lt;br /&gt;
There currently is no cure for PCOS, nor can it be prevented. This can be largely attributed to genetics, and because it can progress without being noticed for an extended period (generally until puberty begins). Treatment maybe involve lifestyle changes or hormonal augmentation in regulating periods, hirsutism, and acne, in addition to regulating androgen levels.&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Current Treatments&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
{|border=&amp;quot;1&amp;quot;&lt;br /&gt;
|-bgcolor=&amp;quot;DDCEF2&amp;quot;&lt;br /&gt;
| '''CURRENT TREATMENT'''&lt;br /&gt;
| '''DISADVANTAGES'''&lt;br /&gt;
|-&lt;br /&gt;
| General Practitioners tend to prescribe oral anti-oestrogens, most commonly the contraceptive pill, to restore ovulation.&lt;br /&gt;
| This method only has a 50% success rate in PCOS patients. It does not directly increase fertility rates, but restores the menstrual cycle. &amp;lt;ref    name= pink&amp;gt;&amp;lt;pubmed&amp;gt;26194691&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;       &lt;br /&gt;
 &lt;br /&gt;
|-bgcolor=&amp;quot;FAF5FF&amp;quot;&lt;br /&gt;
| Lifestyle changes are highly encouraged by medical practitioners. Diet and exercise regimes can be designed with a dietitian or nutritionist. &amp;lt;ref name= purple&amp;gt;&amp;lt;pubmed&amp;gt;26289303&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Exercise and diet plans do not directly increase fertility. They are designed to enhance weight loss, which in some patients can encourage normal hormone levels from the pituitary and thyroid. &amp;lt;ref name=purple/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Clomiphene citrate administration (generally in pill form, as prescribed by a GP). Such pills stimulate the pituitary gland to release GnRH to simulate ovulation (with a 72% success rate). &amp;lt;ref name= green&amp;gt;&amp;lt;pubmed&amp;gt;26150870&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Clomiphene can cause multiple side effects, most notably abnormal uterine bleeding and pelvic pain to due enlargement of the ovaries. &lt;br /&gt;
&lt;br /&gt;
Thus, it cannot be as frequently prescribed as the contraceptive pill, and careful patient monitoring is imperative &amp;lt;ref name=green/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
|-bgcolor=&amp;quot;FAF5FF&amp;quot;&lt;br /&gt;
| Higher fertility rates are observed in treatments combining clomiphene citrate and metformin (79% success) &amp;lt;ref name=green/&amp;gt;.&lt;br /&gt;
| Similar disadvantages as clomiphene, above.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Note that the success rates for current PCOS treatments vary between patients. Some individuals may require more than a simple diet and exercise plan and may need various medicines and even ovarian drilling (detailed below) to encourage fertility. Oral contraceptives do not have a significant impact on fertility rates, but rather regulate the menstrual cycle and in turn, hormone levels (oestrogen and progesterone).'''&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Laparoscopic Ovarian Drilling&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
Laparoscopic Ovarian drilling (LOD) is a surgical method of treating polycystic ovaries and is typically used when an infertile woman does not respond to administration of clomiphene citrate. &amp;lt;ref name=blue&amp;gt;&amp;lt;pubmed&amp;gt;PMC4367066&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The most common form of LOD involves electrocautery through the use of an insulinated uniupolar needle electrode. The exact method of action of LOD is poorly understood. The most accepted hypothesis however is that the breakdown of ovarian follicles and stroma via heat, laser or mechanical drilling brings about a decrease in androgen and inhibin levels, followed by a rise in the levels of FSH. Inflammatory growth factors produced in response to the thermal injury caused by laser drilling can enhance the action that FSH has on folliculogenesis. Improved blood flow often results from LOD which serves to drastically improves the delivery of gonadotrophins to the ovary.&amp;lt;ref name=blue&amp;gt;&amp;lt;pubmed&amp;gt;PMC4367066&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
LOD can be an appealing alternative to treatment with gonadotrophins, as the latter is typically time consuming, expensive and requires constant monitoring in order to be effective.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22696324&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The overall effectiveness of LOD as a standalone treatment for PCOS is still questionable. Several studies have shown that there is no evidence of significant differences in pregnancy and live births in women undergoing LOD and those undergoing other medical treatments. &amp;lt;ref name=blue&amp;gt;&amp;lt;pubmed&amp;gt;PMC4367066&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=JH-Yx1QWUBk&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Ovarian Drilling by Laparoscopy for PCOS &amp;lt;ref&amp;gt;Mishra, R., (2014, September 8) Ovarian Drilling by Laparoscopy for PCOS. Retrieved from https://www.youtube.com/watch?v=JH-Yx1QWUBk&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;New Trials&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
Some studies have found that regular Selenium supplements can encourage fertility among PCOS patients. The program, which is still in its early trial period, requires women to consume selenium tablets for 8 weeks. This study has found a significant decrease in dehydroepiandrosterone (DHEA) levels in patients, thus reducing excessive hair growth associated with PCOS. A direct link to increased fertility is yet to be established, and thus further testing is required.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26267328&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
=PCOS and Conceiving=&lt;br /&gt;
&lt;br /&gt;
[[File:Tarryn &amp;amp; PCOS Diet Support.jpg|400px|thumb|right|Tarryn and her daughter, after she overcame her PCOS with various treatments. &amp;lt;ref name=ropeaccesstechnician&amp;lt;&amp;gt;Tarryn '''About PCOS Diet Support''' Date Retrieved: 22nd October 2015. http://www.pcosdietsupport.com/about-pcos-diet/ &amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
Although PCOS can significantly hinder a woman's chances of conceiving, many women with the condition do give birth to healthy children. This is largely due to modern day medical treatments, as detailed above. The following is a blog post written by 'Tarryn,' the founder of PCOS Diet Support (www.pcosdietsupport.com):&lt;br /&gt;
&lt;br /&gt;
:''I’m Tarryn and I was diagnosed with PCOS in January 2010. I always suspected something was amiss as my menstrual cycle has always been irregular. In 2001 or 2002 I consulted a Gynaecologist who did an ultrasound and told me that I don’t ovulate every month and put me on the pill. He made no mention of PCOS.''&lt;br /&gt;
&lt;br /&gt;
:''When hubby and I decided to start trying for a baby in 2009, I just knew something was wrong. So, I went to my doctor who did some blood tests and diagnosed me with PCOS. Although I had my suspicions already, I was devastated.''&lt;br /&gt;
&lt;br /&gt;
:''I decided I had to do something and went on a low GI diet and exercised regularly. I fell pregnant 9 months later. I had been taking my basal body temperature every morning and the only time I ovulated in 9 months, I fell pregnant with our beautiful daughter.''&lt;br /&gt;
&lt;br /&gt;
:''Toward the end of 2012, we decided we’d like to give our little girl a brother or sister. I was very careful with my diet and supplements. It took 5 months to fall pregnant but we are now a family of 4. Our little boy was born in December 2013.''&lt;br /&gt;
&lt;br /&gt;
:''It is possible to overcome PCOS! I’m still determined to continue the fight against PCOS and keep it under control with diet and lifestyle changes.''  &amp;lt;ref name=ropeaccesstechnician/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
=Glossary=&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Cyst''' - a general term for a fluid filled sac that grows abnormally on various organs (i.e. ovarian, kidney cysts).&lt;br /&gt;
&lt;br /&gt;
'''FSH''' - Follicle Stimulating Hormone. Stimulates the production of eggs or sperm in the human gonads; produced by the anterior pituitary. &lt;br /&gt;
&lt;br /&gt;
'''Hirsutism''' - An abnormal growth of hair on a woman's face or body.&lt;br /&gt;
&lt;br /&gt;
'''hCG''' -  Human Chorionic Gonadotrophin. A hormone secreted by the placenta in the early stages of pregnancy. It encourages the production of other hormones such as progesterone by ovarian cells in order to maintain pregnancy. &lt;br /&gt;
&lt;br /&gt;
'''GnRH''' - Gonadotrophin Releasing Hormone, responsible for the release of LH and FSH from the pituitary. &lt;br /&gt;
&lt;br /&gt;
'''LH''' - Luteinizing Hormone. Produced by the anterior pituitary, stimulating ovulation.&lt;br /&gt;
&lt;br /&gt;
'''LOD''' - Laparoscopic Ovarian Drilling (detailed in the '''Treatment''' section).&lt;br /&gt;
&lt;br /&gt;
'''PCOS''' - Polycystic Ovarian Syndrome&lt;br /&gt;
&lt;br /&gt;
'''mRNA''' - Messenger Ribonucleic acid; a transcribed version of a section of DNA that is later translated to produce a protein.&lt;br /&gt;
&lt;br /&gt;
'''DHEA''' - Dehydroepiandrosterone sulfate; a steroid hormone produced by various organs (reproductive organs, the brain and the adrenal glands).&lt;br /&gt;
&lt;br /&gt;
'''Proband''' - The first family member who is affected by a genetic disorder and seeks medical attention.&lt;br /&gt;
&lt;br /&gt;
=References=&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=File:Polycystic_rat_ovary.jpg&amp;diff=208403</id>
		<title>File:Polycystic rat ovary.jpg</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=File:Polycystic_rat_ovary.jpg&amp;diff=208403"/>
		<updated>2015-10-23T07:58:55Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: A normal follicle and a polycystic follicle found in a rat ovary&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Examples of cystic follicles found in the polycystic ovaries of a rat specimen.&lt;br /&gt;
&lt;br /&gt;
PMCID: PMC3395821&lt;br /&gt;
&lt;br /&gt;
==Polycystic Rat Ovary==&lt;br /&gt;
An exampe of a polycystic follicle present in the ovary of a rat. Observe the absence of an ovum and the accumulation of fluid (antrum) in the polycystic follicle.&lt;br /&gt;
&lt;br /&gt;
'''Reference'''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3395821&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Copyright'''&lt;br /&gt;
&lt;br /&gt;
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.&lt;br /&gt;
&lt;br /&gt;
{{Template:Student Image}}&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=File:Polycystic_rat_ovary.jpg&amp;diff=208395</id>
		<title>File:Polycystic rat ovary.jpg</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=File:Polycystic_rat_ovary.jpg&amp;diff=208395"/>
		<updated>2015-10-23T07:55:31Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: Z3416054 uploaded a new version of File:Polycystic rat ovary.jpg&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Examples of cystic follicles found in the polycystic ovaries of a rat specimen.&lt;br /&gt;
&lt;br /&gt;
PMCID: PMC3395821&lt;br /&gt;
&lt;br /&gt;
==Polycystic Rat Ovary==&lt;br /&gt;
Several cystic follicles present in a polycystic ovary of a rat.&lt;br /&gt;
&lt;br /&gt;
'''Reference'''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3395821&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Copyright'''&lt;br /&gt;
&lt;br /&gt;
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.&lt;br /&gt;
&lt;br /&gt;
{{Template:Student Image}}&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=File:Polycystic_rat_ovary.jpg&amp;diff=208387</id>
		<title>File:Polycystic rat ovary.jpg</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=File:Polycystic_rat_ovary.jpg&amp;diff=208387"/>
		<updated>2015-10-23T07:54:00Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: Z3416054 uploaded a new version of File:Polycystic rat ovary.jpg&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Examples of cystic follicles found in the polycystic ovaries of a rat specimen.&lt;br /&gt;
&lt;br /&gt;
PMCID: PMC3395821&lt;br /&gt;
&lt;br /&gt;
==Polycystic Rat Ovary==&lt;br /&gt;
Several cystic follicles present in a polycystic ovary of a rat.&lt;br /&gt;
&lt;br /&gt;
'''Reference'''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3395821&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Copyright'''&lt;br /&gt;
&lt;br /&gt;
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.&lt;br /&gt;
&lt;br /&gt;
{{Template:Student Image}}&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=File:Polycystic_rat_ovary.jpg&amp;diff=208385</id>
		<title>File:Polycystic rat ovary.jpg</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=File:Polycystic_rat_ovary.jpg&amp;diff=208385"/>
		<updated>2015-10-23T07:53:36Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: Z3416054 uploaded a new version of File:Polycystic rat ovary.jpg&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Examples of cystic follicles found in the polycystic ovaries of a rat specimen.&lt;br /&gt;
&lt;br /&gt;
PMCID: PMC3395821&lt;br /&gt;
&lt;br /&gt;
==Polycystic Rat Ovary==&lt;br /&gt;
Several cystic follicles present in a polycystic ovary of a rat.&lt;br /&gt;
&lt;br /&gt;
'''Reference'''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3395821&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Copyright'''&lt;br /&gt;
&lt;br /&gt;
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.&lt;br /&gt;
&lt;br /&gt;
{{Template:Student Image}}&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=File:Polycystic_rat_ovary.jpg&amp;diff=208383</id>
		<title>File:Polycystic rat ovary.jpg</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=File:Polycystic_rat_ovary.jpg&amp;diff=208383"/>
		<updated>2015-10-23T07:53:22Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: Z3416054 uploaded a new version of File:Polycystic rat ovary.jpg&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Examples of cystic follicles found in the polycystic ovaries of a rat specimen.&lt;br /&gt;
&lt;br /&gt;
PMCID: PMC3395821&lt;br /&gt;
&lt;br /&gt;
==Polycystic Rat Ovary==&lt;br /&gt;
Several cystic follicles present in a polycystic ovary of a rat.&lt;br /&gt;
&lt;br /&gt;
'''Reference'''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3395821&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Copyright'''&lt;br /&gt;
&lt;br /&gt;
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.&lt;br /&gt;
&lt;br /&gt;
{{Template:Student Image}}&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=File:Polycystic_rat_ovary.jpg&amp;diff=208379</id>
		<title>File:Polycystic rat ovary.jpg</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=File:Polycystic_rat_ovary.jpg&amp;diff=208379"/>
		<updated>2015-10-23T07:51:15Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: Z3416054 uploaded a new version of File:Polycystic rat ovary.jpg&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Examples of cystic follicles found in the polycystic ovaries of a rat specimen.&lt;br /&gt;
&lt;br /&gt;
PMCID: PMC3395821&lt;br /&gt;
&lt;br /&gt;
==Polycystic Rat Ovary==&lt;br /&gt;
Several cystic follicles present in a polycystic ovary of a rat.&lt;br /&gt;
&lt;br /&gt;
'''Reference'''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3395821&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Copyright'''&lt;br /&gt;
&lt;br /&gt;
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.&lt;br /&gt;
&lt;br /&gt;
{{Template:Student Image}}&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=File:Patholophysiology_of_Polycystic_Ovarian_Syndrome.jpg&amp;diff=208341</id>
		<title>File:Patholophysiology of Polycystic Ovarian Syndrome.jpg</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=File:Patholophysiology_of_Polycystic_Ovarian_Syndrome.jpg&amp;diff=208341"/>
		<updated>2015-10-23T07:16:10Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
&lt;br /&gt;
==Pathophysiology of Polycystic Ovarian Syndrome==&lt;br /&gt;
An outline of the impact that hyperinsulinemia, and hyperandrogenemia have upon the development of polycystic ovarian syndrome. As can be seen, insulin resistance is often the precursor of hyperinsulinemia and can contribute to the development of chronic inflammation. Both hyperinsulinemia and chronic inflammation can cause hyperandrogenemia which is fundamental to the development of polycystic ovaries.&lt;br /&gt;
&lt;br /&gt;
'''Reference'''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4334071&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Copyright'''&lt;br /&gt;
&lt;br /&gt;
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.&lt;br /&gt;
&lt;br /&gt;
{{Template:Student Image}}&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=File:Patholophysiology_of_Polycystic_Ovarian_Syndrome.jpg&amp;diff=208337</id>
		<title>File:Patholophysiology of Polycystic Ovarian Syndrome.jpg</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=File:Patholophysiology_of_Polycystic_Ovarian_Syndrome.jpg&amp;diff=208337"/>
		<updated>2015-10-23T07:11:24Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;PMCID: PMC4334071&lt;br /&gt;
&lt;br /&gt;
==Pathophysiology of Polycystic Ovarian Syndrome==&lt;br /&gt;
An outline of the impact that hyperinsulinemia, and hyperandrogenemia have upon the development of polycystic ovarian syndrome. As can be seen, insulin resistance is often the precursor of hyperinsulinemia and can contribute to the development of chronic inflammation. Both hyperinsulinemia and chronic inflammation can cause hyperandrogenemia which is fundamental to the development of polycystic ovaries.&lt;br /&gt;
&lt;br /&gt;
'''Reference'''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4334071&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Copyright'''&lt;br /&gt;
&lt;br /&gt;
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.&lt;br /&gt;
&lt;br /&gt;
{{Template:Student Image}}&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=207923</id>
		<title>User:Z3416054</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=207923"/>
		<updated>2015-10-23T01:32:27Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Hi there&lt;br /&gt;
Just giving the editor a good old test run.&lt;br /&gt;
[[Test student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:45, 7 August 2015 (AEST)&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:47, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 14:06, 14 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:57, 21 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 12:22, 28 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:20, 4 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:18, 11 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:10, 25 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:28, 16 October 2015 (AEDT)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 12:32, 23 October 2015 (AEDT)&lt;br /&gt;
==Picture Tutorial==&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
===Article 1===&lt;br /&gt;
This research article aimed to determine the clinical outcomes following IVF (in vitro fertilisation) and embryo transfer treatments in subjects suffering from the sexually transmitted disease syphilis. The clinical outcomes mentioned are the rates of pregnancy and health of newborns following treatment via IVF. Couples engaged in sexual intercourse over 12 months without the use of contraception and who failed to conceive were deemed as being infertile.&lt;br /&gt;
&lt;br /&gt;
The subjects were divided into two groups based on serology results, a syphilis infected group and a control group, each with 160 individuals, giving a total of 320 subjects. The Syphilis infected group was further divided into three subcategories, a male infected group, a female infected group and a couple (male and female) infected group. Penicillin G20 (an anti-syphilis treatment) was given to the individuals in the syphilis group. IVF treatment commenced one month proceeding the disappearance of clinical syphilis symptoms or if test results gave a negative result for syphilis infection.&lt;br /&gt;
&lt;br /&gt;
The results of this experiment revealed no significant differences in regards to the basal FSH and LH of both the control and syphilis groups. However, the thickness of the endometrium differed greatly, with the syphilis group demonstrating a thicker endometrial wall (16.9±5.4mm) compared to the control group (13.0±4.7mm). Further differences were noted in blastocyst implantation rates, with the syphilis group having less successful implantations compared to the control (24.2% vs. 34.4% respectively).Normal oocyte cleavage differed between the two groups with the syphilis group demonstrating less normal oocyte cleavage compared to the control group  (6.3±4.7 vs. 8.1±4.6). Furthermore, the clinical pregnancy rates of the syphilis group stood at 43.8% compared to 55.6% of the control group.&lt;br /&gt;
&lt;br /&gt;
Syphilis infection appeared to have a significant impact on the success and clinical outcomes of IVF. Syphilis associated pelvic inflammatory disease can lead to an increase in the thickness of the endometrium, which can adversely affect blastocyte implantation and endometrial receptivity. Successful pregnancy rates typically correlate with an endometrial thickness of 7-14mm, with any thickness beyond 14mm often corresponding with decreased clinical pregnancies. Rates of clinical pregnancy and miscarriage rates did not differ between the three syphilis subgroups. Conception involving a male infected partner was associated with a shorter gestational period and decreased offspring birth weight, when compared to the female infected and couple infected subgroups. No explanation for this phenomenon was provided.&lt;br /&gt;
&lt;br /&gt;
PMID 26208116&lt;br /&gt;
&lt;br /&gt;
''Article 1 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4514756&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
===Article 2===&lt;br /&gt;
The effects of oxygen levels on factors such as cleavage, implantation and pregnancy rates in IVF cultured embryos was the primary focus of this article.  Women between the ages of 20-48 who were seeking treatment for infertility were utilised in this experiment.&lt;br /&gt;
Gametes were allocated to be incubated in one of three environments, each with a different oxygen concentration. The first group was placed in an atmosphere with an oxygen concentration of 20%. The second group rested in a 20% oxygen environment for a day before being moved to a 5% oxygen, 5% carbon dioxide and 90% nitrogen atmosphere. The third group consisted of a 5% carbon dioxide, 5% oxygen and 90% nitrogen atmosphere. The gametes (spermatozoa and oocytes) were incubated together in their respective environmental conditions for 4-6 hours after which fertilisation is presumed to have occurred.&lt;br /&gt;
&lt;br /&gt;
Successful embryos were transferred at Day 3 cleavage. A biochemical analysis of HCG validated pregnancy, whilst ultrasound was used to confirm the presence of a heartbeat 28 days following the transfer.&lt;br /&gt;
IVF fertilisation rates were calculated as being the number of fertilised oocytes over the number of oocytes inseminated. Cleavage rates were characterised by the number of blastomeres over the number of fertilised and abortion rate by the amount of miscarriages divided by the number of transfers.&lt;br /&gt;
&lt;br /&gt;
The research article concluded that the embryos from the 5% oxygen group had the highest rates of fertilisation and implantation. The 20% oxygen group had the second highest rates of fertilisation and maintained excellent embryo quality, whilst the 20% to 5% group had the lowest rates overall. Abortion and miscarriage rates did not differ at all between the three groups. The group incubated at 5% oxygen demonstrated higher quality embryos and increased rates of pregnancy when compared to the 20% oxygen group. The article concludes that implantation, pregnancy and embryo quality can be somewhat affected by a set oxygen concentration, but are affected adversely by a shift from one concentration to another. &lt;br /&gt;
Shifting from one oxygen concentration to another appeared to have an adverse effect on the cleavage of the embryo and would likely impact future development and the overall success of the IVF treatment.&lt;br /&gt;
&lt;br /&gt;
PMID 26131222 &lt;br /&gt;
&lt;br /&gt;
''Article 2 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4483955&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These are quite good descriptions of these 2 articles. (5/5)&lt;br /&gt;
==Lab 2 Assessment==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Notch Signalling - Ovulation in Drosphila.jpg|Caption]]&lt;br /&gt;
&lt;br /&gt;
===Image Reference===&lt;br /&gt;
Jianjun Sun, Allan C Spradling Ovulation in Drosophila is controlled by secretory cells of the female reproductive tract. Elife: 2013, 2;e00415 PubMed 23599892&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 23599892&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) Image uploaded and named correctly. All reference, copyright and student image template included. You might have included in the summary box an explanation to the terms that appear in the image as there is no way for the reader to interpret what is shown in each panel. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 3 Assessment==&lt;br /&gt;
===Causes===&lt;br /&gt;
====The Genetics of Infertility: Current Status of the Field====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3885174&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This article attempted to determine the role that genetics plays in female infertility. It was noted that several prominent causes of female infertility such as Galactosemia and Primary Ovarian Failure (POF) were associated with specific genes, with the GALT gene contributing to the former condition and the FMR1 gene contributing to the latter.&lt;br /&gt;
&lt;br /&gt;
====Causes of Sterility in Bosnia-Herzegovina Population====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4499307&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
The study conducted as laid out in this article examined the causes of female sterility in the Bosnia-Herzegovina population. Married participants were arranged into various groups based upon their age. The experiment came to the conclusion that in approximately 42% of infertile married couples, female sterility was the primary cause. The two primary causes of female infertility were tubal deficiencies (31% of cases) and Diminished Ovarian Reserves (38% of cases)&lt;br /&gt;
&lt;br /&gt;
====Epidemiology, diagnosis, and management of polycystic ovary syndrome====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3872139&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This research article examines the causes of polycystic ovary syndrome (POS), a common cause of infertility in women. The article concluded that 50-70% of women suffer from insulin resistance secondary to Type 2 Diabetes and in many cases obseity, which may contribute partially to POS. Furthermore, 85-90% of women with oligomenorrhea also had POS, suggesting that it is an underlying cause. However, the exact pathophysiology of POS was not determined.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These papers relate to your group project, I hope they are useful for the final submission. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 4 Assessment==&lt;br /&gt;
===Quiz===&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
{Primary villi are produced during which stage of development?:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ Week 2&lt;br /&gt;
- Week 1&lt;br /&gt;
- Week 3&lt;br /&gt;
- None of the above&lt;br /&gt;
|| Primary Villi appear during Week 2 of development, whilst secondary villi appear during Week 3 of development.&lt;br /&gt;
&lt;br /&gt;
{Mesoderm is a precursor for all of the following EXCEPT:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Skeletal Muscle Cells&lt;br /&gt;
- Cardiac Muscle Cells&lt;br /&gt;
- Erythrocytes&lt;br /&gt;
+ Epidermal Skin Cells&lt;br /&gt;
- Smooth Muscle&lt;br /&gt;
|| Epidermal skin cells originate from ectoderm. Skeletal, cardiac and smooth muscle along with erythrocytes originate from the mesoderm.&lt;br /&gt;
&lt;br /&gt;
{Which of the following shows the correct developmental pathway of the male gamete:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatogonia &amp;gt; Spermatozoa&lt;br /&gt;
- Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell &amp;gt; Spermatozoa &amp;gt; Spermatid&lt;br /&gt;
- Sertoli Cell &amp;gt; Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatozoa&lt;br /&gt;
- Spermatid &amp;gt; Spermatozoa &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell&lt;br /&gt;
+ Spermatogonia &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatid &amp;gt; Spermatozoa&lt;br /&gt;
|| Spermatogonia represent the beginning of male sex cell development, with spermatozoa being the mature gamete.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) No descriptive title to your questions. Q1 relates to the timing of villi development. These types of questions encourage &amp;quot;student guessing&amp;quot; and you could have given a more detailed explanation and links to resources in your revealed answer e.g. [[Placenta - Villi Development]]. Q2 is a reasonable question, but only requiring the student only to know that Epidermal Skin Cells are from ectoderm. Once again it is your revealed answer that needs more work. Q3 is a little easy, as long as you know Spermatogonia are the diploid start cell you can quickly exclude most options, need more work. (8/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5 Assessment==&lt;br /&gt;
===Gastroschisis and Omphalocele===&lt;br /&gt;
&lt;br /&gt;
Gastroschisis is classified as a full thickness cleft found in the abdominal wall, adjacent to the site of insertion of the umbilical cord. The defining features of this abnormality is the absence of a membranous sac shrouding the intestines. As a result of this the intestines will become eviscerated, thereby protruding out of the abdominal wall and will be on the exterior, rather than the interior of the body. It is believed that disruption to the vascular supply of the right abdominal wall is the primary gass of gastroschisis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2166158&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Omphalocele is an abnormality characterised by the herniation of visceral organs such as the intestines, liver and spleen outside of the abdominal cavity. The visceral organs are enclosed in a membranous sac, into which the umbilical cord is inserted.  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC1355659&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The primary difference between gastroschisis and omphalocele lies in the presence of a membraneous sac and the exact organs herniating from the abdominal wall. Gastroschisis involves the intestines protruding to the outside of the body but are not covered by a membranous sac. Omphalocele however is characterised by the protrusion of multiple visceral organs (liver, spleen etc.) which are enclosed within a membranous. Furthermore, the size of both abnormalities differs greatly, with gastroschisis typically being 2-5 cm in size whilst omphalocele can vary between 2-15cm. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2552910&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) This is an adequate description of the differences between these conditions. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 7 Assessment==&lt;br /&gt;
&lt;br /&gt;
1: This research paper aimed to examine the relationship between fetal adrenal cells and the differentiated adrenal cortex. In particular, research was focussed upon possible pregenitor cells involved in maintenance of the adrenal cortex. It was hypothesised that the the most likely precursor cells of the adult cortex were the 'Glil' expressing cells found in the adrenal capsule. A number of mice adrenal glands were taken, treated with antigen retrieval solution, after which fluorescence microscopy was conducted.&lt;br /&gt;
&lt;br /&gt;
The results of the paper concluded that 'Glil' expressing descendants of fetal adrenal cells are the pregenitors of the differentiated adrenal cortex. Furthermore, it was found that the 'Glil' expressing cells oringinated from 'FAdE-Cre' expressing fetal adrenal cells. Thus the authors of this research article came to the conclusion that 'Glil' expressing cells found in the adrenal cortex play an important role in the development, differentiation and maintenance of the adrenal cortex. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3817941&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
2: A number of embryonic layers and tissues contribute to the development of teeth. The primary contributing layers are mesoderm, ectoderm and neural crest ectomesenchyme. Furthermore, neural crest may contribute through interactions with the ectoderm. Odontoblasts originate from neural crest derived mesenchymal cells and are responsible for forming predentin which calificies to create dentin (which forms the bulk of the tooth). Ameloblasts are responsible for the production of enamel, which provides teeth with the hardness required to engage in mastication. &lt;br /&gt;
&lt;br /&gt;
==Peer Assessment==&lt;br /&gt;
&lt;br /&gt;
===Group 1 Peer Assessment===&lt;br /&gt;
Hi guys! I'll start of by saying that the images and video you have included are excellent and are relevant to your topic of discussion. Also, you have a large number of reliable references which is good to see. However you have yet to include a hand drawn image, which is required for the wiki page. I feel like  you could probably eliminate the typed out 'timeline of mitochondrial donation' and instead use this as an opportunity to use a hand drawn image of the timeline. Furthermore, the timeline under 'cystoplasmic transfer' feels a bit awkward and unnecessary. You could probably include this timeline alongside the 'timeline of mitochondrial donation'. &lt;br /&gt;
&lt;br /&gt;
Under the 'Technical Progression' section it would be best to incorporate human embryo, mouse and human models under a sub-sub heading, as at the moment it feels a bit jumbled.&lt;br /&gt;
&lt;br /&gt;
I would also recommend moving the 'Benefits' heading towards the end of the page. It feels odd reading about the benefits of three person embryos before I gain a proper understanding of how they work. Also it might be worth talking about the disadvantages (if there are any) to three person embryos to balance out the 'benefits' section. As has been previously stated, make sure you sort out the copyright information for your video as it would be a shame to lose marks if it was missing. Also, don't forget to add the 'student template' to the 'Swapping mitochondrial DNA mammalian oocytes' image as it is currently absent.&lt;br /&gt;
&lt;br /&gt;
===Group 2 Peer Assessment===&lt;br /&gt;
So far your wiki page gives a very good coverage of Ovarian Hyper-Stimulation Syndrome. The progression of your subheadings progresses logically from one topic to another. It's good to see that you've included an excellent hand-drawn image which is well suited to the 'pathophysiology' subheading. The amount of textual information you have under each heading is vast and gives a comprehensive description of OHSS. Furthermore, you have an excellent range of sources to support your discussion.&lt;br /&gt;
&lt;br /&gt;
I feel however that asides from your hand-drawn image, your use of images and other source of media is definitely lacking. As is, your page is largely text with little to no breaks, making it quite difficult to read. The use of images would not only help break up the monotony of the text, but also help reinforce some of your ideas. I feel that the inclusion of images in the 'symptoms' and 'complications' subheadings would be suitable. &lt;br /&gt;
&lt;br /&gt;
It may also be worthwhile to include subheadings concerning current research, to inform readers about contemporary developments regarding OHSS. Furthermore,  'future research' could also be another potential subheading and could illuminate potential areas that are beginning to be or could be investigated in coming years.&lt;br /&gt;
&lt;br /&gt;
Overall, a very impressive page so far, that could be enhanced with the addition of relevant images and other media.&lt;br /&gt;
&lt;br /&gt;
===Group 4 Peer Assessment===&lt;br /&gt;
Very impressive work so far guys! Your page covers a comprehensive topic very well, without focussing too much on certain subheadings at the expense of others. Your use of both tables and images is excellent so far. It's good to see that you have also included a video to give some variety to the media on your page. The 'background information' gives context to the issues which you discuss and though it might not be of great use for someone familiar with embryology, it would be a great help to those with no experience in this field and is therefore useful in establishing the topic of male infertility.&lt;br /&gt;
&lt;br /&gt;
The only things that could be changed to improve your wiki page is perhaps altering the location of tables and pictures on your page. For example all pictures are located on the right side of the page, although not a significant issue, becomes slightly monotonous as one progresses through the page. It may be worth alternating pictures between left and right to mix things up a little bit and improve the overall flow of the page. &lt;br /&gt;
It might also be worth including a short video underneath the 'surgical treatments' subheading to give a visual example of some of the techniques discussed.&lt;br /&gt;
&lt;br /&gt;
Furthermore a subheading on future research could possibly be included under the 'treatments' subheading to give the reader information on techniques and therapies which may come to prominence in the near future.&lt;br /&gt;
&lt;br /&gt;
Your wiki page thus far is very impressive! Excellent work so far. &lt;br /&gt;
===Group 5 Peer Assessment===&lt;br /&gt;
Awesome page so far guys! I commend you on your use of various videos to assist in conveying your ideas. Furthermore, the images you have chosen are highly relevant to the topic of discussion and assist the reader in gaining a greater understanding of oncofertility. All copyright information is present for the images you have used which is excellent to see.&lt;br /&gt;
It may be worth including a hand drawn image under the 'radiation' subheading, as we are required to include at least one such image. The current image under the radiation subheading could easily be replicated by hand and could fulfill this portion of the criteria.&lt;br /&gt;
&lt;br /&gt;
I am nitpicking here, but I would also recommend including some kind of media, most likely a picture, underneath the surgery subheading. It might even be worth doing the hand drawn image here if possible. A picture may also be good underneath the 'types of chemotherapy drugs' subheading, just to break up the wall of text and improve the reading experience for the reader.&lt;br /&gt;
It might also be worth restructuring the 'oncofertility limitations' subheading into the form of a table (if possible), as the bullet point format feels quite awkward and out of place compared to the rest of the page.&lt;br /&gt;
The inclusion of a glossary is also recommended, as this page will be accessible by the general public and a glossary will assist those without a background in embryology to understand and appreciate your content.&lt;br /&gt;
&lt;br /&gt;
Keep up the great work guys! Your page is absolutely amazing so far and the effort you have put in is definitely reflected in the high quality of your page.&lt;br /&gt;
===Group 6 Peer Assessment===&lt;br /&gt;
A very snazzy wiki page so far! You have used a wide variety of images to convey the concepts of prenatal genetic diagnosis to those reading your wiki page. Copyright information and student templates were present for all the images which you provided which is great to see. A hand drawn image is absent, which is a requirement for every wiki page. It might be worth including the hand drawn image in the 'history section' as the information here could easily be represented by a hand drawn flow chart.&lt;br /&gt;
&lt;br /&gt;
I commend you on your inclusion of a 'future/current research' subheading as this gives the reader a perspective of where the field of prenatal genetic diagnosis is heading in the distant future.&lt;br /&gt;
&lt;br /&gt;
I see that you have included a table underneath the 'biopsy methods' subheading. It would be great to see you compile the advantages and disadvantages of blastomere biopsy and trophectoderm biopsy into a tabular format as this would make for an easier reading experience. Furthermore, tables may also be incorporated for the disadvantages and advantages of genetic techniques.&lt;br /&gt;
I would recommend the inclusion of other forms of media such as a video or gif to assist in the conveyance of information under certain subheadings. A video/gif would fit nicely underneath the 'biopsy method' subheading, though this is just a suggestion.&lt;br /&gt;
&lt;br /&gt;
Overall your assignment is superb so far. You have successfully covered a vast topic and made successful use of a broad range of sources to support your page. Your inclusion of images has been appropriate, however a hand drawn image is still required. &lt;br /&gt;
Keep up the good work guys! &lt;br /&gt;
&lt;br /&gt;
==Lab 10 Assessment==&lt;br /&gt;
[https://embryology.med.unsw.edu.au/embryology/Slides/Embryo_Stages/Stage22/08-eye/Stage22-08-eye.html?zoom=6&amp;amp;lat=-4961.72287&amp;amp;lon=4821.89847&amp;amp;layers=B Retina of the Eye]&lt;br /&gt;
&lt;br /&gt;
The retina is the light sensitive portion of the eye. It contains 10 separate layers, including the photoreceptor layer which is comprised of rods and cones. These rods and cones convert light into signals, which are then communicated to the brain via the optic nerve. Optic cup morphogenesis is responsible for the development of the vertebrate eye, and it is believed that this process significantly contributes to the development of the retina.&lt;br /&gt;
The image above displays a Carnegie Stage 22 retina. The nerve fibre layer is particularly prominent in this image and is the pale layer closest to the vitreous chamber. The processes of rods, cones and ganglion cells can be observed migrating towards the optic nerve. &lt;br /&gt;
'''Embryology Link''' [[Vision - Retina Development]]&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_3&amp;diff=207119</id>
		<title>2015 Group Project 3</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_3&amp;diff=207119"/>
		<updated>2015-10-21T23:19:01Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015header}}&lt;br /&gt;
&lt;br /&gt;
=Female Infertility &amp;amp; Polycystic Ovarian Syndrome=&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Polycystic Ovary juxtaposed with a Standard Ovary.png|700px|thumb|centre|PCOS Ovary vs. Non-PCOS Ovary]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Introduction&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
[[File:Prevalence of Primary Infertility in 2010.jpeg|400px|thumb|right|Prevalence of Primary Infertility in 2010]]&lt;br /&gt;
&lt;br /&gt;
Female Infertility refers to the failure to conceive after one year of regular unprotected intercourse in females &amp;lt;ref name=one&amp;gt;&amp;lt;pubmed&amp;gt;26150870&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. In 2010, infertility affected 48.5 million couples world wide and the areas of highest prevalence included North Africa and Middle East, South Asia, Central/Eastern Europe and Central Asia and Sub-Saharan Africa &amp;lt;ref name=two&amp;gt;&amp;lt;pubmed&amp;gt;23271957&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. As there are several causes of female infertility, we will be focusing on infertility that is caused by '''Polycystic Ovarian Syndrome''' (PCOS), the most common cause of infertility that is medically treatable &amp;lt;ref name=one/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
{|&lt;br /&gt;
|-bgcolor=&amp;quot;DDCEF2&amp;quot; &lt;br /&gt;
|&lt;br /&gt;
* '''Polycystic Ovarian Syndrome (PCOS) is a common endocrine disorder, affecting up to 20% of reproductive aged women &amp;lt;ref name=hey&amp;gt;&amp;lt;pubmed&amp;gt;21896560&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. It is the most common cause of anovulatory infertility &amp;lt;ref name=one/&amp;gt; which refers to infertility caused by the the absence of ovulation.'''&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
=Causes=&lt;br /&gt;
&lt;br /&gt;
PCOS is a disorder of heterogeneous origin with unknown aetiology &amp;lt;ref name=hey/&amp;gt;. Studies have shown that both genetic and environmental factors contribute to the development of PCOS in women however there is limited research into the actual interactions between these two factors &amp;lt;ref name=un&amp;gt;&amp;lt;pubmed&amp;gt;17185788&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Genetic Factors&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
Despite the lack of information regarding its aetiology, there is increasing evidence for a genetic involvement in the endocrine disorder. Studies have shown that genes play an important role in contributing towards the clinical and biochemical features of the disease. This evidence includes the family clustering of cases, greater unanimity between monozygotic twins than heterozygotic twins and the ability to inherit endocrine and  metabolic features of PCOS &amp;lt;ref name=hey/&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
In one study, 115 sisters of women with PCOS were examined and results showed that half of these sisters had high testosterone levels, suggesting that hyperandrogenemia is a common trait with a dominant pattern of inheritance. These results strongly supported the idea of the familial clustering of biochemical features such as hyperandrogenism in first degree relatives &amp;lt;ref name=deux&amp;gt;&amp;lt;pubmed&amp;gt;9843997&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Several genes have been considered to play an important role in the development of PCOS such as CYP11A, the insulin gene, the follistatin gene and a region near the insulin receptor gene. Yet, the evidence supporting most of these genes has been refuted by larger studies, except for the region near the insulin receptor gene &amp;lt;ref name=deux/&amp;gt;. Among these, the gene CYP11a is the one that is strongly associated with hyperandrogenism in women with PCOS. &amp;lt;ref name=cinq&amp;gt;&amp;lt;pubmed&amp;gt;9147642&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; While it doesn't isolate this gene as the sole cause of PCOS, variation of the genotype at this locus contributes to production of excess androgen &amp;lt;ref name=h4&amp;gt;&amp;lt;pubmed&amp;gt;7962289&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Studies have also shown that there is strong evidence for linkage between the alleles at the Variable Number Tandem Repeats (VNTR) which is situated 5' to the insulin gene and PCOS. The data from the study suggests that it is a very susceptible region in PCOS and also may play a role in the development of hyperinsulinaemia &amp;lt;ref name=trois&amp;gt;&amp;lt;pubmed&amp;gt;9455828&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Environmental Factors&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
The prevalence of PCOS in populations where there has been a constant gene pool indicates that environmental factors play a significant role in the aetiology of PCOS &amp;lt;ref name=un/&amp;gt; &lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Obesity and Diet&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
Obesity is the major environmental factor driving the development of PCOS in susceptible individuals. The rising rates of PCOS have been paralleled by the widespread emergence of obesity and type 2 diabetes which are prevalent in developed countries. The risk of developing PCOS from obesity is compounded by  poor dietary choices and lack of physical activity which has begun to characterise the lifestyle in developed countries &amp;lt;ref name=deux/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Medication&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
Studies have shown that valproic acid in medication used to treat epilepsy and bipolar disorders contributes to the development of PCOS. Women with these disorders  may develop the typical features of PCOS such as polycystic ovaries, anovulation, hyperandrogenism and obesity &amp;lt;ref name=quartre&amp;gt;&amp;lt;pubmed&amp;gt;8413434&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Recent studies also suggest that the weight gain from medication is significant as it can lead to the development of PCOS &amp;lt;ref name=deux/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
=Pathogenesis=&lt;br /&gt;
&lt;br /&gt;
The pathogenesis of polycystic ovarian syndrome is poorly understood, however it is believed that insulin resistance and excess androgens such as testosterone play a fundamental role.&lt;br /&gt;
Underlying factors such as obesity and genetic predispositions likely contribute to the onset of polycystic ovarian syndrome through the development of a combination of hyperinsulinemia and hyperandrogenemia.&amp;lt;ref name=eleven&amp;gt;&amp;lt;pubmed&amp;gt;PMC4556908&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Hyperinsulinemia&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
Hyperinsulinemia is a term that defines the presence of excessive amounts of insulin in the blood relative to the amount of glucose. &amp;lt;ref name=fourteen&amp;gt;&amp;lt;pubmed&amp;gt;PMC4114053&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This phenomenon is typically associated with obesity and excess adipose tissue, both of which are associated with insulin resistance. In order to overcome this resistance, insulin secretion is increased in an attempt to normalise blood glucose levels, thereby leading to hyperinsulineamia. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2782313&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Excessive levels of insulin typically cause disruption to the hypothalamus-hypophysis-ovary axis whilst insulin resistance in ovarian tissues leads to decreased metabolic signalling. However, steroidogenic activity is largely unaffected by the impaired metabolic signalling, thereby paving the way androgens to become more effect and paving the way towards hyperandrogenemia. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC4334071&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
[[File:Patholophysiology of Polycystic Ovarian Syndrome.jpg|500px|thumb|left|The impact of hyperinsulinemia and hyperandrogenemia on the development of polycystic ovarian syndrome]]&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Hyperandrogenemia&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
Hyperandrogenemia is a hallmark of the development of polycystic ovarian syndrome, with 80% of women presenting with excess androgen also having polycystic ovaries.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3872139&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The disruption of the hypothalamus hypophysis ovary axis as a result of hyperinsulinemia increases the release of GnRH and LH, leading to increased androgen production in the ovarian theca cells. Hyperandrogenemia decreases the feedback sensitivity of both estradiol and progesterone within gonadotropic hypothalmic cells. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC4334071&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A deficiency of FSH is observed and correlates with the increased secretion of Gonadotrophin-releasing hormone (GnRH) and Luteinizing hormone (LH). As a result of this deficiency, graunlosa  cell aromatisation to oestrogens as well as follicle maturation and ovulation will be drastically impaired.  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3453528&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
As a consequence of the impairment of follicle maturation, small antral follicles will accumulate within the periphery of the ovary and develop a cystic morphology. Ovulation will be unable to occur due to the absence of mature follicles, culminating in infertility.  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC4562327&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Hyperandrogenism&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
====Animal Models====&lt;br /&gt;
&lt;br /&gt;
Studies conducted on female rhesus monkeys have supported evidence for the foetal origins of the clinical features of PCOS &amp;lt;ref name=h1&amp;gt;&amp;lt;pubmed&amp;gt;18406243&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.  It has been shown that in human females, an excess of androgen exposure at any stage from the development of the ovaries to the onset of puberty manifests as characteristic features of PCOS, such as resistance to insulin and LH hypersecretion. After exposure to levels of testosterone matching those of fetal males, in utero, female rhesus monkeys were found to display the clinical and biochemical features typical of PCOS such as hypersecretion of LH and abnormal insulin action. These results correlated to those of similar studies conducted on sheep, where the pregnant ewe was exposed to excessive levels of testosterone and LH secretion and abnormality in ovarian cycles were again prominent features &amp;lt;ref name=sheep&amp;gt;Padmanabhan V, Evans NP, Taylor JA, Robinson JE1997 '''Prenatal exposure to  androgens  leads  to  the  development  of  cystic  ovaries  in  the  sheep'''. Biol Reprod 56:194&amp;lt;/ref&amp;gt;. While these studies indicate that similar biochemical and clinical manifestations in humans originate from excess androgen exposure of the female fetus, it must be noted that it is very unlikely for any excess androgen production to be passed across the placenta from the mother to her daughter. This is because mechanisms such as androgen binding proteins and placental metabolism of androgen prevent excess androgen entering the circulation of the fetus &amp;lt;ref name=h2&amp;gt;&amp;lt;pubmed&amp;gt;12098657&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
====Cell Culture Models====&lt;br /&gt;
&lt;br /&gt;
While studies have shown that the adrenal could be a source of excess androgen such as the adrenal &amp;lt;ref name=h3&amp;gt;&amp;lt;pubmed&amp;gt;7962325&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;, they were followed by various studies using cell culture models which demonstrated that the ovary was the major source of excess androgen &amp;lt;ref name=h4/&amp;gt; &amp;lt;ref name=h5&amp;gt;&amp;lt;pubmed&amp;gt;9302378&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. ''In vitro'' studies have shown that the production of steroids is abnormal in theca cells &amp;lt;ref name=h3/&amp;gt;. In women affected by PCOS, stimulation by human chorionic gonadotrophin (hCG) is followed by an increase in thecal steroid production after suppression of LH by a GnRH analogue &amp;lt;ref name=h5/&amp;gt;. Theca cells cultured from polycystic ovaries produce 20 times as much androstenedione as those from normal ovaries &amp;lt;ref name=h4/&amp;gt; with increased expression of mRNA for enzymes responsible for making steroids also reported in following studies. &amp;lt;ref name=h6&amp;gt;&amp;lt;pubmed&amp;gt;10852468&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; These results have prompted many studies on genes encoding these steroidogeneic enzymes.&lt;br /&gt;
&lt;br /&gt;
[[File:Polycystic_rat_ovary.jpg|500px|thumb|right|An example of polycysts present in the polycystic ovaries of a rat specimen]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
=Signs and Symptoms=&lt;br /&gt;
&lt;br /&gt;
The symptoms of PCOS are different for each women. The three cardinal signs of PCOS are hyperandrogenism, polycystic ovaries and ovarian dysfunction &amp;lt;ref name=sign1&amp;gt;&amp;lt;pubmed&amp;gt;14688154&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Common clinical symptoms include &amp;lt;ref&amp;gt; Women's Heath, U.S. Department of Health and Human Services ,[ http://www.womenshealth.gov/publications/our-publications/fact-sheet/polycystic-ovary-syndrome.html#d ], 'Polycystic ovary syndrome (PCOS) fact sheet'&amp;lt;/ref&amp;gt; ;&lt;br /&gt;
&lt;br /&gt;
{|&lt;br /&gt;
|-bgcolor=&amp;quot;DDCEF2&amp;quot; &lt;br /&gt;
|&lt;br /&gt;
* Infertility- due to anovulation. &lt;br /&gt;
* Irregular Menstrual Cycles&lt;br /&gt;
* Hirsutism&lt;br /&gt;
* Ovarian Cysts&lt;br /&gt;
* Obesity&lt;br /&gt;
* Male Pattern Baldness&lt;br /&gt;
* Skin Tags&lt;br /&gt;
* Pelvic Pain&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
Along with obesity, PCOS is also associated with other metabolic issues such as insulin resistance, hyperinsulinemia and type 2 diabetes mellitus. It has also been associated with cardiovascular problems and cancers of the breast and endometrium &amp;lt;ref name=sign3&amp;gt;&amp;lt;pubmed&amp;gt;PMC4341818&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
=Diagnosis=&lt;br /&gt;
&lt;br /&gt;
A major diagnostic tool for PCOS is a pelvic ultrasound, but PCOS diagnosis cannot be completely dependent on just pelvic ultrasounds. A patient with PCOS may not necessarily have polycystic ovaries, and those with ovarian cysts may not necessarily have PCOS. A range of diagnostic assessments and associated symptoms have to be thoroughly investigated.&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Medical history and examination&amp;lt;/u&amp;gt;===&lt;br /&gt;
Clinical questions are asked or filled out in the form of a questionnaire to assess and assist in the diagnosis of PCOS. Studies show that those with a history:&lt;br /&gt;
*infrequent and irregular menstruation&lt;br /&gt;
*hirsutism (related to high levels of androgens in the blood – hyperandrogenism)&lt;br /&gt;
*obesity&lt;br /&gt;
*acne production &lt;br /&gt;
are at a higher predictive risk of PCOS. But questions regarding failed pregnancy attempts and history of nipple discharge proved no correlation in diagnosing PCOS. &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 17872783 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Ultrasound of Polycystic Ovaries .jpg|400px|thumb|right|Ultrasound of Polycystic Ovaries]]&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Blood Test&amp;lt;/u&amp;gt;===&lt;br /&gt;
A patient with elevated levels of androgens, a medical condition called &amp;lt;b&amp;gt;hyperandrogenism &amp;lt;/b&amp;gt;, is very highly likely to have PCOS. &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 20591140 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt; Androgens &amp;lt;/b&amp;gt; , such as testosterone, and &amp;lt;b&amp;gt;free androgen index (FAI) &amp;lt;/b&amp;gt; are the two tests best used in diagnosing hyperandrogenism.&lt;br /&gt;
Androgen excess in PCOS is a result from increased synthesis and release of ovarian androgens. &amp;lt;b&amp;gt;Dehydroepiandrosterone sulfate &amp;lt;/b&amp;gt; (DHEA-S) levels are used as a biomarker for testing androgen levels, as it is made exclusively by the adrenal glands. DHEA-S levels of above 1890 micromol/L is extremely suggestive of hyperandrogenism. &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 18844715 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Free androgen index (FAI) &amp;lt;/b&amp;gt; is the ratio of total testosterone measurement to levels of &amp;lt;b&amp;gt; sex hormone-binding globulin &amp;lt;/b&amp;gt; (SHBG). Those with PCOS will have high FAI, as this indicates a high ration of free testosterone in the body.&lt;br /&gt;
Other blood tests are also done to help exclude other predisposing factors such as levels of &amp;lt;b&amp;gt; Thyroid Stimulating Hormone &amp;lt;/b&amp;gt; (LSH) and &amp;lt;b&amp;gt; Follicle-stimulating hormone &amp;lt;/b&amp;gt; (FSH). An elevated ratio of LSH to FSH, of above 2:1 &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 14737959 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;, indicates a possibility, but not definitively, of PCOS.&lt;br /&gt;
The effect of &amp;lt;b&amp;gt; insulin &amp;lt;/b&amp;gt; on blood can also be tested for insulin resistance. Insulin resistance enhances androgen production and increases free androgen levels by reducing SHBG. This can used as an indication marker for the possibility of PCOS&lt;br /&gt;
A study in 2014 showed that &amp;lt;b&amp;gt; Anti-Müllerian hormone &amp;lt;/b&amp;gt; (AMH) is found to be elevated in patients with PCOS &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 24821925 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;, giving rise to its potential clinical implication in diagnosing PCOS. AMH is exclusively produced in ovarian follicles, with individual AMH concentration reflecting the quantity of remaining primordial follicles and measure of ovarian reserve. &lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Gynecologic ultrasonography&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
Gynecologic ultrasonography is a pelvic ultrasound, specifically to the female pelvic region, with regards to the uterus, ovaries and the fallopian tube. The examination can be performed by transabdominal ultrasonography, with a full bladder, or transvaginal ultrasonography with a vaginal transducer. Typically transvaginal imaging shows a better and clearer image than transabdominal ultrasonography, as it uses higher frequency imaging, but is limited to areas it can reach. In the case of PCOS, both techniques can provide an image of the ovaries. Studies suggest that if more than 25 follicles are seen in an ovary, predominantly in the periphery, in women between 18-35 years, it is described to have a polycystic ovarian morphology. &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 24345633 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Magnetic Resonance Imaging&amp;lt;/u&amp;gt;===&lt;br /&gt;
Ovaries can also be seen on MRIs. On MRIs, PCOS is characterized by numberous peripheral cysts where the ovaries affected to be slightly larger than normal. Although MRI is seen to be effective in ovarian imaging, the finding of peripheral ovarian cysts in MRIsmay not be PCOS specific. &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 8888256 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt; But studies have seen that MR imaging in adolescence uncover distinct differences between young patients with and without PCOS &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 23292744 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;, with also great diagnostic sensitivity with patients between the age of 21-30 &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 19241321 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;, providing assistance of imagery in patients whom may be opposed to transvaginal ultrasounds.&lt;br /&gt;
&lt;br /&gt;
=Prevention and Treatment=&lt;br /&gt;
&lt;br /&gt;
There currently is no cure for PCOS, nor can it be prevented. This can be largely attributed to genetics, and because it can progress without being noticed for an extended period (generally until puberty begins). Treatment maybe involve lifestyle changes or hormonal augmentation in regulating periods, hirsutism, and acne, in addition to regulating androgen levels.&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Current Treatments&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|border=&amp;quot;1&amp;quot;&lt;br /&gt;
|-bgcolor=&amp;quot;DDCEF2&amp;quot;&lt;br /&gt;
| '''CURRENT TREATMENT'''&lt;br /&gt;
| '''DISADVANTAGES'''&lt;br /&gt;
|-&lt;br /&gt;
| General Practitioners tend to prescribe oral anti-oestrogens, most commonly the contraceptive pill, to restore ovulation.&lt;br /&gt;
| This method only has a 50% success rate in PCOS patients. It does not directly increase fertility rates, but restores the menstrual cycle. &amp;lt;ref    name= pink&amp;gt;&amp;lt;pubmed&amp;gt;26194691&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;       &lt;br /&gt;
 &lt;br /&gt;
|-bgcolor=&amp;quot;FAF5FF&amp;quot;&lt;br /&gt;
| Lifestyle changes are highly encouraged by medical practitioners. Diet and exercise regimes can be designed with a dietitian or nutritionist. &amp;lt;ref name= purple&amp;gt;&amp;lt;pubmed&amp;gt;26289303&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Exercise and diet plans do not directly increase fertility. They are designed to enhance weight loss, which in some patients can encourage normal hormone levels from the pituitary and thyroid. &amp;lt;ref name=purple/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Clomiphene citrate administration (generally in pill form, as prescribed by a GP). Such pills stimulate the pituitary gland to release GnRH to simulate ovulation (with a 72% success rate). &amp;lt;ref name= green&amp;gt;&amp;lt;pubmed&amp;gt;26150870&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Clomiphene can cause multiple side effects, most notably abnormal uterine bleeding and pelvic pain to due enlargement of the ovaries. &lt;br /&gt;
&lt;br /&gt;
Thus, it cannot be as frequently prescribed as the contraceptive pill, and careful patient monitoring is imperative &amp;lt;ref name=green/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
|-bgcolor=&amp;quot;FAF5FF&amp;quot;&lt;br /&gt;
| Higher fertility rates are observed in treatments combining clomiphene citrate and metformin (79% success) &amp;lt;ref name=green/&amp;gt;.&lt;br /&gt;
| Similar disadvantages as clomiphene, above.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Laparoscopic Ovarian Drilling===&lt;br /&gt;
Laparoscopic ovarian drilling (LOD) is a surgical method of treating polycystic ovaries and is typically used when an infertile woman does not respond to administration of clomiphene citrate. &amp;lt;ref name=blue&amp;gt;&amp;lt;pubmed&amp;gt;PMC4367066&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The most common form of LOD involves electrocautery through the use of an insulinated uniupolar needle electrode. The exact method of action of LOD is poorly understood. The most accepted hypothesis however is that the breakdown of ovarian follicles and stroma via heat, laser or mechanical drilling brings about a decrease in androgen and inhibin levels, followed by a rise in the levels of FSH. Inflammatory growth factors produced in response to the thermal injury caused by laser drilling can enhance the action that FSH has on folliculogenesis. Improved blood flow often results from LOD which serves to drastically improves the delivery of gonadotrophins to the ovary.&amp;lt;ref name=blue&amp;gt;&amp;lt;pubmed&amp;gt;PMC4367066&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
LOD can be an appealing alternative to treatment with gonadotrophins, as the latter is typically time consuming, expensive and requires constant monitoring in order to be effective.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22696324&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The overall effectiveness of LOD as a standalone treatment for PCOS is still questionable. Several studies have shown that there is no evidence of significant differences in pregnancy and live births in women undergoing LOD and those undergoing other medical treatments. &amp;lt;ref name=blue&amp;gt;&amp;lt;pubmed&amp;gt;PMC4367066&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=JH-Yx1QWUBk&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Ovarian Drilling by Laparoscopy for PCOS &amp;lt;ref&amp;gt;Mishra, R., (2014, September 8) Ovarian Drilling by Laparoscopy for PCOS. Retrieved from https://www.youtube.com/watch?v=JH-Yx1QWUBk&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;New Trials&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Some studies have found that regular Selenium supplements can encourage fertility among PCOS patients. The program, which is still in its early trial period, requires women to consume selenium tablets for 8 weeks. This study has found a significant decrease in dehydroepiandrosterone (DHEA) levels in patients, thus reducing excessive hair growth associated with PCOS. A direct link to increased fertility is yet to be established, and thus further testing is required.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26267328&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
=Current and Future Research=&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
=Glossary=&lt;br /&gt;
&lt;br /&gt;
'''FSH''' - Follicle Stimulating Hormone&lt;br /&gt;
&lt;br /&gt;
'''Hirsutism''' - An abnormal growth of hair on a woman's face or body&lt;br /&gt;
&lt;br /&gt;
'''hCG''' -  human Chorionic Gonadotrophin&lt;br /&gt;
&lt;br /&gt;
'''GnRH''' - Gonadotrophin-releasing hormone&lt;br /&gt;
&lt;br /&gt;
'''LH''' - Luteinizing Hormone&lt;br /&gt;
&lt;br /&gt;
'''LOD''' - Laparoscopic Ovarian Drilling&lt;br /&gt;
&lt;br /&gt;
'''PCOS''' - Polycystic Ovarian Syndrome&lt;br /&gt;
=References=&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{ANAT2341Project2015header}}&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=ANAT2341_Lab_10_-_Online_Assessment_2015&amp;diff=207117</id>
		<title>ANAT2341 Lab 10 - Online Assessment 2015</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=ANAT2341_Lab_10_-_Online_Assessment_2015&amp;diff=207117"/>
		<updated>2015-10-21T23:16:33Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Header}}&lt;br /&gt;
&lt;br /&gt;
==Individual Assessment==&lt;br /&gt;
* Place your work on this page under a sub-sub-heading of your ROI.&lt;br /&gt;
* Add your own sub-sub-heading '''below''' any existing student ROI.&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wikitable mw-collapsible mw-collapsed&amp;quot;&lt;br /&gt;
! About this Assessment&lt;br /&gt;
|-&lt;br /&gt;
| A demonstration of this assessment will be given in the practical class. Below in the collapsible table are examples of links from a virtual slide. There is also a [[Help:Virtual Slides Permalink|permalink help page]].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{Virtual Slide Features - Stage 22 Liver}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Using the Human Embryo Carnegie Stage 22 [[Embryo Virtual Slides|virtual slides]] shown below:&lt;br /&gt;
&lt;br /&gt;
# Using the &amp;quot;mobile view&amp;quot; Identify a sensory region of interest ('''ROI''') in one of the virtual slides below.&lt;br /&gt;
# View at a high magnification (detailed view) the region of interest.&lt;br /&gt;
#  Generate a [[Help:Virtual Slides Permalink|permalink]] to the ROI.&lt;br /&gt;
# Paste the link on your own page and write a brief description of what the linked region is showing.&lt;br /&gt;
# Add a link to the embryology page and sub-heading that relates to your identified feature.&lt;br /&gt;
# Paste all the content (text and links) you have just generated on [[ANAT2341 Lab 10 - Online Assessment 2015|'''this page''']] under a sub-heading named after your ROI.&lt;br /&gt;
&lt;br /&gt;
{|&lt;br /&gt;
| valign=bottom|{{SlideStage22-08}}&lt;br /&gt;
| valign=bottom|{{SlideStage22-08-eye}}&lt;br /&gt;
|-&lt;br /&gt;
| valign=bottom|{{SlideStage22-11}}&lt;br /&gt;
| valign=bottom|{{SlideStage22-15}}&lt;br /&gt;
|}&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Student ROIs==&lt;br /&gt;
&lt;br /&gt;
===This is a sub-sub-heading===&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Cochlear Duct===&lt;br /&gt;
&lt;br /&gt;
link to permalink image:[https://embryology.med.unsw.edu.au/embryology/Slides/Embryo_Stages/Stage22/11/Stage22-11.html?zoom=6&amp;amp;lat=-3948&amp;amp;lon=6149&amp;amp;layers=B | Cochlear Duct ]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
The '''cochlear duct''' is an fluid filled cavity inside the cochlea. It located between the tympanic duct and the vestibular duct, and between the basilr membrane and reissner's memebrane. It derived from otic placode, otic vesicle, and originated from surface ectoderm.&lt;br /&gt;
&lt;br /&gt;
'''embryology link''' [[Sensory - Hearing and Balance Development]]   --Inner Ear&lt;br /&gt;
&lt;br /&gt;
===Semicircular Canal===&lt;br /&gt;
&lt;br /&gt;
link to permalink image:[https://embryology.med.unsw.edu.au/embryology/Slides/Embryo_Stages/Stage22/11/Stage22-11.html?zoom=6&amp;amp;lat=-5565.50267&amp;amp;lon=7382.99733&amp;amp;layers=B | Semicircular Canal ]&lt;br /&gt;
&lt;br /&gt;
The '''semicircular canals''' are part of the inner ear.They are lined with cilia  and filled with endolymph which is a liquid substance. Every time the head moves, the endolymph moves the cilia and this movements of the cilia are communicated to the brain. As a result, the brain knows how to keep the body balanced, regardless of the posture.&lt;br /&gt;
&lt;br /&gt;
'''embryology link''' [[Hearing - Inner Ear Development]] -- Inner Ear &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Lens of the Eye===&lt;br /&gt;
&lt;br /&gt;
Link to permalink image: [https://embryology.med.unsw.edu.au/embryology/Slides/Embryo_Stages/Stage22/08-eye/Stage22-08-eye.html?zoom=6&amp;amp;lat=-2022&amp;amp;lon=2991&amp;amp;layers=B Anterior portion of the Lens of the embryonic eye] &lt;br /&gt;
&lt;br /&gt;
The lens of the eye is derived from surface ectoderm. Said ectoderm forms a lens/optic placode in the head region which then invaginates to form a lens pit and then later a lens vessel. Lens fibres then develop and are surrounded by a lens capsule. The main function of the lens is to focus light onto the retina. &lt;br /&gt;
&lt;br /&gt;
'''Embryology link''' [[Vision - Lens Development]]  --Development Overview &lt;br /&gt;
&lt;br /&gt;
===Retina of the Eye===&lt;br /&gt;
Link to permalink image: [https://embryology.med.unsw.edu.au/embryology/Slides/Embryo_Stages/Stage22/08-eye/Stage22-08-eye.html?zoom=6&amp;amp;lat=-4961.72287&amp;amp;lon=4821.89847&amp;amp;layers=B Retina of the Eye]&lt;br /&gt;
&lt;br /&gt;
The retina is the light sensitive portion of the eye. It contains 10 separate layers, including the photoreceptor layer which is comprised of rods and cones. These rods and cones convert light into signals, which are then communicated to the brain via the optic nerve. Optic cup morphogenesis is responsible for the development of the vertebrate eye, and it is believed that this process significantly contributes to the development of the retina.&lt;br /&gt;
The image above displays a Carnegie Stage 22 retina. The nerve fibre layer is particularly prominent in this image and is the pale layer closest to the vitreous chamber. The processes of rods, cones and ganglion cells can be observed migrating towards the optic nerve.&lt;br /&gt;
&lt;br /&gt;
'''Embryology Link''' [[Vision - Retina Development]]&lt;br /&gt;
&lt;br /&gt;
===Retinal Pigment Epithelium===&lt;br /&gt;
&lt;br /&gt;
Link to permalink image: [https://embryology.med.unsw.edu.au/embryology/Slides/Embryo_Stages/Stage22/08-eye/Stage22-08-eye.html?zoom=6&amp;amp;lat=-5391.23146&amp;amp;lon=3580.5&amp;amp;layers=B Retinal Pigment Epithelium]&lt;br /&gt;
&lt;br /&gt;
The '''Retinal Pigment Epithelium (RPE)''' is a complex differentiation of the retina, is generated from the optic neuroepithelium, and is structurally made up of cuboidal cells and multiple villi on its apical side. Its lateral sides are joined together by gap junctions and adherens and the RPE's basal side is in contact with Bruch's membrane. It lies between the neuronal retina and the choroid. The section shows that in the embryo the pigmented retina is still separated by a space from the neuronal retina. This space will be decreased in the adult and closely appose the two to each other.   &lt;br /&gt;
&lt;br /&gt;
'''Embryology Link''' [[Vision - Retina Development#Retinal Pigment Epithelium]]&lt;br /&gt;
&lt;br /&gt;
===Cornea===&lt;br /&gt;
&lt;br /&gt;
Permalink: [https://embryology.med.unsw.edu.au/embryology/Slides/Embryo_Stages/Stage22/08-eye/Stage22-08-eye.html?zoom=5&amp;amp;lat=-1186.66894&amp;amp;lon=2284.66894&amp;amp;layers=B Cornea]&lt;br /&gt;
&lt;br /&gt;
The cornea is the front layer of the eye covering the iris, pupil and anterior chamber. The cornea is a transparent layer that accounts for 2/3 of the eyes total optic power by refracting light along with the anterior chamber and lens. The cornea in humans consist of 5 layers as shown in the permalink, the Corneal epithelium, followed by Bowman’s layer, Corneal stroma, Descemet’s membrane and corneal endothelium. The corneal stroma and endothelium are derived from cranial neural crest cells and the corneal epithelium differentiates from ectoderm interacting with the developing lens. &lt;br /&gt;
&lt;br /&gt;
Embryology link: [https://embryology.med.unsw.edu.au/embryology/index.php/Vision_-_Cornea_Development Vision – Cornea Development]&lt;br /&gt;
&lt;br /&gt;
===Middle Ear Ossicles===&lt;br /&gt;
&lt;br /&gt;
Link to permalink image: [https://embryology.med.unsw.edu.au/embryology/Slides/Embryo_Stages/Stage22/11/Stage22-11.html?zoom=6&amp;amp;lat=-4243.78168&amp;amp;lon=7877.35627&amp;amp;layers=B Middle Ear Ossicles]&lt;br /&gt;
&lt;br /&gt;
The middle ear ossicles named the malleus, incus, and stapes, are involved in transmitting vibrations from the tympanic membrane to the oval window, and ultimately to the inner ear. The are attached to muscles, tensor tympani and stapedius, to assist in reducing sound vibration and oscillations at the oval window. Embryologically, the malleus and incus are derived from the cartilage of the 1st pharyngeal arch, and the stapes is derived from the cartilage of the 2nd pharyngeal arch. In ossicle development, the malleus and incus initially form as a single structure from Meckel's cartilage, that are later separated by joint that forms between them. This process occurs within solid mesenchyme of the pharyngeal arches, therefore the ossicles are not functioning. It is only after birth that elongation of the auditory tube occurs to form the middle ear cavity that the middle ear ossicles are situated in. &lt;br /&gt;
&lt;br /&gt;
'''Embryology Link''' [[Hearing - Middle Ear Development]]&lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
{{ANAT2341Lab10}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{2015ANAT2341}}&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=207115</id>
		<title>User:Z3416054</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=207115"/>
		<updated>2015-10-21T23:15:54Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Hi there&lt;br /&gt;
Just giving the editor a good old test run.&lt;br /&gt;
[[Test student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:45, 7 August 2015 (AEST)&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:47, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 14:06, 14 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:57, 21 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 12:22, 28 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:20, 4 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:18, 11 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:10, 25 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:28, 16 October 2015 (AEDT)&lt;br /&gt;
==Picture Tutorial==&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
===Article 1===&lt;br /&gt;
This research article aimed to determine the clinical outcomes following IVF (in vitro fertilisation) and embryo transfer treatments in subjects suffering from the sexually transmitted disease syphilis. The clinical outcomes mentioned are the rates of pregnancy and health of newborns following treatment via IVF. Couples engaged in sexual intercourse over 12 months without the use of contraception and who failed to conceive were deemed as being infertile.&lt;br /&gt;
&lt;br /&gt;
The subjects were divided into two groups based on serology results, a syphilis infected group and a control group, each with 160 individuals, giving a total of 320 subjects. The Syphilis infected group was further divided into three subcategories, a male infected group, a female infected group and a couple (male and female) infected group. Penicillin G20 (an anti-syphilis treatment) was given to the individuals in the syphilis group. IVF treatment commenced one month proceeding the disappearance of clinical syphilis symptoms or if test results gave a negative result for syphilis infection.&lt;br /&gt;
&lt;br /&gt;
The results of this experiment revealed no significant differences in regards to the basal FSH and LH of both the control and syphilis groups. However, the thickness of the endometrium differed greatly, with the syphilis group demonstrating a thicker endometrial wall (16.9±5.4mm) compared to the control group (13.0±4.7mm). Further differences were noted in blastocyst implantation rates, with the syphilis group having less successful implantations compared to the control (24.2% vs. 34.4% respectively).Normal oocyte cleavage differed between the two groups with the syphilis group demonstrating less normal oocyte cleavage compared to the control group  (6.3±4.7 vs. 8.1±4.6). Furthermore, the clinical pregnancy rates of the syphilis group stood at 43.8% compared to 55.6% of the control group.&lt;br /&gt;
&lt;br /&gt;
Syphilis infection appeared to have a significant impact on the success and clinical outcomes of IVF. Syphilis associated pelvic inflammatory disease can lead to an increase in the thickness of the endometrium, which can adversely affect blastocyte implantation and endometrial receptivity. Successful pregnancy rates typically correlate with an endometrial thickness of 7-14mm, with any thickness beyond 14mm often corresponding with decreased clinical pregnancies. Rates of clinical pregnancy and miscarriage rates did not differ between the three syphilis subgroups. Conception involving a male infected partner was associated with a shorter gestational period and decreased offspring birth weight, when compared to the female infected and couple infected subgroups. No explanation for this phenomenon was provided.&lt;br /&gt;
&lt;br /&gt;
PMID 26208116&lt;br /&gt;
&lt;br /&gt;
''Article 1 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4514756&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
===Article 2===&lt;br /&gt;
The effects of oxygen levels on factors such as cleavage, implantation and pregnancy rates in IVF cultured embryos was the primary focus of this article.  Women between the ages of 20-48 who were seeking treatment for infertility were utilised in this experiment.&lt;br /&gt;
Gametes were allocated to be incubated in one of three environments, each with a different oxygen concentration. The first group was placed in an atmosphere with an oxygen concentration of 20%. The second group rested in a 20% oxygen environment for a day before being moved to a 5% oxygen, 5% carbon dioxide and 90% nitrogen atmosphere. The third group consisted of a 5% carbon dioxide, 5% oxygen and 90% nitrogen atmosphere. The gametes (spermatozoa and oocytes) were incubated together in their respective environmental conditions for 4-6 hours after which fertilisation is presumed to have occurred.&lt;br /&gt;
&lt;br /&gt;
Successful embryos were transferred at Day 3 cleavage. A biochemical analysis of HCG validated pregnancy, whilst ultrasound was used to confirm the presence of a heartbeat 28 days following the transfer.&lt;br /&gt;
IVF fertilisation rates were calculated as being the number of fertilised oocytes over the number of oocytes inseminated. Cleavage rates were characterised by the number of blastomeres over the number of fertilised and abortion rate by the amount of miscarriages divided by the number of transfers.&lt;br /&gt;
&lt;br /&gt;
The research article concluded that the embryos from the 5% oxygen group had the highest rates of fertilisation and implantation. The 20% oxygen group had the second highest rates of fertilisation and maintained excellent embryo quality, whilst the 20% to 5% group had the lowest rates overall. Abortion and miscarriage rates did not differ at all between the three groups. The group incubated at 5% oxygen demonstrated higher quality embryos and increased rates of pregnancy when compared to the 20% oxygen group. The article concludes that implantation, pregnancy and embryo quality can be somewhat affected by a set oxygen concentration, but are affected adversely by a shift from one concentration to another. &lt;br /&gt;
Shifting from one oxygen concentration to another appeared to have an adverse effect on the cleavage of the embryo and would likely impact future development and the overall success of the IVF treatment.&lt;br /&gt;
&lt;br /&gt;
PMID 26131222 &lt;br /&gt;
&lt;br /&gt;
''Article 2 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4483955&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These are quite good descriptions of these 2 articles. (5/5)&lt;br /&gt;
==Lab 2 Assessment==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Notch Signalling - Ovulation in Drosphila.jpg|Caption]]&lt;br /&gt;
&lt;br /&gt;
===Image Reference===&lt;br /&gt;
Jianjun Sun, Allan C Spradling Ovulation in Drosophila is controlled by secretory cells of the female reproductive tract. Elife: 2013, 2;e00415 PubMed 23599892&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 23599892&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) Image uploaded and named correctly. All reference, copyright and student image template included. You might have included in the summary box an explanation to the terms that appear in the image as there is no way for the reader to interpret what is shown in each panel. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 3 Assessment==&lt;br /&gt;
===Causes===&lt;br /&gt;
====The Genetics of Infertility: Current Status of the Field====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3885174&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This article attempted to determine the role that genetics plays in female infertility. It was noted that several prominent causes of female infertility such as Galactosemia and Primary Ovarian Failure (POF) were associated with specific genes, with the GALT gene contributing to the former condition and the FMR1 gene contributing to the latter.&lt;br /&gt;
&lt;br /&gt;
====Causes of Sterility in Bosnia-Herzegovina Population====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4499307&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
The study conducted as laid out in this article examined the causes of female sterility in the Bosnia-Herzegovina population. Married participants were arranged into various groups based upon their age. The experiment came to the conclusion that in approximately 42% of infertile married couples, female sterility was the primary cause. The two primary causes of female infertility were tubal deficiencies (31% of cases) and Diminished Ovarian Reserves (38% of cases)&lt;br /&gt;
&lt;br /&gt;
====Epidemiology, diagnosis, and management of polycystic ovary syndrome====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3872139&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This research article examines the causes of polycystic ovary syndrome (POS), a common cause of infertility in women. The article concluded that 50-70% of women suffer from insulin resistance secondary to Type 2 Diabetes and in many cases obseity, which may contribute partially to POS. Furthermore, 85-90% of women with oligomenorrhea also had POS, suggesting that it is an underlying cause. However, the exact pathophysiology of POS was not determined.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These papers relate to your group project, I hope they are useful for the final submission. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 4 Assessment==&lt;br /&gt;
===Quiz===&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
{Primary villi are produced during which stage of development?:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ Week 2&lt;br /&gt;
- Week 1&lt;br /&gt;
- Week 3&lt;br /&gt;
- None of the above&lt;br /&gt;
|| Primary Villi appear during Week 2 of development, whilst secondary villi appear during Week 3 of development.&lt;br /&gt;
&lt;br /&gt;
{Mesoderm is a precursor for all of the following EXCEPT:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Skeletal Muscle Cells&lt;br /&gt;
- Cardiac Muscle Cells&lt;br /&gt;
- Erythrocytes&lt;br /&gt;
+ Epidermal Skin Cells&lt;br /&gt;
- Smooth Muscle&lt;br /&gt;
|| Epidermal skin cells originate from ectoderm. Skeletal, cardiac and smooth muscle along with erythrocytes originate from the mesoderm.&lt;br /&gt;
&lt;br /&gt;
{Which of the following shows the correct developmental pathway of the male gamete:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatogonia &amp;gt; Spermatozoa&lt;br /&gt;
- Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell &amp;gt; Spermatozoa &amp;gt; Spermatid&lt;br /&gt;
- Sertoli Cell &amp;gt; Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatozoa&lt;br /&gt;
- Spermatid &amp;gt; Spermatozoa &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell&lt;br /&gt;
+ Spermatogonia &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatid &amp;gt; Spermatozoa&lt;br /&gt;
|| Spermatogonia represent the beginning of male sex cell development, with spermatozoa being the mature gamete.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) No descriptive title to your questions. Q1 relates to the timing of villi development. These types of questions encourage &amp;quot;student guessing&amp;quot; and you could have given a more detailed explanation and links to resources in your revealed answer e.g. [[Placenta - Villi Development]]. Q2 is a reasonable question, but only requiring the student only to know that Epidermal Skin Cells are from ectoderm. Once again it is your revealed answer that needs more work. Q3 is a little easy, as long as you know Spermatogonia are the diploid start cell you can quickly exclude most options, need more work. (8/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5 Assessment==&lt;br /&gt;
===Gastroschisis and Omphalocele===&lt;br /&gt;
&lt;br /&gt;
Gastroschisis is classified as a full thickness cleft found in the abdominal wall, adjacent to the site of insertion of the umbilical cord. The defining features of this abnormality is the absence of a membranous sac shrouding the intestines. As a result of this the intestines will become eviscerated, thereby protruding out of the abdominal wall and will be on the exterior, rather than the interior of the body. It is believed that disruption to the vascular supply of the right abdominal wall is the primary gass of gastroschisis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2166158&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Omphalocele is an abnormality characterised by the herniation of visceral organs such as the intestines, liver and spleen outside of the abdominal cavity. The visceral organs are enclosed in a membranous sac, into which the umbilical cord is inserted.  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC1355659&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The primary difference between gastroschisis and omphalocele lies in the presence of a membraneous sac and the exact organs herniating from the abdominal wall. Gastroschisis involves the intestines protruding to the outside of the body but are not covered by a membranous sac. Omphalocele however is characterised by the protrusion of multiple visceral organs (liver, spleen etc.) which are enclosed within a membranous. Furthermore, the size of both abnormalities differs greatly, with gastroschisis typically being 2-5 cm in size whilst omphalocele can vary between 2-15cm. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2552910&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) This is an adequate description of the differences between these conditions. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 7 Assessment==&lt;br /&gt;
&lt;br /&gt;
1: This research paper aimed to examine the relationship between fetal adrenal cells and the differentiated adrenal cortex. In particular, research was focussed upon possible pregenitor cells involved in maintenance of the adrenal cortex. It was hypothesised that the the most likely precursor cells of the adult cortex were the 'Glil' expressing cells found in the adrenal capsule. A number of mice adrenal glands were taken, treated with antigen retrieval solution, after which fluorescence microscopy was conducted.&lt;br /&gt;
&lt;br /&gt;
The results of the paper concluded that 'Glil' expressing descendants of fetal adrenal cells are the pregenitors of the differentiated adrenal cortex. Furthermore, it was found that the 'Glil' expressing cells oringinated from 'FAdE-Cre' expressing fetal adrenal cells. Thus the authors of this research article came to the conclusion that 'Glil' expressing cells found in the adrenal cortex play an important role in the development, differentiation and maintenance of the adrenal cortex. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3817941&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
2: A number of embryonic layers and tissues contribute to the development of teeth. The primary contributing layers are mesoderm, ectoderm and neural crest ectomesenchyme. Furthermore, neural crest may contribute through interactions with the ectoderm. Odontoblasts originate from neural crest derived mesenchymal cells and are responsible for forming predentin which calificies to create dentin (which forms the bulk of the tooth). Ameloblasts are responsible for the production of enamel, which provides teeth with the hardness required to engage in mastication. &lt;br /&gt;
&lt;br /&gt;
==Peer Assessment==&lt;br /&gt;
&lt;br /&gt;
===Group 1 Peer Assessment===&lt;br /&gt;
Hi guys! I'll start of by saying that the images and video you have included are excellent and are relevant to your topic of discussion. Also, you have a large number of reliable references which is good to see. However you have yet to include a hand drawn image, which is required for the wiki page. I feel like  you could probably eliminate the typed out 'timeline of mitochondrial donation' and instead use this as an opportunity to use a hand drawn image of the timeline. Furthermore, the timeline under 'cystoplasmic transfer' feels a bit awkward and unnecessary. You could probably include this timeline alongside the 'timeline of mitochondrial donation'. &lt;br /&gt;
&lt;br /&gt;
Under the 'Technical Progression' section it would be best to incorporate human embryo, mouse and human models under a sub-sub heading, as at the moment it feels a bit jumbled.&lt;br /&gt;
&lt;br /&gt;
I would also recommend moving the 'Benefits' heading towards the end of the page. It feels odd reading about the benefits of three person embryos before I gain a proper understanding of how they work. Also it might be worth talking about the disadvantages (if there are any) to three person embryos to balance out the 'benefits' section. As has been previously stated, make sure you sort out the copyright information for your video as it would be a shame to lose marks if it was missing. Also, don't forget to add the 'student template' to the 'Swapping mitochondrial DNA mammalian oocytes' image as it is currently absent.&lt;br /&gt;
&lt;br /&gt;
===Group 2 Peer Assessment===&lt;br /&gt;
So far your wiki page gives a very good coverage of Ovarian Hyper-Stimulation Syndrome. The progression of your subheadings progresses logically from one topic to another. It's good to see that you've included an excellent hand-drawn image which is well suited to the 'pathophysiology' subheading. The amount of textual information you have under each heading is vast and gives a comprehensive description of OHSS. Furthermore, you have an excellent range of sources to support your discussion.&lt;br /&gt;
&lt;br /&gt;
I feel however that asides from your hand-drawn image, your use of images and other source of media is definitely lacking. As is, your page is largely text with little to no breaks, making it quite difficult to read. The use of images would not only help break up the monotony of the text, but also help reinforce some of your ideas. I feel that the inclusion of images in the 'symptoms' and 'complications' subheadings would be suitable. &lt;br /&gt;
&lt;br /&gt;
It may also be worthwhile to include subheadings concerning current research, to inform readers about contemporary developments regarding OHSS. Furthermore,  'future research' could also be another potential subheading and could illuminate potential areas that are beginning to be or could be investigated in coming years.&lt;br /&gt;
&lt;br /&gt;
Overall, a very impressive page so far, that could be enhanced with the addition of relevant images and other media.&lt;br /&gt;
&lt;br /&gt;
===Group 4 Peer Assessment===&lt;br /&gt;
Very impressive work so far guys! Your page covers a comprehensive topic very well, without focussing too much on certain subheadings at the expense of others. Your use of both tables and images is excellent so far. It's good to see that you have also included a video to give some variety to the media on your page. The 'background information' gives context to the issues which you discuss and though it might not be of great use for someone familiar with embryology, it would be a great help to those with no experience in this field and is therefore useful in establishing the topic of male infertility.&lt;br /&gt;
&lt;br /&gt;
The only things that could be changed to improve your wiki page is perhaps altering the location of tables and pictures on your page. For example all pictures are located on the right side of the page, although not a significant issue, becomes slightly monotonous as one progresses through the page. It may be worth alternating pictures between left and right to mix things up a little bit and improve the overall flow of the page. &lt;br /&gt;
It might also be worth including a short video underneath the 'surgical treatments' subheading to give a visual example of some of the techniques discussed.&lt;br /&gt;
&lt;br /&gt;
Furthermore a subheading on future research could possibly be included under the 'treatments' subheading to give the reader information on techniques and therapies which may come to prominence in the near future.&lt;br /&gt;
&lt;br /&gt;
Your wiki page thus far is very impressive! Excellent work so far. &lt;br /&gt;
===Group 5 Peer Assessment===&lt;br /&gt;
Awesome page so far guys! I commend you on your use of various videos to assist in conveying your ideas. Furthermore, the images you have chosen are highly relevant to the topic of discussion and assist the reader in gaining a greater understanding of oncofertility. All copyright information is present for the images you have used which is excellent to see.&lt;br /&gt;
It may be worth including a hand drawn image under the 'radiation' subheading, as we are required to include at least one such image. The current image under the radiation subheading could easily be replicated by hand and could fulfill this portion of the criteria.&lt;br /&gt;
&lt;br /&gt;
I am nitpicking here, but I would also recommend including some kind of media, most likely a picture, underneath the surgery subheading. It might even be worth doing the hand drawn image here if possible. A picture may also be good underneath the 'types of chemotherapy drugs' subheading, just to break up the wall of text and improve the reading experience for the reader.&lt;br /&gt;
It might also be worth restructuring the 'oncofertility limitations' subheading into the form of a table (if possible), as the bullet point format feels quite awkward and out of place compared to the rest of the page.&lt;br /&gt;
The inclusion of a glossary is also recommended, as this page will be accessible by the general public and a glossary will assist those without a background in embryology to understand and appreciate your content.&lt;br /&gt;
&lt;br /&gt;
Keep up the great work guys! Your page is absolutely amazing so far and the effort you have put in is definitely reflected in the high quality of your page.&lt;br /&gt;
===Group 6 Peer Assessment===&lt;br /&gt;
A very snazzy wiki page so far! You have used a wide variety of images to convey the concepts of prenatal genetic diagnosis to those reading your wiki page. Copyright information and student templates were present for all the images which you provided which is great to see. A hand drawn image is absent, which is a requirement for every wiki page. It might be worth including the hand drawn image in the 'history section' as the information here could easily be represented by a hand drawn flow chart.&lt;br /&gt;
&lt;br /&gt;
I commend you on your inclusion of a 'future/current research' subheading as this gives the reader a perspective of where the field of prenatal genetic diagnosis is heading in the distant future.&lt;br /&gt;
&lt;br /&gt;
I see that you have included a table underneath the 'biopsy methods' subheading. It would be great to see you compile the advantages and disadvantages of blastomere biopsy and trophectoderm biopsy into a tabular format as this would make for an easier reading experience. Furthermore, tables may also be incorporated for the disadvantages and advantages of genetic techniques.&lt;br /&gt;
I would recommend the inclusion of other forms of media such as a video or gif to assist in the conveyance of information under certain subheadings. A video/gif would fit nicely underneath the 'biopsy method' subheading, though this is just a suggestion.&lt;br /&gt;
&lt;br /&gt;
Overall your assignment is superb so far. You have successfully covered a vast topic and made successful use of a broad range of sources to support your page. Your inclusion of images has been appropriate, however a hand drawn image is still required. &lt;br /&gt;
Keep up the good work guys! &lt;br /&gt;
&lt;br /&gt;
==Lab 10 Assessment==&lt;br /&gt;
[https://embryology.med.unsw.edu.au/embryology/Slides/Embryo_Stages/Stage22/08-eye/Stage22-08-eye.html?zoom=6&amp;amp;lat=-4961.72287&amp;amp;lon=4821.89847&amp;amp;layers=B Retina of the Eye]&lt;br /&gt;
&lt;br /&gt;
The retina is the light sensitive portion of the eye. It contains 10 separate layers, including the photoreceptor layer which is comprised of rods and cones. These rods and cones convert light into signals, which are then communicated to the brain via the optic nerve. Optic cup morphogenesis is responsible for the development of the vertebrate eye, and it is believed that this process significantly contributes to the development of the retina.&lt;br /&gt;
The image above displays a Carnegie Stage 22 retina. The nerve fibre layer is particularly prominent in this image and is the pale layer closest to the vitreous chamber. The processes of rods, cones and ganglion cells can be observed migrating towards the optic nerve. &lt;br /&gt;
'''Embryology Link''' [[Vision - Retina Development]]&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_3&amp;diff=207063</id>
		<title>2015 Group Project 3</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_3&amp;diff=207063"/>
		<updated>2015-10-21T09:17:05Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015header}}&lt;br /&gt;
&lt;br /&gt;
=Female Infertility &amp;amp; Polycystic Ovarian Syndrome=&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Polycystic Ovary juxtaposed with a Standard Ovary.png|700px|thumb|centre|PCOS Ovary vs. Non-PCOS Ovary]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Introduction&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
[[File:Prevalence of Primary Infertility in 2010.jpeg|400px|thumb|right|Prevalence of Primary Infertility in 2010]]&lt;br /&gt;
&lt;br /&gt;
Female Infertility refers to the failure to conceive after one year of regular unprotected intercourse in females &amp;lt;ref name=one&amp;gt;&amp;lt;pubmed&amp;gt;26150870&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. In 2010, infertility affected 48.5 million couples world wide and the areas of highest prevalence included North Africa and Middle East, South Asia, Central/Eastern Europe and Central Asia and Sub-Saharan Africa &amp;lt;ref name=two&amp;gt;&amp;lt;pubmed&amp;gt;23271957&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. As there are several causes of female infertility, we will be focusing on infertility that is caused by '''Polycystic Ovarian Syndrome''' (PCOS), the most common cause of infertility that is medically treatable &amp;lt;ref name=one/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
{|&lt;br /&gt;
|-bgcolor=&amp;quot;DDCEF2&amp;quot; &lt;br /&gt;
|&lt;br /&gt;
* '''Polycystic Ovarian Syndrome (PCOS) is a common endocrine disorder, affecting up to 20% of reproductive aged women &amp;lt;ref name=hey&amp;gt;&amp;lt;pubmed&amp;gt;21896560&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. It is the most common cause of anovulatory infertility &amp;lt;ref name=one/&amp;gt; which refers to infertility caused by the the absence of ovulation.'''&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
=Causes=&lt;br /&gt;
&lt;br /&gt;
PCOS is a disorder of heterogeneous origin with unknown aetiology &amp;lt;ref name=hey/&amp;gt;. Studies have shown that both genetic and environmental factors contribute to the development of PCOS in women however there is limited research into the actual interactions between these two factors &amp;lt;ref name=un&amp;gt;&amp;lt;pubmed&amp;gt;17185788&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Genetic Factors&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
Despite the lack of information regarding its aetiology, there is increasing evidence for a genetic involvement in the endocrine disorder. Studies have shown that genes play an important role in contributing towards the clinical and biochemical features of the disease. This evidence includes the family clustering of cases, greater unanimity between monozygotic twins than heterozygotic twins and the ability to inherit endocrine and  metabolic features of PCOS &amp;lt;ref name=hey/&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
In one study, 115 sisters of women with PCOS were examined and results showed that half of these sisters had high testosterone levels, suggesting that hyperandrogenemia is a common trait with a dominant pattern of inheritance. These results strongly supported the idea of the familial clustering of biochemical features such as hyperandrogenism in first degree relatives &amp;lt;ref name=deux&amp;gt;&amp;lt;pubmed&amp;gt;9843997&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Several genes have been considered to play an important role in the development of PCOS such as CYP11A, the insulin gene, the follistatin gene and a region near the insulin receptor gene. Yet, the evidence supporting most of these genes has been refuted by larger studies, except for the region near the insulin receptor gene &amp;lt;ref name=deux/&amp;gt;. Among these, the gene CYP11a is the one that is strongly associated with hyperandrogenism in women with PCOS. &amp;lt;ref name=cinq&amp;gt;&amp;lt;pubmed&amp;gt;9147642&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; While it doesn't isolate this gene as the sole cause of PCOS, variation of the genotype at this locus contributes to production of excess androgen &amp;lt;ref name=h4&amp;gt;&amp;lt;pubmed&amp;gt;7962289&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Studies have also shown that there is strong evidence for linkage between the alleles at the Variable Number Tandem Repeats (VNTR) which is situated 5' to the insulin gene and PCOS. The data from the study suggests that it is a very susceptible region in PCOS and also may play a role in the development of hyperinsulinaemia &amp;lt;ref name=trois&amp;gt;&amp;lt;pubmed&amp;gt;9455828&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Environmental Factors&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
The prevalence of PCOS in populations where there has been a constant gene pool indicates that environmental factors play a significant role in the aetiology of PCOS &amp;lt;ref name=un/&amp;gt; &lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Obesity and Diet&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
Obesity is the major environmental factor driving the development of PCOS in susceptible individuals. The rising rates of PCOS have been paralleled by the widespread emergence of obesity and type 2 diabetes which are prevalent in developed countries. The risk of developing PCOS from obesity is compounded by  poor dietary choices and lack of physical activity which has begun to characterise the lifestyle in developed countries &amp;lt;ref name=deux/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Medication&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
Studies have shown that valproic acid in medication used to treat epilepsy and bipolar disorders contributes to the development of PCOS. Women with these disorders  may develop the typical features of PCOS such as polycystic ovaries, anovulation, hyperandrogenism and obesity &amp;lt;ref name=quartre&amp;gt;&amp;lt;pubmed&amp;gt;8413434&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Recent studies also suggest that the weight gain from medication is significant as it can lead to the development of PCOS &amp;lt;ref name=deux/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
=Pathogenesis=&lt;br /&gt;
&lt;br /&gt;
The pathogenesis of polycystic ovarian syndrome is poorly understood, however it is believed that insulin resistance and excess androgens such as testosterone play a fundamental role.&lt;br /&gt;
Underlying factors such as obesity and genetic predispositions likely contribute to the onset of polycystic ovarian syndrome through the development of a combination of hyperinsulinemia and hyperandrogenemia.&amp;lt;ref name=eleven&amp;gt;&amp;lt;pubmed&amp;gt;PMC4556908&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Hyperinsulinemia&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
Hyperinsulinemia is a term that defines the presence of excessive amounts of insulin in the blood relative to the amount of glucose. &amp;lt;ref name=fourteen&amp;gt;&amp;lt;pubmed&amp;gt;PMC4114053&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This phenomenon is typically associated with obesity and excess adipose tissue, both of which are associated with insulin resistance. In order to overcome this resistance, insulin secretion is increased in an attempt to normalise blood glucose levels, thereby leading to hyperinsulineamia. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2782313&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Excessive levels of insulin typically cause disruption to the hypothalamus-hypophysis-ovary axis whilst insulin resistance in ovarian tissues leads to decreased metabolic signalling. However, steroidogenic activity is largely unaffected by the impaired metabolic signalling, thereby paving the way androgens to become more effect and paving the way towards hyperandrogenemia. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC4334071&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
[[File:Patholophysiology of Polycystic Ovarian Syndrome.jpg|500px|thumb|left|The impact of hyperinsulinemia and hyperandrogenemia on the development of polycystic ovarian syndrome]]&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Hyperandrogenemia&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
Hyperandrogenemia is a hallmark of the development of polycystic ovarian syndrome, with 80% of women presenting with excess androgen also having polycystic ovaries.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3872139&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The disruption of the hypothalamus hypophysis ovary axis as a result of hyperinsulinemia increases the release of GnRH and LH, leading to increased androgen production in the ovarian theca cells. Hyperandrogenemia decreases the feedback sensitivity of both estradiol and progesterone within gonadotropic hypothalmic cells. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC4334071&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A deficiency of FSH is observed and correlates with the increased secretion of Gonadotrophin-releasing hormone (GnRH) and Luteinizing hormone (LH). As a result of this deficiency, graunlosa  cell aromatisation to oestrogens as well as follicle maturation and ovulation will be drastically impaired.  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3453528&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
As a consequence of the impairment of follicle maturation, small antral follicles will accumulate within the periphery of the ovary and develop a cystic morphology. Ovulation will be unable to occur due to the absence of mature follicles, culminating in infertility.  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC4562327&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Hyperandrogenism&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
====Animal Models====&lt;br /&gt;
&lt;br /&gt;
Studies conducted on female rhesus monkeys have supported evidence for the foetal origins of the clinical features of PCOS &amp;lt;ref name=h1&amp;gt;&amp;lt;pubmed&amp;gt;18406243&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.  It has been shown that in human females, an excess of androgen exposure at any stage from the development of the ovaries to the onset of puberty manifests as characteristic features of PCOS, such as resistance to insulin and LH hypersecretion. After exposure to levels of testosterone matching those of fetal males, in utero, female rhesus monkeys were found to display the clinical and biochemical features typical of PCOS such as hypersecretion of LH and abnormal insulin action. These results correlated to those of similar studies conducted on sheep, where the pregnant ewe was exposed to excessive levels of testosterone and LH secretion and abnormality in ovarian cycles were again prominent features &amp;lt;ref name=sheep&amp;gt;Padmanabhan V, Evans NP, Taylor JA, Robinson JE1997 '''Prenatal exposure to  androgens  leads  to  the  development  of  cystic  ovaries  in  the  sheep'''. Biol Reprod 56:194&amp;lt;/ref&amp;gt;. While these studies indicate that similar biochemical and clinical manifestations in humans originate from excess androgen exposure of the female fetus, it must be noted that it is very unlikely for any excess androgen production to be passed across the placenta from the mother to her daughter. This is because mechanisms such as androgen binding proteins and placental metabolism of androgen prevent excess androgen entering the circulation of the fetus &amp;lt;ref name=h2&amp;gt;&amp;lt;pubmed&amp;gt;12098657&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
====Cell Culture Models====&lt;br /&gt;
&lt;br /&gt;
While studies have shown that the adrenal could be a source of excess androgen such as the adrenal &amp;lt;ref name=h3&amp;gt;&amp;lt;pubmed&amp;gt;7962325&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;, they were followed by various studies using cell culture models which demonstrated that the ovary was the major source of excess androgen &amp;lt;ref name=h4/&amp;gt; &amp;lt;ref name=h5&amp;gt;&amp;lt;pubmed&amp;gt;9302378&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. ''In vitro'' studies have shown that the production of steroids is abnormal in theca cells &amp;lt;ref name=h3/&amp;gt;. In women affected by PCOS, stimulation by human chorionic gonadotrophin (hCG) is followed by an increase in thecal steroid production after suppression of LH by a GnRH analogue &amp;lt;ref name=h5/&amp;gt;. Theca cells cultured from polycystic ovaries produce 20 times as much androstenedione as those from normal ovaries &amp;lt;ref name=h4/&amp;gt; with increased expression of mRNA for enzymes responsible for making steroids also reported in following studies. &amp;lt;ref name=h6&amp;gt;&amp;lt;pubmed&amp;gt;10852468&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; These results have prompted many studies on genes encoding these steroidogeneic enzymes.&lt;br /&gt;
&lt;br /&gt;
[[File:Polycystic_rat_ovary.jpg|500px|thumb|right|An example of polycysts present in the polycystic ovaries of a rat specimen]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
=Signs and Symptoms=&lt;br /&gt;
&lt;br /&gt;
The symptoms of PCOS are different for each women. The three cardinal signs of PCOS are hyperandrogenism, polycystic ovaries and ovarian dysfunction &amp;lt;ref name=sign1&amp;gt;&amp;lt;pubmed&amp;gt;14688154&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Common clinical symptoms include &amp;lt;ref&amp;gt; Women's Heath, U.S. Department of Health and Human Services ,[ http://www.womenshealth.gov/publications/our-publications/fact-sheet/polycystic-ovary-syndrome.html#d ], 'Polycystic ovary syndrome (PCOS) fact sheet'&amp;lt;/ref&amp;gt; ;&lt;br /&gt;
&lt;br /&gt;
{|&lt;br /&gt;
|-bgcolor=&amp;quot;DDCEF2&amp;quot; &lt;br /&gt;
|&lt;br /&gt;
* Infertility- due to anovulation. &lt;br /&gt;
* Irregular Menstrual Cycles&lt;br /&gt;
* Hirsutism&lt;br /&gt;
* Ovarian Cysts&lt;br /&gt;
* Obesity&lt;br /&gt;
* Male Pattern Baldness&lt;br /&gt;
* Skin Tags&lt;br /&gt;
* Pelvic Pain&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
Along with obesity, PCOS is also associated with other metabolic issues such as insulin resistance, hyperinsulinemia and type 2 diabetes mellitus. It has also been associated with cardiovascular problems and cancers of the breast and endometrium &amp;lt;ref name=sign3&amp;gt;&amp;lt;pubmed&amp;gt;PMC4341818&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
=Diagnosis=&lt;br /&gt;
&lt;br /&gt;
A major diagnostic tool for PCOS is a pelvic ultrasound, but PCOS diagnosis cannot be completely dependent on just pelvic ultrasounds. A patient with PCOS may not necessarily have polycystic ovaries, and those with ovarian cysts may not necessarily have PCOS. A range of diagnostic assessments and associated symptoms have to be thoroughly investigated.&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Medical history and examination&amp;lt;/u&amp;gt;===&lt;br /&gt;
Clinical questions are asked or filled out in the form of a questionnaire to assess and assist in the diagnosis of PCOS. Studies show that those with a history:&lt;br /&gt;
*infrequent and irregular menstruation&lt;br /&gt;
*hirsutism (related to high levels of androgens in the blood – hyperandrogenism)&lt;br /&gt;
*obesity&lt;br /&gt;
*acne production &lt;br /&gt;
are at a higher predictive risk of PCOS. But questions regarding failed pregnancy attempts and history of nipple discharge proved no correlation in diagnosing PCOS. &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 17872783 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Ultrasound of Polycystic Ovaries .jpg|400px|thumb|right|Ultrasound of Polycystic Ovaries]]&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Blood Test&amp;lt;/u&amp;gt;===&lt;br /&gt;
A patient with elevated levels of androgens, a medical condition called &amp;lt;b&amp;gt;hyperandrogenism &amp;lt;/b&amp;gt;, is very highly likely to have PCOS. &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 20591140 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt; Androgens &amp;lt;/b&amp;gt; , such as testosterone, and &amp;lt;b&amp;gt;free androgen index (FAI) &amp;lt;/b&amp;gt; are the two tests best used in diagnosing hyperandrogenism.&lt;br /&gt;
Androgen excess in PCOS is a result from increased synthesis and release of ovarian androgens. &amp;lt;b&amp;gt;Dehydroepiandrosterone sulfate &amp;lt;/b&amp;gt; (DHEA-S) levels are used as a biomarker for testing androgen levels, as it is made exclusively by the adrenal glands. DHEA-S levels of above 1890 micromol/L is extremely suggestive of hyperandrogenism. &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 18844715 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Free androgen index (FAI) &amp;lt;/b&amp;gt; is the ratio of total testosterone measurement to levels of &amp;lt;b&amp;gt; sex hormone-binding globulin &amp;lt;/b&amp;gt; (SHBG). Those with PCOS will have high FAI, as this indicates a high ration of free testosterone in the body.&lt;br /&gt;
Other blood tests are also done to help exclude other predisposing factors such as levels of &amp;lt;b&amp;gt; Thyroid Stimulating Hormone &amp;lt;/b&amp;gt; (LSH) and &amp;lt;b&amp;gt; Follicle-stimulating hormone &amp;lt;/b&amp;gt; (FSH). An elevated ratio of LSH to FSH, of above 2:1 &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 14737959 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;, indicates a possibility, but not definitively, of PCOS.&lt;br /&gt;
The effect of &amp;lt;b&amp;gt; insulin &amp;lt;/b&amp;gt; on blood can also be tested for insulin resistance. Insulin resistance enhances androgen production and increases free androgen levels by reducing SHBG. This can used as an indication marker for the possibility of PCOS&lt;br /&gt;
A study in 2014 showed that &amp;lt;b&amp;gt; Anti-Müllerian hormone &amp;lt;/b&amp;gt; (AMH) is found to be elevated in patients with PCOS &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 24821925 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;, giving rise to its potential clinical implication in diagnosing PCOS. AMH is exclusively produced in ovarian follicles, with individual AMH concentration reflecting the quantity of remaining primordial follicles and measure of ovarian reserve. &lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Gynecologic ultrasonography&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
Gynecologic ultrasonography is a pelvic ultrasound, specifically to the female pelvic region, with regards to the uterus, ovaries and the fallopian tube. The examination can be performed by transabdominal ultrasonography, with a full bladder, or transvaginal ultrasonography with a vaginal transducer. Typically transvaginal imaging shows a better and clearer image than transabdominal ultrasonography, as it uses higher frequency imaging, but is limited to areas it can reach. In the case of PCOS, both techniques can provide an image of the ovaries. Studies suggest that if more than 25 follicles are seen in an ovary, predominantly in the periphery, in women between 18-35 years, it is described to have a polycystic ovarian morphology. &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 24345633 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Magnetic Resonance Imaging&amp;lt;/u&amp;gt;===&lt;br /&gt;
Ovaries can also be seen on MRIs. On MRIs, PCOS is characterized by numberous peripheral cysts where the ovaries affected to be slightly larger than normal. Although MRI is seen to be effective in ovarian imaging, the finding of peripheral ovarian cysts in MRIsmay not be PCOS specific. &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 8888256 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt; But studies have seen that MR imaging in adolescence uncover distinct differences between young patients with and without PCOS &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 23292744 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;, with also great diagnostic sensitivity with patients between the age of 21-30 &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 19241321 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;, providing assistance of imagery in patients whom may be opposed to transvaginal ultrasounds.&lt;br /&gt;
&lt;br /&gt;
=Prevention and Treatment=&lt;br /&gt;
&lt;br /&gt;
There currently is no cure for PCOS, nor can it be prevented. This can be largely attributed to genetics, and because it can progress without being noticed for an extended period (generally until puberty begins). Treatment maybe involve lifestyle changes or hormonal augmentation in regulating periods, hirsutism, and acne, in addition to regulating androgen levels.&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Current Treatments&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|border=&amp;quot;1&amp;quot;&lt;br /&gt;
|-bgcolor=&amp;quot;DDCEF2&amp;quot;&lt;br /&gt;
| '''CURRENT TREATMENT'''&lt;br /&gt;
| '''DISADVANTAGES'''&lt;br /&gt;
|-&lt;br /&gt;
| General Practitioners tend to prescribe oral anti-oestrogens, most commonly the contraceptive pill, to restore ovulation.&lt;br /&gt;
| This method only has a 50% success rate in PCOS patients. It does not directly increase fertility rates, but restores the menstrual cycle. &amp;lt;ref    name= pink&amp;gt;&amp;lt;pubmed&amp;gt;26194691&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;       &lt;br /&gt;
 &lt;br /&gt;
|-bgcolor=&amp;quot;FAF5FF&amp;quot;&lt;br /&gt;
| Lifestyle changes are highly encouraged by medical practitioners. Diet and exercise regimes can be designed with a dietitian or nutritionist. &amp;lt;ref name= purple&amp;gt;&amp;lt;pubmed&amp;gt;26289303&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Exercise and diet plans do not directly increase fertility. They are designed to enhance weight loss, which in some patients can encourage normal hormone levels from the pituitary and thyroid. &amp;lt;ref name=purple/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Clomiphene citrate administration (generally in pill form, as prescribed by a GP). Such pills stimulate the pituitary gland to release GnRH to simulate ovulation (with a 72% success rate). &amp;lt;ref name= green&amp;gt;&amp;lt;pubmed&amp;gt;26150870&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Clomiphene can cause multiple side effects, most notably abnormal uterine bleeding and pelvic pain to due enlargement of the ovaries. &lt;br /&gt;
&lt;br /&gt;
Thus, it cannot be as frequently prescribed as the contraceptive pill, and careful patient monitoring is imperative &amp;lt;ref name=green/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
|-bgcolor=&amp;quot;FAF5FF&amp;quot;&lt;br /&gt;
| Higher fertility rates are observed in treatments combining clomiphene citrate and metformin (79% success) &amp;lt;ref name=green/&amp;gt;.&lt;br /&gt;
| Similar disadvantages as clomiphene, above.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Laparoscopic Ovarian Drilling===&lt;br /&gt;
Laparoscopic ovarian drilling (LOD) is a surgical method of treating polycystic ovaries and is typically used when an infertile woman does not respond to administration of clomiphene citrate. &amp;lt;ref name=blue&amp;gt;&amp;lt;pubmed&amp;gt;PMC4367066&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The most common form of LOD involves electrocautery through the use of an insulinated uniupolar needle electrode. The exact method of action of LOD is poorly understood. The most accepted hypothesis however is that the breakdown of ovarian follicles and stroma via heat, laser or mechanical drilling brings about a decrease in androgen and inhibin levels, followed by a rise in the levels of FSH. Inflammatory growth factors produced in response to the thermal injury caused by laser drilling can enhance the action that FSH has on folliculogenesis. Improved blood flow often results from LOD which serves to drastically improves the delivery of gonadotrophins to the ovary.&amp;lt;ref name=blue&amp;gt;&amp;lt;pubmed&amp;gt;PMC4367066&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
LOD can be an appealing alternative to treatment with gonadotrophins, as the latter is typically time consuming, expensive and requires constant monitoring in order to be effective.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22696324&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The overall effectiveness of LOD as a standalone treatment for PCOS is still questionable. Several studies have shown that there is no evidence of significant differences in pregnancy and live births in women undergoing LOD and those undergoing other medical treatments. &amp;lt;ref name=blue&amp;gt;&amp;lt;pubmed&amp;gt;PMC4367066&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=JH-Yx1QWUBk&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Ovarian Drilling by Laparoscopy for PCOS &amp;lt;ref&amp;gt;Mishra, R., (2014, September 8) Ovarian Drilling by Laparoscopy for PCOS. Retrieved from https://www.youtube.com/watch?v=JH-Yx1QWUBk&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;New Trials&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Some studies have found that regular Selenium supplements can encourage fertility among PCOS patients. The program, which is still in its early trial period, requires women to consume selenium tablets for 8 weeks. This study has found a significant decrease in dehydroepiandrosterone (DHEA) levels in patients, thus reducing excessive hair growth associated with PCOS. A direct link to increased fertility is yet to be established, and thus further testing is required.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26267328&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
=Current and Future Research=&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
=Glossary=&lt;br /&gt;
&lt;br /&gt;
'''FSH''' - Follicle Stimulating Hormone&lt;br /&gt;
&lt;br /&gt;
'''Hirsutism'''&lt;br /&gt;
&lt;br /&gt;
'''hCG''' -  human Chorionic Gonadotrophin&lt;br /&gt;
&lt;br /&gt;
'''GnRH''' - Gonadotrophin-releasing hormone&lt;br /&gt;
&lt;br /&gt;
'''LH''' - Luteinizing Hormone&lt;br /&gt;
&lt;br /&gt;
'''LOD''' - Laparoscopic Ovarian Drilling&lt;br /&gt;
&lt;br /&gt;
'''PCOS''' - Polycystic Ovarian Syndrome&lt;br /&gt;
=References=&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{ANAT2341Project2015header}}&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_3&amp;diff=206453</id>
		<title>2015 Group Project 3</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_3&amp;diff=206453"/>
		<updated>2015-10-19T04:01:39Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015header}}&lt;br /&gt;
&lt;br /&gt;
=Female Infertility &amp;amp; Polycystic Ovarian Syndrome=&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Polycystic Ovary juxtaposed with a Standard Ovary.png|700px|thumb|centre|PCOS Ovary vs. Non-PCOS Ovary]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Definition&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
[[File:Prevalence of Primary Infertility in 2010.jpeg|400px|thumb|right|Prevalence of Primary Infertility in 2010]]&lt;br /&gt;
&lt;br /&gt;
Female Infertility refers to the failure to conceive after one year of regular unprotected intercourse in females &amp;lt;ref name=one&amp;gt;&amp;lt;pubmed&amp;gt;26150870&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. In 2010, infertility affected 48.5 million couples world wide and the areas of highest prevalence included North Africa and Middle East, South Asia, Central/Eastern Europe and Central Asia and Sub-Saharan Africa &amp;lt;ref name=two&amp;gt;&amp;lt;pubmed&amp;gt;23271957&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. As there are several causes of female infertility, we will be focusing on infertility that is caused by '''Polycystic Ovarian Syndrome''' (PCOS), the most common cause of infertility that is medically treatable &amp;lt;ref name=one/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
{|&lt;br /&gt;
|-bgcolor=&amp;quot;DDCEF2&amp;quot; &lt;br /&gt;
|&lt;br /&gt;
* '''Polycystic Ovarian Syndrome (PCOS) is a common endocrine disorder, affecting up to 20% of reproductive aged women &amp;lt;ref name=three&amp;gt;&amp;lt;pubmed&amp;gt;21896560&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. It is the most common cause of anovulatory infertility &amp;lt;ref name=one/&amp;gt; which refers to infertility caused by the the absence of ovulation.'''&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
=Causes=&lt;br /&gt;
&lt;br /&gt;
PCOS is a disorder of heterogeneous origin with unknown aetiology &amp;lt;ref name=four&amp;gt;&amp;lt;pubmed&amp;gt;21896560&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Studies have shown that both genetic and environmental factors contribute to the development of PCOS in women however there is limited research into the actual interactions between these two factors &amp;lt;ref name=un&amp;gt;&amp;lt;pubmed&amp;gt;17185788&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Genetic Factors&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
Despite the lack of information regarding its aetiology, there is increasing evidence for a genetic involvement in the endocrine disorder. Studies have shown that genes play an important role in contributing towards the clinical and biochemical features of the disease &amp;lt;ref name=four/&amp;gt;. This evidence includes the family clustering of cases, greater unanimity between monozygotic twins than heterozygotic twins and the ability to inherit endocrine and  metabolic features of PCOS &amp;lt;ref name=four/&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
In one study, 115 sisters of women with PCOS were examined and results showed that half of these sisters had high testosterone levels, suggesting that hyperandrogenemia is a common trait with a dominant pattern of inheritance. These results strongly supported the idea of the familial clustering of biochemical features such as hyperandrogenism in first degree relatives &amp;lt;ref name=deux&amp;gt;&amp;lt;pubmed&amp;gt;9843997&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Several genes have been considered to play an important role in the development of PCOS such as CYP11A, the insulin gene, the follistatin gene and a region near the insulin receptor gene. Yet, the evidence supporting most of these genes has been refuted by larger studies, except for the region near the insulin receptor gene &amp;lt;ref name=deux/&amp;gt;. Among these, the gene CYP11a is the one that is strongly associated with hyperandrogenism in women with PCOS. &amp;lt;ref name=cinq&amp;gt;&amp;lt;pubmed&amp;gt;9147642&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; While it doesn't isolate this gene as the sole cause of PCOS, variation of the genotype at this locus contributes to production of excess androgen &amp;lt;ref name=h4&amp;gt;&amp;lt;pubmed&amp;gt;7962289&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Studies have also shown that there is strong evidence for linkage between the alleles at the Variable Number Tandem Repeats (VNTR) which is situated 5' to the insulin gene and PCOS. The data from the study suggests that it is a very susceptible region in PCOS and also may play a role in the development of hyperinsulinaemia &amp;lt;ref name=trois&amp;gt;&amp;lt;pubmed&amp;gt;9455828&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Environmental Factors&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
The prevalence of PCOS in populations where there has been a constant gene pool indicates that environmental factors play a significant role in the aetiology of PCOS.&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Obesity and Diet&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
Obesity is the major environmental factor driving the development of PCOS in susceptible individuals. The rising rates of PCOS have been paralleled by the widespread emergence of obesity and type 2 diabetes which are prevalent in developed countries. The risk of developing PCOS from obesity is compounded by  poor dietary choices and lack of physical activity which has begun to characterise the lifestyle in developed countries &amp;lt;ref name=deux/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Medication&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
Studies have shown that valproic acid in medication used to treat epilepsy and bipolar disorders contributes to the development of PCOS. Women with these disorders  may develop the typical features of PCOS such as polycystic ovaries, anovulation, hyperandrogenism and obesity &amp;lt;ref name=quartre&amp;gt;&amp;lt;pubmed&amp;gt;8413434&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Recent studies also suggest that the weight gain from medication is significant as it can lead to the development of PCOS &amp;lt;ref name=deux/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
=Pathogenesis=&lt;br /&gt;
&lt;br /&gt;
The pathogenesis of polycystic ovarian syndrome is poorly understood, however it is believed that insulin resistance and excess androgens such as testosterone play a fundamental role.&lt;br /&gt;
Underlying factors such as obesity and genetic predispositions likely contribute to the onset of polycystic ovarian syndrome through the development of a combination of hyperinsulinemia and hyperandrogenemia.&amp;lt;ref name=eleven&amp;gt;&amp;lt;pubmed&amp;gt;PMC4556908&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Hyperinsulinemia&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
Hyperinsulinemia is a term that defines the presence of excessive amounts of insulin in the blood relative to the amount of glucose. &amp;lt;ref name=fourteen&amp;gt;&amp;lt;pubmed&amp;gt;PMC4114053&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This phenomenon is typically associated with obesity and excess adipose tissue, both of which are associated with insulin resistance. In order to overcome this resistance, insulin secretion is increased in an attempt to normalise blood glucose levels, thereby leading to hyperinsulineamia. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2782313&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Excessive levels of insulin typically cause disruption to the hypothalamus-hypophysis-ovary axis whilst insulin resistance in ovarian tissues leads to decreased metabolic signalling. However, steroidogenic activity is largely unaffected by the impaired metabolic signalling, thereby paving the way androgens to become more effect and paving the way towards hyperandrogenemia. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC4334071&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
[[File:Patholophysiology of Polycystic Ovarian Syndrome.jpg|500px|thumb|left|The impact of hyperinsulinemia and hyperandrogenemia on the development of polycystic ovarian syndrome]]&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Hyperandrogenemia&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
Hyperandrogenemia is a hallmark of the development of polycystic ovarian syndrome, with 80% of women presenting with excess androgen also having polycystic ovaries.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3872139&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The disruption of the hypothalamus hypophysis ovary axis as a result of hyperinsulinemia increases the release of GnRH and LH, leading to increased androgen production in the ovarian theca cells. Hyperandrogenemia decreases the feedback sensitivity of both estradiol and progesterone within gonadotropic hypothalmic cells. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC4334071&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A deficiency of FSH is observed and correlates with the increased secretion of GnRH and LH. As a result of this deficiency, graunlosa  cell aromatisation to oestrogens as well as follicle maturation and ovulation will be drastically impaired.  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3453528&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
As a consequence of the impairment of follicle maturation, small antral follicles will accumulate within the periphery of the ovary and develop a cystic morphology. Ovulation will be unable to occur due to the absence of mature follicles, culminating in infertility.  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC4562327&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Hyperandrogenism&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
====Animal Models====&lt;br /&gt;
&lt;br /&gt;
Studies conducted on female rhesus monkeys have supported evidence for the foetal origins of the clinical features of PCOS &amp;lt;ref name=h1&amp;gt;&amp;lt;pubmed&amp;gt;18406243&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.  It has been shown that in human females, an excess of androgen exposure at any stage from the development of the ovaries to the onset of puberty manifests as characteristic features of PCOS, such as resistance to insulin and Luteinising Hormone (LH) hypersecretion. After exposure to levels of testosterone matching those of fetal males, in utero, female rhesus monkeys were found to display the clinical and biochemical features typical of PCOS such as hypersecretion of LH and abnormal insulin action. These results correlated to those of similar studies conducted on sheep, where the pregnant ewe was exposed to excessive levels of testosterone and LH secretion and abnormality in ovarian cycles were again prominent features &amp;lt;ref name=sheep&amp;gt;Padmanabhan V, Evans NP, Taylor JA, Robinson JE1997 '''Prenatal exposure to  androgens  leads  to  the  development  of  cystic  ovaries  in  the  sheep'''. Biol Reprod 56:194&amp;lt;/ref&amp;gt;. While these studies indicate that similar biochemical and clinical manifestations in humans originate from excess androgen exposure of the female fetus, it must be noted that it is very unlikely for any excess androgen production to be passed across the placenta from the mother to her daughter. This is because mechanisms such as androgen binding proteins and placental metabolism of androgen prevent excess androgen entering the circulation of the fetus &amp;lt;ref name=h2&amp;gt;&amp;lt;pubmed&amp;gt;12098657&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
====Cell Culture Models====&lt;br /&gt;
&lt;br /&gt;
While studies have shown that the adrenal could be a source of excess androgen such as the adrenal &amp;lt;ref name=h3&amp;gt;&amp;lt;pubmed&amp;gt;7962325&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;, they were followed by various studies using cell culture models which demonstrated that the ovary was the major source of excess androgen &amp;lt;ref name=h4/&amp;gt; &amp;lt;ref name=h5&amp;gt;&amp;lt;pubmed&amp;gt;9302378&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. ''In vitro'' studies have shown that the production of steroids is abnormal in theca cells &amp;lt;ref name=h3/&amp;gt;. In women affected by PCOS, stimulation by human chorionic gonadotrophin (hCG) is followed by an increase in thecal steroid production after suppression of LH by a GnRH analogue &amp;lt;ref name=h5/&amp;gt;. Theca cells cultured from polycystic ovaries produce 20 times as much androstenedione as those from normal ovaries &amp;lt;ref name=h4/&amp;gt; with increased expression of mRNA for enzymes responsible for making steroids also reported in following studies. &amp;lt;ref name=h6&amp;gt;&amp;lt;pubmed&amp;gt;10852468&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; These results have prompted many studies on genes encoding these steroidogeneic enzymes.&lt;br /&gt;
&lt;br /&gt;
[[File:Polycystic_rat_ovary.jpg|500px|thumb|right|An example of polycysts present in the polycystic ovaries of a rat specimen]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
=Signs and Symptoms=&lt;br /&gt;
&lt;br /&gt;
The symptoms of PCOS are different for each women. The three cardinal signs of PCOS are hyperandrogenism, polycystic ovaries and ovarian dysfunction &amp;lt;ref name=sign1&amp;gt;&amp;lt;pubmed&amp;gt;14688154&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Common clinical symptoms include &amp;lt;ref&amp;gt; Women's Heath, U.S. Department of Health and Human Services ,[ http://www.womenshealth.gov/publications/our-publications/fact-sheet/polycystic-ovary-syndrome.html#d ], 'Polycystic ovary syndrome (PCOS) fact sheet'&amp;lt;/ref&amp;gt; ;&lt;br /&gt;
&lt;br /&gt;
{|&lt;br /&gt;
|-bgcolor=&amp;quot;DDCEF2&amp;quot; &lt;br /&gt;
|&lt;br /&gt;
* Infertility- due to anovulation. &lt;br /&gt;
* Irregular Menstrual Cycles&lt;br /&gt;
* Hirsutism&lt;br /&gt;
* Ovarian Cysts&lt;br /&gt;
* Obesity&lt;br /&gt;
* Male Pattern Baldness&lt;br /&gt;
* Skin Tags&lt;br /&gt;
* Pelvic Pain&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
Along with obesity, PCOS is also associated with other metabolic issues such as insulin resistance, hyperinsulinemia and type 2 diabetes mellitus. It has also been associated with cardiovascular problems and cancers of the breast and endometrium &amp;lt;ref name=sign3&amp;gt;&amp;lt;pubmed&amp;gt;PMC4341818&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
=Diagnosis=&lt;br /&gt;
&lt;br /&gt;
A major diagnostic tool for PCOS is a pelvic ultrasound, but PCOS diagnosis cannot be completely dependent on just pelvic ultrasounds. A patient with PCOS may not necessarily have polycystic ovaries, and those with ovarian cysts may not necessarily have PCOS. A range of diagnostic assessments and associated symptoms have to be thoroughly investigated.&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Medical history and examination&amp;lt;/u&amp;gt;===&lt;br /&gt;
Clinical questions are asked or filled out in the form of a questionnaire to assess and assist in the diagnosis of PCOS. Studies show that those with a history:&lt;br /&gt;
*infrequent and irregular menstruation&lt;br /&gt;
*hirsutism (related to high levels of androgens in the blood – hyperandrogenism)&lt;br /&gt;
*obesity&lt;br /&gt;
*acne production &lt;br /&gt;
are at a higher predictive risk of PCOS. But questions regarding failed pregnancy attempts and history of nipple discharge proved no correlation in diagnosing PCOS. &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 17872783 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Ultrasound of Polycystic Ovaries .jpg|400px|thumb|right|Ultrasound of Polycystic Ovaries]]&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Blood Test&amp;lt;/u&amp;gt;===&lt;br /&gt;
A patient with elevated levels of androgens, a medical condition called &amp;lt;b&amp;gt;hyperandrogenism &amp;lt;/b&amp;gt;, is very highly likely to have PCOS. &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 20591140 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt; Androgens &amp;lt;/b&amp;gt; , such as testosterone, and &amp;lt;b&amp;gt;free androgen index (FAI) &amp;lt;/b&amp;gt; are the two tests best used in diagnosing hyperandrogenism.&lt;br /&gt;
Androgen excess in PCOS is a result from increased synthesis and release of ovarian androgens. &amp;lt;b&amp;gt;Dehydroepiandrosterone sulfate &amp;lt;/b&amp;gt; (DHEA-S) levels are used as a biomarker for testing androgen levels, as it is made exclusively by the adrenal glands. DHEA-S levels of above 1890 micromol/L is extremely suggestive of hyperandrogenism. &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 18844715 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Free androgen index (FAI) &amp;lt;/b&amp;gt; is the ratio of total testosterone measurement to levels of &amp;lt;b&amp;gt; sex hormone-binding globulin &amp;lt;/b&amp;gt; (SHBG). Those with PCOS will have high FAI, as this indicates a high ration of free testosterone in the body.&lt;br /&gt;
Other blood tests are also done to help exclude other predisposing factors such as levels of &amp;lt;b&amp;gt; Thyroid Stimulating Hormone &amp;lt;/b&amp;gt; (LSH) and &amp;lt;b&amp;gt; Follicle-stimulating hormone &amp;lt;/b&amp;gt; (FSH). An elevated ratio of LSH to FSH, of above 2:1 &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 14737959 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;, indicates a possibility, but not definitively, of PCOS.&lt;br /&gt;
The effect of &amp;lt;b&amp;gt; insulin &amp;lt;/b&amp;gt; on blood can also be tested for insulin resistance. Insulin resistance enhances androgen production and increases free androgen levels by reducing SHBG. This can used as an indication marker for the possibility of PCOS&lt;br /&gt;
A study in 2014 showed that &amp;lt;b&amp;gt; Anti-Müllerian hormone &amp;lt;/b&amp;gt; (AMH) is found to be elevated in patients with PCOS &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 24821925 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;, giving rise to its potential clinical implication in diagnosing PCOS. AMH is exclusively produced in ovarian follicles, with individual AMH concentration reflecting the quantity of remaining primordial follicles and measure of ovarian reserve. &lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Gynecologic ultrasonography&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
Gynecologic ultrasonography is a pelvic ultrasound, specifically to the female pelvic region, with regards to the uterus, ovaries and the fallopian tube. The examination can be performed by transabdominal ultrasonography, with a full bladder, or transvaginal ultrasonography with a vaginal transducer. Typically transvaginal imaging shows a better and clearer image than transabdominal ultrasonography, as it uses higher frequency imaging, but is limited to areas it can reach. In the case of PCOS, both techniques can provide an image of the ovaries. Studies suggest that if more than 25 follicles are seen in an ovary, predominantly in the periphery, in women between 18-35 years, it is described to have a polycystic ovarian morphology. &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 24345633 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Magnetic Resonance Imaging&amp;lt;/u&amp;gt;===&lt;br /&gt;
Ovaries can also be seen on MRIs. On MRIs, PCOS is characterized by numberous peripheral cysts where the ovaries affected to be slightly larger than normal. Although MRI is seen to be effective in ovarian imaging, the finding of peripheral ovarian cysts in MRIsmay not be PCOS specific. &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 8888256 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt; But studies have seen that MR imaging in adolescence uncover distinct differences between young patients with and without PCOS &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 23292744 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;, with also great diagnostic sensitivity with patients between the age of 21-30 &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 19241321 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;, providing assistance of imagery in patients whom may be opposed to transvaginal ultrasounds.&lt;br /&gt;
&lt;br /&gt;
=Prevention and Treatment=&lt;br /&gt;
&lt;br /&gt;
There currently is no cure for PCOS, nor can it be prevented. This can be largely attributed to genetics, and because it can progress without being noticed for an extended period (generally until puberty begins). Treatment maybe involve lifestyle changes or hormonal augmentation in regulating periods, hirsutism, and acne, in addition to regulating androgen levels.&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Current Treatments&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|border=&amp;quot;1&amp;quot;&lt;br /&gt;
|-bgcolor=&amp;quot;DDCEF2&amp;quot;&lt;br /&gt;
| '''CURRENT TREATMENT'''&lt;br /&gt;
| '''DISADVANTAGES'''&lt;br /&gt;
|-&lt;br /&gt;
| General Practitioners tend to prescribe oral anti-oestrogens, most commonly the contraceptive pill, to restore ovulation.&lt;br /&gt;
| This method only has a 50% success rate in PCOS patients. It does not directly increase fertility rates, but restores the menstrual cycle. &amp;lt;ref    name= pink&amp;gt;&amp;lt;pubmed&amp;gt;26194691&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;       &lt;br /&gt;
 &lt;br /&gt;
|-bgcolor=&amp;quot;FAF5FF&amp;quot;&lt;br /&gt;
| Lifestyle changes are highly encouraged by medical practitioners. Diet and exercise regimes can be designed with a dietitian or nutritionist. &amp;lt;ref name= purple&amp;gt;&amp;lt;pubmed&amp;gt;26289303&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Exercise and diet plans do not directly increase fertility. They are designed to enhance weight loss, which in some patients can encourage normal hormone levels from the pituitary and thyroid. &amp;lt;ref name=purple/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Clomiphene citrate administration (generally in pill form, as prescribed by a GP). Such pills stimulate the pituitary gland to release GnRH to simulate ovulation (with a 72% success rate). &amp;lt;ref name= green&amp;gt;&amp;lt;pubmed&amp;gt;26150870&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Clomiphene can cause multiple side effects, most notably abnormal uterine bleeding and pelvic pain to due enlargement of the ovaries. &lt;br /&gt;
&lt;br /&gt;
Thus, it cannot be as frequently prescribed as the contraceptive pill, and careful patient monitoring is imperative &amp;lt;ref name=green/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
|-bgcolor=&amp;quot;FAF5FF&amp;quot;&lt;br /&gt;
| Higher fertility rates are observed in treatments combining clomiphene citrate and metformin (79% success) &amp;lt;ref name=green/&amp;gt;.&lt;br /&gt;
| Similar disadvantages as clomiphene, above.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Laparoscopic Ovarian Drilling===&lt;br /&gt;
Laparoscopic ovarian drilling (LOD) is a surgical method of treating polycystic ovaries and is typically used when an infertile woman does not respond to administration of clomiphene citrate. &amp;lt;ref name=blue&amp;gt;&amp;lt;pubmed&amp;gt;PMC4367066&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The most common form of LOD involves electrocautery through the use of an insulinated uniupolar needle electrode. The exact method of action of LOD is poorly understood. The most accepted hypothesis however is that the breakdown of ovarian follicles and stroma via heat, laser or mechanical drilling brings about a decrease in androgen and inhibin levels, followed by a rise in the levels of FSH. Inflammatory growth factors produced in response to the thermal injury caused by laser drilling can enhance the action that FSH has on folliculogenesis. Improved blood flow often results from LOD which serves to drastically improves the delivery of gonadotrophins to the ovary.&amp;lt;ref name=blue&amp;gt;&amp;lt;pubmed&amp;gt;PMC4367066&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
LOD can be an appealing alternative to treatment with gonadotrophins, as the latter is typically time consuming, expensive and requires constant monitoring in order to be effective.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22696324&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The overall effectiveness of LOD as a standalone treatment for PCOS is still questionable. Several studies have shown that there is no evidence of significant differences in pregnancy and live births in women undergoing LOD and those undergoing other medical treatments. &amp;lt;ref name=blue&amp;gt;&amp;lt;pubmed&amp;gt;PMC4367066&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=JH-Yx1QWUBk&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Ovarian Drilling by Laparoscopy for PCOS &amp;lt;ref&amp;gt;Mishra, R., (2014, September 8) Ovarian Drilling by Laparoscopy for PCOS. Retrieved from https://www.youtube.com/watch?v=JH-Yx1QWUBk&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;New Trials&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Some studies have found that regular Selenium supplements can encourage fertility among PCOS patients. The program, which is still in its early trial period, requires women to consume selenium tablets for 8 weeks. This study has found a significant decrease in dehydroepiandrosterone (DHEA) levels in patients, thus reducing excessive hair growth associated with PCOS. A direct link to increased fertility is yet to be established, and thus further testing is required.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26267328&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
=References=&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{ANAT2341Project2015header}}&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_3&amp;diff=206449</id>
		<title>2015 Group Project 3</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_3&amp;diff=206449"/>
		<updated>2015-10-19T03:31:23Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015header}}&lt;br /&gt;
&lt;br /&gt;
=Female Infertility &amp;amp; Polycystic Ovarian Syndrome=&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Polycystic Ovary juxtaposed with a Standard Ovary.png|700px|thumb|centre|PCOS Ovary vs. Non-PCOS Ovary]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Definition&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
[[File:Prevalence of Primary Infertility in 2010.jpeg|400px|thumb|right|Prevalence of Primary Infertility in 2010]]&lt;br /&gt;
&lt;br /&gt;
Female Infertility refers to the failure to conceive after one year of regular unprotected intercourse in females &amp;lt;ref name=one&amp;gt;&amp;lt;pubmed&amp;gt;26150870&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. In 2010, infertility affected 48.5 million couples world wide and the areas of highest prevalence included North Africa and Middle East, South Asia, Central/Eastern Europe and Central Asia and Sub-Saharan Africa &amp;lt;ref name=two&amp;gt;&amp;lt;pubmed&amp;gt;23271957&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. As there are several causes of female infertility, we will be focusing on infertility that is caused by '''Polycystic Ovarian Syndrome''' (PCOS), the most common cause of infertility that is medically treatable &amp;lt;ref name=one/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
{|&lt;br /&gt;
|-bgcolor=&amp;quot;DDCEF2&amp;quot; &lt;br /&gt;
|&lt;br /&gt;
* '''Polycystic Ovarian Syndrome (PCOS) is a common endocrine disorder, affecting up to 20% of reproductive aged women &amp;lt;ref name=three&amp;gt;&amp;lt;pubmed&amp;gt;21896560&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. It is the most common cause of anovulatory infertility &amp;lt;ref name=one/&amp;gt; which refers to infertility caused by the the absence of ovulation.'''&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
=Causes=&lt;br /&gt;
&lt;br /&gt;
PCOS is a disorder of heterogeneous origin with unknown aetiology &amp;lt;ref name=four&amp;gt;&amp;lt;pubmed&amp;gt;21896560&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Studies have shown that both genetic and environmental factors contribute to the development of PCOS in women however there is limited research into the actual interactions between these two factors &amp;lt;ref name=un&amp;gt;&amp;lt;pubmed&amp;gt;17185788&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Genetic Factors&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
Despite the lack of information regarding its aetiology, there is increasing evidence for a genetic involvement in the endocrine disorder. Studies have shown that genes play an important role in contributing towards the clinical and biochemical features of the disease &amp;lt;ref name=four/&amp;gt;. This evidence includes the family clustering of cases, greater unanimity between monozygotic twins than heterozygotic twins and the ability to inherit endocrine and  metabolic features of PCOS &amp;lt;ref name=four/&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
In one study, 115 sisters of women with PCOS were examined and results showed that half of these sisters had high testosterone levels, suggesting that hyperandrogenemia is a common trait with a dominant pattern of inheritance. These results strongly supported the idea of the familial clustering of biochemical features such as hyperandrogenism in first degree relatives &amp;lt;ref name=deux&amp;gt;&amp;lt;pubmed&amp;gt;9843997&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Several genes have been considered to play an important role in the development of PCOS such as CYP11A, the insulin gene, the follistatin gene and a region near the insulin receptor gene. Yet, the evidence supporting most of these genes has been refuted by larger studies, except for the region near the insulin receptor gene &amp;lt;ref name=deux/&amp;gt;. Among these, the gene CYP11a is the one that is strongly associated with hyperandrogenism in women with PCOS. &amp;lt;ref name=cinq&amp;gt;&amp;lt;pubmed&amp;gt;9147642&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; While it doesn't isolate this gene as the sole cause of PCOS, variation of the genotype at this locus contributes to production of excess androgen &amp;lt;ref name=h4&amp;gt;&amp;lt;pubmed&amp;gt;7962289&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Studies have also shown that there is strong evidence for linkage between the alleles at the Variable Number Tandem Repeats (VNTR) which is situated 5' to the insulin gene and PCOS. The data from the study suggests that it is a very susceptible region in PCOS and also may play a role in the development of hyperinsulinaemia &amp;lt;ref name=trois&amp;gt;&amp;lt;pubmed&amp;gt;9455828&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Environmental Factors&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
The prevalence of PCOS in populations where there has been a constant gene pool indicates that environmental factors play a significant role in the aetiology of PCOS.&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Obesity and Diet&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
Obesity is the major environmental factor driving the development of PCOS in susceptible individuals. The rising rates of PCOS have been paralleled by the widespread emergence of obesity and type 2 diabetes which are prevalent in developed countries. The risk of developing PCOS from obesity is compounded by  poor dietary choices and lack of physical activity which has begun to characterise the lifestyle in developed countries &amp;lt;ref name=deux/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Medication&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
Studies have shown that valproic acid in medication used to treat epilepsy and bipolar disorders contributes to the development of PCOS. Women with these disorders  may develop the typical features of PCOS such as polycystic ovaries, anovulation, hyperandrogenism and obesity &amp;lt;ref name=quartre&amp;gt;&amp;lt;pubmed&amp;gt;8413434&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Recent studies also suggest that the weight gain from medication is significant as it can lead to the development of PCOS &amp;lt;ref name=deux/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
=Pathogenesis=&lt;br /&gt;
&lt;br /&gt;
The pathogenesis of polycystic ovarian syndrome is poorly understood, however it is believed that insulin resistance and excess androgens such as testosterone play a fundamental role.&lt;br /&gt;
Underlying factors such as obesity and genetic predispositions likely contribute to the onset of polycystic ovarian syndrome through the development of a combination of hyperinsulinemia and hyperandrogenemia.&amp;lt;ref name=eleven&amp;gt;&amp;lt;pubmed&amp;gt;PMC4556908&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Hyperinsulinemia&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
Hyperinsulinemia is a term that defines the presence of excessive amounts of insulin in the blood relative to the amount of glucose. &amp;lt;ref name=fourteen&amp;gt;&amp;lt;pubmed&amp;gt;PMC4114053&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This phenomenon is typically associated with obesity and excess adipose tissue, both of which are associated with insulin resistance. In order to overcome this resistance, insulin secretion is increased in an attempt to normalise blood glucose levels, thereby leading to hyperinsulineamia. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2782313&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Excessive levels of insulin typically cause disruption to the hypothalamus-hypophysis-ovary axis whilst insulin resistance in ovarian tissues leads to decreased metabolic signalling. However, steroidogenic activity is largely unaffected by the impaired metabolic signalling, thereby paving the way androgens to become more effect and paving the way towards hyperandrogenemia. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC4334071&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
[[File:Patholophysiology of Polycystic Ovarian Syndrome.jpg|500px|thumb|left|The impact of hyperinsulinemia and hyperandrogenemia on the development of polycystic ovarian syndrome]]&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Hyperandrogenemia&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
Hyperandrogenemia is a hallmark of the development of polycystic ovarian syndrome, with 80% of women presenting with excess androgen also having polycystic ovaries.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3872139&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The disruption of the hypothalamus hypophysis ovary axis as a result of hyperinsulinemia increases the release of GnRH and LH, leading to increased androgen production in the ovarian theca cells. Hyperandrogenemia decreases the feedback sensitivity of both estradiol and progesterone within gonadotropic hypothalmic cells. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC4334071&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A deficiency of FSH is observed and correlates with the increased secretion of GnRH and LH. As a result of this deficiency, graunlosa  cell aromatisation to oestrogens as well as follicle maturation and ovulation will be drastically impaired.  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3453528&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
As a consequence of the impairment of follicle maturation, small antral follicles will accumulate within the periphery of the ovary and develop a cystic morphology. Ovulation will be unable to occur due to the absence of mature follicles, culminating in infertility.  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC4562327&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Hyperandrogenism&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
====Animal Models====&lt;br /&gt;
&lt;br /&gt;
Studies conducted on female rhesus monkeys have supported evidence for the foetal origins of the clinical features of PCOS &amp;lt;ref name=h1&amp;gt;&amp;lt;pubmed&amp;gt;18406243&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.  It has been shown that in human females, an excess of androgen exposure at any stage from the development of the ovaries to the onset of puberty manifests as characteristic features of PCOS, such as resistance to insulin and Luteinising Hormone (LH) hypersecretion. After exposure to levels of testosterone matching those of fetal males, in utero, female rhesus monkeys were found to display the clinical and biochemical features typical of PCOS such as hypersecretion of LH and abnormal insulin action. These results correlated to those of similar studies conducted on sheep, where the pregnant ewe was exposed to excessive levels of testosterone and LH secretion and abnormality in ovarian cycles were again prominent features &amp;lt;ref name=sheep&amp;gt;Padmanabhan V, Evans NP, Taylor JA, Robinson JE1997 '''Prenatal exposure to  androgens  leads  to  the  development  of  cystic  ovaries  in  the  sheep'''. Biol Reprod 56:194&amp;lt;/ref&amp;gt;. While these studies indicate that similar biochemical and clinical manifestations in humans originate from excess androgen exposure of the female fetus, it must be noted that it is very unlikely for any excess androgen production to be passed across the placenta from the mother to her daughter. This is because mechanisms such as androgen binding proteins and placental metabolism of androgen prevent excess androgen entering the circulation of the fetus &amp;lt;ref name=h2&amp;gt;&amp;lt;pubmed&amp;gt;12098657&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
====Cell Culture Models====&lt;br /&gt;
&lt;br /&gt;
While studies have shown that the adrenal could be a source of excess androgen such as the adrenal &amp;lt;ref name=h3&amp;gt;&amp;lt;pubmed&amp;gt;7962325&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;, they were followed by various studies using cell culture models which demonstrated that the ovary was the major source of excess androgen &amp;lt;ref name=h4/&amp;gt; &amp;lt;ref name=h5&amp;gt;&amp;lt;pubmed&amp;gt;9302378&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. ''In vitro'' studies have shown that the production of steroids is abnormal in theca cells &amp;lt;ref name=h3/&amp;gt;. In women affected by PCOS, stimulation by human chorionic gonadotrophin (hCG) is followed by an increase in thecal steroid production after suppression of LH by a GnRH analogue &amp;lt;ref name=h5/&amp;gt;. Theca cells cultured from polycystic ovaries produce 20 times as much androstenedione as those from normal ovaries &amp;lt;ref name=h4/&amp;gt; with increased expression of mRNA for enzymes responsible for making steroids also reported in following studies. &amp;lt;ref name=h6&amp;gt;&amp;lt;pubmed&amp;gt;10852468&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; These results have prompted many studies on genes encoding these steroidogeneic enzymes.&lt;br /&gt;
&lt;br /&gt;
[[File:Polycystic_rat_ovary.jpg|500px|thumb|right|An example of polycysts present in the polycystic ovaries of a rat specimen]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
=Signs and Symptoms=&lt;br /&gt;
&lt;br /&gt;
The symptoms of PCOS are different for each women. The three cardinal signs of PCOS are hyperandrogenism, polycystic ovaries and ovarian dysfunction &amp;lt;ref name=sign1&amp;gt;&amp;lt;pubmed&amp;gt;14688154&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Common clinical symptoms include &amp;lt;ref&amp;gt; Women's Heath, U.S. Department of Health and Human Services ,[ http://www.womenshealth.gov/publications/our-publications/fact-sheet/polycystic-ovary-syndrome.html#d ], 'Polycystic ovary syndrome (PCOS) fact sheet'&amp;lt;/ref&amp;gt; ;&lt;br /&gt;
&lt;br /&gt;
{|&lt;br /&gt;
|-bgcolor=&amp;quot;DDCEF2&amp;quot; &lt;br /&gt;
|&lt;br /&gt;
* Infertility- due to anovulation. &lt;br /&gt;
* Irregular Menstrual Cycles&lt;br /&gt;
* Hirsutism&lt;br /&gt;
* Ovarian Cysts&lt;br /&gt;
* Obesity&lt;br /&gt;
* Male Pattern Baldness&lt;br /&gt;
* Skin Tags&lt;br /&gt;
* Pelvic Pain&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
Along with obesity, PCOS is also associated with other metabolic issues such as insulin resistance, hyperinsulinemia and type 2 diabetes mellitus. It has also been associated with cardiovascular problems and cancers of the breast and endometrium &amp;lt;ref name=sign3&amp;gt;&amp;lt;pubmed&amp;gt;PMC4341818&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
=Diagnosis=&lt;br /&gt;
&lt;br /&gt;
A major diagnostic tool for PCOS is a pelvic ultrasound, but PCOS diagnosis cannot be completely dependent on just pelvic ultrasounds. A patient with PCOS may not necessarily have polycystic ovaries, and those with ovarian cysts may not necessarily have PCOS. A range of diagnostic assessments and associated symptoms have to be thoroughly investigated.&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Medical history and examination&amp;lt;/u&amp;gt;===&lt;br /&gt;
Clinical questions are asked or filled out in the form of a questionnaire to assess and assist in the diagnosis of PCOS. Studies show that those with a history:&lt;br /&gt;
*infrequent and irregular menstruation&lt;br /&gt;
*hirsutism (related to high levels of androgens in the blood – hyperandrogenism)&lt;br /&gt;
*obesity&lt;br /&gt;
*acne production &lt;br /&gt;
are at a higher predictive risk of PCOS. But questions regarding failed pregnancy attempts and history of nipple discharge proved no correlation in diagnosing PCOS. &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 17872783 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Ultrasound of Polycystic Ovaries .jpg|400px|thumb|right|Ultrasound of Polycystic Ovaries]]&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Blood Test&amp;lt;/u&amp;gt;===&lt;br /&gt;
A patient with elevated levels of androgens, a medical condition called &amp;lt;b&amp;gt;hyperandrogenism &amp;lt;/b&amp;gt;, is very highly likely to have PCOS. &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 20591140 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt; Androgens &amp;lt;/b&amp;gt; , such as testosterone, and &amp;lt;b&amp;gt;free androgen index (FAI) &amp;lt;/b&amp;gt; are the two tests best used in diagnosing hyperandrogenism.&lt;br /&gt;
Androgen excess in PCOS is a result from increased synthesis and release of ovarian androgens. &amp;lt;b&amp;gt;Dehydroepiandrosterone sulfate &amp;lt;/b&amp;gt; (DHEA-S) levels are used as a biomarker for testing androgen levels, as it is made exclusively by the adrenal glands. DHEA-S levels of above 1890 micromol/L is extremely suggestive of hyperandrogenism. &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 18844715 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Free androgen index (FAI) &amp;lt;/b&amp;gt; is the ratio of total testosterone measurement to levels of &amp;lt;b&amp;gt; sex hormone-binding globulin &amp;lt;/b&amp;gt; (SHBG). Those with PCOS will have high FAI, as this indicates a high ration of free testosterone in the body.&lt;br /&gt;
Other blood tests are also done to help exclude other predisposing factors such as levels of &amp;lt;b&amp;gt; Thyroid Stimulating Hormone &amp;lt;/b&amp;gt; (LSH) and &amp;lt;b&amp;gt; Follicle-stimulating hormone &amp;lt;/b&amp;gt; (FSH). An elevated ratio of LSH to FSH, of above 2:1 &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 14737959 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;, indicates a possibility, but not definitively, of PCOS.&lt;br /&gt;
The effect of &amp;lt;b&amp;gt; insulin &amp;lt;/b&amp;gt; on blood can also be tested for insulin resistance. Insulin resistance enhances androgen production and increases free androgen levels by reducing SHBG. This can used as an indication marker for the possibility of PCOS&lt;br /&gt;
A study in 2014 showed that &amp;lt;b&amp;gt; Anti-Müllerian hormone &amp;lt;/b&amp;gt; (AMH) is found to be elevated in patients with PCOS &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 24821925 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;, giving rise to its potential clinical implication in diagnosing PCOS. AMH is exclusively produced in ovarian follicles, with individual AMH concentration reflecting the quantity of remaining primordial follicles and measure of ovarian reserve. &lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Gynecologic ultrasonography&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
Gynecologic ultrasonography is a pelvic ultrasound, specifically to the female pelvic region, with regards to the uterus, ovaries and the fallopian tube. The examination can be performed by transabdominal ultrasonography, with a full bladder, or transvaginal ultrasonography with a vaginal transducer. Typically transvaginal imaging shows a better and clearer image than transabdominal ultrasonography, as it uses higher frequency imaging, but is limited to areas it can reach. In the case of PCOS, both techniques can provide an image of the ovaries. Studies suggest that if more than 25 follicles are seen in an ovary, predominantly in the periphery, in women between 18-35 years, it is described to have a polycystic ovarian morphology. &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 24345633 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Magnetic Resonance Imaging&amp;lt;/u&amp;gt;===&lt;br /&gt;
Ovaries can also be seen on MRIs. On MRIs, PCOS is characterized by numberous peripheral cysts where the ovaries affected to be slightly larger than normal. Although MRI is seen to be effective in ovarian imaging, the finding of peripheral ovarian cysts in MRIsmay not be PCOS specific. &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 8888256 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt; But studies have seen that MR imaging in adolescence uncover distinct differences between young patients with and without PCOS &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 23292744 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;, with also great diagnostic sensitivity with patients between the age of 21-30 &amp;lt;ref&amp;gt; &amp;lt;pubmed&amp;gt; 19241321 &amp;lt;/pubmed&amp;gt; &amp;lt;/ref&amp;gt;, providing assistance of imagery in patients whom may be opposed to transvaginal ultrasounds.&lt;br /&gt;
&lt;br /&gt;
=Prevention and Treatment=&lt;br /&gt;
&lt;br /&gt;
There currently is no cure for PCOS, nor can it be prevented. This can be largely attributed to genetics, and because it can progress without being noticed for an extended period (generally until puberty begins). Treatment maybe involve lifestyle changes or hormonal augmentation in regulating periods, hirsutism, and acne, in addition to regulating androgen levels.&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;Current Treatments&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|border=&amp;quot;1&amp;quot;&lt;br /&gt;
|-bgcolor=&amp;quot;DDCEF2&amp;quot;&lt;br /&gt;
| '''CURRENT TREATMENT'''&lt;br /&gt;
| '''DISADVANTAGES'''&lt;br /&gt;
|-&lt;br /&gt;
| General Practitioners tend to prescribe oral anti-oestrogens, most commonly the contraceptive pill, to restore ovulation.&lt;br /&gt;
| This method only has a 50% success rate in PCOS patients. It does not directly increase fertility rates, but restores the menstrual cycle. &amp;lt;ref    name= pink&amp;gt;&amp;lt;pubmed&amp;gt;26194691&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;       &lt;br /&gt;
 &lt;br /&gt;
|-bgcolor=&amp;quot;FAF5FF&amp;quot;&lt;br /&gt;
| Lifestyle changes are highly encouraged by medical practitioners. Diet and exercise regimes can be designed with a dietitian or nutritionist. &amp;lt;ref name= purple&amp;gt;&amp;lt;pubmed&amp;gt;26289303&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Exercise and diet plans do not directly increase fertility. They are designed to enhance weight loss, which in some patients can encourage normal hormone levels from the pituitary and thyroid. &amp;lt;ref name=purple/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| Clomiphene citrate administration (generally in pill form, as prescribed by a GP). Such pills stimulate the pituitary gland to release GnRH to simulate ovulation (with a 72% success rate). &amp;lt;ref name= green&amp;gt;&amp;lt;pubmed&amp;gt;26150870&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Clomiphene can cause multiple side effects, most notably abnormal uterine bleeding and pelvic pain to due enlargement of the ovaries. &lt;br /&gt;
&lt;br /&gt;
Thus, it cannot be as frequently prescribed as the contraceptive pill, and careful patient monitoring is imperative &amp;lt;ref name=green/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
|-bgcolor=&amp;quot;FAF5FF&amp;quot;&lt;br /&gt;
| Higher fertility rates are observed in treatments combining clomiphene citrate and metformin (79% success) &amp;lt;ref name=green/&amp;gt;.&lt;br /&gt;
| Similar disadvantages as clomiphene, above.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Laparoscopic Ovarian Drilling===&lt;br /&gt;
Laparoscopic ovarian drilling (LOD) is a surgical method of treating polycystic ovaries and is typically used when an infertile woman does not respond to administration of clomiphene citrate. &amp;lt;ref name=blue&amp;gt;&amp;lt;pubmed&amp;gt;PMC4367066&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The exact method of action of LOD is poorly understood. The most accepted hypothesis however is that the breakdown of ovarian follicles and stroma via heat, laser or mechanical drilling brings about a decrease in androgen and inhibin levels, followed by a rise in the levels of FSH. Inflammatory growth factors produced in response to the thermal injury caused by laser drilling can enhance the action that FSH has on folliculogenesis. Improved blood flow often results from LOD which serves to drastically improves the delivery of gonadotrophins to the ovary.&amp;lt;ref name=blue&amp;gt;&amp;lt;pubmed&amp;gt;PMC4367066&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
LOD can be an appealing alternative to treatment with gonadotrophins, as the latter is typically time consuming, expensive and requires constant monitoring in order to be effective.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22696324&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===&amp;lt;u&amp;gt;New Trials&amp;lt;/u&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Some studies have found that regular Selenium supplements can encourage fertility among PCOS patients. The program, which is still in its early trial period, requires women to consume selenium tablets for 8 weeks. This study has found a significant decrease in dehydroepiandrosterone (DHEA) levels in patients, thus reducing excessive hair growth associated with PCOS. A direct link to increased fertility is yet to be established, and thus further testing is required.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26267328&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
=References=&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{ANAT2341Project2015header}}&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=ANAT2341_Lab_10_-_Online_Assessment_2015&amp;diff=206329</id>
		<title>ANAT2341 Lab 10 - Online Assessment 2015</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=ANAT2341_Lab_10_-_Online_Assessment_2015&amp;diff=206329"/>
		<updated>2015-10-17T14:26:30Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Header}}&lt;br /&gt;
&lt;br /&gt;
==Individual Assessment==&lt;br /&gt;
* Place your work on this page under a sub-sub-heading of your ROI.&lt;br /&gt;
* Add your own sub-sub-heading '''below''' any existing student ROI.&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wikitable mw-collapsible mw-collapsed&amp;quot;&lt;br /&gt;
! About this Assessment&lt;br /&gt;
|-&lt;br /&gt;
| A demonstration of this assessment will be given in the practical class. Below in the collapsible table are examples of links from a virtual slide. There is also a [[Help:Virtual Slides Permalink|permalink help page]].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{Virtual Slide Features - Stage 22 Liver}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Using the Human Embryo Carnegie Stage 22 [[Embryo Virtual Slides|virtual slides]] shown below:&lt;br /&gt;
&lt;br /&gt;
# Using the &amp;quot;mobile view&amp;quot; Identify a sensory region of interest ('''ROI''') in one of the virtual slides below.&lt;br /&gt;
# View at a high magnification (detailed view) the region of interest.&lt;br /&gt;
#  Generate a [[Help:Virtual Slides Permalink|permalink]] to the ROI.&lt;br /&gt;
# Paste the link on your own page and write a brief description of what the linked region is showing.&lt;br /&gt;
# Add a link to the embryology page and sub-heading that relates to your identified feature.&lt;br /&gt;
# Paste all the content (text and links) you have just generated on [[ANAT2341 Lab 10 - Online Assessment 2015|'''this page''']] under a sub-heading named after your ROI.&lt;br /&gt;
&lt;br /&gt;
{|&lt;br /&gt;
| valign=bottom|{{SlideStage22-08}}&lt;br /&gt;
| valign=bottom|{{SlideStage22-08-eye}}&lt;br /&gt;
|-&lt;br /&gt;
| valign=bottom|{{SlideStage22-11}}&lt;br /&gt;
| valign=bottom|{{SlideStage22-15}}&lt;br /&gt;
|}&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Student ROIs==&lt;br /&gt;
&lt;br /&gt;
===This is a sub-sub-heading===&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Cochlear Duct===&lt;br /&gt;
&lt;br /&gt;
link to permalink image:[https://embryology.med.unsw.edu.au/embryology/Slides/Embryo_Stages/Stage22/11/Stage22-11.html?zoom=6&amp;amp;lat=-3948&amp;amp;lon=6149&amp;amp;layers=B | Cochlear Duct ]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
The '''cochlear duct''' is an fluid filled cavity inside the cochlea. It located between the tympanic duct and the vestibular duct, and between the basilr membrane and reissner's memebrane. It derived from otic placode, otic vesicle, and originated from surface ectoderm.&lt;br /&gt;
&lt;br /&gt;
'''embryology link''' [[Sensory - Hearing and Balance Development]]   --Inner Ear&lt;br /&gt;
&lt;br /&gt;
===Semicircular Canal===&lt;br /&gt;
&lt;br /&gt;
link to permalink image:[https://embryology.med.unsw.edu.au/embryology/Slides/Embryo_Stages/Stage22/11/Stage22-11.html?zoom=6&amp;amp;lat=-5565.50267&amp;amp;lon=7382.99733&amp;amp;layers=B | Semicircular Canal ]&lt;br /&gt;
&lt;br /&gt;
The '''semicircular canals''' are part of the inner ear.They are lined with cilia  and filled with endolymph which is a liquid substance. Every time the head moves, the endolymph moves the cilia and this movements of the cilia are communicated to the brain. As a result, the brain knows how to keep the body balanced, regardless of the posture.&lt;br /&gt;
&lt;br /&gt;
'''embryology link''' [[Hearing - Inner Ear Development]] -- Inner Ear &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Lens of the Eye===&lt;br /&gt;
&lt;br /&gt;
Link to permalink image: [https://embryology.med.unsw.edu.au/embryology/Slides/Embryo_Stages/Stage22/08-eye/Stage22-08-eye.html?zoom=6&amp;amp;lat=-2022&amp;amp;lon=2991&amp;amp;layers=B Anterior portion of the Lens of the embryonic eye] &lt;br /&gt;
&lt;br /&gt;
The lens of the eye is derived from surface ectoderm. Said ectoderm forms a lens/optic placode in the head region which then invaginates to form a lens pit and then later a lens vessel. Lens fibres then develop and are surrounded by a lens capsule. The main function of the lens is to focus light onto the retina. &lt;br /&gt;
&lt;br /&gt;
'''Embryology link''' [[Vision - Lens Development]]  --Development Overview &lt;br /&gt;
&lt;br /&gt;
===Retina of the Eye===&lt;br /&gt;
Link to permalink image: [https://embryology.med.unsw.edu.au/embryology/Slides/Embryo_Stages/Stage22/08-eye/Stage22-08-eye.html?zoom=6&amp;amp;lat=-4961.72287&amp;amp;lon=4821.89847&amp;amp;layers=B Retina of the Eye]&lt;br /&gt;
&lt;br /&gt;
The retina is the light sensitive portion of the eye. It contains 10 separate layers, including the photoreceptor layer which is comprised of rods and cones. These rods and cones convert light into signals, which are then communicated to the brain via the optic nerve.&lt;br /&gt;
The image above displays a Carnegie Stage 22 retina. The nerve fibre layer is particularly prominent in this image and is the pale layer closest to the vitreous chamber. The processes of rods, cones and ganglion cells can be observed migrating towards the optic nerve.&lt;br /&gt;
&lt;br /&gt;
'''Embryology Link''' [[Vision - Retina Development]]&lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{{ANAT2341Lab10}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{2015ANAT2341}}&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=206327</id>
		<title>User:Z3416054</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=206327"/>
		<updated>2015-10-17T14:25:26Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Hi there&lt;br /&gt;
Just giving the editor a good old test run.&lt;br /&gt;
[[Test student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:45, 7 August 2015 (AEST)&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:47, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 14:06, 14 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:57, 21 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 12:22, 28 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:20, 4 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:18, 11 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:10, 25 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:28, 16 October 2015 (AEDT)&lt;br /&gt;
==Picture Tutorial==&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
===Article 1===&lt;br /&gt;
This research article aimed to determine the clinical outcomes following IVF (in vitro fertilisation) and embryo transfer treatments in subjects suffering from the sexually transmitted disease syphilis. The clinical outcomes mentioned are the rates of pregnancy and health of newborns following treatment via IVF. Couples engaged in sexual intercourse over 12 months without the use of contraception and who failed to conceive were deemed as being infertile.&lt;br /&gt;
&lt;br /&gt;
The subjects were divided into two groups based on serology results, a syphilis infected group and a control group, each with 160 individuals, giving a total of 320 subjects. The Syphilis infected group was further divided into three subcategories, a male infected group, a female infected group and a couple (male and female) infected group. Penicillin G20 (an anti-syphilis treatment) was given to the individuals in the syphilis group. IVF treatment commenced one month proceeding the disappearance of clinical syphilis symptoms or if test results gave a negative result for syphilis infection.&lt;br /&gt;
&lt;br /&gt;
The results of this experiment revealed no significant differences in regards to the basal FSH and LH of both the control and syphilis groups. However, the thickness of the endometrium differed greatly, with the syphilis group demonstrating a thicker endometrial wall (16.9±5.4mm) compared to the control group (13.0±4.7mm). Further differences were noted in blastocyst implantation rates, with the syphilis group having less successful implantations compared to the control (24.2% vs. 34.4% respectively).Normal oocyte cleavage differed between the two groups with the syphilis group demonstrating less normal oocyte cleavage compared to the control group  (6.3±4.7 vs. 8.1±4.6). Furthermore, the clinical pregnancy rates of the syphilis group stood at 43.8% compared to 55.6% of the control group.&lt;br /&gt;
&lt;br /&gt;
Syphilis infection appeared to have a significant impact on the success and clinical outcomes of IVF. Syphilis associated pelvic inflammatory disease can lead to an increase in the thickness of the endometrium, which can adversely affect blastocyte implantation and endometrial receptivity. Successful pregnancy rates typically correlate with an endometrial thickness of 7-14mm, with any thickness beyond 14mm often corresponding with decreased clinical pregnancies. Rates of clinical pregnancy and miscarriage rates did not differ between the three syphilis subgroups. Conception involving a male infected partner was associated with a shorter gestational period and decreased offspring birth weight, when compared to the female infected and couple infected subgroups. No explanation for this phenomenon was provided.&lt;br /&gt;
&lt;br /&gt;
PMID 26208116&lt;br /&gt;
&lt;br /&gt;
''Article 1 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4514756&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
===Article 2===&lt;br /&gt;
The effects of oxygen levels on factors such as cleavage, implantation and pregnancy rates in IVF cultured embryos was the primary focus of this article.  Women between the ages of 20-48 who were seeking treatment for infertility were utilised in this experiment.&lt;br /&gt;
Gametes were allocated to be incubated in one of three environments, each with a different oxygen concentration. The first group was placed in an atmosphere with an oxygen concentration of 20%. The second group rested in a 20% oxygen environment for a day before being moved to a 5% oxygen, 5% carbon dioxide and 90% nitrogen atmosphere. The third group consisted of a 5% carbon dioxide, 5% oxygen and 90% nitrogen atmosphere. The gametes (spermatozoa and oocytes) were incubated together in their respective environmental conditions for 4-6 hours after which fertilisation is presumed to have occurred.&lt;br /&gt;
&lt;br /&gt;
Successful embryos were transferred at Day 3 cleavage. A biochemical analysis of HCG validated pregnancy, whilst ultrasound was used to confirm the presence of a heartbeat 28 days following the transfer.&lt;br /&gt;
IVF fertilisation rates were calculated as being the number of fertilised oocytes over the number of oocytes inseminated. Cleavage rates were characterised by the number of blastomeres over the number of fertilised and abortion rate by the amount of miscarriages divided by the number of transfers.&lt;br /&gt;
&lt;br /&gt;
The research article concluded that the embryos from the 5% oxygen group had the highest rates of fertilisation and implantation. The 20% oxygen group had the second highest rates of fertilisation and maintained excellent embryo quality, whilst the 20% to 5% group had the lowest rates overall. Abortion and miscarriage rates did not differ at all between the three groups. The group incubated at 5% oxygen demonstrated higher quality embryos and increased rates of pregnancy when compared to the 20% oxygen group. The article concludes that implantation, pregnancy and embryo quality can be somewhat affected by a set oxygen concentration, but are affected adversely by a shift from one concentration to another. &lt;br /&gt;
Shifting from one oxygen concentration to another appeared to have an adverse effect on the cleavage of the embryo and would likely impact future development and the overall success of the IVF treatment.&lt;br /&gt;
&lt;br /&gt;
PMID 26131222 &lt;br /&gt;
&lt;br /&gt;
''Article 2 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4483955&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These are quite good descriptions of these 2 articles. (5/5)&lt;br /&gt;
==Lab 2 Assessment==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Notch Signalling - Ovulation in Drosphila.jpg|Caption]]&lt;br /&gt;
&lt;br /&gt;
===Image Reference===&lt;br /&gt;
Jianjun Sun, Allan C Spradling Ovulation in Drosophila is controlled by secretory cells of the female reproductive tract. Elife: 2013, 2;e00415 PubMed 23599892&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 23599892&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) Image uploaded and named correctly. All reference, copyright and student image template included. You might have included in the summary box an explanation to the terms that appear in the image as there is no way for the reader to interpret what is shown in each panel. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 3 Assessment==&lt;br /&gt;
===Causes===&lt;br /&gt;
====The Genetics of Infertility: Current Status of the Field====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3885174&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This article attempted to determine the role that genetics plays in female infertility. It was noted that several prominent causes of female infertility such as Galactosemia and Primary Ovarian Failure (POF) were associated with specific genes, with the GALT gene contributing to the former condition and the FMR1 gene contributing to the latter.&lt;br /&gt;
&lt;br /&gt;
====Causes of Sterility in Bosnia-Herzegovina Population====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4499307&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
The study conducted as laid out in this article examined the causes of female sterility in the Bosnia-Herzegovina population. Married participants were arranged into various groups based upon their age. The experiment came to the conclusion that in approximately 42% of infertile married couples, female sterility was the primary cause. The two primary causes of female infertility were tubal deficiencies (31% of cases) and Diminished Ovarian Reserves (38% of cases)&lt;br /&gt;
&lt;br /&gt;
====Epidemiology, diagnosis, and management of polycystic ovary syndrome====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3872139&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This research article examines the causes of polycystic ovary syndrome (POS), a common cause of infertility in women. The article concluded that 50-70% of women suffer from insulin resistance secondary to Type 2 Diabetes and in many cases obseity, which may contribute partially to POS. Furthermore, 85-90% of women with oligomenorrhea also had POS, suggesting that it is an underlying cause. However, the exact pathophysiology of POS was not determined.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These papers relate to your group project, I hope they are useful for the final submission. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 4 Assessment==&lt;br /&gt;
===Quiz===&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
{Primary villi are produced during which stage of development?:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ Week 2&lt;br /&gt;
- Week 1&lt;br /&gt;
- Week 3&lt;br /&gt;
- None of the above&lt;br /&gt;
|| Primary Villi appear during Week 2 of development, whilst secondary villi appear during Week 3 of development.&lt;br /&gt;
&lt;br /&gt;
{Mesoderm is a precursor for all of the following EXCEPT:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Skeletal Muscle Cells&lt;br /&gt;
- Cardiac Muscle Cells&lt;br /&gt;
- Erythrocytes&lt;br /&gt;
+ Epidermal Skin Cells&lt;br /&gt;
- Smooth Muscle&lt;br /&gt;
|| Epidermal skin cells originate from ectoderm. Skeletal, cardiac and smooth muscle along with erythrocytes originate from the mesoderm.&lt;br /&gt;
&lt;br /&gt;
{Which of the following shows the correct developmental pathway of the male gamete:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatogonia &amp;gt; Spermatozoa&lt;br /&gt;
- Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell &amp;gt; Spermatozoa &amp;gt; Spermatid&lt;br /&gt;
- Sertoli Cell &amp;gt; Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatozoa&lt;br /&gt;
- Spermatid &amp;gt; Spermatozoa &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell&lt;br /&gt;
+ Spermatogonia &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatid &amp;gt; Spermatozoa&lt;br /&gt;
|| Spermatogonia represent the beginning of male sex cell development, with spermatozoa being the mature gamete.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) No descriptive title to your questions. Q1 relates to the timing of villi development. These types of questions encourage &amp;quot;student guessing&amp;quot; and you could have given a more detailed explanation and links to resources in your revealed answer e.g. [[Placenta - Villi Development]]. Q2 is a reasonable question, but only requiring the student only to know that Epidermal Skin Cells are from ectoderm. Once again it is your revealed answer that needs more work. Q3 is a little easy, as long as you know Spermatogonia are the diploid start cell you can quickly exclude most options, need more work. (8/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5 Assessment==&lt;br /&gt;
===Gastroschisis and Omphalocele===&lt;br /&gt;
&lt;br /&gt;
Gastroschisis is classified as a full thickness cleft found in the abdominal wall, adjacent to the site of insertion of the umbilical cord. The defining features of this abnormality is the absence of a membranous sac shrouding the intestines. As a result of this the intestines will become eviscerated, thereby protruding out of the abdominal wall and will be on the exterior, rather than the interior of the body. It is believed that disruption to the vascular supply of the right abdominal wall is the primary gass of gastroschisis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2166158&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Omphalocele is an abnormality characterised by the herniation of visceral organs such as the intestines, liver and spleen outside of the abdominal cavity. The visceral organs are enclosed in a membranous sac, into which the umbilical cord is inserted.  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC1355659&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The primary difference between gastroschisis and omphalocele lies in the presence of a membraneous sac and the exact organs herniating from the abdominal wall. Gastroschisis involves the intestines protruding to the outside of the body but are not covered by a membranous sac. Omphalocele however is characterised by the protrusion of multiple visceral organs (liver, spleen etc.) which are enclosed within a membranous. Furthermore, the size of both abnormalities differs greatly, with gastroschisis typically being 2-5 cm in size whilst omphalocele can vary between 2-15cm. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2552910&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) This is an adequate description of the differences between these conditions. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 7 Assessment==&lt;br /&gt;
&lt;br /&gt;
1: This research paper aimed to examine the relationship between fetal adrenal cells and the differentiated adrenal cortex. In particular, research was focussed upon possible pregenitor cells involved in maintenance of the adrenal cortex. It was hypothesised that the the most likely precursor cells of the adult cortex were the 'Glil' expressing cells found in the adrenal capsule. A number of mice adrenal glands were taken, treated with antigen retrieval solution, after which fluorescence microscopy was conducted.&lt;br /&gt;
&lt;br /&gt;
The results of the paper concluded that 'Glil' expressing descendants of fetal adrenal cells are the pregenitors of the differentiated adrenal cortex. Furthermore, it was found that the 'Glil' expressing cells oringinated from 'FAdE-Cre' expressing fetal adrenal cells. Thus the authors of this research article came to the conclusion that 'Glil' expressing cells found in the adrenal cortex play an important role in the development, differentiation and maintenance of the adrenal cortex. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3817941&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
2: A number of embryonic layers and tissues contribute to the development of teeth. The primary contributing layers are mesoderm, ectoderm and neural crest ectomesenchyme. Furthermore, neural crest may contribute through interactions with the ectoderm. Odontoblasts originate from neural crest derived mesenchymal cells and are responsible for forming predentin which calificies to create dentin (which forms the bulk of the tooth). Ameloblasts are responsible for the production of enamel, which provides teeth with the hardness required to engage in mastication. &lt;br /&gt;
&lt;br /&gt;
==Peer Assessment==&lt;br /&gt;
&lt;br /&gt;
===Group 1 Peer Assessment===&lt;br /&gt;
Hi guys! I'll start of by saying that the images and video you have included are excellent and are relevant to your topic of discussion. Also, you have a large number of reliable references which is good to see. However you have yet to include a hand drawn image, which is required for the wiki page. I feel like  you could probably eliminate the typed out 'timeline of mitochondrial donation' and instead use this as an opportunity to use a hand drawn image of the timeline. Furthermore, the timeline under 'cystoplasmic transfer' feels a bit awkward and unnecessary. You could probably include this timeline alongside the 'timeline of mitochondrial donation'. &lt;br /&gt;
&lt;br /&gt;
Under the 'Technical Progression' section it would be best to incorporate human embryo, mouse and human models under a sub-sub heading, as at the moment it feels a bit jumbled.&lt;br /&gt;
&lt;br /&gt;
I would also recommend moving the 'Benefits' heading towards the end of the page. It feels odd reading about the benefits of three person embryos before I gain a proper understanding of how they work. Also it might be worth talking about the disadvantages (if there are any) to three person embryos to balance out the 'benefits' section. As has been previously stated, make sure you sort out the copyright information for your video as it would be a shame to lose marks if it was missing. Also, don't forget to add the 'student template' to the 'Swapping mitochondrial DNA mammalian oocytes' image as it is currently absent.&lt;br /&gt;
&lt;br /&gt;
===Group 2 Peer Assessment===&lt;br /&gt;
So far your wiki page gives a very good coverage of Ovarian Hyper-Stimulation Syndrome. The progression of your subheadings progresses logically from one topic to another. It's good to see that you've included an excellent hand-drawn image which is well suited to the 'pathophysiology' subheading. The amount of textual information you have under each heading is vast and gives a comprehensive description of OHSS. Furthermore, you have an excellent range of sources to support your discussion.&lt;br /&gt;
&lt;br /&gt;
I feel however that asides from your hand-drawn image, your use of images and other source of media is definitely lacking. As is, your page is largely text with little to no breaks, making it quite difficult to read. The use of images would not only help break up the monotony of the text, but also help reinforce some of your ideas. I feel that the inclusion of images in the 'symptoms' and 'complications' subheadings would be suitable. &lt;br /&gt;
&lt;br /&gt;
It may also be worthwhile to include subheadings concerning current research, to inform readers about contemporary developments regarding OHSS. Furthermore,  'future research' could also be another potential subheading and could illuminate potential areas that are beginning to be or could be investigated in coming years.&lt;br /&gt;
&lt;br /&gt;
Overall, a very impressive page so far, that could be enhanced with the addition of relevant images and other media.&lt;br /&gt;
&lt;br /&gt;
===Group 4 Peer Assessment===&lt;br /&gt;
Very impressive work so far guys! Your page covers a comprehensive topic very well, without focussing too much on certain subheadings at the expense of others. Your use of both tables and images is excellent so far. It's good to see that you have also included a video to give some variety to the media on your page. The 'background information' gives context to the issues which you discuss and though it might not be of great use for someone familiar with embryology, it would be a great help to those with no experience in this field and is therefore useful in establishing the topic of male infertility.&lt;br /&gt;
&lt;br /&gt;
The only things that could be changed to improve your wiki page is perhaps altering the location of tables and pictures on your page. For example all pictures are located on the right side of the page, although not a significant issue, becomes slightly monotonous as one progresses through the page. It may be worth alternating pictures between left and right to mix things up a little bit and improve the overall flow of the page. &lt;br /&gt;
It might also be worth including a short video underneath the 'surgical treatments' subheading to give a visual example of some of the techniques discussed.&lt;br /&gt;
&lt;br /&gt;
Furthermore a subheading on future research could possibly be included under the 'treatments' subheading to give the reader information on techniques and therapies which may come to prominence in the near future.&lt;br /&gt;
&lt;br /&gt;
Your wiki page thus far is very impressive! Excellent work so far. &lt;br /&gt;
===Group 5 Peer Assessment===&lt;br /&gt;
Awesome page so far guys! I commend you on your use of various videos to assist in conveying your ideas. Furthermore, the images you have chosen are highly relevant to the topic of discussion and assist the reader in gaining a greater understanding of oncofertility. All copyright information is present for the images you have used which is excellent to see.&lt;br /&gt;
It may be worth including a hand drawn image under the 'radiation' subheading, as we are required to include at least one such image. The current image under the radiation subheading could easily be replicated by hand and could fulfill this portion of the criteria.&lt;br /&gt;
&lt;br /&gt;
I am nitpicking here, but I would also recommend including some kind of media, most likely a picture, underneath the surgery subheading. It might even be worth doing the hand drawn image here if possible. A picture may also be good underneath the 'types of chemotherapy drugs' subheading, just to break up the wall of text and improve the reading experience for the reader.&lt;br /&gt;
It might also be worth restructuring the 'oncofertility limitations' subheading into the form of a table (if possible), as the bullet point format feels quite awkward and out of place compared to the rest of the page.&lt;br /&gt;
The inclusion of a glossary is also recommended, as this page will be accessible by the general public and a glossary will assist those without a background in embryology to understand and appreciate your content.&lt;br /&gt;
&lt;br /&gt;
Keep up the great work guys! Your page is absolutely amazing so far and the effort you have put in is definitely reflected in the high quality of your page.&lt;br /&gt;
===Group 6 Peer Assessment===&lt;br /&gt;
A very snazzy wiki page so far! You have used a wide variety of images to convey the concepts of prenatal genetic diagnosis to those reading your wiki page. Copyright information and student templates were present for all the images which you provided which is great to see. A hand drawn image is absent, which is a requirement for every wiki page. It might be worth including the hand drawn image in the 'history section' as the information here could easily be represented by a hand drawn flow chart.&lt;br /&gt;
&lt;br /&gt;
I commend you on your inclusion of a 'future/current research' subheading as this gives the reader a perspective of where the field of prenatal genetic diagnosis is heading in the distant future.&lt;br /&gt;
&lt;br /&gt;
I see that you have included a table underneath the 'biopsy methods' subheading. It would be great to see you compile the advantages and disadvantages of blastomere biopsy and trophectoderm biopsy into a tabular format as this would make for an easier reading experience. Furthermore, tables may also be incorporated for the disadvantages and advantages of genetic techniques.&lt;br /&gt;
I would recommend the inclusion of other forms of media such as a video or gif to assist in the conveyance of information under certain subheadings. A video/gif would fit nicely underneath the 'biopsy method' subheading, though this is just a suggestion.&lt;br /&gt;
&lt;br /&gt;
Overall your assignment is superb so far. You have successfully covered a vast topic and made successful use of a broad range of sources to support your page. Your inclusion of images has been appropriate, however a hand drawn image is still required. &lt;br /&gt;
Keep up the good work guys! &lt;br /&gt;
&lt;br /&gt;
==Lab 10 Assessment==&lt;br /&gt;
[https://embryology.med.unsw.edu.au/embryology/Slides/Embryo_Stages/Stage22/08-eye/Stage22-08-eye.html?zoom=6&amp;amp;lat=-4961.72287&amp;amp;lon=4821.89847&amp;amp;layers=B Retina of the Eye]&lt;br /&gt;
&lt;br /&gt;
The retina is the light sensitive portion of the eye. It contains 10 separate layers, including the photoreceptor layer which is comprised of rods and cones. These rods and cones convert light into signals, which are then communicated to the brain via the optic nerve.&lt;br /&gt;
The image above displays a Carnegie Stage 22 retina. The nerve fibre layer is particularly prominent in this image and is the pale layer closest to the vitreous chamber. The processes of rods, cones and ganglion cells can be observed migrating towards the optic nerve. &lt;br /&gt;
'''Embryology Link''' [[Vision - Retina Development]]&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=206325</id>
		<title>User:Z3416054</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=206325"/>
		<updated>2015-10-17T14:24:08Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Hi there&lt;br /&gt;
Just giving the editor a good old test run.&lt;br /&gt;
[[Test student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:45, 7 August 2015 (AEST)&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:47, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 14:06, 14 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:57, 21 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 12:22, 28 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:20, 4 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:18, 11 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:10, 25 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:28, 16 October 2015 (AEDT)&lt;br /&gt;
==Picture Tutorial==&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
===Article 1===&lt;br /&gt;
This research article aimed to determine the clinical outcomes following IVF (in vitro fertilisation) and embryo transfer treatments in subjects suffering from the sexually transmitted disease syphilis. The clinical outcomes mentioned are the rates of pregnancy and health of newborns following treatment via IVF. Couples engaged in sexual intercourse over 12 months without the use of contraception and who failed to conceive were deemed as being infertile.&lt;br /&gt;
&lt;br /&gt;
The subjects were divided into two groups based on serology results, a syphilis infected group and a control group, each with 160 individuals, giving a total of 320 subjects. The Syphilis infected group was further divided into three subcategories, a male infected group, a female infected group and a couple (male and female) infected group. Penicillin G20 (an anti-syphilis treatment) was given to the individuals in the syphilis group. IVF treatment commenced one month proceeding the disappearance of clinical syphilis symptoms or if test results gave a negative result for syphilis infection.&lt;br /&gt;
&lt;br /&gt;
The results of this experiment revealed no significant differences in regards to the basal FSH and LH of both the control and syphilis groups. However, the thickness of the endometrium differed greatly, with the syphilis group demonstrating a thicker endometrial wall (16.9±5.4mm) compared to the control group (13.0±4.7mm). Further differences were noted in blastocyst implantation rates, with the syphilis group having less successful implantations compared to the control (24.2% vs. 34.4% respectively).Normal oocyte cleavage differed between the two groups with the syphilis group demonstrating less normal oocyte cleavage compared to the control group  (6.3±4.7 vs. 8.1±4.6). Furthermore, the clinical pregnancy rates of the syphilis group stood at 43.8% compared to 55.6% of the control group.&lt;br /&gt;
&lt;br /&gt;
Syphilis infection appeared to have a significant impact on the success and clinical outcomes of IVF. Syphilis associated pelvic inflammatory disease can lead to an increase in the thickness of the endometrium, which can adversely affect blastocyte implantation and endometrial receptivity. Successful pregnancy rates typically correlate with an endometrial thickness of 7-14mm, with any thickness beyond 14mm often corresponding with decreased clinical pregnancies. Rates of clinical pregnancy and miscarriage rates did not differ between the three syphilis subgroups. Conception involving a male infected partner was associated with a shorter gestational period and decreased offspring birth weight, when compared to the female infected and couple infected subgroups. No explanation for this phenomenon was provided.&lt;br /&gt;
&lt;br /&gt;
PMID 26208116&lt;br /&gt;
&lt;br /&gt;
''Article 1 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4514756&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
===Article 2===&lt;br /&gt;
The effects of oxygen levels on factors such as cleavage, implantation and pregnancy rates in IVF cultured embryos was the primary focus of this article.  Women between the ages of 20-48 who were seeking treatment for infertility were utilised in this experiment.&lt;br /&gt;
Gametes were allocated to be incubated in one of three environments, each with a different oxygen concentration. The first group was placed in an atmosphere with an oxygen concentration of 20%. The second group rested in a 20% oxygen environment for a day before being moved to a 5% oxygen, 5% carbon dioxide and 90% nitrogen atmosphere. The third group consisted of a 5% carbon dioxide, 5% oxygen and 90% nitrogen atmosphere. The gametes (spermatozoa and oocytes) were incubated together in their respective environmental conditions for 4-6 hours after which fertilisation is presumed to have occurred.&lt;br /&gt;
&lt;br /&gt;
Successful embryos were transferred at Day 3 cleavage. A biochemical analysis of HCG validated pregnancy, whilst ultrasound was used to confirm the presence of a heartbeat 28 days following the transfer.&lt;br /&gt;
IVF fertilisation rates were calculated as being the number of fertilised oocytes over the number of oocytes inseminated. Cleavage rates were characterised by the number of blastomeres over the number of fertilised and abortion rate by the amount of miscarriages divided by the number of transfers.&lt;br /&gt;
&lt;br /&gt;
The research article concluded that the embryos from the 5% oxygen group had the highest rates of fertilisation and implantation. The 20% oxygen group had the second highest rates of fertilisation and maintained excellent embryo quality, whilst the 20% to 5% group had the lowest rates overall. Abortion and miscarriage rates did not differ at all between the three groups. The group incubated at 5% oxygen demonstrated higher quality embryos and increased rates of pregnancy when compared to the 20% oxygen group. The article concludes that implantation, pregnancy and embryo quality can be somewhat affected by a set oxygen concentration, but are affected adversely by a shift from one concentration to another. &lt;br /&gt;
Shifting from one oxygen concentration to another appeared to have an adverse effect on the cleavage of the embryo and would likely impact future development and the overall success of the IVF treatment.&lt;br /&gt;
&lt;br /&gt;
PMID 26131222 &lt;br /&gt;
&lt;br /&gt;
''Article 2 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4483955&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These are quite good descriptions of these 2 articles. (5/5)&lt;br /&gt;
==Lab 2 Assessment==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Notch Signalling - Ovulation in Drosphila.jpg|Caption]]&lt;br /&gt;
&lt;br /&gt;
===Image Reference===&lt;br /&gt;
Jianjun Sun, Allan C Spradling Ovulation in Drosophila is controlled by secretory cells of the female reproductive tract. Elife: 2013, 2;e00415 PubMed 23599892&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 23599892&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) Image uploaded and named correctly. All reference, copyright and student image template included. You might have included in the summary box an explanation to the terms that appear in the image as there is no way for the reader to interpret what is shown in each panel. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 3 Assessment==&lt;br /&gt;
===Causes===&lt;br /&gt;
====The Genetics of Infertility: Current Status of the Field====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3885174&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This article attempted to determine the role that genetics plays in female infertility. It was noted that several prominent causes of female infertility such as Galactosemia and Primary Ovarian Failure (POF) were associated with specific genes, with the GALT gene contributing to the former condition and the FMR1 gene contributing to the latter.&lt;br /&gt;
&lt;br /&gt;
====Causes of Sterility in Bosnia-Herzegovina Population====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4499307&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
The study conducted as laid out in this article examined the causes of female sterility in the Bosnia-Herzegovina population. Married participants were arranged into various groups based upon their age. The experiment came to the conclusion that in approximately 42% of infertile married couples, female sterility was the primary cause. The two primary causes of female infertility were tubal deficiencies (31% of cases) and Diminished Ovarian Reserves (38% of cases)&lt;br /&gt;
&lt;br /&gt;
====Epidemiology, diagnosis, and management of polycystic ovary syndrome====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3872139&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This research article examines the causes of polycystic ovary syndrome (POS), a common cause of infertility in women. The article concluded that 50-70% of women suffer from insulin resistance secondary to Type 2 Diabetes and in many cases obseity, which may contribute partially to POS. Furthermore, 85-90% of women with oligomenorrhea also had POS, suggesting that it is an underlying cause. However, the exact pathophysiology of POS was not determined.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These papers relate to your group project, I hope they are useful for the final submission. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 4 Assessment==&lt;br /&gt;
===Quiz===&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
{Primary villi are produced during which stage of development?:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ Week 2&lt;br /&gt;
- Week 1&lt;br /&gt;
- Week 3&lt;br /&gt;
- None of the above&lt;br /&gt;
|| Primary Villi appear during Week 2 of development, whilst secondary villi appear during Week 3 of development.&lt;br /&gt;
&lt;br /&gt;
{Mesoderm is a precursor for all of the following EXCEPT:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Skeletal Muscle Cells&lt;br /&gt;
- Cardiac Muscle Cells&lt;br /&gt;
- Erythrocytes&lt;br /&gt;
+ Epidermal Skin Cells&lt;br /&gt;
- Smooth Muscle&lt;br /&gt;
|| Epidermal skin cells originate from ectoderm. Skeletal, cardiac and smooth muscle along with erythrocytes originate from the mesoderm.&lt;br /&gt;
&lt;br /&gt;
{Which of the following shows the correct developmental pathway of the male gamete:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatogonia &amp;gt; Spermatozoa&lt;br /&gt;
- Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell &amp;gt; Spermatozoa &amp;gt; Spermatid&lt;br /&gt;
- Sertoli Cell &amp;gt; Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatozoa&lt;br /&gt;
- Spermatid &amp;gt; Spermatozoa &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell&lt;br /&gt;
+ Spermatogonia &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatid &amp;gt; Spermatozoa&lt;br /&gt;
|| Spermatogonia represent the beginning of male sex cell development, with spermatozoa being the mature gamete.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) No descriptive title to your questions. Q1 relates to the timing of villi development. These types of questions encourage &amp;quot;student guessing&amp;quot; and you could have given a more detailed explanation and links to resources in your revealed answer e.g. [[Placenta - Villi Development]]. Q2 is a reasonable question, but only requiring the student only to know that Epidermal Skin Cells are from ectoderm. Once again it is your revealed answer that needs more work. Q3 is a little easy, as long as you know Spermatogonia are the diploid start cell you can quickly exclude most options, need more work. (8/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5 Assessment==&lt;br /&gt;
===Gastroschisis and Omphalocele===&lt;br /&gt;
&lt;br /&gt;
Gastroschisis is classified as a full thickness cleft found in the abdominal wall, adjacent to the site of insertion of the umbilical cord. The defining features of this abnormality is the absence of a membranous sac shrouding the intestines. As a result of this the intestines will become eviscerated, thereby protruding out of the abdominal wall and will be on the exterior, rather than the interior of the body. It is believed that disruption to the vascular supply of the right abdominal wall is the primary gass of gastroschisis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2166158&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Omphalocele is an abnormality characterised by the herniation of visceral organs such as the intestines, liver and spleen outside of the abdominal cavity. The visceral organs are enclosed in a membranous sac, into which the umbilical cord is inserted.  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC1355659&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The primary difference between gastroschisis and omphalocele lies in the presence of a membraneous sac and the exact organs herniating from the abdominal wall. Gastroschisis involves the intestines protruding to the outside of the body but are not covered by a membranous sac. Omphalocele however is characterised by the protrusion of multiple visceral organs (liver, spleen etc.) which are enclosed within a membranous. Furthermore, the size of both abnormalities differs greatly, with gastroschisis typically being 2-5 cm in size whilst omphalocele can vary between 2-15cm. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2552910&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) This is an adequate description of the differences between these conditions. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 7 Assessment==&lt;br /&gt;
&lt;br /&gt;
1: This research paper aimed to examine the relationship between fetal adrenal cells and the differentiated adrenal cortex. In particular, research was focussed upon possible pregenitor cells involved in maintenance of the adrenal cortex. It was hypothesised that the the most likely precursor cells of the adult cortex were the 'Glil' expressing cells found in the adrenal capsule. A number of mice adrenal glands were taken, treated with antigen retrieval solution, after which fluorescence microscopy was conducted.&lt;br /&gt;
&lt;br /&gt;
The results of the paper concluded that 'Glil' expressing descendants of fetal adrenal cells are the pregenitors of the differentiated adrenal cortex. Furthermore, it was found that the 'Glil' expressing cells oringinated from 'FAdE-Cre' expressing fetal adrenal cells. Thus the authors of this research article came to the conclusion that 'Glil' expressing cells found in the adrenal cortex play an important role in the development, differentiation and maintenance of the adrenal cortex. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3817941&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
2: A number of embryonic layers and tissues contribute to the development of teeth. The primary contributing layers are mesoderm, ectoderm and neural crest ectomesenchyme. Furthermore, neural crest may contribute through interactions with the ectoderm. Odontoblasts originate from neural crest derived mesenchymal cells and are responsible for forming predentin which calificies to create dentin (which forms the bulk of the tooth). Ameloblasts are responsible for the production of enamel, which provides teeth with the hardness required to engage in mastication. &lt;br /&gt;
&lt;br /&gt;
==Peer Assessment==&lt;br /&gt;
&lt;br /&gt;
===Group 1 Peer Assessment===&lt;br /&gt;
Hi guys! I'll start of by saying that the images and video you have included are excellent and are relevant to your topic of discussion. Also, you have a large number of reliable references which is good to see. However you have yet to include a hand drawn image, which is required for the wiki page. I feel like  you could probably eliminate the typed out 'timeline of mitochondrial donation' and instead use this as an opportunity to use a hand drawn image of the timeline. Furthermore, the timeline under 'cystoplasmic transfer' feels a bit awkward and unnecessary. You could probably include this timeline alongside the 'timeline of mitochondrial donation'. &lt;br /&gt;
&lt;br /&gt;
Under the 'Technical Progression' section it would be best to incorporate human embryo, mouse and human models under a sub-sub heading, as at the moment it feels a bit jumbled.&lt;br /&gt;
&lt;br /&gt;
I would also recommend moving the 'Benefits' heading towards the end of the page. It feels odd reading about the benefits of three person embryos before I gain a proper understanding of how they work. Also it might be worth talking about the disadvantages (if there are any) to three person embryos to balance out the 'benefits' section. As has been previously stated, make sure you sort out the copyright information for your video as it would be a shame to lose marks if it was missing. Also, don't forget to add the 'student template' to the 'Swapping mitochondrial DNA mammalian oocytes' image as it is currently absent.&lt;br /&gt;
&lt;br /&gt;
===Group 2 Peer Assessment===&lt;br /&gt;
So far your wiki page gives a very good coverage of Ovarian Hyper-Stimulation Syndrome. The progression of your subheadings progresses logically from one topic to another. It's good to see that you've included an excellent hand-drawn image which is well suited to the 'pathophysiology' subheading. The amount of textual information you have under each heading is vast and gives a comprehensive description of OHSS. Furthermore, you have an excellent range of sources to support your discussion.&lt;br /&gt;
&lt;br /&gt;
I feel however that asides from your hand-drawn image, your use of images and other source of media is definitely lacking. As is, your page is largely text with little to no breaks, making it quite difficult to read. The use of images would not only help break up the monotony of the text, but also help reinforce some of your ideas. I feel that the inclusion of images in the 'symptoms' and 'complications' subheadings would be suitable. &lt;br /&gt;
&lt;br /&gt;
It may also be worthwhile to include subheadings concerning current research, to inform readers about contemporary developments regarding OHSS. Furthermore,  'future research' could also be another potential subheading and could illuminate potential areas that are beginning to be or could be investigated in coming years.&lt;br /&gt;
&lt;br /&gt;
Overall, a very impressive page so far, that could be enhanced with the addition of relevant images and other media.&lt;br /&gt;
&lt;br /&gt;
===Group 4 Peer Assessment===&lt;br /&gt;
Very impressive work so far guys! Your page covers a comprehensive topic very well, without focussing too much on certain subheadings at the expense of others. Your use of both tables and images is excellent so far. It's good to see that you have also included a video to give some variety to the media on your page. The 'background information' gives context to the issues which you discuss and though it might not be of great use for someone familiar with embryology, it would be a great help to those with no experience in this field and is therefore useful in establishing the topic of male infertility.&lt;br /&gt;
&lt;br /&gt;
The only things that could be changed to improve your wiki page is perhaps altering the location of tables and pictures on your page. For example all pictures are located on the right side of the page, although not a significant issue, becomes slightly monotonous as one progresses through the page. It may be worth alternating pictures between left and right to mix things up a little bit and improve the overall flow of the page. &lt;br /&gt;
It might also be worth including a short video underneath the 'surgical treatments' subheading to give a visual example of some of the techniques discussed.&lt;br /&gt;
&lt;br /&gt;
Furthermore a subheading on future research could possibly be included under the 'treatments' subheading to give the reader information on techniques and therapies which may come to prominence in the near future.&lt;br /&gt;
&lt;br /&gt;
Your wiki page thus far is very impressive! Excellent work so far. &lt;br /&gt;
===Group 5 Peer Assessment===&lt;br /&gt;
Awesome page so far guys! I commend you on your use of various videos to assist in conveying your ideas. Furthermore, the images you have chosen are highly relevant to the topic of discussion and assist the reader in gaining a greater understanding of oncofertility. All copyright information is present for the images you have used which is excellent to see.&lt;br /&gt;
It may be worth including a hand drawn image under the 'radiation' subheading, as we are required to include at least one such image. The current image under the radiation subheading could easily be replicated by hand and could fulfill this portion of the criteria.&lt;br /&gt;
&lt;br /&gt;
I am nitpicking here, but I would also recommend including some kind of media, most likely a picture, underneath the surgery subheading. It might even be worth doing the hand drawn image here if possible. A picture may also be good underneath the 'types of chemotherapy drugs' subheading, just to break up the wall of text and improve the reading experience for the reader.&lt;br /&gt;
It might also be worth restructuring the 'oncofertility limitations' subheading into the form of a table (if possible), as the bullet point format feels quite awkward and out of place compared to the rest of the page.&lt;br /&gt;
The inclusion of a glossary is also recommended, as this page will be accessible by the general public and a glossary will assist those without a background in embryology to understand and appreciate your content.&lt;br /&gt;
&lt;br /&gt;
Keep up the great work guys! Your page is absolutely amazing so far and the effort you have put in is definitely reflected in the high quality of your page.&lt;br /&gt;
===Group 6 Peer Assessment===&lt;br /&gt;
A very snazzy wiki page so far! You have used a wide variety of images to convey the concepts of prenatal genetic diagnosis to those reading your wiki page. Copyright information and student templates were present for all the images which you provided which is great to see. A hand drawn image is absent, which is a requirement for every wiki page. It might be worth including the hand drawn image in the 'history section' as the information here could easily be represented by a hand drawn flow chart.&lt;br /&gt;
&lt;br /&gt;
I commend you on your inclusion of a 'future/current research' subheading as this gives the reader a perspective of where the field of prenatal genetic diagnosis is heading in the distant future.&lt;br /&gt;
&lt;br /&gt;
I see that you have included a table underneath the 'biopsy methods' subheading. It would be great to see you compile the advantages and disadvantages of blastomere biopsy and trophectoderm biopsy into a tabular format as this would make for an easier reading experience. Furthermore, tables may also be incorporated for the disadvantages and advantages of genetic techniques.&lt;br /&gt;
I would recommend the inclusion of other forms of media such as a video or gif to assist in the conveyance of information under certain subheadings. A video/gif would fit nicely underneath the 'biopsy method' subheading, though this is just a suggestion.&lt;br /&gt;
&lt;br /&gt;
Overall your assignment is superb so far. You have successfully covered a vast topic and made successful use of a broad range of sources to support your page. Your inclusion of images has been appropriate, however a hand drawn image is still required. &lt;br /&gt;
Keep up the good work guys! &lt;br /&gt;
&lt;br /&gt;
==Lab 10 Assessment==&lt;br /&gt;
[https://embryology.med.unsw.edu.au/embryology/Slides/Embryo_Stages/Stage22/08-eye/Stage22-08-eye.html?zoom=6&amp;amp;lat=-4961.72287&amp;amp;lon=4821.89847&amp;amp;layers=B Retina of the Eye]&lt;br /&gt;
&lt;br /&gt;
The retina is the light sensitive portion of the eye. It contains 10 separate layers, including the photoreceptor layer which is comprised of rods and cones. These rods and cones convert light into signals, which are then communicated to the brain via the optic nerve.&lt;br /&gt;
The image above displays a Carnegie Stage 22 retina. The nerve fibre layer is particularly prominent in this image and is the pale layer closest to the vitreous chamber. The processes of rods, cones and ganglion cells can be observed migrating towards the optic nerve. The choroid, containing &lt;br /&gt;
'''Embryology Link''' [[Vision - Retina Development]]&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=ANAT2341_Lab_10_-_Online_Assessment_2015&amp;diff=206323</id>
		<title>ANAT2341 Lab 10 - Online Assessment 2015</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=ANAT2341_Lab_10_-_Online_Assessment_2015&amp;diff=206323"/>
		<updated>2015-10-17T14:06:52Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Header}}&lt;br /&gt;
&lt;br /&gt;
==Individual Assessment==&lt;br /&gt;
* Place your work on this page under a sub-sub-heading of your ROI.&lt;br /&gt;
* Add your own sub-sub-heading '''below''' any existing student ROI.&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wikitable mw-collapsible mw-collapsed&amp;quot;&lt;br /&gt;
! About this Assessment&lt;br /&gt;
|-&lt;br /&gt;
| A demonstration of this assessment will be given in the practical class. Below in the collapsible table are examples of links from a virtual slide. There is also a [[Help:Virtual Slides Permalink|permalink help page]].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{Virtual Slide Features - Stage 22 Liver}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Using the Human Embryo Carnegie Stage 22 [[Embryo Virtual Slides|virtual slides]] shown below:&lt;br /&gt;
&lt;br /&gt;
# Using the &amp;quot;mobile view&amp;quot; Identify a sensory region of interest ('''ROI''') in one of the virtual slides below.&lt;br /&gt;
# View at a high magnification (detailed view) the region of interest.&lt;br /&gt;
#  Generate a [[Help:Virtual Slides Permalink|permalink]] to the ROI.&lt;br /&gt;
# Paste the link on your own page and write a brief description of what the linked region is showing.&lt;br /&gt;
# Add a link to the embryology page and sub-heading that relates to your identified feature.&lt;br /&gt;
# Paste all the content (text and links) you have just generated on [[ANAT2341 Lab 10 - Online Assessment 2015|'''this page''']] under a sub-heading named after your ROI.&lt;br /&gt;
&lt;br /&gt;
{|&lt;br /&gt;
| valign=bottom|{{SlideStage22-08}}&lt;br /&gt;
| valign=bottom|{{SlideStage22-08-eye}}&lt;br /&gt;
|-&lt;br /&gt;
| valign=bottom|{{SlideStage22-11}}&lt;br /&gt;
| valign=bottom|{{SlideStage22-15}}&lt;br /&gt;
|}&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Student ROIs==&lt;br /&gt;
&lt;br /&gt;
===This is a sub-sub-heading===&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Cochlear Duct===&lt;br /&gt;
&lt;br /&gt;
link to permalink image:[https://embryology.med.unsw.edu.au/embryology/Slides/Embryo_Stages/Stage22/11/Stage22-11.html?zoom=6&amp;amp;lat=-3948&amp;amp;lon=6149&amp;amp;layers=B | Cochlear Duct ]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
The '''cochlear duct''' is an fluid filled cavity inside the cochlea. It located between the tympanic duct and the vestibular duct, and between the basilr membrane and reissner's memebrane. It derived from otic placode, otic vesicle, and originated from surface ectoderm.&lt;br /&gt;
&lt;br /&gt;
'''embryology link''' [[Sensory - Hearing and Balance Development]]   --Inner Ear&lt;br /&gt;
&lt;br /&gt;
===Semicircular Canal===&lt;br /&gt;
&lt;br /&gt;
link to permalink image:[https://embryology.med.unsw.edu.au/embryology/Slides/Embryo_Stages/Stage22/11/Stage22-11.html?zoom=6&amp;amp;lat=-5565.50267&amp;amp;lon=7382.99733&amp;amp;layers=B | Semicircular Canal ]&lt;br /&gt;
&lt;br /&gt;
The '''semicircular canals''' are part of the inner ear.They are lined with cilia  and filled with endolymph which is a liquid substance. Every time the head moves, the endolymph moves the cilia and this movements of the cilia are communicated to the brain. As a result, the brain knows how to keep the body balanced, regardless of the posture.&lt;br /&gt;
&lt;br /&gt;
'''embryology link''' [[Hearing - Inner Ear Development]] -- Inner Ear &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Lens of the Eye===&lt;br /&gt;
&lt;br /&gt;
Link to permalink image: [https://embryology.med.unsw.edu.au/embryology/Slides/Embryo_Stages/Stage22/08-eye/Stage22-08-eye.html?zoom=6&amp;amp;lat=-2022&amp;amp;lon=2991&amp;amp;layers=B Anterior portion of the Lens of the embryonic eye] &lt;br /&gt;
&lt;br /&gt;
The lens of the eye is derived from surface ectoderm. Said ectoderm forms a lens/optic placode in the head region which then invaginates to form a lens pit and then later a lens vessel. Lens fibres then develop and are surrounded by a lens capsule. The main function of the lens is to focus light onto the retina. &lt;br /&gt;
&lt;br /&gt;
'''Embryology link''' [[Vision - Lens Development]]  --Development Overview &lt;br /&gt;
&lt;br /&gt;
===Retina of the Eye===&lt;br /&gt;
Link to permalink image: [https://embryology.med.unsw.edu.au/embryology/Slides/Embryo_Stages/Stage22/08-eye/Stage22-08-eye.html?zoom=6&amp;amp;lat=-4961.72287&amp;amp;lon=4821.89847&amp;amp;layers=B Retina of the Eye]&lt;br /&gt;
&lt;br /&gt;
The retina is the light sensitive portion of the eye. It contains 10 separate layers, including the photoreceptor layer which is comprised of rods and cones. These rods and cones convert light into signals, which are then communicated to the brain via the optic nerve.&lt;br /&gt;
&lt;br /&gt;
'''Embryology Link''' [[Vision - Retina Development]]&lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{{ANAT2341Lab10}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{2015ANAT2341}}&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=206321</id>
		<title>User:Z3416054</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=206321"/>
		<updated>2015-10-17T10:13:01Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Hi there&lt;br /&gt;
Just giving the editor a good old test run.&lt;br /&gt;
[[Test student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:45, 7 August 2015 (AEST)&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:47, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 14:06, 14 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:57, 21 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 12:22, 28 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:20, 4 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:18, 11 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:10, 25 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:28, 16 October 2015 (AEDT)&lt;br /&gt;
==Picture Tutorial==&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
===Article 1===&lt;br /&gt;
This research article aimed to determine the clinical outcomes following IVF (in vitro fertilisation) and embryo transfer treatments in subjects suffering from the sexually transmitted disease syphilis. The clinical outcomes mentioned are the rates of pregnancy and health of newborns following treatment via IVF. Couples engaged in sexual intercourse over 12 months without the use of contraception and who failed to conceive were deemed as being infertile.&lt;br /&gt;
&lt;br /&gt;
The subjects were divided into two groups based on serology results, a syphilis infected group and a control group, each with 160 individuals, giving a total of 320 subjects. The Syphilis infected group was further divided into three subcategories, a male infected group, a female infected group and a couple (male and female) infected group. Penicillin G20 (an anti-syphilis treatment) was given to the individuals in the syphilis group. IVF treatment commenced one month proceeding the disappearance of clinical syphilis symptoms or if test results gave a negative result for syphilis infection.&lt;br /&gt;
&lt;br /&gt;
The results of this experiment revealed no significant differences in regards to the basal FSH and LH of both the control and syphilis groups. However, the thickness of the endometrium differed greatly, with the syphilis group demonstrating a thicker endometrial wall (16.9±5.4mm) compared to the control group (13.0±4.7mm). Further differences were noted in blastocyst implantation rates, with the syphilis group having less successful implantations compared to the control (24.2% vs. 34.4% respectively).Normal oocyte cleavage differed between the two groups with the syphilis group demonstrating less normal oocyte cleavage compared to the control group  (6.3±4.7 vs. 8.1±4.6). Furthermore, the clinical pregnancy rates of the syphilis group stood at 43.8% compared to 55.6% of the control group.&lt;br /&gt;
&lt;br /&gt;
Syphilis infection appeared to have a significant impact on the success and clinical outcomes of IVF. Syphilis associated pelvic inflammatory disease can lead to an increase in the thickness of the endometrium, which can adversely affect blastocyte implantation and endometrial receptivity. Successful pregnancy rates typically correlate with an endometrial thickness of 7-14mm, with any thickness beyond 14mm often corresponding with decreased clinical pregnancies. Rates of clinical pregnancy and miscarriage rates did not differ between the three syphilis subgroups. Conception involving a male infected partner was associated with a shorter gestational period and decreased offspring birth weight, when compared to the female infected and couple infected subgroups. No explanation for this phenomenon was provided.&lt;br /&gt;
&lt;br /&gt;
PMID 26208116&lt;br /&gt;
&lt;br /&gt;
''Article 1 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4514756&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
===Article 2===&lt;br /&gt;
The effects of oxygen levels on factors such as cleavage, implantation and pregnancy rates in IVF cultured embryos was the primary focus of this article.  Women between the ages of 20-48 who were seeking treatment for infertility were utilised in this experiment.&lt;br /&gt;
Gametes were allocated to be incubated in one of three environments, each with a different oxygen concentration. The first group was placed in an atmosphere with an oxygen concentration of 20%. The second group rested in a 20% oxygen environment for a day before being moved to a 5% oxygen, 5% carbon dioxide and 90% nitrogen atmosphere. The third group consisted of a 5% carbon dioxide, 5% oxygen and 90% nitrogen atmosphere. The gametes (spermatozoa and oocytes) were incubated together in their respective environmental conditions for 4-6 hours after which fertilisation is presumed to have occurred.&lt;br /&gt;
&lt;br /&gt;
Successful embryos were transferred at Day 3 cleavage. A biochemical analysis of HCG validated pregnancy, whilst ultrasound was used to confirm the presence of a heartbeat 28 days following the transfer.&lt;br /&gt;
IVF fertilisation rates were calculated as being the number of fertilised oocytes over the number of oocytes inseminated. Cleavage rates were characterised by the number of blastomeres over the number of fertilised and abortion rate by the amount of miscarriages divided by the number of transfers.&lt;br /&gt;
&lt;br /&gt;
The research article concluded that the embryos from the 5% oxygen group had the highest rates of fertilisation and implantation. The 20% oxygen group had the second highest rates of fertilisation and maintained excellent embryo quality, whilst the 20% to 5% group had the lowest rates overall. Abortion and miscarriage rates did not differ at all between the three groups. The group incubated at 5% oxygen demonstrated higher quality embryos and increased rates of pregnancy when compared to the 20% oxygen group. The article concludes that implantation, pregnancy and embryo quality can be somewhat affected by a set oxygen concentration, but are affected adversely by a shift from one concentration to another. &lt;br /&gt;
Shifting from one oxygen concentration to another appeared to have an adverse effect on the cleavage of the embryo and would likely impact future development and the overall success of the IVF treatment.&lt;br /&gt;
&lt;br /&gt;
PMID 26131222 &lt;br /&gt;
&lt;br /&gt;
''Article 2 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4483955&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These are quite good descriptions of these 2 articles. (5/5)&lt;br /&gt;
==Lab 2 Assessment==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Notch Signalling - Ovulation in Drosphila.jpg|Caption]]&lt;br /&gt;
&lt;br /&gt;
===Image Reference===&lt;br /&gt;
Jianjun Sun, Allan C Spradling Ovulation in Drosophila is controlled by secretory cells of the female reproductive tract. Elife: 2013, 2;e00415 PubMed 23599892&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 23599892&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) Image uploaded and named correctly. All reference, copyright and student image template included. You might have included in the summary box an explanation to the terms that appear in the image as there is no way for the reader to interpret what is shown in each panel. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 3 Assessment==&lt;br /&gt;
===Causes===&lt;br /&gt;
====The Genetics of Infertility: Current Status of the Field====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3885174&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This article attempted to determine the role that genetics plays in female infertility. It was noted that several prominent causes of female infertility such as Galactosemia and Primary Ovarian Failure (POF) were associated with specific genes, with the GALT gene contributing to the former condition and the FMR1 gene contributing to the latter.&lt;br /&gt;
&lt;br /&gt;
====Causes of Sterility in Bosnia-Herzegovina Population====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4499307&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
The study conducted as laid out in this article examined the causes of female sterility in the Bosnia-Herzegovina population. Married participants were arranged into various groups based upon their age. The experiment came to the conclusion that in approximately 42% of infertile married couples, female sterility was the primary cause. The two primary causes of female infertility were tubal deficiencies (31% of cases) and Diminished Ovarian Reserves (38% of cases)&lt;br /&gt;
&lt;br /&gt;
====Epidemiology, diagnosis, and management of polycystic ovary syndrome====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3872139&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This research article examines the causes of polycystic ovary syndrome (POS), a common cause of infertility in women. The article concluded that 50-70% of women suffer from insulin resistance secondary to Type 2 Diabetes and in many cases obseity, which may contribute partially to POS. Furthermore, 85-90% of women with oligomenorrhea also had POS, suggesting that it is an underlying cause. However, the exact pathophysiology of POS was not determined.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These papers relate to your group project, I hope they are useful for the final submission. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 4 Assessment==&lt;br /&gt;
===Quiz===&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
{Primary villi are produced during which stage of development?:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ Week 2&lt;br /&gt;
- Week 1&lt;br /&gt;
- Week 3&lt;br /&gt;
- None of the above&lt;br /&gt;
|| Primary Villi appear during Week 2 of development, whilst secondary villi appear during Week 3 of development.&lt;br /&gt;
&lt;br /&gt;
{Mesoderm is a precursor for all of the following EXCEPT:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Skeletal Muscle Cells&lt;br /&gt;
- Cardiac Muscle Cells&lt;br /&gt;
- Erythrocytes&lt;br /&gt;
+ Epidermal Skin Cells&lt;br /&gt;
- Smooth Muscle&lt;br /&gt;
|| Epidermal skin cells originate from ectoderm. Skeletal, cardiac and smooth muscle along with erythrocytes originate from the mesoderm.&lt;br /&gt;
&lt;br /&gt;
{Which of the following shows the correct developmental pathway of the male gamete:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatogonia &amp;gt; Spermatozoa&lt;br /&gt;
- Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell &amp;gt; Spermatozoa &amp;gt; Spermatid&lt;br /&gt;
- Sertoli Cell &amp;gt; Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatozoa&lt;br /&gt;
- Spermatid &amp;gt; Spermatozoa &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell&lt;br /&gt;
+ Spermatogonia &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatid &amp;gt; Spermatozoa&lt;br /&gt;
|| Spermatogonia represent the beginning of male sex cell development, with spermatozoa being the mature gamete.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) No descriptive title to your questions. Q1 relates to the timing of villi development. These types of questions encourage &amp;quot;student guessing&amp;quot; and you could have given a more detailed explanation and links to resources in your revealed answer e.g. [[Placenta - Villi Development]]. Q2 is a reasonable question, but only requiring the student only to know that Epidermal Skin Cells are from ectoderm. Once again it is your revealed answer that needs more work. Q3 is a little easy, as long as you know Spermatogonia are the diploid start cell you can quickly exclude most options, need more work. (8/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5 Assessment==&lt;br /&gt;
===Gastroschisis and Omphalocele===&lt;br /&gt;
&lt;br /&gt;
Gastroschisis is classified as a full thickness cleft found in the abdominal wall, adjacent to the site of insertion of the umbilical cord. The defining features of this abnormality is the absence of a membranous sac shrouding the intestines. As a result of this the intestines will become eviscerated, thereby protruding out of the abdominal wall and will be on the exterior, rather than the interior of the body. It is believed that disruption to the vascular supply of the right abdominal wall is the primary gass of gastroschisis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2166158&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Omphalocele is an abnormality characterised by the herniation of visceral organs such as the intestines, liver and spleen outside of the abdominal cavity. The visceral organs are enclosed in a membranous sac, into which the umbilical cord is inserted.  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC1355659&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The primary difference between gastroschisis and omphalocele lies in the presence of a membraneous sac and the exact organs herniating from the abdominal wall. Gastroschisis involves the intestines protruding to the outside of the body but are not covered by a membranous sac. Omphalocele however is characterised by the protrusion of multiple visceral organs (liver, spleen etc.) which are enclosed within a membranous. Furthermore, the size of both abnormalities differs greatly, with gastroschisis typically being 2-5 cm in size whilst omphalocele can vary between 2-15cm. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2552910&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) This is an adequate description of the differences between these conditions. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 7 Assessment==&lt;br /&gt;
&lt;br /&gt;
1: This research paper aimed to examine the relationship between fetal adrenal cells and the differentiated adrenal cortex. In particular, research was focussed upon possible pregenitor cells involved in maintenance of the adrenal cortex. It was hypothesised that the the most likely precursor cells of the adult cortex were the 'Glil' expressing cells found in the adrenal capsule. A number of mice adrenal glands were taken, treated with antigen retrieval solution, after which fluorescence microscopy was conducted.&lt;br /&gt;
&lt;br /&gt;
The results of the paper concluded that 'Glil' expressing descendants of fetal adrenal cells are the pregenitors of the differentiated adrenal cortex. Furthermore, it was found that the 'Glil' expressing cells oringinated from 'FAdE-Cre' expressing fetal adrenal cells. Thus the authors of this research article came to the conclusion that 'Glil' expressing cells found in the adrenal cortex play an important role in the development, differentiation and maintenance of the adrenal cortex. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3817941&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
2: A number of embryonic layers and tissues contribute to the development of teeth. The primary contributing layers are mesoderm, ectoderm and neural crest ectomesenchyme. Furthermore, neural crest may contribute through interactions with the ectoderm. Odontoblasts originate from neural crest derived mesenchymal cells and are responsible for forming predentin which calificies to create dentin (which forms the bulk of the tooth). Ameloblasts are responsible for the production of enamel, which provides teeth with the hardness required to engage in mastication. &lt;br /&gt;
&lt;br /&gt;
==Peer Assessment==&lt;br /&gt;
&lt;br /&gt;
===Group 1 Peer Assessment===&lt;br /&gt;
Hi guys! I'll start of by saying that the images and video you have included are excellent and are relevant to your topic of discussion. Also, you have a large number of reliable references which is good to see. However you have yet to include a hand drawn image, which is required for the wiki page. I feel like  you could probably eliminate the typed out 'timeline of mitochondrial donation' and instead use this as an opportunity to use a hand drawn image of the timeline. Furthermore, the timeline under 'cystoplasmic transfer' feels a bit awkward and unnecessary. You could probably include this timeline alongside the 'timeline of mitochondrial donation'. &lt;br /&gt;
&lt;br /&gt;
Under the 'Technical Progression' section it would be best to incorporate human embryo, mouse and human models under a sub-sub heading, as at the moment it feels a bit jumbled.&lt;br /&gt;
&lt;br /&gt;
I would also recommend moving the 'Benefits' heading towards the end of the page. It feels odd reading about the benefits of three person embryos before I gain a proper understanding of how they work. Also it might be worth talking about the disadvantages (if there are any) to three person embryos to balance out the 'benefits' section. As has been previously stated, make sure you sort out the copyright information for your video as it would be a shame to lose marks if it was missing. Also, don't forget to add the 'student template' to the 'Swapping mitochondrial DNA mammalian oocytes' image as it is currently absent.&lt;br /&gt;
&lt;br /&gt;
===Group 2 Peer Assessment===&lt;br /&gt;
So far your wiki page gives a very good coverage of Ovarian Hyper-Stimulation Syndrome. The progression of your subheadings progresses logically from one topic to another. It's good to see that you've included an excellent hand-drawn image which is well suited to the 'pathophysiology' subheading. The amount of textual information you have under each heading is vast and gives a comprehensive description of OHSS. Furthermore, you have an excellent range of sources to support your discussion.&lt;br /&gt;
&lt;br /&gt;
I feel however that asides from your hand-drawn image, your use of images and other source of media is definitely lacking. As is, your page is largely text with little to no breaks, making it quite difficult to read. The use of images would not only help break up the monotony of the text, but also help reinforce some of your ideas. I feel that the inclusion of images in the 'symptoms' and 'complications' subheadings would be suitable. &lt;br /&gt;
&lt;br /&gt;
It may also be worthwhile to include subheadings concerning current research, to inform readers about contemporary developments regarding OHSS. Furthermore,  'future research' could also be another potential subheading and could illuminate potential areas that are beginning to be or could be investigated in coming years.&lt;br /&gt;
&lt;br /&gt;
Overall, a very impressive page so far, that could be enhanced with the addition of relevant images and other media.&lt;br /&gt;
&lt;br /&gt;
===Group 4 Peer Assessment===&lt;br /&gt;
Very impressive work so far guys! Your page covers a comprehensive topic very well, without focussing too much on certain subheadings at the expense of others. Your use of both tables and images is excellent so far. It's good to see that you have also included a video to give some variety to the media on your page. The 'background information' gives context to the issues which you discuss and though it might not be of great use for someone familiar with embryology, it would be a great help to those with no experience in this field and is therefore useful in establishing the topic of male infertility.&lt;br /&gt;
&lt;br /&gt;
The only things that could be changed to improve your wiki page is perhaps altering the location of tables and pictures on your page. For example all pictures are located on the right side of the page, although not a significant issue, becomes slightly monotonous as one progresses through the page. It may be worth alternating pictures between left and right to mix things up a little bit and improve the overall flow of the page. &lt;br /&gt;
It might also be worth including a short video underneath the 'surgical treatments' subheading to give a visual example of some of the techniques discussed.&lt;br /&gt;
&lt;br /&gt;
Furthermore a subheading on future research could possibly be included under the 'treatments' subheading to give the reader information on techniques and therapies which may come to prominence in the near future.&lt;br /&gt;
&lt;br /&gt;
Your wiki page thus far is very impressive! Excellent work so far. &lt;br /&gt;
===Group 5 Peer Assessment===&lt;br /&gt;
Awesome page so far guys! I commend you on your use of various videos to assist in conveying your ideas. Furthermore, the images you have chosen are highly relevant to the topic of discussion and assist the reader in gaining a greater understanding of oncofertility. All copyright information is present for the images you have used which is excellent to see.&lt;br /&gt;
It may be worth including a hand drawn image under the 'radiation' subheading, as we are required to include at least one such image. The current image under the radiation subheading could easily be replicated by hand and could fulfill this portion of the criteria.&lt;br /&gt;
&lt;br /&gt;
I am nitpicking here, but I would also recommend including some kind of media, most likely a picture, underneath the surgery subheading. It might even be worth doing the hand drawn image here if possible. A picture may also be good underneath the 'types of chemotherapy drugs' subheading, just to break up the wall of text and improve the reading experience for the reader.&lt;br /&gt;
It might also be worth restructuring the 'oncofertility limitations' subheading into the form of a table (if possible), as the bullet point format feels quite awkward and out of place compared to the rest of the page.&lt;br /&gt;
The inclusion of a glossary is also recommended, as this page will be accessible by the general public and a glossary will assist those without a background in embryology to understand and appreciate your content.&lt;br /&gt;
&lt;br /&gt;
Keep up the great work guys! Your page is absolutely amazing so far and the effort you have put in is definitely reflected in the high quality of your page.&lt;br /&gt;
===Group 6 Peer Assessment===&lt;br /&gt;
A very snazzy wiki page so far! You have used a wide variety of images to convey the concepts of prenatal genetic diagnosis to those reading your wiki page. Copyright information and student templates were present for all the images which you provided which is great to see. A hand drawn image is absent, which is a requirement for every wiki page. It might be worth including the hand drawn image in the 'history section' as the information here could easily be represented by a hand drawn flow chart.&lt;br /&gt;
&lt;br /&gt;
I commend you on your inclusion of a 'future/current research' subheading as this gives the reader a perspective of where the field of prenatal genetic diagnosis is heading in the distant future.&lt;br /&gt;
&lt;br /&gt;
I see that you have included a table underneath the 'biopsy methods' subheading. It would be great to see you compile the advantages and disadvantages of blastomere biopsy and trophectoderm biopsy into a tabular format as this would make for an easier reading experience. Furthermore, tables may also be incorporated for the disadvantages and advantages of genetic techniques.&lt;br /&gt;
I would recommend the inclusion of other forms of media such as a video or gif to assist in the conveyance of information under certain subheadings. A video/gif would fit nicely underneath the 'biopsy method' subheading, though this is just a suggestion.&lt;br /&gt;
&lt;br /&gt;
Overall your assignment is superb so far. You have successfully covered a vast topic and made successful use of a broad range of sources to support your page. Your inclusion of images has been appropriate, however a hand drawn image is still required. &lt;br /&gt;
Keep up the good work guys! &lt;br /&gt;
&lt;br /&gt;
==Lab 10 Assessment==&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=206059</id>
		<title>User:Z3416054</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=206059"/>
		<updated>2015-10-16T02:45:45Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Hi there&lt;br /&gt;
Just giving the editor a good old test run.&lt;br /&gt;
[[Test student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:45, 7 August 2015 (AEST)&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:47, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 14:06, 14 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:57, 21 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 12:22, 28 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:20, 4 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:18, 11 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:10, 25 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:28, 16 October 2015 (AEDT)&lt;br /&gt;
==Picture Tutorial==&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
===Article 1===&lt;br /&gt;
This research article aimed to determine the clinical outcomes following IVF (in vitro fertilisation) and embryo transfer treatments in subjects suffering from the sexually transmitted disease syphilis. The clinical outcomes mentioned are the rates of pregnancy and health of newborns following treatment via IVF. Couples engaged in sexual intercourse over 12 months without the use of contraception and who failed to conceive were deemed as being infertile.&lt;br /&gt;
&lt;br /&gt;
The subjects were divided into two groups based on serology results, a syphilis infected group and a control group, each with 160 individuals, giving a total of 320 subjects. The Syphilis infected group was further divided into three subcategories, a male infected group, a female infected group and a couple (male and female) infected group. Penicillin G20 (an anti-syphilis treatment) was given to the individuals in the syphilis group. IVF treatment commenced one month proceeding the disappearance of clinical syphilis symptoms or if test results gave a negative result for syphilis infection.&lt;br /&gt;
&lt;br /&gt;
The results of this experiment revealed no significant differences in regards to the basal FSH and LH of both the control and syphilis groups. However, the thickness of the endometrium differed greatly, with the syphilis group demonstrating a thicker endometrial wall (16.9±5.4mm) compared to the control group (13.0±4.7mm). Further differences were noted in blastocyst implantation rates, with the syphilis group having less successful implantations compared to the control (24.2% vs. 34.4% respectively).Normal oocyte cleavage differed between the two groups with the syphilis group demonstrating less normal oocyte cleavage compared to the control group  (6.3±4.7 vs. 8.1±4.6). Furthermore, the clinical pregnancy rates of the syphilis group stood at 43.8% compared to 55.6% of the control group.&lt;br /&gt;
&lt;br /&gt;
Syphilis infection appeared to have a significant impact on the success and clinical outcomes of IVF. Syphilis associated pelvic inflammatory disease can lead to an increase in the thickness of the endometrium, which can adversely affect blastocyte implantation and endometrial receptivity. Successful pregnancy rates typically correlate with an endometrial thickness of 7-14mm, with any thickness beyond 14mm often corresponding with decreased clinical pregnancies. Rates of clinical pregnancy and miscarriage rates did not differ between the three syphilis subgroups. Conception involving a male infected partner was associated with a shorter gestational period and decreased offspring birth weight, when compared to the female infected and couple infected subgroups. No explanation for this phenomenon was provided.&lt;br /&gt;
&lt;br /&gt;
PMID 26208116&lt;br /&gt;
&lt;br /&gt;
''Article 1 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4514756&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
===Article 2===&lt;br /&gt;
The effects of oxygen levels on factors such as cleavage, implantation and pregnancy rates in IVF cultured embryos was the primary focus of this article.  Women between the ages of 20-48 who were seeking treatment for infertility were utilised in this experiment.&lt;br /&gt;
Gametes were allocated to be incubated in one of three environments, each with a different oxygen concentration. The first group was placed in an atmosphere with an oxygen concentration of 20%. The second group rested in a 20% oxygen environment for a day before being moved to a 5% oxygen, 5% carbon dioxide and 90% nitrogen atmosphere. The third group consisted of a 5% carbon dioxide, 5% oxygen and 90% nitrogen atmosphere. The gametes (spermatozoa and oocytes) were incubated together in their respective environmental conditions for 4-6 hours after which fertilisation is presumed to have occurred.&lt;br /&gt;
&lt;br /&gt;
Successful embryos were transferred at Day 3 cleavage. A biochemical analysis of HCG validated pregnancy, whilst ultrasound was used to confirm the presence of a heartbeat 28 days following the transfer.&lt;br /&gt;
IVF fertilisation rates were calculated as being the number of fertilised oocytes over the number of oocytes inseminated. Cleavage rates were characterised by the number of blastomeres over the number of fertilised and abortion rate by the amount of miscarriages divided by the number of transfers.&lt;br /&gt;
&lt;br /&gt;
The research article concluded that the embryos from the 5% oxygen group had the highest rates of fertilisation and implantation. The 20% oxygen group had the second highest rates of fertilisation and maintained excellent embryo quality, whilst the 20% to 5% group had the lowest rates overall. Abortion and miscarriage rates did not differ at all between the three groups. The group incubated at 5% oxygen demonstrated higher quality embryos and increased rates of pregnancy when compared to the 20% oxygen group. The article concludes that implantation, pregnancy and embryo quality can be somewhat affected by a set oxygen concentration, but are affected adversely by a shift from one concentration to another. &lt;br /&gt;
Shifting from one oxygen concentration to another appeared to have an adverse effect on the cleavage of the embryo and would likely impact future development and the overall success of the IVF treatment.&lt;br /&gt;
&lt;br /&gt;
PMID 26131222 &lt;br /&gt;
&lt;br /&gt;
''Article 2 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4483955&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These are quite good descriptions of these 2 articles. (5/5)&lt;br /&gt;
==Lab 2 Assessment==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Notch Signalling - Ovulation in Drosphila.jpg|Caption]]&lt;br /&gt;
&lt;br /&gt;
===Image Reference===&lt;br /&gt;
Jianjun Sun, Allan C Spradling Ovulation in Drosophila is controlled by secretory cells of the female reproductive tract. Elife: 2013, 2;e00415 PubMed 23599892&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 23599892&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) Image uploaded and named correctly. All reference, copyright and student image template included. You might have included in the summary box an explanation to the terms that appear in the image as there is no way for the reader to interpret what is shown in each panel. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 3 Assessment==&lt;br /&gt;
===Causes===&lt;br /&gt;
====The Genetics of Infertility: Current Status of the Field====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3885174&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This article attempted to determine the role that genetics plays in female infertility. It was noted that several prominent causes of female infertility such as Galactosemia and Primary Ovarian Failure (POF) were associated with specific genes, with the GALT gene contributing to the former condition and the FMR1 gene contributing to the latter.&lt;br /&gt;
&lt;br /&gt;
====Causes of Sterility in Bosnia-Herzegovina Population====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4499307&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
The study conducted as laid out in this article examined the causes of female sterility in the Bosnia-Herzegovina population. Married participants were arranged into various groups based upon their age. The experiment came to the conclusion that in approximately 42% of infertile married couples, female sterility was the primary cause. The two primary causes of female infertility were tubal deficiencies (31% of cases) and Diminished Ovarian Reserves (38% of cases)&lt;br /&gt;
&lt;br /&gt;
====Epidemiology, diagnosis, and management of polycystic ovary syndrome====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3872139&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This research article examines the causes of polycystic ovary syndrome (POS), a common cause of infertility in women. The article concluded that 50-70% of women suffer from insulin resistance secondary to Type 2 Diabetes and in many cases obseity, which may contribute partially to POS. Furthermore, 85-90% of women with oligomenorrhea also had POS, suggesting that it is an underlying cause. However, the exact pathophysiology of POS was not determined.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These papers relate to your group project, I hope they are useful for the final submission. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 4 Assessment==&lt;br /&gt;
===Quiz===&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
{Primary villi are produced during which stage of development?:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ Week 2&lt;br /&gt;
- Week 1&lt;br /&gt;
- Week 3&lt;br /&gt;
- None of the above&lt;br /&gt;
|| Primary Villi appear during Week 2 of development, whilst secondary villi appear during Week 3 of development.&lt;br /&gt;
&lt;br /&gt;
{Mesoderm is a precursor for all of the following EXCEPT:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Skeletal Muscle Cells&lt;br /&gt;
- Cardiac Muscle Cells&lt;br /&gt;
- Erythrocytes&lt;br /&gt;
+ Epidermal Skin Cells&lt;br /&gt;
- Smooth Muscle&lt;br /&gt;
|| Epidermal skin cells originate from ectoderm. Skeletal, cardiac and smooth muscle along with erythrocytes originate from the mesoderm.&lt;br /&gt;
&lt;br /&gt;
{Which of the following shows the correct developmental pathway of the male gamete:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatogonia &amp;gt; Spermatozoa&lt;br /&gt;
- Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell &amp;gt; Spermatozoa &amp;gt; Spermatid&lt;br /&gt;
- Sertoli Cell &amp;gt; Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatozoa&lt;br /&gt;
- Spermatid &amp;gt; Spermatozoa &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell&lt;br /&gt;
+ Spermatogonia &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatid &amp;gt; Spermatozoa&lt;br /&gt;
|| Spermatogonia represent the beginning of male sex cell development, with spermatozoa being the mature gamete.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) No descriptive title to your questions. Q1 relates to the timing of villi development. These types of questions encourage &amp;quot;student guessing&amp;quot; and you could have given a more detailed explanation and links to resources in your revealed answer e.g. [[Placenta - Villi Development]]. Q2 is a reasonable question, but only requiring the student only to know that Epidermal Skin Cells are from ectoderm. Once again it is your revealed answer that needs more work. Q3 is a little easy, as long as you know Spermatogonia are the diploid start cell you can quickly exclude most options, need more work. (8/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5 Assessment==&lt;br /&gt;
===Gastroschisis and Omphalocele===&lt;br /&gt;
&lt;br /&gt;
Gastroschisis is classified as a full thickness cleft found in the abdominal wall, adjacent to the site of insertion of the umbilical cord. The defining features of this abnormality is the absence of a membranous sac shrouding the intestines. As a result of this the intestines will become eviscerated, thereby protruding out of the abdominal wall and will be on the exterior, rather than the interior of the body. It is believed that disruption to the vascular supply of the right abdominal wall is the primary gass of gastroschisis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2166158&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Omphalocele is an abnormality characterised by the herniation of visceral organs such as the intestines, liver and spleen outside of the abdominal cavity. The visceral organs are enclosed in a membranous sac, into which the umbilical cord is inserted.  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC1355659&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The primary difference between gastroschisis and omphalocele lies in the presence of a membraneous sac and the exact organs herniating from the abdominal wall. Gastroschisis involves the intestines protruding to the outside of the body but are not covered by a membranous sac. Omphalocele however is characterised by the protrusion of multiple visceral organs (liver, spleen etc.) which are enclosed within a membranous. Furthermore, the size of both abnormalities differs greatly, with gastroschisis typically being 2-5 cm in size whilst omphalocele can vary between 2-15cm. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2552910&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) This is an adequate description of the differences between these conditions. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 7 Assessment==&lt;br /&gt;
&lt;br /&gt;
1: This research paper aimed to examine the relationship between fetal adrenal cells and the differentiated adrenal cortex. In particular, research was focussed upon possible pregenitor cells involved in maintenance of the adrenal cortex. It was hypothesised that the the most likely precursor cells of the adult cortex were the 'Glil' expressing cells found in the adrenal capsule. A number of mice adrenal glands were taken, treated with antigen retrieval solution, after which fluorescence microscopy was conducted.&lt;br /&gt;
&lt;br /&gt;
The results of the paper concluded that 'Glil' expressing descendants of fetal adrenal cells are the pregenitors of the differentiated adrenal cortex. Furthermore, it was found that the 'Glil' expressing cells oringinated from 'FAdE-Cre' expressing fetal adrenal cells. Thus the authors of this research article came to the conclusion that 'Glil' expressing cells found in the adrenal cortex play an important role in the development, differentiation and maintenance of the adrenal cortex. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3817941&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
2: A number of embryonic layers and tissues contribute to the development of teeth. The primary contributing layers are mesoderm, ectoderm and neural crest ectomesenchyme. Furthermore, neural crest may contribute through interactions with the ectoderm. Odontoblasts originate from neural crest derived mesenchymal cells and are responsible for forming predentin which calificies to create dentin (which forms the bulk of the tooth). Ameloblasts are responsible for the production of enamel, which provides teeth with the hardness required to engage in mastication. &lt;br /&gt;
&lt;br /&gt;
==Peer Assessment==&lt;br /&gt;
&lt;br /&gt;
===Group 1 Peer Assessment===&lt;br /&gt;
Hi guys! I'll start of by saying that the images and video you have included are excellent and are relevant to your topic of discussion. Also, you have a large number of reliable references which is good to see. However you have yet to include a hand drawn image, which is required for the wiki page. I feel like  you could probably eliminate the typed out 'timeline of mitochondrial donation' and instead use this as an opportunity to use a hand drawn image of the timeline. Furthermore, the timeline under 'cystoplasmic transfer' feels a bit awkward and unnecessary. You could probably include this timeline alongside the 'timeline of mitochondrial donation'. &lt;br /&gt;
&lt;br /&gt;
Under the 'Technical Progression' section it would be best to incorporate human embryo, mouse and human models under a sub-sub heading, as at the moment it feels a bit jumbled.&lt;br /&gt;
&lt;br /&gt;
I would also recommend moving the 'Benefits' heading towards the end of the page. It feels odd reading about the benefits of three person embryos before I gain a proper understanding of how they work. Also it might be worth talking about the disadvantages (if there are any) to three person embryos to balance out the 'benefits' section. As has been previously stated, make sure you sort out the copyright information for your video as it would be a shame to lose marks if it was missing. Also, don't forget to add the 'student template' to the 'Swapping mitochondrial DNA mammalian oocytes' image as it is currently absent.&lt;br /&gt;
&lt;br /&gt;
===Group 2 Peer Assessment===&lt;br /&gt;
So far your wiki page gives a very good coverage of Ovarian Hyper-Stimulation Syndrome. The progression of your subheadings progresses logically from one topic to another. It's good to see that you've included an excellent hand-drawn image which is well suited to the 'pathophysiology' subheading. The amount of textual information you have under each heading is vast and gives a comprehensive description of OHSS. Furthermore, you have an excellent range of sources to support your discussion.&lt;br /&gt;
&lt;br /&gt;
I feel however that asides from your hand-drawn image, your use of images and other source of media is definitely lacking. As is, your page is largely text with little to no breaks, making it quite difficult to read. The use of images would not only help break up the monotony of the text, but also help reinforce some of your ideas. I feel that the inclusion of images in the 'symptoms' and 'complications' subheadings would be suitable. &lt;br /&gt;
&lt;br /&gt;
It may also be worthwhile to include subheadings concerning current research, to inform readers about contemporary developments regarding OHSS. Furthermore,  'future research' could also be another potential subheading and could illuminate potential areas that are beginning to be or could be investigated in coming years.&lt;br /&gt;
&lt;br /&gt;
Overall, a very impressive page so far, that could be enhanced with the addition of relevant images and other media.&lt;br /&gt;
&lt;br /&gt;
===Group 4 Peer Assessment===&lt;br /&gt;
Very impressive work so far guys! Your page covers a comprehensive topic very well, without focussing too much on certain subheadings at the expense of others. Your use of both tables and images is excellent so far. It's good to see that you have also included a video to give some variety to the media on your page. The 'background information' gives context to the issues which you discuss and though it might not be of great use for someone familiar with embryology, it would be a great help to those with no experience in this field and is therefore useful in establishing the topic of male infertility.&lt;br /&gt;
&lt;br /&gt;
The only things that could be changed to improve your wiki page is perhaps altering the location of tables and pictures on your page. For example all pictures are located on the right side of the page, although not a significant issue, becomes slightly monotonous as one progresses through the page. It may be worth alternating pictures between left and right to mix things up a little bit and improve the overall flow of the page. &lt;br /&gt;
It might also be worth including a short video underneath the 'surgical treatments' subheading to give a visual example of some of the techniques discussed.&lt;br /&gt;
&lt;br /&gt;
Furthermore a subheading on future research could possibly be included under the 'treatments' subheading to give the reader information on techniques and therapies which may come to prominence in the near future.&lt;br /&gt;
&lt;br /&gt;
Your wiki page thus far is very impressive! Excellent work so far. &lt;br /&gt;
===Group 5 Peer Assessment===&lt;br /&gt;
Awesome page so far guys! I commend you on your use of various videos to assist in conveying your ideas. Furthermore, the images you have chosen are highly relevant to the topic of discussion and assist the reader in gaining a greater understanding of oncofertility. All copyright information is present for the images you have used which is excellent to see.&lt;br /&gt;
It may be worth including a hand drawn image under the 'radiation' subheading, as we are required to include at least one such image. The current image under the radiation subheading could easily be replicated by hand and could fulfill this portion of the criteria.&lt;br /&gt;
&lt;br /&gt;
I am nitpicking here, but I would also recommend including some kind of media, most likely a picture, underneath the surgery subheading. It might even be worth doing the hand drawn image here if possible. A picture may also be good underneath the 'types of chemotherapy drugs' subheading, just to break up the wall of text and improve the reading experience for the reader.&lt;br /&gt;
It might also be worth restructuring the 'oncofertility limitations' subheading into the form of a table (if possible), as the bullet point format feels quite awkward and out of place compared to the rest of the page.&lt;br /&gt;
The inclusion of a glossary is also recommended, as this page will be accessible by the general public and a glossary will assist those without a background in embryology to understand and appreciate your content.&lt;br /&gt;
&lt;br /&gt;
Keep up the great work guys! Your page is absolutely amazing so far and the effort you have put in is definitely reflected in the high quality of your page.&lt;br /&gt;
===Group 6 Peer Assessment===&lt;br /&gt;
A very snazzy wiki page so far! You have used a wide variety of images to convey the concepts of prenatal genetic diagnosis to those reading your wiki page. Copyright information and student templates were present for all the images which you provided which is great to see. A hand drawn image is absent, which is a requirement for every wiki page. It might be worth including the hand drawn image in the 'history section' as the information here could easily be represented by a hand drawn flow chart.&lt;br /&gt;
&lt;br /&gt;
I commend you on your inclusion of a 'future/current research' subheading as this gives the reader a perspective of where the field of prenatal genetic diagnosis is heading in the distant future.&lt;br /&gt;
&lt;br /&gt;
I see that you have included a table underneath the 'biopsy methods' subheading. It would be great to see you compile the advantages and disadvantages of blastomere biopsy and trophectoderm biopsy into a tabular format as this would make for an easier reading experience. Furthermore, tables may also be incorporated for the disadvantages and advantages of genetic techniques.&lt;br /&gt;
I would recommend the inclusion of other forms of media such as a video or gif to assist in the conveyance of information under certain subheadings. A video/gif would fit nicely underneath the 'biopsy method' subheading, though this is just a suggestion.&lt;br /&gt;
&lt;br /&gt;
Overall your assignment is superb so far. You have successfully covered a vast topic and made successful use of a broad range of sources to support your page. Your inclusion of images has been appropriate, however a hand drawn image is still required. &lt;br /&gt;
Keep up the good work guys! &lt;br /&gt;
&lt;br /&gt;
==Lab 10 Assessment==&lt;br /&gt;
&lt;br /&gt;
https://atlas.mindmup.com/2015/10/78150f40555b0133026d3b99584df1e6/bjjoffencemindmap/index.html&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=206055</id>
		<title>User:Z3416054</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=206055"/>
		<updated>2015-10-16T02:44:27Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Hi there&lt;br /&gt;
Just giving the editor a good old test run.&lt;br /&gt;
[[Test student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:45, 7 August 2015 (AEST)&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:47, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 14:06, 14 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:57, 21 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 12:22, 28 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:20, 4 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:18, 11 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:10, 25 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:28, 16 October 2015 (AEDT)&lt;br /&gt;
==Picture Tutorial==&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
===Article 1===&lt;br /&gt;
This research article aimed to determine the clinical outcomes following IVF (in vitro fertilisation) and embryo transfer treatments in subjects suffering from the sexually transmitted disease syphilis. The clinical outcomes mentioned are the rates of pregnancy and health of newborns following treatment via IVF. Couples engaged in sexual intercourse over 12 months without the use of contraception and who failed to conceive were deemed as being infertile.&lt;br /&gt;
&lt;br /&gt;
The subjects were divided into two groups based on serology results, a syphilis infected group and a control group, each with 160 individuals, giving a total of 320 subjects. The Syphilis infected group was further divided into three subcategories, a male infected group, a female infected group and a couple (male and female) infected group. Penicillin G20 (an anti-syphilis treatment) was given to the individuals in the syphilis group. IVF treatment commenced one month proceeding the disappearance of clinical syphilis symptoms or if test results gave a negative result for syphilis infection.&lt;br /&gt;
&lt;br /&gt;
The results of this experiment revealed no significant differences in regards to the basal FSH and LH of both the control and syphilis groups. However, the thickness of the endometrium differed greatly, with the syphilis group demonstrating a thicker endometrial wall (16.9±5.4mm) compared to the control group (13.0±4.7mm). Further differences were noted in blastocyst implantation rates, with the syphilis group having less successful implantations compared to the control (24.2% vs. 34.4% respectively).Normal oocyte cleavage differed between the two groups with the syphilis group demonstrating less normal oocyte cleavage compared to the control group  (6.3±4.7 vs. 8.1±4.6). Furthermore, the clinical pregnancy rates of the syphilis group stood at 43.8% compared to 55.6% of the control group.&lt;br /&gt;
&lt;br /&gt;
Syphilis infection appeared to have a significant impact on the success and clinical outcomes of IVF. Syphilis associated pelvic inflammatory disease can lead to an increase in the thickness of the endometrium, which can adversely affect blastocyte implantation and endometrial receptivity. Successful pregnancy rates typically correlate with an endometrial thickness of 7-14mm, with any thickness beyond 14mm often corresponding with decreased clinical pregnancies. Rates of clinical pregnancy and miscarriage rates did not differ between the three syphilis subgroups. Conception involving a male infected partner was associated with a shorter gestational period and decreased offspring birth weight, when compared to the female infected and couple infected subgroups. No explanation for this phenomenon was provided.&lt;br /&gt;
&lt;br /&gt;
PMID 26208116&lt;br /&gt;
&lt;br /&gt;
''Article 1 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4514756&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
===Article 2===&lt;br /&gt;
The effects of oxygen levels on factors such as cleavage, implantation and pregnancy rates in IVF cultured embryos was the primary focus of this article.  Women between the ages of 20-48 who were seeking treatment for infertility were utilised in this experiment.&lt;br /&gt;
Gametes were allocated to be incubated in one of three environments, each with a different oxygen concentration. The first group was placed in an atmosphere with an oxygen concentration of 20%. The second group rested in a 20% oxygen environment for a day before being moved to a 5% oxygen, 5% carbon dioxide and 90% nitrogen atmosphere. The third group consisted of a 5% carbon dioxide, 5% oxygen and 90% nitrogen atmosphere. The gametes (spermatozoa and oocytes) were incubated together in their respective environmental conditions for 4-6 hours after which fertilisation is presumed to have occurred.&lt;br /&gt;
&lt;br /&gt;
Successful embryos were transferred at Day 3 cleavage. A biochemical analysis of HCG validated pregnancy, whilst ultrasound was used to confirm the presence of a heartbeat 28 days following the transfer.&lt;br /&gt;
IVF fertilisation rates were calculated as being the number of fertilised oocytes over the number of oocytes inseminated. Cleavage rates were characterised by the number of blastomeres over the number of fertilised and abortion rate by the amount of miscarriages divided by the number of transfers.&lt;br /&gt;
&lt;br /&gt;
The research article concluded that the embryos from the 5% oxygen group had the highest rates of fertilisation and implantation. The 20% oxygen group had the second highest rates of fertilisation and maintained excellent embryo quality, whilst the 20% to 5% group had the lowest rates overall. Abortion and miscarriage rates did not differ at all between the three groups. The group incubated at 5% oxygen demonstrated higher quality embryos and increased rates of pregnancy when compared to the 20% oxygen group. The article concludes that implantation, pregnancy and embryo quality can be somewhat affected by a set oxygen concentration, but are affected adversely by a shift from one concentration to another. &lt;br /&gt;
Shifting from one oxygen concentration to another appeared to have an adverse effect on the cleavage of the embryo and would likely impact future development and the overall success of the IVF treatment.&lt;br /&gt;
&lt;br /&gt;
PMID 26131222 &lt;br /&gt;
&lt;br /&gt;
''Article 2 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4483955&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These are quite good descriptions of these 2 articles. (5/5)&lt;br /&gt;
==Lab 2 Assessment==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Notch Signalling - Ovulation in Drosphila.jpg|Caption]]&lt;br /&gt;
&lt;br /&gt;
===Image Reference===&lt;br /&gt;
Jianjun Sun, Allan C Spradling Ovulation in Drosophila is controlled by secretory cells of the female reproductive tract. Elife: 2013, 2;e00415 PubMed 23599892&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 23599892&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) Image uploaded and named correctly. All reference, copyright and student image template included. You might have included in the summary box an explanation to the terms that appear in the image as there is no way for the reader to interpret what is shown in each panel. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 3 Assessment==&lt;br /&gt;
===Causes===&lt;br /&gt;
====The Genetics of Infertility: Current Status of the Field====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3885174&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This article attempted to determine the role that genetics plays in female infertility. It was noted that several prominent causes of female infertility such as Galactosemia and Primary Ovarian Failure (POF) were associated with specific genes, with the GALT gene contributing to the former condition and the FMR1 gene contributing to the latter.&lt;br /&gt;
&lt;br /&gt;
====Causes of Sterility in Bosnia-Herzegovina Population====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4499307&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
The study conducted as laid out in this article examined the causes of female sterility in the Bosnia-Herzegovina population. Married participants were arranged into various groups based upon their age. The experiment came to the conclusion that in approximately 42% of infertile married couples, female sterility was the primary cause. The two primary causes of female infertility were tubal deficiencies (31% of cases) and Diminished Ovarian Reserves (38% of cases)&lt;br /&gt;
&lt;br /&gt;
====Epidemiology, diagnosis, and management of polycystic ovary syndrome====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3872139&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This research article examines the causes of polycystic ovary syndrome (POS), a common cause of infertility in women. The article concluded that 50-70% of women suffer from insulin resistance secondary to Type 2 Diabetes and in many cases obseity, which may contribute partially to POS. Furthermore, 85-90% of women with oligomenorrhea also had POS, suggesting that it is an underlying cause. However, the exact pathophysiology of POS was not determined.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These papers relate to your group project, I hope they are useful for the final submission. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 4 Assessment==&lt;br /&gt;
===Quiz===&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
{Primary villi are produced during which stage of development?:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ Week 2&lt;br /&gt;
- Week 1&lt;br /&gt;
- Week 3&lt;br /&gt;
- None of the above&lt;br /&gt;
|| Primary Villi appear during Week 2 of development, whilst secondary villi appear during Week 3 of development.&lt;br /&gt;
&lt;br /&gt;
{Mesoderm is a precursor for all of the following EXCEPT:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Skeletal Muscle Cells&lt;br /&gt;
- Cardiac Muscle Cells&lt;br /&gt;
- Erythrocytes&lt;br /&gt;
+ Epidermal Skin Cells&lt;br /&gt;
- Smooth Muscle&lt;br /&gt;
|| Epidermal skin cells originate from ectoderm. Skeletal, cardiac and smooth muscle along with erythrocytes originate from the mesoderm.&lt;br /&gt;
&lt;br /&gt;
{Which of the following shows the correct developmental pathway of the male gamete:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatogonia &amp;gt; Spermatozoa&lt;br /&gt;
- Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell &amp;gt; Spermatozoa &amp;gt; Spermatid&lt;br /&gt;
- Sertoli Cell &amp;gt; Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatozoa&lt;br /&gt;
- Spermatid &amp;gt; Spermatozoa &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell&lt;br /&gt;
+ Spermatogonia &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatid &amp;gt; Spermatozoa&lt;br /&gt;
|| Spermatogonia represent the beginning of male sex cell development, with spermatozoa being the mature gamete.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) No descriptive title to your questions. Q1 relates to the timing of villi development. These types of questions encourage &amp;quot;student guessing&amp;quot; and you could have given a more detailed explanation and links to resources in your revealed answer e.g. [[Placenta - Villi Development]]. Q2 is a reasonable question, but only requiring the student only to know that Epidermal Skin Cells are from ectoderm. Once again it is your revealed answer that needs more work. Q3 is a little easy, as long as you know Spermatogonia are the diploid start cell you can quickly exclude most options, need more work. (8/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5 Assessment==&lt;br /&gt;
===Gastroschisis and Omphalocele===&lt;br /&gt;
&lt;br /&gt;
Gastroschisis is classified as a full thickness cleft found in the abdominal wall, adjacent to the site of insertion of the umbilical cord. The defining features of this abnormality is the absence of a membranous sac shrouding the intestines. As a result of this the intestines will become eviscerated, thereby protruding out of the abdominal wall and will be on the exterior, rather than the interior of the body. It is believed that disruption to the vascular supply of the right abdominal wall is the primary gass of gastroschisis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2166158&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Omphalocele is an abnormality characterised by the herniation of visceral organs such as the intestines, liver and spleen outside of the abdominal cavity. The visceral organs are enclosed in a membranous sac, into which the umbilical cord is inserted.  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC1355659&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The primary difference between gastroschisis and omphalocele lies in the presence of a membraneous sac and the exact organs herniating from the abdominal wall. Gastroschisis involves the intestines protruding to the outside of the body but are not covered by a membranous sac. Omphalocele however is characterised by the protrusion of multiple visceral organs (liver, spleen etc.) which are enclosed within a membranous. Furthermore, the size of both abnormalities differs greatly, with gastroschisis typically being 2-5 cm in size whilst omphalocele can vary between 2-15cm. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2552910&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) This is an adequate description of the differences between these conditions. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 7 Assessment==&lt;br /&gt;
&lt;br /&gt;
1: This research paper aimed to examine the relationship between fetal adrenal cells and the differentiated adrenal cortex. In particular, research was focussed upon possible pregenitor cells involved in maintenance of the adrenal cortex. It was hypothesised that the the most likely precursor cells of the adult cortex were the 'Glil' expressing cells found in the adrenal capsule. A number of mice adrenal glands were taken, treated with antigen retrieval solution, after which fluorescence microscopy was conducted.&lt;br /&gt;
&lt;br /&gt;
The results of the paper concluded that 'Glil' expressing descendants of fetal adrenal cells are the pregenitors of the differentiated adrenal cortex. Furthermore, it was found that the 'Glil' expressing cells oringinated from 'FAdE-Cre' expressing fetal adrenal cells. Thus the authors of this research article came to the conclusion that 'Glil' expressing cells found in the adrenal cortex play an important role in the development, differentiation and maintenance of the adrenal cortex. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3817941&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
2: A number of embryonic layers and tissues contribute to the development of teeth. The primary contributing layers are mesoderm, ectoderm and neural crest ectomesenchyme. Furthermore, neural crest may contribute through interactions with the ectoderm. Odontoblasts originate from neural crest derived mesenchymal cells and are responsible for forming predentin which calificies to create dentin (which forms the bulk of the tooth). Ameloblasts are responsible for the production of enamel, which provides teeth with the hardness required to engage in mastication. &lt;br /&gt;
&lt;br /&gt;
==Peer Assessment==&lt;br /&gt;
&lt;br /&gt;
===Group 1 Peer Assessment===&lt;br /&gt;
Hi guys! I'll start of by saying that the images and video you have included are excellent and are relevant to your topic of discussion. Also, you have a large number of reliable references which is good to see. However you have yet to include a hand drawn image, which is required for the wiki page. I feel like  you could probably eliminate the typed out 'timeline of mitochondrial donation' and instead use this as an opportunity to use a hand drawn image of the timeline. Furthermore, the timeline under 'cystoplasmic transfer' feels a bit awkward and unnecessary. You could probably include this timeline alongside the 'timeline of mitochondrial donation'. &lt;br /&gt;
&lt;br /&gt;
Under the 'Technical Progression' section it would be best to incorporate human embryo, mouse and human models under a sub-sub heading, as at the moment it feels a bit jumbled.&lt;br /&gt;
&lt;br /&gt;
I would also recommend moving the 'Benefits' heading towards the end of the page. It feels odd reading about the benefits of three person embryos before I gain a proper understanding of how they work. Also it might be worth talking about the disadvantages (if there are any) to three person embryos to balance out the 'benefits' section. As has been previously stated, make sure you sort out the copyright information for your video as it would be a shame to lose marks if it was missing. Also, don't forget to add the 'student template' to the 'Swapping mitochondrial DNA mammalian oocytes' image as it is currently absent.&lt;br /&gt;
&lt;br /&gt;
===Group 2 Peer Assessment===&lt;br /&gt;
So far your wiki page gives a very good coverage of Ovarian Hyper-Stimulation Syndrome. The progression of your subheadings progresses logically from one topic to another. It's good to see that you've included an excellent hand-drawn image which is well suited to the 'pathophysiology' subheading. The amount of textual information you have under each heading is vast and gives a comprehensive description of OHSS. Furthermore, you have an excellent range of sources to support your discussion.&lt;br /&gt;
&lt;br /&gt;
I feel however that asides from your hand-drawn image, your use of images and other source of media is definitely lacking. As is, your page is largely text with little to no breaks, making it quite difficult to read. The use of images would not only help break up the monotony of the text, but also help reinforce some of your ideas. I feel that the inclusion of images in the 'symptoms' and 'complications' subheadings would be suitable. &lt;br /&gt;
&lt;br /&gt;
It may also be worthwhile to include subheadings concerning current research, to inform readers about contemporary developments regarding OHSS. Furthermore,  'future research' could also be another potential subheading and could illuminate potential areas that are beginning to be or could be investigated in coming years.&lt;br /&gt;
&lt;br /&gt;
Overall, a very impressive page so far, that could be enhanced with the addition of relevant images and other media.&lt;br /&gt;
&lt;br /&gt;
===Group 4 Peer Assessment===&lt;br /&gt;
Very impressive work so far guys! Your page covers a comprehensive topic very well, without focussing too much on certain subheadings at the expense of others. Your use of both tables and images is excellent so far. It's good to see that you have also included a video to give some variety to the media on your page. The 'background information' gives context to the issues which you discuss and though it might not be of great use for someone familiar with embryology, it would be a great help to those with no experience in this field and is therefore useful in establishing the topic of male infertility.&lt;br /&gt;
&lt;br /&gt;
The only things that could be changed to improve your wiki page is perhaps altering the location of tables and pictures on your page. For example all pictures are located on the right side of the page, although not a significant issue, becomes slightly monotonous as one progresses through the page. It may be worth alternating pictures between left and right to mix things up a little bit and improve the overall flow of the page. &lt;br /&gt;
It might also be worth including a short video underneath the 'surgical treatments' subheading to give a visual example of some of the techniques discussed.&lt;br /&gt;
&lt;br /&gt;
Furthermore a subheading on future research could possibly be included under the 'treatments' subheading to give the reader information on techniques and therapies which may come to prominence in the near future.&lt;br /&gt;
&lt;br /&gt;
Your wiki page thus far is very impressive! Excellent work so far. &lt;br /&gt;
===Group 5 Peer Assessment===&lt;br /&gt;
Awesome page so far guys! I commend you on your use of various videos to assist in conveying your ideas. Furthermore, the images you have chosen are highly relevant to the topic of discussion and assist the reader in gaining a greater understanding of oncofertility. All copyright information is present for the images you have used which is excellent to see.&lt;br /&gt;
It may be worth including a hand drawn image under the 'radiation' subheading, as we are required to include at least one such image. The current image under the radiation subheading could easily be replicated by hand and could fulfill this portion of the criteria.&lt;br /&gt;
&lt;br /&gt;
I am nitpicking here, but I would also recommend including some kind of media, most likely a picture, underneath the surgery subheading. It might even be worth doing the hand drawn image here if possible. A picture may also be good underneath the 'types of chemotherapy drugs' subheading, just to break up the wall of text and improve the reading experience for the reader.&lt;br /&gt;
It might also be worth restructuring the 'oncofertility limitations' subheading into the form of a table (if possible), as the bullet point format feels quite awkward and out of place compared to the rest of the page.&lt;br /&gt;
The inclusion of a glossary is also recommended, as this page will be accessible by the general public and a glossary will assist those without a background in embryology to understand and appreciate your content.&lt;br /&gt;
&lt;br /&gt;
Keep up the great work guys! Your page is absolutely amazing so far and the effort you have put in is definitely reflected in the high quality of your page.&lt;br /&gt;
===Group 6 Peer Assessment===&lt;br /&gt;
A very snazzy wiki page so far! You have used a wide variety of images to convey the concepts of prenatal genetic diagnosis to those reading your wiki page. Copyright information and student templates were present for all the images which you provided which is great to see. A hand drawn image is absent, which is a requirement for every wiki page. It might be worth including the hand drawn image in the 'history section' as the information here could easily be represented by a hand drawn flow chart.&lt;br /&gt;
&lt;br /&gt;
I commend you on your inclusion of a 'future/current research' subheading as this gives the reader a perspective of where the field of prenatal genetic diagnosis is heading in the distant future.&lt;br /&gt;
&lt;br /&gt;
I see that you have included a table underneath the 'biopsy methods' subheading. It would be great to see you compile the advantages and disadvantages of blastomere biopsy and trophectoderm biopsy into a tabular format as this would make for an easier reading experience. Furthermore, tables may also be incorporated for the disadvantages and advantages of genetic techniques.&lt;br /&gt;
I would recommend the inclusion of other forms of media such as a video or gif to assist in the conveyance of information under certain subheadings. A video/gif would fit nicely underneath the 'biopsy method' subheading, though this is just a suggestion.&lt;br /&gt;
&lt;br /&gt;
Overall your assignment is superb so far. You have successfully covered a vast topic and made successful use of a broad range of sources to support your page. Your inclusion of images has been appropriate, however a hand drawn image is still required. &lt;br /&gt;
Keep up the good work guys! &lt;br /&gt;
Look at this!&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Lab 10 Assessment==&lt;br /&gt;
&lt;br /&gt;
https://atlas.mindmup.com/2015/10/78150f40555b0133026d3b99584df1e6/bjjoffencemindmap/index.html&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=206051</id>
		<title>User:Z3416054</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=206051"/>
		<updated>2015-10-16T02:41:25Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Hi there&lt;br /&gt;
Just giving the editor a good old test run.&lt;br /&gt;
[[Test student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:45, 7 August 2015 (AEST)&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:47, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 14:06, 14 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:57, 21 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 12:22, 28 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:20, 4 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:18, 11 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:10, 25 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:28, 16 October 2015 (AEDT)&lt;br /&gt;
==Picture Tutorial==&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
===Article 1===&lt;br /&gt;
This research article aimed to determine the clinical outcomes following IVF (in vitro fertilisation) and embryo transfer treatments in subjects suffering from the sexually transmitted disease syphilis. The clinical outcomes mentioned are the rates of pregnancy and health of newborns following treatment via IVF. Couples engaged in sexual intercourse over 12 months without the use of contraception and who failed to conceive were deemed as being infertile.&lt;br /&gt;
&lt;br /&gt;
The subjects were divided into two groups based on serology results, a syphilis infected group and a control group, each with 160 individuals, giving a total of 320 subjects. The Syphilis infected group was further divided into three subcategories, a male infected group, a female infected group and a couple (male and female) infected group. Penicillin G20 (an anti-syphilis treatment) was given to the individuals in the syphilis group. IVF treatment commenced one month proceeding the disappearance of clinical syphilis symptoms or if test results gave a negative result for syphilis infection.&lt;br /&gt;
&lt;br /&gt;
The results of this experiment revealed no significant differences in regards to the basal FSH and LH of both the control and syphilis groups. However, the thickness of the endometrium differed greatly, with the syphilis group demonstrating a thicker endometrial wall (16.9±5.4mm) compared to the control group (13.0±4.7mm). Further differences were noted in blastocyst implantation rates, with the syphilis group having less successful implantations compared to the control (24.2% vs. 34.4% respectively).Normal oocyte cleavage differed between the two groups with the syphilis group demonstrating less normal oocyte cleavage compared to the control group  (6.3±4.7 vs. 8.1±4.6). Furthermore, the clinical pregnancy rates of the syphilis group stood at 43.8% compared to 55.6% of the control group.&lt;br /&gt;
&lt;br /&gt;
Syphilis infection appeared to have a significant impact on the success and clinical outcomes of IVF. Syphilis associated pelvic inflammatory disease can lead to an increase in the thickness of the endometrium, which can adversely affect blastocyte implantation and endometrial receptivity. Successful pregnancy rates typically correlate with an endometrial thickness of 7-14mm, with any thickness beyond 14mm often corresponding with decreased clinical pregnancies. Rates of clinical pregnancy and miscarriage rates did not differ between the three syphilis subgroups. Conception involving a male infected partner was associated with a shorter gestational period and decreased offspring birth weight, when compared to the female infected and couple infected subgroups. No explanation for this phenomenon was provided.&lt;br /&gt;
&lt;br /&gt;
PMID 26208116&lt;br /&gt;
&lt;br /&gt;
''Article 1 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4514756&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
===Article 2===&lt;br /&gt;
The effects of oxygen levels on factors such as cleavage, implantation and pregnancy rates in IVF cultured embryos was the primary focus of this article.  Women between the ages of 20-48 who were seeking treatment for infertility were utilised in this experiment.&lt;br /&gt;
Gametes were allocated to be incubated in one of three environments, each with a different oxygen concentration. The first group was placed in an atmosphere with an oxygen concentration of 20%. The second group rested in a 20% oxygen environment for a day before being moved to a 5% oxygen, 5% carbon dioxide and 90% nitrogen atmosphere. The third group consisted of a 5% carbon dioxide, 5% oxygen and 90% nitrogen atmosphere. The gametes (spermatozoa and oocytes) were incubated together in their respective environmental conditions for 4-6 hours after which fertilisation is presumed to have occurred.&lt;br /&gt;
&lt;br /&gt;
Successful embryos were transferred at Day 3 cleavage. A biochemical analysis of HCG validated pregnancy, whilst ultrasound was used to confirm the presence of a heartbeat 28 days following the transfer.&lt;br /&gt;
IVF fertilisation rates were calculated as being the number of fertilised oocytes over the number of oocytes inseminated. Cleavage rates were characterised by the number of blastomeres over the number of fertilised and abortion rate by the amount of miscarriages divided by the number of transfers.&lt;br /&gt;
&lt;br /&gt;
The research article concluded that the embryos from the 5% oxygen group had the highest rates of fertilisation and implantation. The 20% oxygen group had the second highest rates of fertilisation and maintained excellent embryo quality, whilst the 20% to 5% group had the lowest rates overall. Abortion and miscarriage rates did not differ at all between the three groups. The group incubated at 5% oxygen demonstrated higher quality embryos and increased rates of pregnancy when compared to the 20% oxygen group. The article concludes that implantation, pregnancy and embryo quality can be somewhat affected by a set oxygen concentration, but are affected adversely by a shift from one concentration to another. &lt;br /&gt;
Shifting from one oxygen concentration to another appeared to have an adverse effect on the cleavage of the embryo and would likely impact future development and the overall success of the IVF treatment.&lt;br /&gt;
&lt;br /&gt;
PMID 26131222 &lt;br /&gt;
&lt;br /&gt;
''Article 2 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4483955&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These are quite good descriptions of these 2 articles. (5/5)&lt;br /&gt;
==Lab 2 Assessment==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Notch Signalling - Ovulation in Drosphila.jpg|Caption]]&lt;br /&gt;
&lt;br /&gt;
===Image Reference===&lt;br /&gt;
Jianjun Sun, Allan C Spradling Ovulation in Drosophila is controlled by secretory cells of the female reproductive tract. Elife: 2013, 2;e00415 PubMed 23599892&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 23599892&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) Image uploaded and named correctly. All reference, copyright and student image template included. You might have included in the summary box an explanation to the terms that appear in the image as there is no way for the reader to interpret what is shown in each panel. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 3 Assessment==&lt;br /&gt;
===Causes===&lt;br /&gt;
====The Genetics of Infertility: Current Status of the Field====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3885174&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This article attempted to determine the role that genetics plays in female infertility. It was noted that several prominent causes of female infertility such as Galactosemia and Primary Ovarian Failure (POF) were associated with specific genes, with the GALT gene contributing to the former condition and the FMR1 gene contributing to the latter.&lt;br /&gt;
&lt;br /&gt;
====Causes of Sterility in Bosnia-Herzegovina Population====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4499307&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
The study conducted as laid out in this article examined the causes of female sterility in the Bosnia-Herzegovina population. Married participants were arranged into various groups based upon their age. The experiment came to the conclusion that in approximately 42% of infertile married couples, female sterility was the primary cause. The two primary causes of female infertility were tubal deficiencies (31% of cases) and Diminished Ovarian Reserves (38% of cases)&lt;br /&gt;
&lt;br /&gt;
====Epidemiology, diagnosis, and management of polycystic ovary syndrome====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3872139&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This research article examines the causes of polycystic ovary syndrome (POS), a common cause of infertility in women. The article concluded that 50-70% of women suffer from insulin resistance secondary to Type 2 Diabetes and in many cases obseity, which may contribute partially to POS. Furthermore, 85-90% of women with oligomenorrhea also had POS, suggesting that it is an underlying cause. However, the exact pathophysiology of POS was not determined.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These papers relate to your group project, I hope they are useful for the final submission. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 4 Assessment==&lt;br /&gt;
===Quiz===&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
{Primary villi are produced during which stage of development?:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ Week 2&lt;br /&gt;
- Week 1&lt;br /&gt;
- Week 3&lt;br /&gt;
- None of the above&lt;br /&gt;
|| Primary Villi appear during Week 2 of development, whilst secondary villi appear during Week 3 of development.&lt;br /&gt;
&lt;br /&gt;
{Mesoderm is a precursor for all of the following EXCEPT:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Skeletal Muscle Cells&lt;br /&gt;
- Cardiac Muscle Cells&lt;br /&gt;
- Erythrocytes&lt;br /&gt;
+ Epidermal Skin Cells&lt;br /&gt;
- Smooth Muscle&lt;br /&gt;
|| Epidermal skin cells originate from ectoderm. Skeletal, cardiac and smooth muscle along with erythrocytes originate from the mesoderm.&lt;br /&gt;
&lt;br /&gt;
{Which of the following shows the correct developmental pathway of the male gamete:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatogonia &amp;gt; Spermatozoa&lt;br /&gt;
- Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell &amp;gt; Spermatozoa &amp;gt; Spermatid&lt;br /&gt;
- Sertoli Cell &amp;gt; Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatozoa&lt;br /&gt;
- Spermatid &amp;gt; Spermatozoa &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell&lt;br /&gt;
+ Spermatogonia &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatid &amp;gt; Spermatozoa&lt;br /&gt;
|| Spermatogonia represent the beginning of male sex cell development, with spermatozoa being the mature gamete.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) No descriptive title to your questions. Q1 relates to the timing of villi development. These types of questions encourage &amp;quot;student guessing&amp;quot; and you could have given a more detailed explanation and links to resources in your revealed answer e.g. [[Placenta - Villi Development]]. Q2 is a reasonable question, but only requiring the student only to know that Epidermal Skin Cells are from ectoderm. Once again it is your revealed answer that needs more work. Q3 is a little easy, as long as you know Spermatogonia are the diploid start cell you can quickly exclude most options, need more work. (8/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5 Assessment==&lt;br /&gt;
===Gastroschisis and Omphalocele===&lt;br /&gt;
&lt;br /&gt;
Gastroschisis is classified as a full thickness cleft found in the abdominal wall, adjacent to the site of insertion of the umbilical cord. The defining features of this abnormality is the absence of a membranous sac shrouding the intestines. As a result of this the intestines will become eviscerated, thereby protruding out of the abdominal wall and will be on the exterior, rather than the interior of the body. It is believed that disruption to the vascular supply of the right abdominal wall is the primary gass of gastroschisis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2166158&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Omphalocele is an abnormality characterised by the herniation of visceral organs such as the intestines, liver and spleen outside of the abdominal cavity. The visceral organs are enclosed in a membranous sac, into which the umbilical cord is inserted.  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC1355659&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The primary difference between gastroschisis and omphalocele lies in the presence of a membraneous sac and the exact organs herniating from the abdominal wall. Gastroschisis involves the intestines protruding to the outside of the body but are not covered by a membranous sac. Omphalocele however is characterised by the protrusion of multiple visceral organs (liver, spleen etc.) which are enclosed within a membranous. Furthermore, the size of both abnormalities differs greatly, with gastroschisis typically being 2-5 cm in size whilst omphalocele can vary between 2-15cm. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2552910&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) This is an adequate description of the differences between these conditions. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 7 Assessment==&lt;br /&gt;
&lt;br /&gt;
1: This research paper aimed to examine the relationship between fetal adrenal cells and the differentiated adrenal cortex. In particular, research was focussed upon possible pregenitor cells involved in maintenance of the adrenal cortex. It was hypothesised that the the most likely precursor cells of the adult cortex were the 'Glil' expressing cells found in the adrenal capsule. A number of mice adrenal glands were taken, treated with antigen retrieval solution, after which fluorescence microscopy was conducted.&lt;br /&gt;
&lt;br /&gt;
The results of the paper concluded that 'Glil' expressing descendants of fetal adrenal cells are the pregenitors of the differentiated adrenal cortex. Furthermore, it was found that the 'Glil' expressing cells oringinated from 'FAdE-Cre' expressing fetal adrenal cells. Thus the authors of this research article came to the conclusion that 'Glil' expressing cells found in the adrenal cortex play an important role in the development, differentiation and maintenance of the adrenal cortex. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3817941&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
2: A number of embryonic layers and tissues contribute to the development of teeth. The primary contributing layers are mesoderm, ectoderm and neural crest ectomesenchyme. Furthermore, neural crest may contribute through interactions with the ectoderm. Odontoblasts originate from neural crest derived mesenchymal cells and are responsible for forming predentin which calificies to create dentin (which forms the bulk of the tooth). Ameloblasts are responsible for the production of enamel, which provides teeth with the hardness required to engage in mastication. &lt;br /&gt;
&lt;br /&gt;
==Peer Assessment==&lt;br /&gt;
&lt;br /&gt;
===Group 1 Peer Assessment===&lt;br /&gt;
Hi guys! I'll start of by saying that the images and video you have included are excellent and are relevant to your topic of discussion. Also, you have a large number of reliable references which is good to see. However you have yet to include a hand drawn image, which is required for the wiki page. I feel like  you could probably eliminate the typed out 'timeline of mitochondrial donation' and instead use this as an opportunity to use a hand drawn image of the timeline. Furthermore, the timeline under 'cystoplasmic transfer' feels a bit awkward and unnecessary. You could probably include this timeline alongside the 'timeline of mitochondrial donation'. &lt;br /&gt;
&lt;br /&gt;
Under the 'Technical Progression' section it would be best to incorporate human embryo, mouse and human models under a sub-sub heading, as at the moment it feels a bit jumbled.&lt;br /&gt;
&lt;br /&gt;
I would also recommend moving the 'Benefits' heading towards the end of the page. It feels odd reading about the benefits of three person embryos before I gain a proper understanding of how they work. Also it might be worth talking about the disadvantages (if there are any) to three person embryos to balance out the 'benefits' section. As has been previously stated, make sure you sort out the copyright information for your video as it would be a shame to lose marks if it was missing. Also, don't forget to add the 'student template' to the 'Swapping mitochondrial DNA mammalian oocytes' image as it is currently absent.&lt;br /&gt;
&lt;br /&gt;
===Group 2 Peer Assessment===&lt;br /&gt;
So far your wiki page gives a very good coverage of Ovarian Hyper-Stimulation Syndrome. The progression of your subheadings progresses logically from one topic to another. It's good to see that you've included an excellent hand-drawn image which is well suited to the 'pathophysiology' subheading. The amount of textual information you have under each heading is vast and gives a comprehensive description of OHSS. Furthermore, you have an excellent range of sources to support your discussion.&lt;br /&gt;
&lt;br /&gt;
I feel however that asides from your hand-drawn image, your use of images and other source of media is definitely lacking. As is, your page is largely text with little to no breaks, making it quite difficult to read. The use of images would not only help break up the monotony of the text, but also help reinforce some of your ideas. I feel that the inclusion of images in the 'symptoms' and 'complications' subheadings would be suitable. &lt;br /&gt;
&lt;br /&gt;
It may also be worthwhile to include subheadings concerning current research, to inform readers about contemporary developments regarding OHSS. Furthermore,  'future research' could also be another potential subheading and could illuminate potential areas that are beginning to be or could be investigated in coming years.&lt;br /&gt;
&lt;br /&gt;
Overall, a very impressive page so far, that could be enhanced with the addition of relevant images and other media.&lt;br /&gt;
&lt;br /&gt;
===Group 4 Peer Assessment===&lt;br /&gt;
Very impressive work so far guys! Your page covers a comprehensive topic very well, without focussing too much on certain subheadings at the expense of others. Your use of both tables and images is excellent so far. It's good to see that you have also included a video to give some variety to the media on your page. The 'background information' gives context to the issues which you discuss and though it might not be of great use for someone familiar with embryology, it would be a great help to those with no experience in this field and is therefore useful in establishing the topic of male infertility.&lt;br /&gt;
&lt;br /&gt;
The only things that could be changed to improve your wiki page is perhaps altering the location of tables and pictures on your page. For example all pictures are located on the right side of the page, although not a significant issue, becomes slightly monotonous as one progresses through the page. It may be worth alternating pictures between left and right to mix things up a little bit and improve the overall flow of the page. &lt;br /&gt;
It might also be worth including a short video underneath the 'surgical treatments' subheading to give a visual example of some of the techniques discussed.&lt;br /&gt;
&lt;br /&gt;
Furthermore a subheading on future research could possibly be included under the 'treatments' subheading to give the reader information on techniques and therapies which may come to prominence in the near future.&lt;br /&gt;
&lt;br /&gt;
Your wiki page thus far is very impressive! Excellent work so far. &lt;br /&gt;
===Group 5 Peer Assessment===&lt;br /&gt;
Awesome page so far guys! I commend you on your use of various videos to assist in conveying your ideas. Furthermore, the images you have chosen are highly relevant to the topic of discussion and assist the reader in gaining a greater understanding of oncofertility. All copyright information is present for the images you have used which is excellent to see.&lt;br /&gt;
It may be worth including a hand drawn image under the 'radiation' subheading, as we are required to include at least one such image. The current image under the radiation subheading could easily be replicated by hand and could fulfill this portion of the criteria.&lt;br /&gt;
&lt;br /&gt;
I am nitpicking here, but I would also recommend including some kind of media, most likely a picture, underneath the surgery subheading. It might even be worth doing the hand drawn image here if possible. A picture may also be good underneath the 'types of chemotherapy drugs' subheading, just to break up the wall of text and improve the reading experience for the reader.&lt;br /&gt;
It might also be worth restructuring the 'oncofertility limitations' subheading into the form of a table (if possible), as the bullet point format feels quite awkward and out of place compared to the rest of the page.&lt;br /&gt;
The inclusion of a glossary is also recommended, as this page will be accessible by the general public and a glossary will assist those without a background in embryology to understand and appreciate your content.&lt;br /&gt;
&lt;br /&gt;
Keep up the great work guys! Your page is absolutely amazing so far and the effort you have put in is definitely reflected in the high quality of your page.&lt;br /&gt;
===Group 6 Peer Assessment===&lt;br /&gt;
A very snazzy wiki page so far! You have used a wide variety of images to convey the concepts of prenatal genetic diagnosis to those reading your wiki page. Copyright information and student templates were present for all the images which you provided which is great to see. A hand drawn image is absent, which is a requirement for every wiki page. It might be worth including the hand drawn image in the 'history section' as the information here could easily be represented by a hand drawn flow chart.&lt;br /&gt;
&lt;br /&gt;
I commend you on your inclusion of a 'future/current research' subheading as this gives the reader a perspective of where the field of prenatal genetic diagnosis is heading in the distant future.&lt;br /&gt;
&lt;br /&gt;
I see that you have included a table underneath the 'biopsy methods' subheading. It would be great to see you compile the advantages and disadvantages of blastomere biopsy and trophectoderm biopsy into a tabular format as this would make for an easier reading experience. Furthermore, tables may also be incorporated for the disadvantages and advantages of genetic techniques.&lt;br /&gt;
I would recommend the inclusion of other forms of media such as a video or gif to assist in the conveyance of information under certain subheadings. A video/gif would fit nicely underneath the 'biopsy method' subheading, though this is just a suggestion.&lt;br /&gt;
&lt;br /&gt;
Overall your assignment is superb so far. You have successfully covered a vast topic and made successful use of a broad range of sources to support your page. Your inclusion of images has been appropriate, however a hand drawn image is still required. &lt;br /&gt;
Keep up the good work guys! &lt;br /&gt;
Look at this!&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Lab 10 Assessment==&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=206045</id>
		<title>User:Z3416054</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=206045"/>
		<updated>2015-10-16T02:29:03Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Hi there&lt;br /&gt;
Just giving the editor a good old test run.&lt;br /&gt;
[[Test student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:45, 7 August 2015 (AEST)&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:47, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 14:06, 14 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:57, 21 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 12:22, 28 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:20, 4 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:18, 11 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:10, 25 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:28, 16 October 2015 (AEDT)&lt;br /&gt;
==Picture Tutorial==&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
===Article 1===&lt;br /&gt;
This research article aimed to determine the clinical outcomes following IVF (in vitro fertilisation) and embryo transfer treatments in subjects suffering from the sexually transmitted disease syphilis. The clinical outcomes mentioned are the rates of pregnancy and health of newborns following treatment via IVF. Couples engaged in sexual intercourse over 12 months without the use of contraception and who failed to conceive were deemed as being infertile.&lt;br /&gt;
&lt;br /&gt;
The subjects were divided into two groups based on serology results, a syphilis infected group and a control group, each with 160 individuals, giving a total of 320 subjects. The Syphilis infected group was further divided into three subcategories, a male infected group, a female infected group and a couple (male and female) infected group. Penicillin G20 (an anti-syphilis treatment) was given to the individuals in the syphilis group. IVF treatment commenced one month proceeding the disappearance of clinical syphilis symptoms or if test results gave a negative result for syphilis infection.&lt;br /&gt;
&lt;br /&gt;
The results of this experiment revealed no significant differences in regards to the basal FSH and LH of both the control and syphilis groups. However, the thickness of the endometrium differed greatly, with the syphilis group demonstrating a thicker endometrial wall (16.9±5.4mm) compared to the control group (13.0±4.7mm). Further differences were noted in blastocyst implantation rates, with the syphilis group having less successful implantations compared to the control (24.2% vs. 34.4% respectively).Normal oocyte cleavage differed between the two groups with the syphilis group demonstrating less normal oocyte cleavage compared to the control group  (6.3±4.7 vs. 8.1±4.6). Furthermore, the clinical pregnancy rates of the syphilis group stood at 43.8% compared to 55.6% of the control group.&lt;br /&gt;
&lt;br /&gt;
Syphilis infection appeared to have a significant impact on the success and clinical outcomes of IVF. Syphilis associated pelvic inflammatory disease can lead to an increase in the thickness of the endometrium, which can adversely affect blastocyte implantation and endometrial receptivity. Successful pregnancy rates typically correlate with an endometrial thickness of 7-14mm, with any thickness beyond 14mm often corresponding with decreased clinical pregnancies. Rates of clinical pregnancy and miscarriage rates did not differ between the three syphilis subgroups. Conception involving a male infected partner was associated with a shorter gestational period and decreased offspring birth weight, when compared to the female infected and couple infected subgroups. No explanation for this phenomenon was provided.&lt;br /&gt;
&lt;br /&gt;
PMID 26208116&lt;br /&gt;
&lt;br /&gt;
''Article 1 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4514756&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
===Article 2===&lt;br /&gt;
The effects of oxygen levels on factors such as cleavage, implantation and pregnancy rates in IVF cultured embryos was the primary focus of this article.  Women between the ages of 20-48 who were seeking treatment for infertility were utilised in this experiment.&lt;br /&gt;
Gametes were allocated to be incubated in one of three environments, each with a different oxygen concentration. The first group was placed in an atmosphere with an oxygen concentration of 20%. The second group rested in a 20% oxygen environment for a day before being moved to a 5% oxygen, 5% carbon dioxide and 90% nitrogen atmosphere. The third group consisted of a 5% carbon dioxide, 5% oxygen and 90% nitrogen atmosphere. The gametes (spermatozoa and oocytes) were incubated together in their respective environmental conditions for 4-6 hours after which fertilisation is presumed to have occurred.&lt;br /&gt;
&lt;br /&gt;
Successful embryos were transferred at Day 3 cleavage. A biochemical analysis of HCG validated pregnancy, whilst ultrasound was used to confirm the presence of a heartbeat 28 days following the transfer.&lt;br /&gt;
IVF fertilisation rates were calculated as being the number of fertilised oocytes over the number of oocytes inseminated. Cleavage rates were characterised by the number of blastomeres over the number of fertilised and abortion rate by the amount of miscarriages divided by the number of transfers.&lt;br /&gt;
&lt;br /&gt;
The research article concluded that the embryos from the 5% oxygen group had the highest rates of fertilisation and implantation. The 20% oxygen group had the second highest rates of fertilisation and maintained excellent embryo quality, whilst the 20% to 5% group had the lowest rates overall. Abortion and miscarriage rates did not differ at all between the three groups. The group incubated at 5% oxygen demonstrated higher quality embryos and increased rates of pregnancy when compared to the 20% oxygen group. The article concludes that implantation, pregnancy and embryo quality can be somewhat affected by a set oxygen concentration, but are affected adversely by a shift from one concentration to another. &lt;br /&gt;
Shifting from one oxygen concentration to another appeared to have an adverse effect on the cleavage of the embryo and would likely impact future development and the overall success of the IVF treatment.&lt;br /&gt;
&lt;br /&gt;
PMID 26131222 &lt;br /&gt;
&lt;br /&gt;
''Article 2 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4483955&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These are quite good descriptions of these 2 articles. (5/5)&lt;br /&gt;
==Lab 2 Assessment==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Notch Signalling - Ovulation in Drosphila.jpg|Caption]]&lt;br /&gt;
&lt;br /&gt;
===Image Reference===&lt;br /&gt;
Jianjun Sun, Allan C Spradling Ovulation in Drosophila is controlled by secretory cells of the female reproductive tract. Elife: 2013, 2;e00415 PubMed 23599892&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 23599892&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) Image uploaded and named correctly. All reference, copyright and student image template included. You might have included in the summary box an explanation to the terms that appear in the image as there is no way for the reader to interpret what is shown in each panel. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 3 Assessment==&lt;br /&gt;
===Causes===&lt;br /&gt;
====The Genetics of Infertility: Current Status of the Field====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3885174&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This article attempted to determine the role that genetics plays in female infertility. It was noted that several prominent causes of female infertility such as Galactosemia and Primary Ovarian Failure (POF) were associated with specific genes, with the GALT gene contributing to the former condition and the FMR1 gene contributing to the latter.&lt;br /&gt;
&lt;br /&gt;
====Causes of Sterility in Bosnia-Herzegovina Population====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4499307&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
The study conducted as laid out in this article examined the causes of female sterility in the Bosnia-Herzegovina population. Married participants were arranged into various groups based upon their age. The experiment came to the conclusion that in approximately 42% of infertile married couples, female sterility was the primary cause. The two primary causes of female infertility were tubal deficiencies (31% of cases) and Diminished Ovarian Reserves (38% of cases)&lt;br /&gt;
&lt;br /&gt;
====Epidemiology, diagnosis, and management of polycystic ovary syndrome====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3872139&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This research article examines the causes of polycystic ovary syndrome (POS), a common cause of infertility in women. The article concluded that 50-70% of women suffer from insulin resistance secondary to Type 2 Diabetes and in many cases obseity, which may contribute partially to POS. Furthermore, 85-90% of women with oligomenorrhea also had POS, suggesting that it is an underlying cause. However, the exact pathophysiology of POS was not determined.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These papers relate to your group project, I hope they are useful for the final submission. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 4 Assessment==&lt;br /&gt;
===Quiz===&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
{Primary villi are produced during which stage of development?:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ Week 2&lt;br /&gt;
- Week 1&lt;br /&gt;
- Week 3&lt;br /&gt;
- None of the above&lt;br /&gt;
|| Primary Villi appear during Week 2 of development, whilst secondary villi appear during Week 3 of development.&lt;br /&gt;
&lt;br /&gt;
{Mesoderm is a precursor for all of the following EXCEPT:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Skeletal Muscle Cells&lt;br /&gt;
- Cardiac Muscle Cells&lt;br /&gt;
- Erythrocytes&lt;br /&gt;
+ Epidermal Skin Cells&lt;br /&gt;
- Smooth Muscle&lt;br /&gt;
|| Epidermal skin cells originate from ectoderm. Skeletal, cardiac and smooth muscle along with erythrocytes originate from the mesoderm.&lt;br /&gt;
&lt;br /&gt;
{Which of the following shows the correct developmental pathway of the male gamete:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatogonia &amp;gt; Spermatozoa&lt;br /&gt;
- Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell &amp;gt; Spermatozoa &amp;gt; Spermatid&lt;br /&gt;
- Sertoli Cell &amp;gt; Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatozoa&lt;br /&gt;
- Spermatid &amp;gt; Spermatozoa &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell&lt;br /&gt;
+ Spermatogonia &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatid &amp;gt; Spermatozoa&lt;br /&gt;
|| Spermatogonia represent the beginning of male sex cell development, with spermatozoa being the mature gamete.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) No descriptive title to your questions. Q1 relates to the timing of villi development. These types of questions encourage &amp;quot;student guessing&amp;quot; and you could have given a more detailed explanation and links to resources in your revealed answer e.g. [[Placenta - Villi Development]]. Q2 is a reasonable question, but only requiring the student only to know that Epidermal Skin Cells are from ectoderm. Once again it is your revealed answer that needs more work. Q3 is a little easy, as long as you know Spermatogonia are the diploid start cell you can quickly exclude most options, need more work. (8/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5 Assessment==&lt;br /&gt;
===Gastroschisis and Omphalocele===&lt;br /&gt;
&lt;br /&gt;
Gastroschisis is classified as a full thickness cleft found in the abdominal wall, adjacent to the site of insertion of the umbilical cord. The defining features of this abnormality is the absence of a membranous sac shrouding the intestines. As a result of this the intestines will become eviscerated, thereby protruding out of the abdominal wall and will be on the exterior, rather than the interior of the body. It is believed that disruption to the vascular supply of the right abdominal wall is the primary gass of gastroschisis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2166158&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Omphalocele is an abnormality characterised by the herniation of visceral organs such as the intestines, liver and spleen outside of the abdominal cavity. The visceral organs are enclosed in a membranous sac, into which the umbilical cord is inserted.  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC1355659&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The primary difference between gastroschisis and omphalocele lies in the presence of a membraneous sac and the exact organs herniating from the abdominal wall. Gastroschisis involves the intestines protruding to the outside of the body but are not covered by a membranous sac. Omphalocele however is characterised by the protrusion of multiple visceral organs (liver, spleen etc.) which are enclosed within a membranous. Furthermore, the size of both abnormalities differs greatly, with gastroschisis typically being 2-5 cm in size whilst omphalocele can vary between 2-15cm. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2552910&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) This is an adequate description of the differences between these conditions. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 7 Assessment==&lt;br /&gt;
&lt;br /&gt;
1: This research paper aimed to examine the relationship between fetal adrenal cells and the differentiated adrenal cortex. In particular, research was focussed upon possible pregenitor cells involved in maintenance of the adrenal cortex. It was hypothesised that the the most likely precursor cells of the adult cortex were the 'Glil' expressing cells found in the adrenal capsule. A number of mice adrenal glands were taken, treated with antigen retrieval solution, after which fluorescence microscopy was conducted.&lt;br /&gt;
&lt;br /&gt;
The results of the paper concluded that 'Glil' expressing descendants of fetal adrenal cells are the pregenitors of the differentiated adrenal cortex. Furthermore, it was found that the 'Glil' expressing cells oringinated from 'FAdE-Cre' expressing fetal adrenal cells. Thus the authors of this research article came to the conclusion that 'Glil' expressing cells found in the adrenal cortex play an important role in the development, differentiation and maintenance of the adrenal cortex. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3817941&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
2: A number of embryonic layers and tissues contribute to the development of teeth. The primary contributing layers are mesoderm, ectoderm and neural crest ectomesenchyme. Furthermore, neural crest may contribute through interactions with the ectoderm. Odontoblasts originate from neural crest derived mesenchymal cells and are responsible for forming predentin which calificies to create dentin (which forms the bulk of the tooth). Ameloblasts are responsible for the production of enamel, which provides teeth with the hardness required to engage in mastication. &lt;br /&gt;
&lt;br /&gt;
==Peer Assessment==&lt;br /&gt;
&lt;br /&gt;
===Group 1 Peer Assessment===&lt;br /&gt;
Hi guys! I'll start of by saying that the images and video you have included are excellent and are relevant to your topic of discussion. Also, you have a large number of reliable references which is good to see. However you have yet to include a hand drawn image, which is required for the wiki page. I feel like  you could probably eliminate the typed out 'timeline of mitochondrial donation' and instead use this as an opportunity to use a hand drawn image of the timeline. Furthermore, the timeline under 'cystoplasmic transfer' feels a bit awkward and unnecessary. You could probably include this timeline alongside the 'timeline of mitochondrial donation'. &lt;br /&gt;
&lt;br /&gt;
Under the 'Technical Progression' section it would be best to incorporate human embryo, mouse and human models under a sub-sub heading, as at the moment it feels a bit jumbled.&lt;br /&gt;
&lt;br /&gt;
I would also recommend moving the 'Benefits' heading towards the end of the page. It feels odd reading about the benefits of three person embryos before I gain a proper understanding of how they work. Also it might be worth talking about the disadvantages (if there are any) to three person embryos to balance out the 'benefits' section. As has been previously stated, make sure you sort out the copyright information for your video as it would be a shame to lose marks if it was missing. Also, don't forget to add the 'student template' to the 'Swapping mitochondrial DNA mammalian oocytes' image as it is currently absent.&lt;br /&gt;
&lt;br /&gt;
===Group 2 Peer Assessment===&lt;br /&gt;
So far your wiki page gives a very good coverage of Ovarian Hyper-Stimulation Syndrome. The progression of your subheadings progresses logically from one topic to another. It's good to see that you've included an excellent hand-drawn image which is well suited to the 'pathophysiology' subheading. The amount of textual information you have under each heading is vast and gives a comprehensive description of OHSS. Furthermore, you have an excellent range of sources to support your discussion.&lt;br /&gt;
&lt;br /&gt;
I feel however that asides from your hand-drawn image, your use of images and other source of media is definitely lacking. As is, your page is largely text with little to no breaks, making it quite difficult to read. The use of images would not only help break up the monotony of the text, but also help reinforce some of your ideas. I feel that the inclusion of images in the 'symptoms' and 'complications' subheadings would be suitable. &lt;br /&gt;
&lt;br /&gt;
It may also be worthwhile to include subheadings concerning current research, to inform readers about contemporary developments regarding OHSS. Furthermore,  'future research' could also be another potential subheading and could illuminate potential areas that are beginning to be or could be investigated in coming years.&lt;br /&gt;
&lt;br /&gt;
Overall, a very impressive page so far, that could be enhanced with the addition of relevant images and other media.&lt;br /&gt;
&lt;br /&gt;
===Group 4 Peer Assessment===&lt;br /&gt;
Very impressive work so far guys! Your page covers a comprehensive topic very well, without focussing too much on certain subheadings at the expense of others. Your use of both tables and images is excellent so far. It's good to see that you have also included a video to give some variety to the media on your page. The 'background information' gives context to the issues which you discuss and though it might not be of great use for someone familiar with embryology, it would be a great help to those with no experience in this field and is therefore useful in establishing the topic of male infertility.&lt;br /&gt;
&lt;br /&gt;
The only things that could be changed to improve your wiki page is perhaps altering the location of tables and pictures on your page. For example all pictures are located on the right side of the page, although not a significant issue, becomes slightly monotonous as one progresses through the page. It may be worth alternating pictures between left and right to mix things up a little bit and improve the overall flow of the page. &lt;br /&gt;
It might also be worth including a short video underneath the 'surgical treatments' subheading to give a visual example of some of the techniques discussed.&lt;br /&gt;
&lt;br /&gt;
Furthermore a subheading on future research could possibly be included under the 'treatments' subheading to give the reader information on techniques and therapies which may come to prominence in the near future.&lt;br /&gt;
&lt;br /&gt;
Your wiki page thus far is very impressive! Excellent work so far. &lt;br /&gt;
===Group 5 Peer Assessment===&lt;br /&gt;
Awesome page so far guys! I commend you on your use of various videos to assist in conveying your ideas. Furthermore, the images you have chosen are highly relevant to the topic of discussion and assist the reader in gaining a greater understanding of oncofertility. All copyright information is present for the images you have used which is excellent to see.&lt;br /&gt;
It may be worth including a hand drawn image under the 'radiation' subheading, as we are required to include at least one such image. The current image under the radiation subheading could easily be replicated by hand and could fulfill this portion of the criteria.&lt;br /&gt;
&lt;br /&gt;
I am nitpicking here, but I would also recommend including some kind of media, most likely a picture, underneath the surgery subheading. It might even be worth doing the hand drawn image here if possible. A picture may also be good underneath the 'types of chemotherapy drugs' subheading, just to break up the wall of text and improve the reading experience for the reader.&lt;br /&gt;
It might also be worth restructuring the 'oncofertility limitations' subheading into the form of a table (if possible), as the bullet point format feels quite awkward and out of place compared to the rest of the page.&lt;br /&gt;
The inclusion of a glossary is also recommended, as this page will be accessible by the general public and a glossary will assist those without a background in embryology to understand and appreciate your content.&lt;br /&gt;
&lt;br /&gt;
Keep up the great work guys! Your page is absolutely amazing so far and the effort you have put in is definitely reflected in the high quality of your page.&lt;br /&gt;
===Group 6 Peer Assessment===&lt;br /&gt;
A very snazzy wiki page so far! You have used a wide variety of images to convey the concepts of prenatal genetic diagnosis to those reading your wiki page. Copyright information and student templates were present for all the images which you provided which is great to see. A hand drawn image is absent, which is a requirement for every wiki page. It might be worth including the hand drawn image in the 'history section' as the information here could easily be represented by a hand drawn flow chart.&lt;br /&gt;
&lt;br /&gt;
I commend you on your inclusion of a 'future/current research' subheading as this gives the reader a perspective of where the field of prenatal genetic diagnosis is heading in the distant future.&lt;br /&gt;
&lt;br /&gt;
I see that you have included a table underneath the 'biopsy methods' subheading. It would be great to see you compile the advantages and disadvantages of blastomere biopsy and trophectoderm biopsy into a tabular format as this would make for an easier reading experience. Furthermore, tables may also be incorporated for the disadvantages and advantages of genetic techniques.&lt;br /&gt;
I would recommend the inclusion of other forms of media such as a video or gif to assist in the conveyance of information under certain subheadings. A video/gif would fit nicely underneath the 'biopsy method' subheading, though this is just a suggestion.&lt;br /&gt;
&lt;br /&gt;
Overall your assignment is superb so far. You have successfully covered a vast topic and made successful use of a broad range of sources to support your page. Your inclusion of images has been appropriate, however a hand drawn image is still required. &lt;br /&gt;
Keep up the good work guys! &lt;br /&gt;
Look at this!&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_6&amp;diff=205263</id>
		<title>Talk:2015 Group Project 6</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_6&amp;diff=205263"/>
		<updated>2015-10-14T01:26:40Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015discussionheader}}&lt;br /&gt;
&lt;br /&gt;
[[Science_Student_Projects]]&lt;br /&gt;
&lt;br /&gt;
[[Abnormal Development - Genetic]]&lt;br /&gt;
FISH Image [https://www.genome.gov/images/content/FISH_factsheet.jpg]&lt;br /&gt;
associated copyright [https://www.genome.gov/copyright.cfm]&lt;br /&gt;
fish data - [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1120169/] [http://www.nature.com/scitable/topicpage/fluorescence-in-situ-hybridization-fish-327] [http://www.rarechromo.org/information/Other/FISH%20FTNW.pdf]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:26, 25 September 2015 (AEST) OK this is such an easy project to find resources for, so where are they? Everyone in research, support groups, genetic inheritance are talking about this topic and the techniques. But this is not on your project page.&lt;br /&gt;
 Like my comments for the other project pages, animal models and media, graphics, statistics, graphs to support the project information???? Your project is not ready for peer review.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 16:26, 1 September 2015 (AEST) I would like to see some content (sub-headings) on your project page.&lt;br /&gt;
&lt;br /&gt;
==Peer Reviews==&lt;br /&gt;
&lt;br /&gt;
===1===&lt;br /&gt;
&lt;br /&gt;
I’ll start by saying, you have an extremely extensive list of references.  Well done! It shows you have really done your research and made good use of it. Your citations are consistent throughout the page and most paragraphs have multiple sources. I would suggest to perhaps include a hand-drawn image somewhere on the page as well as a video. Aside from the section “biopsy methods”, the page could use a few more illustrations. From what I can see, the image under the subheadings “FISH” and “future/current research”, does not appear to have been added correctly according to the guidelines Mark gave us a few weeks back. There is no caption for the image like there are for the other images.&lt;br /&gt;
&lt;br /&gt;
I really like, how under the “diagnosis” heading, you have made the table of applicable diseases for PGD an expandable table. It helps keep the page clean and easier to control. Perhaps though add a little blurb below the table describing it. You have a great set of heading and subheadings that all relate back to your topic. Given that, you have addressed all important areas pertaining to your topic. May I suggest, that in the introduction section, which I am assuming is yet to be done, you add some epidemiological information and perhaps a video speaking briefly on the topic as it can be quite complex.&lt;br /&gt;
&lt;br /&gt;
Well done on the section titled “future/current research”. It is really useful for students seeking a higher degree of information on this topic as it goes into great detail. However, some direct references in the text to some papers would be good. I also suggest adding a glossary of words to the bottom of the page to cater to those who read the page, with a lower level of embryology knowledge than you or I. In addition to that, it may be good to try and break-down some of your paragraphs as there is a lot of text and it can be hard to take in for some people. Bullet points and tables are great. The page does however, focus well on embryological learning aims. &lt;br /&gt;
&lt;br /&gt;
Lastly, to conclude, I feel a though the table and image under “biopsy method” is a little cluttered and could be spaced out a bit more. Overall, this is a really good and detailed framework and with a little more work will be a great project.&lt;br /&gt;
&lt;br /&gt;
===2===&lt;br /&gt;
A very snazzy wiki page so far! You have used a wide variety of images to convey the concepts of prenatal genetic diagnosis to those reading your wiki page. Copyright information and student templates were present for all the images which you provided which is great to see. A hand drawn image is absent, which is a requirement for every wiki page. It might be worth including the hand drawn image in the 'history section' as the information here could easily be represented by a hand drawn flow chart.&lt;br /&gt;
&lt;br /&gt;
I commend you on your inclusion of a 'future/current research' subheading as this gives the reader a perspective of where the field of prenatal genetic diagnosis is heading in the distant future.&lt;br /&gt;
&lt;br /&gt;
I see that you have included a table underneath the 'biopsy methods' subheading. It would be great to see you compile the advantages and disadvantages of blastomere biopsy and trophectoderm biopsy into a tabular format as this would make for an easier reading experience. Furthermore, tables may also be incorporated for the disadvantages and advantages of genetic techniques.&lt;br /&gt;
I would recommend the inclusion of other forms of media such as a video or gif to assist in the conveyance of information under certain subheadings. A video/gif would fit nicely underneath the 'biopsy method' subheading, though this is just a suggestion.&lt;br /&gt;
&lt;br /&gt;
Overall your assignment is superb so far. You have successfully covered a vast topic and made successful use of a broad range of sources to support your page. Your inclusion of images has been appropriate, however a hand drawn image is still required. &lt;br /&gt;
Keep up the good work guys! &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===3===&lt;br /&gt;
&lt;br /&gt;
===4===&lt;br /&gt;
&lt;br /&gt;
===5===&lt;br /&gt;
&lt;br /&gt;
===6===&lt;br /&gt;
&lt;br /&gt;
===7===&lt;br /&gt;
&lt;br /&gt;
==Discussion==&lt;br /&gt;
[[User:Z5088434|Z5088434]]([[User talk:Z5088434|talk]] Would the part you added in indication rather be part of the introduction since it pretty much sums up what the page is about? Maybe go into when PGD and PGS are applied? as for the multiple instances citations: first in text citation has to be like this: &amp;lt;ref name=&amp;quot;PMID...&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;...&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; and the following ones are like this: &amp;lt;ref name=&amp;quot;PMID...&amp;quot;/&amp;gt; (just check for the code in the edit mode, can't figure out how to just show the code without it actually configuring it...)&lt;br /&gt;
==To Do List== &lt;br /&gt;
&lt;br /&gt;
===Week 4=== &lt;br /&gt;
&lt;br /&gt;
*text book summary and some notes&lt;br /&gt;
&lt;br /&gt;
*journal article &lt;br /&gt;
&lt;br /&gt;
*1 relevant media article &lt;br /&gt;
&lt;br /&gt;
*post in this discussion and on your own page under lab 3 assignment &lt;br /&gt;
&lt;br /&gt;
*for links or informal questions please use the facebook Group&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Prenatal Genetic Diagnosis==&lt;br /&gt;
&lt;br /&gt;
===Headings===&lt;br /&gt;
 &lt;br /&gt;
* Polar body&lt;br /&gt;
* Genetic techniques &lt;br /&gt;
* Laws in different countries and states &lt;br /&gt;
* Cell extraction from zygotes, blastomeres, morula&lt;br /&gt;
* How analysis is conducted e.g. PCR&lt;br /&gt;
* Gene Mapping &lt;br /&gt;
* Inheritance patterns &lt;br /&gt;
* Conducted prior to implantation&lt;br /&gt;
&lt;br /&gt;
In order (?): &lt;br /&gt;
* '''Introduction''' (GP)&lt;br /&gt;
* '''History/Development (include transition from post to preimplantation)''' (GP)&lt;br /&gt;
* '''Indications, Inheritance patterns''' (SL)&lt;br /&gt;
** Preimplantation Genetic Diagnosis (PGD) &lt;br /&gt;
** Preimplantation Genetic Screening (PGS)&lt;br /&gt;
* '''Cell Extraction Methods, side effect''' (SK)&lt;br /&gt;
** Polar Body Analysis&lt;br /&gt;
** Blastomere biopsy &lt;br /&gt;
** Trophectoderm biopsy&lt;br /&gt;
* '''Genetic Techniques ''' (GP)&lt;br /&gt;
** Fluorescent In Situ Hybridisation (FISH)&lt;br /&gt;
** PCR&lt;br /&gt;
**Array Comparative Genomic Hybridisation (aCGH)&lt;br /&gt;
PMID 26100406 PMID 24771116&lt;br /&gt;
**Single Nucleotide Polymorphism&lt;br /&gt;
&lt;br /&gt;
history&lt;br /&gt;
explanation&lt;br /&gt;
specific examples&lt;br /&gt;
application&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Next Generation Sequencing&lt;br /&gt;
* '''Diagnosis (table, gene mapping)''' (SL)&lt;br /&gt;
* '''Utilization of Diseased Cell Lines''' (SK) &lt;br /&gt;
* '''Laws/ Legal status''' (SL)&lt;br /&gt;
* '''Future/Current Research'''&lt;br /&gt;
* '''Ethics'''&lt;br /&gt;
&lt;br /&gt;
==Content==&lt;br /&gt;
&lt;br /&gt;
===Legistation for ARTS===&lt;br /&gt;
&lt;br /&gt;
[https://www.nhmrc.gov.au/health-ethics/ethical-issues/assisted-reproductive-technology-art Assisted Reproductive Technology Ethics]&lt;br /&gt;
&lt;br /&gt;
[https://cbhd.org/content/g12-country-regulations-assisted-reproductive-technologies G12 Country Regulations of Assisted Reproductive Technologies]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Cell Extraction Methods==&lt;br /&gt;
Polar bodies: Applying PGD to polar bodies is desired as it can be used before conception. Since genetic testing can be conducted within twenty four hours this makes it possible for the transfer to the mother at the blastomere stage. However this method isn’t commonly used due to the fact that all oocytes must be tested including those that may not progress to mature and only genetic material from the female can be retrieved &amp;lt;ref name=&amp;quot;Coward, K. &amp;amp; Wells, D. (2013). Textbook of Clinical Embryology New York: Cambridge University Press.&amp;quot;&amp;gt;Coward, K. &amp;amp; Wells, D. (2013). Textbook of Clinical Embryology New York: Cambridge University Press.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Cleavage stage: This involves the biopsy of the blastomere (6 to 10 cells) &amp;lt;ref name=&amp;quot;PMID11325751&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11325751&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. It is advantageous to work on blastomeres as they are totipotent, meaning they can give rise to a diverse range of cells. Studies have also shown that there is no increase in congenital abnormality rates caused by the removal of blastomere cells &amp;lt;ref name=&amp;quot;Coward, K. &amp;amp; Wells, D. (2013). Textbook of Clinical Embryology New York: Cambridge University Press.&amp;quot;/&amp;gt;. Contrarily, studies have shown that the standard removal of two blastomeres at one time will decrease its potential to develop into a blastocyst &amp;lt;ref name=&amp;quot;PMID19773223&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19773223&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Along with the fragility of the cells at this stage, highly skilled embryologists are required to minimise poorly performed biopsies which could subsequently lead to impaired growth and a decrease in implantation. Unlike polar bodies both maternal and paternal genes can be tested if PGD is performed at this stage. &amp;lt;ref name=&amp;quot;Coward, K. &amp;amp; Wells, D. (2013). Textbook of Clinical Embryology New York: Cambridge University Press.&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Blastocyst: Performing PGD at this stage is the least common since many patients do not produce embryos healthy enough to reach this stage. Multiple cells can be extracted at this stage for biopsy producing more accurate results. This is possible due to the fact that biopsies have little effect on the development of the embryo. Genetic tests must also be conducted rapidly since implantation is optimal at this stage &amp;lt;ref name=&amp;quot;Coward, K. &amp;amp; Wells, D. (2013). Textbook of Clinical Embryology New York: Cambridge University Press.&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Textbooks==&lt;br /&gt;
&lt;br /&gt;
===The Developing Human 9th Edition: Birth Defects caused by Genetic factors===&lt;br /&gt;
&amp;lt;ref&amp;gt; Moore, K.L., Persaud, T.V.N. &amp;amp; Torchia, M.G. (2011). The developing human: clinically oriented embryology (9th ed.). Philadelphia: Saunders.&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
* Estimated to cause one third of all defects &lt;br /&gt;
* Abnormalities in chromosomes are usually due to structural or numerical changes. These can occur in sex chromosomes or autosomes. &lt;br /&gt;
** Numerical abnormalities are a result of nondisjunction. Nondisjunction is when a pair or chromatids fail to disjoin during meiosis or mitosis. E.g. Turners Syndrome, Trisomy 21 (Down syndrome) and Trisomy 18 (Edward’s Syndrome). &lt;br /&gt;
** Structural abnormalities are usually a result of chromosome breakage followed by reconstitution in an abnormal combination. There are different types of structural abnormalities including translocation and deletion of chromosomes &lt;br /&gt;
* Mutations cause 8% of birth defects. It involves the loss or change in the function of a gene which is permanent and heritable.&lt;br /&gt;
&lt;br /&gt;
===Williams Obstetrics, Twenty-Fourth Edition: Preimplantation Genetic Testing===&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt; Cunningham F, Leveno K.J., Bloom S.L., Spong C.Y., Dashe J.S., Hoffman B.L., Casey B.M., Sheffield J.S. (2013). Prenatal Diagnosis. In Cunningham F, Leveno K.J., Bloom S.L., Spong C.Y., Dashe J.S., Hoffman B.L., Casey B.M., Sheffield J.S.  (Eds), Williams Obstetrics, Twenty-Fourth Edition. Retrieved August 25, 2015 from {http://accessmedicine.mhmedical.com/content.aspx?bookid=1057&amp;amp;Sectionid=59789152.} &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* two categories of preimplantation genetic testing: PGS (-Screening) &amp;amp; PGD (-Diagnosis); different indications&lt;br /&gt;
** PGS: IVF procedure due to infertility without known genetic abnormalities in patients&lt;br /&gt;
** PGD: IVF procedure &amp;amp; genetic testing chosen because of known genetic abnormalities in patients&lt;br /&gt;
* Methods: &lt;br /&gt;
** Polar body analysis: first and second polar body are extruded following completion of meiosis I and meiosis II&lt;br /&gt;
*** Advantages: does not harm embryo, can be used to detect 146 Mendelian disorders, reported 99% accuracy &lt;br /&gt;
*** Disadvantages: paternal genetic contribution is not investigated --&amp;gt; additional procedures &lt;br /&gt;
** Blastomere biopsy: embryo is 3 day old, 6-8 cells stage, most commonly used, hole is made in zona pellucida to retrieve one cell&lt;br /&gt;
*** Disadvantages: 10% pregnancy reduction,&amp;quot;mosaicism of the blastomeres may not reflect the chromosomal complement of the developing embryo&amp;quot;&lt;br /&gt;
** Trophectoderm biopsy: 5-6 day old blastocyst, 5-7 cells are removed&lt;br /&gt;
*** Advantage: no cells removed from embryo&lt;br /&gt;
*** Disadvantage: additional procedures may be necessary because of later stage of developing embryo (cryopreservation, implantation at later IVF-cycle)&lt;br /&gt;
&lt;br /&gt;
===Maternal, Fetal &amp;amp; Neonatal physiology: a Clinical perspective :Prenatal Diagnosis and Maternal, Fetal &amp;amp; Neonatal physiology: a Clinical perspective: Prenatal Diagnosis:=== &lt;br /&gt;
&lt;br /&gt;
Prenatal diagnosis is the screening process that tests an early fetus for overall growth, complications of pregnancy, birth defects and chromosomal or genetic abnormalities within the first 2 trimesters. It aims to provide the parents with as information as possible to help them make an informed decision about the infants quality of life. In 90-95% of the cases negative outcomes occur; confirming the healthy state of the fetus, should a genetic abnormality be present, it provides the parents with the opportunity to  investigate further with other tests, and possible fetal therapeutic treatments available as well  plan and prepare for the disabled infant  or to terminate the pregnancy. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
*Indicators for prenatal screening/ high risk factors include:&lt;br /&gt;
**maternal ages &amp;gt; 35 years&lt;br /&gt;
**paternal ages &amp;gt; 50-55&lt;br /&gt;
**history of 2+ miscarriages&lt;br /&gt;
**previous pregnancy or family history of a preexisting genetic or chromosomal disorder&lt;br /&gt;
**suspected carriers of genetic disorders&lt;br /&gt;
** maternal disease/condition present (high BP, diabetes)&lt;br /&gt;
**abnormal ultrasound or serum test results within the first 2 trimesters&lt;br /&gt;
**family history of neural tube or other birth defects &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
*Ultrasonography:&lt;br /&gt;
**high frequency sound waves are used to generate a image of the fetus &lt;br /&gt;
**relatively non-invasion; its conducted transabdominally or transvaginally ( producing a higher resolution image) &lt;br /&gt;
**It reveals the presence/absence of congenital abnormalities, characteristics of fetal growth and development, uterine development status; amount of **amniotic fluid, placental position, umbilical blood flow and the presence of multiple gestation. &lt;br /&gt;
**(if abnormalities are detected further testing is recommended)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
*Amniotic Fluid Analysis/:&lt;br /&gt;
**samples are obtained through amniocentesis &lt;br /&gt;
**the amniotic fluid is analyzed for its biochemical composition &lt;br /&gt;
**earlier in the pregnancy it can be examined for sex determination and to diagnose genetic or chromosomal disorders present. &lt;br /&gt;
**Later into the pregnancy it provides an indication of fetal maturity and well being&lt;br /&gt;
**Feta; cells recovered from the amniotic fluid can be cultured for specific karyotypes, to test for Chromosomal Abnormalities, and analysed for Alpha- fetoprotein (AFP) a biochemical marker of metabolic disorders and neural tube defects as well as other abnormalities.  &lt;br /&gt;
**Amniocentesis- occurs usually between weeks 14-20 as amniotic fluid has reached the optimal volume (150-250mls) allowing 20-30mls to be removed with a relatively low risk or fetal or maternal complication, and in time for a 2nd trimester abortion.&lt;br /&gt;
**early amniocentesis ( before week 13) increase the risk of fetal loss, leakage of essential amniotic  fluid and talipes equinovarus.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
*Chronic Villus Sampling  (CVS):&lt;br /&gt;
**occurs  roughly 10-13 weeks after last menstrual cycle, ensuing a sufficiently developed chorionic villi but before the chorion laeve forms the definitive placenta. &lt;br /&gt;
**ultrasounds is used to locate the gestational sac and implantation then a transcervial or transabdominal approach is used to aspirate living tropoblast tissue.&lt;br /&gt;
**sample is analyzed for chromosomal abnormalities or with enzyme assay. &lt;br /&gt;
**advantages: earlier diagnosis , decreased waiting period&lt;br /&gt;
**disadvantages: risk of spontaneous abortion, bacterial infection, bleeding, leakage of amniotic fluid, inability to diagnose neural tube defects this early, early cleavage (before wk 10) is associated with increased risk of limb defects (due to insufficiently developed chronic villi) &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
*Umbilical Blood Sampling:&lt;br /&gt;
**can occur as early as 16 weeks &lt;br /&gt;
**using the umbilical cord to obtain fetal blood samples - with real time ultrasound &lt;br /&gt;
**used to diagnose inherited blood disorders, to detect congenital infections, to assess fetal anemia and in treatments such as blood transfusions. &lt;br /&gt;
**disadvantages: risks of infection, preterm labor, thrombosis, bleeding &amp;amp; transient fetal arrhythmia &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
*Fluroscent in Situ Hybridisation (FISH)&lt;br /&gt;
**rapidly detects (within 24 hours of testing )  the presence of Trisomies 21, 13 and 8 and alterations in sex chromosomes in uncultured cells. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
*early diagnosis allows the opportunity for intervention with fetal therapies: &lt;br /&gt;
**surgical intervention urinary tract obstruction ; aiming to reduce prenatal renal damage&lt;br /&gt;
**fetal transfusions ( feta anemia &lt;br /&gt;
**fetal medical treatmetn ( fetal cardiac arrhythmias,impaired thyroid function etc.) treatment occurs   usually through the mother &lt;br /&gt;
** infusions for hematologic conditions &lt;br /&gt;
**stem cell transplantation&lt;br /&gt;
**gene therapy  &lt;br /&gt;
**pharmocolic interventions &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
textbooks used : &lt;br /&gt;
&lt;br /&gt;
*Maternal, Fetal &amp;amp; Neonatal physiology: a Clinical perspective &amp;lt;ref&amp;gt; Blackburn, S.L. (2003) '''Maternal, Fetal &amp;amp; Neonatal physiology: a Clinical perspective''' (2nd ed.). Seattle: Saudners &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Langman's Medical Embryology (12th ed.)Chapter 9, pages 125-129 &amp;lt;ref&amp;gt; Sadler T.W.(2012) '''Langman's Medical Embryology''' (12th ed.) &lt;br /&gt;
Philadelphia: Lipincott, Wiliams &amp;amp; Wilkins, a Wolters Kluwer Business  &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
the following are two articles about a newly available and accessible prenatal non- invasive genetic test- Blood sampling:&lt;br /&gt;
&lt;br /&gt;
*Report on Cutting edge prenatal screening technology to become available in Australia &amp;lt;ref&amp;gt; Carbonell, R. Shinners, A. Amor, D. Mark, D. (2015) '''Report on Cutting edge prenatal screening technology to become available in Australia:''' ''Prepared for ABC news, PM with Mark Colvin.''  Retrieved from {http://www.abc.net.au/pm/content/2015/s4203200.htm} &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Blood Test takes risk out of prenatal testing &amp;lt;ref&amp;gt; Begley, S. (05/07/2015) '''Blood Test takes risk out of prenatal testing'''. ''ABC Science.'' Retrieved from&lt;br /&gt;
{http://www.abc.net.au/science/articles/2012/07/05/3539549.htm} &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* Prenatal screening and Diagnostic Tests Information Pamphlet &amp;lt;ref&amp;gt; Western Australia. Department of Health Genetics Council Prenatal Diagnosis Committee (2011)'''Prenatal screening and Diagnostic Tests'''. Retrieved from {http://www.health.wa.gov.au/docreg/Education/Prevention/Genetics/HP3131_prenatal.pdf} &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Articles==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24810687&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;23773313&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26201722&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26168107&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
''This article reviews the cytogenetic techniques and embryo biopsies required for PGD &amp;amp; PGS and gives an account on the differences in PGD for single gene defects and chromosomal translocations.'' &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;22723007&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
''This article gives relatively recent and detailed information on the three types of biopsy performed on embryos at different stages of development (before conception, after fertilization, and early cleavage or blastocyst stage)''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24515905&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
''This article reviews indications for PGD focusing on single gene disorders.''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;20966459&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
''This article gives detailed laboratory instructions and guidelines for PGD procedures, which might be useful for the methodological part of the website''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
''The following articles are about diseased cells/embryos derived from PGD procedures for further research:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;23242925&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;22735930&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
''Other articles''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;21748341&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26259216&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26258137&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;22404048&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26238130&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26168107&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
IVF and prenatal genetic testing in Australia &lt;br /&gt;
[[http://virtushealth.com.au/australian-first-new-genetic-testing-set-improve-access-and-outcomes-ivf-patients]]&lt;br /&gt;
&lt;br /&gt;
the following are two articles about a newly available and accessible prenatal non- invasive genetic test- Blood sampling:&lt;br /&gt;
[[http://www.abc.net.au/pm/content/2015/s4203200.htm]]&lt;br /&gt;
[[http://www.abc.net.au/science/articles/2012/07/05/3539549.htm]]&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_5&amp;diff=205259</id>
		<title>Talk:2015 Group Project 5</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_5&amp;diff=205259"/>
		<updated>2015-10-14T01:26:11Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015discussionheader}}&lt;br /&gt;
&lt;br /&gt;
Hey guys - i tried to upload a video for the how cancer cells work section  - but i have no idea how to do it, tried looking it up but have failed immensely! so i you know how to do it - please explain haha so grateful! thanks --[[User:Z5015534|Z5015534]] ([[User talk:Z5015534|talk]]) 12:42, 4 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:23, 25 September 2015 (AEST) OK, there is so much more that should be on your project page by now. That currently consists of all text, no media, histology, graphics, tables etc. Furthermore no discussion of animal models used in research for this topic. This project page is not ready for peer review.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hi everyone,&lt;br /&gt;
the page is coming together well. &lt;br /&gt;
only thing is while we write up our parts can we focus on all using in text referencing so that we are consistent and can just have a single reference list at the bottom.&lt;br /&gt;
I found out how to use the same reference again and only have it associated with one in text number, so if you are using the same reference and would like me to show you how to do this let me know :)&lt;br /&gt;
--[[User:Z3463667|Z3463667]] ([[User talk:Z3463667|talk]]) 21:40, 14 September 2015 (AEST)&lt;br /&gt;
 &lt;br /&gt;
I have added some of the references + citations but not yet finished as this is only the draft and I might delete some of the parts so there is no point adding the citations/ text referencing now. I will add my part at the end. I'm still waiting for your part to see what to do. http://www.ncbi.nlm.nih.gov/pubmed/15951668&lt;br /&gt;
--[[User:Z3463890|Z3463890]] ([[User talk:Z3463890|talk]]) 08:35, 17 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
=Research/Review articles=&lt;br /&gt;
&lt;br /&gt;
===[Oncofertility and breast cancer: Where have we come from, where are we going?].===&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;25991386&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This article focuses on the current context of national and international recommendations, techniques development to evaluate and preserve fertility and patients' claims, this study aims to make a survey about the management of patients' breast cancer regarding oncofertility. This article concludes that , in order to satisfy patients' requests, several improvements have to be made regarding the patients' information, the health professionals' awareness and care coordination.I don't go through it now but very interesting article to read and useful for our group project.&lt;br /&gt;
&lt;br /&gt;
===Emergency fertility preservation for female patients with cancer: clinical perspectives.===&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26026071&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This article explains about clinical perspectives to explore the new as well as the currently available options and strategies that can be used for emergency fertility preservation of female cancer patients.Such options include emergency ovarian stimulation, embryo freezing, egg freezing, ovarian tissue freezing and autotransplantation, in vitro maturation, and ovarian protection techniques. This article also mentions the advantages and disadvantages of each option as well as a new comprehensive multi-step strategy for these situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Sexual dysfunction and infertility as late effects of cancer treatment===&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26217165&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
As all we know, Sexual dysfunction is the main consequence of cancer treatment. Problems are usually linked to damage to nerves, blood vessels, and hormones that underlie normal sexual function. This article emphasizes on these sexual dysfunction and does in depth. It addresses that innovations in cancer treatment such as robotic surgery or more targeted radiation therapy have not had the anticipated result of reducing sexual dysfunction. Therefore, advances in both technologies and in knowledge about how cancer treatments can damage fertility, offer hope to patients who want children.&lt;br /&gt;
&lt;br /&gt;
===Impact of fertility preservation counseling and treatment on psychological outcomes among women with cancer: A systematic review===&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26264701&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This article explains about psychological outcomes in female cancer patients who undergo fertility preservation counseling/consultation (FPC), with or without fertility preservation (FP).I read through the whole article as I found it really interesting and relevant to our group project. This is another subheadings we can add to those.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3463890|Z3463890]] ([[User talk:Z3463890|talk]]) 11:24, 24 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
I DID THE SAME :) &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Variability in the practice of fertility preservation for patients with cancer.===&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26010087&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This is an interesting article on how reproductive endocrinologists counselled cancer patients on fertility preservation. This is relevant to our group projects because it gives us an idea of what techniques and services are currently being utilised to help women. &lt;br /&gt;
&lt;br /&gt;
===Strategies for fertility preservation in young patients with cancer: a comprehensive approach.===&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24669162&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This article recognises that as cancer treatment improves the life span of patients, with it comes the treat to fertility. It is a great article as it clearly states what methods are currently available for addressing fertility preservation in males and females. &lt;br /&gt;
&lt;br /&gt;
===Clinical guide to fertility preservation in hematopoietic cell transplant recipients.===&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24419521&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This article focuses specifically on patients suffering infertility due to hematopoietic cell transplantation. It lists the options available to the patients whether female or male, which are applicable to patients who underwent other treatments and also lists the barriers to fertility preservation.&lt;br /&gt;
&lt;br /&gt;
===Fertility preservation in patients with haematological disorders: a retrospective cohort study.===&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24140311&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This article addresses fertility treatment in patients with haematological disorders specifically. However, is it a really good article as it is a cohort study comparing patients at various stages in their cancer journey, such as those who have had prior chemotherapy, those who pursued ovarian stimulation and those who did not pursue fertility treatment at all.&lt;br /&gt;
&lt;br /&gt;
just moving my articles here for reference while i edit the project page. &lt;br /&gt;
--[[User:Z3463667|Z3463667]] ([[User talk:Z3463667|talk]]) 11:39, 14 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
Hi&lt;br /&gt;
I have added some points to the page but i will add more info soon. In terms of references and accurate citation, I have written down all the references and I will add those at the end as I might edit/delete some of them. I will explain those fertility drugs too. just added the names and do them over weekend.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3463890|Z3463890]] ([[User talk:Z3463890|talk]]) 08:58, 11 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hi everyone, &lt;br /&gt;
&lt;br /&gt;
yes, I agree we have to assign everyone a certain section to write about, I'm happy to do Infertility causing cancers ( I already found those related articles from pubmed) and Oncofertility timeline. so if everyone is happy I can start it :)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3463890|Z3463890]] ([[User talk:Z3463890|talk]]) 08:05, 27 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hi People, &lt;br /&gt;
&lt;br /&gt;
Does anyone know how to reference a non pubmed source? I'm not sure how to reference the general information that we want to put on our page? &lt;br /&gt;
I definitely think also that we should assign everyone a certain section to cover - so that were not all just editing and adding stuff in chaos - Ive started editing the chemotherapy section of the page - i hope this is alright if i take that on- i found some good info! dont worry the stuff i have up now is no where near finished.. just having a play around with general stuff and trying to get the hang of editing etc... (literally no nothing about IT...) But at the end it obviously will be all sorted and good :) &lt;br /&gt;
&lt;br /&gt;
Thanks&lt;br /&gt;
&lt;br /&gt;
--[[User:Z5015534|Z5015534]] ([[User talk:Z5015534|talk]]) 16:18, 26 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hey everyone, &lt;br /&gt;
&lt;br /&gt;
As discussed we will be researching oncofertility as our topic for this week, and depending on how successful our research is we will decide on whether we stick to the topic or not. &lt;br /&gt;
I have added some potential subheadings to help guide our research, feel free to change them and add more. &lt;br /&gt;
We need to pick a subheading each and find research articles related to it for this weeks individual lab assessment. &lt;br /&gt;
https://oncofertility.northwestern.edu/patients/fertility-preservation-options-nu --&amp;gt; this is a good website to trigger ideas to research. &lt;br /&gt;
--[[User:Z3463667|Z3463667]] ([[User talk:Z3463667|talk]]) 17:12, 23 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
==Peer Review===&lt;br /&gt;
&lt;br /&gt;
===1===&lt;br /&gt;
&lt;br /&gt;
Let me start off by commending this group on a fantastic page! It is incredibly thorough, detailed and long. You can immediately see that a lot of work and research has gone into it. You have a great list of references and they appear to be cited correctly throughout the page. However, some sections which appear to be incomplete and lack some citations e.g. “fertility preservation”. &lt;br /&gt;
&lt;br /&gt;
One suggestion I will make, is it would be good to see the addition of some hand-drawn images, perhaps one under either of the first 3 headings. Some more images could be used under the heading “surgery”. The videos used on this page are great. Really informative, relevant and easy to watch. I also think the “what are cancer cells” section should be higher up on the page as it is part of the basis of what the whole page is about. It also cuts between the two sections “chemotherapy” and “how does chemotherapy work?” which should be one after another. On the topic of formatting, you have a heading in there called “oncofertility timeline”, I think it would be better placed at the beginning of the page where it is more relevant. &lt;br /&gt;
&lt;br /&gt;
I also think there is just too much text in some areas e.g.  “Fertility preservation in women” and “surgery”. It makes that part of the page look clustered and difficult to read. Perhaps simplifying it more into bullet points, as you have done in other areas of the page, would be good. Conversely though, I think areas such as “targeted drugs” and “bone marrow or stem cells transplant” could use more work, however, it is possible you still intend to work on those areas anyway. &lt;br /&gt;
&lt;br /&gt;
I would suggest adding a glossary to the bottom of your page to assist in those who view your page with a lower level of scientific knowledge. You have covered an expansive range of topics pertaining to your topic, all of which are relevant and link well with each other. The page has a great focus on the learning aims of embryology. I think with some formatting corrections and some simplification of the text, this will be a really wonderful page.&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
Awesome page so far guys! I commend you on your use of various videos to assist in conveying your ideas. Furthermore, the images you have chosen are highly relevant to the topic of discussion and assist the reader in gaining a greater understanding of oncofertility. All copyright information is present for the images you have used which is excellent to see.&lt;br /&gt;
It may be worth including a hand drawn image under the 'radiation' subheading, as we are required to include at least one such image. The current image under the radiation subheading could easily be replicated by hand and could fulfill this portion of the criteria.&lt;br /&gt;
&lt;br /&gt;
I am nitpicking here, but I would also recommend including some kind of media, most likely a picture, underneath the surgery subheading. It might even be worth doing the hand drawn image here if possible. A picture may also be good underneath the 'types of chemotherapy drugs' subheading, just to break up the wall of text and improve the reading experience for the reader.&lt;br /&gt;
It might also be worth restructuring the 'oncofertility limitations' subheading into the form of a table (if possible), as the bullet point format feels quite awkward and out of place compared to the rest of the page.&lt;br /&gt;
The inclusion of a glossary is also recommended, as this page will be accessible by the general public and a glossary will assist those without a background in embryology to understand and appreciate your content.&lt;br /&gt;
&lt;br /&gt;
Keep up the great work guys! Your page is absolutely amazing so far and the effort you have put in is definitely reflected in the high quality of your page.&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_4&amp;diff=205257</id>
		<title>Talk:2015 Group Project 4</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_4&amp;diff=205257"/>
		<updated>2015-10-14T01:25:55Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015discussionheader}}&lt;br /&gt;
&lt;br /&gt;
==Discussion==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:20, 25 September 2015 (AEST) OK I discussed this with your group in last week's lab. you have not shown animal models, graphics, histology, media etc to really build your project page. The introduction does not give me a clear idea of the scope of the project. Not ready for peer review.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hey guys, I have just had a really quick look on PubMed and I found a good starting article. Its a review article (I'm pretty sure) so I'm not sure if we can use it, but it discusses some interesting genetic causes of male infertility and also references a lot of primary articles. &lt;br /&gt;
&lt;br /&gt;
PMID 26178295 &lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:38, 25 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
I can't seem to view anything but the first page of the article but the introduction gives a good idea on what male infertility is and how it arises. At the moment I have found 2 research articles that address factors that can increase male fertility. Although they do not address male infertility conditions specifically, in the discussion they imply that these methods can be applied to men who have them such as oligospermia and azoospermia. I feel as though we can use these articles when discussing alternative therapies for successful conception. Please have a read and share your opinions! &lt;br /&gt;
&lt;br /&gt;
PMID 22958644 - note that you can only view the condensed version of this article&lt;br /&gt;
&lt;br /&gt;
PMID 26097523 - you can view the whole article on biomed (subheadings in the discussion particularly addresses male infertility)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462297|Z3462297]] ([[User talk:Z3462297|talk]]) 14:17, 25 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hey guys, it was pretty hard finding research articles from Pubmed regarding the epidemiology of male infertility.  For now, I have found an article about sperm extraction which I thought could be an alternative for treatments.  However I can't view the full article without paying, but the abstract from Pubmed seems to sum it up.&lt;br /&gt;
So, I came across a research article addressing the epidemiology and aetiology of male infertility, through Pubmed it doesn't have a direct link to the full PDF article however I linked it you guys on Facebook so have a read!&lt;br /&gt;
&lt;br /&gt;
PMID 22128297&lt;br /&gt;
&lt;br /&gt;
PMID 9663768&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3463514|Z3463514]] ([[User talk:Z3463514|talk]]) 11:59, 26 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hello everyone! To get started, I just added a few headings on the page where you can add your research/review articles. Feel free to add more subheadings or change the wording of the titles - I'm sure we will need to as we research more. From looking at other groups' pages, I think it is also important we add a bit of 'Background Information&amp;quot; regarding the process of spermatogenesis and how any abnormalities can cause infertility so we can all look for articles as we go. Remember we are targeting this towards students like us, so a bit of key background info is essential. &lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462297|Z3462297]] ([[User talk:Z3462297|talk]]) 00:06, 27 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
I just posted the articles that I found on male infertility. It was kind of hard to find ones because I stuck to studies in humans- but i found some good ones that were studies on rats (not sure if we can use them) and also some good secondary or review articles that we could use as background information maybe? So I'll just post the PMID's here..&lt;br /&gt;
* PMID 26303086&lt;br /&gt;
* PMID 23725463 &lt;br /&gt;
* PMID 25160621&lt;br /&gt;
* PMID 25142466&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 09:59, 27 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Not sure if we are review articles are any good, but I thought that it's also important to talk about &amp;quot;detecting abnormalities&amp;quot;.  I came across this review article which talks about the &amp;quot;male genital tract - colour dopple ultrasound&amp;quot; is a useful tool to detect impaired reproductive health.&lt;br /&gt;
&lt;br /&gt;
PMID 25038770 &lt;br /&gt;
&lt;br /&gt;
--[[User:Z3463514|Z3463514]] ([[User talk:Z3463514|talk]]) 19:59, 27 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Good thinking! If anyone comes across more articles regarding this, please post them up! I'll add a 'diagnosis' sub-heading to the page &lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462297|Z3462297]] ([[User talk:Z3462297|talk]]) 22:23, 27 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hey guys, found a couple of articles describing different methods of ARTs for male infertility:&lt;br /&gt;
&lt;br /&gt;
These 2 talk about Intrauterine Insemination (IUI)&lt;br /&gt;
PMID 26294874&lt;br /&gt;
PMID 26288981&lt;br /&gt;
&lt;br /&gt;
Also, another potential sub-heading to research might be the risks involved different ARTs&lt;br /&gt;
E.g. the following article about the prevalence of birth defects after a number of different male-related ARTs&lt;br /&gt;
PMID 26265143&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462833|Z3462833]] ([[User talk:Z3462833|talk]]) 23:38, 27 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
That sounds good. I think mentioning risks are important to show what is successful and what isnt. Feel free to add it under the &amp;quot;ART&amp;quot; heading (as a sub-heading)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462297|Z3462297]] ([[User talk:Z3462297|talk]]) 23:06, 31 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hey I found this article that discusses some ARTs for infertile men. Its not a bad read and has info on two different methods, Intracytoplasmic morphologically selected sperm injection (IMSI) and conventional intracytoplasmic sperm injection (cICSI). You can read the full text on biomod &lt;br /&gt;
&lt;br /&gt;
PMID 26307050&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462297|Z3462297]] ([[User talk:Z3462297|talk]]) 17:27, 1 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
LOOK! &lt;br /&gt;
This is a really good review article that talks about causes, diagnosis AND treatments. I recommend everyone to read it!  &lt;br /&gt;
&lt;br /&gt;
PMID 21243017 &lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462297|Z3462297]] ([[User talk:Z3462297|talk]]) 11:09, 2 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
==Peer Assessment==&lt;br /&gt;
&lt;br /&gt;
===1===&lt;br /&gt;
&lt;br /&gt;
To start, I think some of your subheadings are a bit unnecessary, for example, you could get away without having the subheading “background information” and just having the sub-subheadings as subheadings below your intro. Whilst some subheadings are good as it helps break down the info in the table of contents, it makes the actual page difficult to read and follow. &lt;br /&gt;
&lt;br /&gt;
Great use of images on the page. There are many, without it cluttering the page and they are simple and relevant. However, the pictures you have used under “background information” appear to be a bit lifeless and complex. Perhaps using more simplified images with some colours would help liven up the section as well as allow people who use this page, with less scientific knowledge than you, to understand what they are seeing. They are important images as they set the basis for the rest of the page. It would also be good to see a hand-drawn image on the page. &lt;br /&gt;
&lt;br /&gt;
Your use of tables is also great, it really helps to break down the information. I would suggest however, you include a little more information and references under the section “male infertility disorders”. It is a big vague and there are no citations.  Your list of references is incredible and you should be commended on that. It shows a great deal of research has gone into this page. Your citations appear to be correctly done throughout the page. Your “Causes of fertility” section is done really well and is very thorough. The video accompanying it is good to as it is easy to understand and explanatory. Your “risk factors and prevention” heading could use more work. I would suggest actually splitting them up into two separate headings and really delving more into prevention and how to handle infertility. &lt;br /&gt;
&lt;br /&gt;
Your “treatment” section is really well done and thorough. I would suggest however, to make it easier to read, that you simplify some of your paragraphs into bullet points. A glossary section may also be useful for people reading this page with a lesser degree of embryology knowledge than you or I. I will say, this page has covered its chosen topic well and has attacked it from an embryologically focused angle. Lastly I would suggest including a section on animal models and the literature for the more advanced student.&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
Very impressive work so far guys! Your page covers a comprehensive topic very well, without focussing too much on certain subheadings at the expense of others. Your use of both tables and images is excellent so far. All necessary copyright information seems to be present for the images that you have uploaded. It's good to see that you have also included a video to give some variety to the media on your page. The 'background information' gives context to the issues which you discuss and though it might not be of great use for someone familiar with embryology, it would be a great help to those with no experience in this field and is therefore useful in establishing the topic of male infertility.&lt;br /&gt;
&lt;br /&gt;
The only things that could be changed to improve your wiki page is perhaps altering the location of tables and pictures on your page. For example all pictures are located on the right side of the page, although not a significant issue, becomes slightly monotonous as one progresses through the page. It may be worth alternating pictures between left and right to mix things up a little bit and improve the overall flow of the page. &lt;br /&gt;
It might also be worth including a short video underneath the 'surgical treatments' subheading to give a visual example of some of the techniques discussed.&lt;br /&gt;
&lt;br /&gt;
Furthermore a subheading on future research could possibly be included under the 'treatments' subheading to give the reader information on techniques and therapies which may come to prominence in the near future.&lt;br /&gt;
&lt;br /&gt;
Your wiki page thus far is very impressive! Excellent work so far.&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_2&amp;diff=205255</id>
		<title>Talk:2015 Group Project 2</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_2&amp;diff=205255"/>
		<updated>2015-10-14T01:25:38Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015discussionheader}}&lt;br /&gt;
&lt;br /&gt;
--[[User:Z5016784|Z5016784]] ([[User talk:Z5016784|talk]]) 14:42, 13 October 2015 (AEDT) Just regarding the peer reviewing of other group projects, do we have to be assessing all 5 other projects?&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:16, 25 September 2015 (AEST) Hmm still a little thin. There should be some animal model info, histology images, physiological data, drug info, and genetic information.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3374116|Z3374116]] ([[User talk:Z3374116|talk]]) 17:15, 18 August 2015 (AEST) Hello there&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3415911|Z3415911]] ([[User talk:Z3415911|talk]]) 16:12, 24 August 2015 (AEST) Hey guys! So I've gone and added a few subheadings that may be useful to start researching. For this weeks assessment we need to choose one each and find 3 articles to go with it etc. So if we all choose one and start researching it, that would be good :)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3415911|Z3415911]] ([[User talk:Z3415911|talk]]) 11:02, 26 August 2015 (AEST) Good article for treatment http://humupd.oxfordjournals.org/content/16/5/459.abstract?etoc&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3374116|Z3374116]] ([[User talk:Z3374116|talk]]) 19:20, 26 August 2015 (AEST) Sweet, Thanks for putting up those headings to get things going. Lets all put up related documents by Thursday so we have can discuss things at the Lab this Friday!&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3374116|Z3374116]] ([[User talk:Z3374116|talk]]) 19:29, 26 August 2015 (AEST) I've put up some interesting pubmed documents on our main page, Have a read through them (I haven't read them all yet)&lt;br /&gt;
&lt;br /&gt;
=== &amp;lt;span style=&amp;quot;font-size:75%&amp;quot;&amp;gt;'''Classifications of Ovarian Hyper-stimulation Syndrome'''&amp;lt;/span&amp;gt; ===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Classification'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;650px&amp;quot;| '''Symptoms'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Mild''' &lt;br /&gt;
|style=&amp;quot;height: 75px; background: #CCEEEE;&amp;quot;| '''Grade 1''' - Abdominal distention and discomfort&lt;br /&gt;
'''Grade 2''' - Abdominal distention, discomfort with nausea, vomiting and/or diarrhea and ovarian enlargement from 5~12cm&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Moderate'''&lt;br /&gt;
|style=&amp;quot;height: 75px; background: #EEEEEE;&amp;quot;| '''Grade 3''' - All features of Mild OHSS with ultrasonographic evidence of ascites&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Severe''' &lt;br /&gt;
|style=&amp;quot;height: 75px; background: #CCEEEE;&amp;quot;| '''Grade 4''' - All features of Moderate OHSS with the addition of clinical evidence of ascites and breathing difficulties present&lt;br /&gt;
'''Grade 5''' - All of the above symptoms along with a change in the blood volume, increased blood viscosity due to coagulation and diminished renal function&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3374116|Z3374116]] ([[User talk:Z3374116|talk]]) 11:40, 28 August 2015 (AEST) I wont be able to make it to uni today for the lab and the meetup after it. Got to take my cousin to the ER&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3374116|Z3374116]] ([[User talk:Z3374116|talk]]) 12:07, 28 August 2015 (AEST) I was thinking to include the risk factors in the 'causative' subheading&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3374116|Z3374116]] ([[User talk:Z3374116|talk]]) 13:22, 28 August 2015 (AEST) So basically in the Causative subheading, I was planning&lt;br /&gt;
1) Identify the different causes (including primary and secondary risk factors)&lt;br /&gt;
2) What difference occurs from a normal cycle (e.g. level of hCG normally)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3415911|Z3415911]] ([[User talk:Z3415911|talk]]) 13:36, 28 August 2015 (AEST) No problem! I hope your cousin is okay. Whoever added a sub heading called: Tests and Diagnosis, there already is the same kind of subheading, Symptoms and Diagnosis so we need to merge the two. It also needs to be in chronological order&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3372824|Z3372824]] ([[User talk:Z3372824|talk]]) 13:46, 28 August 2015 (AEST)Hope he gets well! Talking about sections, I'll try and work on Prevention, and get the research summaries done for that section by next week.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3372824|Z3372824]] ([[User talk:Z3372824|talk]]) 14:00, 28 August 2015 (AEST) J and I had a little discussion about how we're going to go about completing this. We can all work on each others sections and collaborate that way. Let's focus on finding research articles, collating them, referencing them i.e. get to the meat of the matter. Once we've done that we can cut to the point and make it more easy-to-read/user-friendly. We also think that our 1 wiki page reference should be the OHSS Wiki page. Also, when writing about your section, always compare/refer to the Controlled Ovarian Stimulation case. Bring those picture/youtube suggestions in!&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3374116|Z3374116]] ([[User talk:Z3374116|talk]]) 00:12, 29 August 2015 (AEST) Sweet, thanks for the info. Will be on the lookout for youtube clips and pictures. Is the OHSS wikipage you are referring to https://en.wikipedia.org/wiki/Ovarian_hyperstimulation_syndrome&lt;br /&gt;
this one?? And I agree on helping each other with respective sections and then cutting it down to the fine details&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3415911|Z3415911]] ([[User talk:Z3415911|talk]]) 21:49, 1 September 2015 (AEST) Yes, that's the wiki page :) I have already started taking down information from it in each section so when you see '''[OHSS Wiki]''', that's where the information is from. I just don't know how to reference something that is not pubmed yet haha&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3415911|Z3415911]] ([[User talk:Z3415911|talk]]) 22:11, 1 September 2015 (AEST) Also guys please note, I have not used any info. from wiki in regards to TREATMENT and PREVENTION as it appears someone is already working on those subheadings and I don't want to interfere, so yea, that info. is still out there for you guys to use.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3415911|Z3415911]] ([[User talk:Z3415911|talk]]) 11:51, 13 September 2015 (AEST) Hey guys, can everyone please send me an email with your full names so I can add you on fb and make  group. I feel like we need a better way of communicating. Thanks, z3415911@student.unsw.edu.au.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z5016784|Z5016784]] ([[User talk:Z5016784|talk]]) 16:25, 13 October 2015 (AEDT) Hey guys, i am working on a few sections, mark said not to add to the project until the peer assessments are done, so i was thinking of bringing my information to class on Friday so yous can have a look and see if it is useful enough, i will place the link to one article, it has two tables in there that i think can be used, what are your thoughts about them?&lt;br /&gt;
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2842872/&lt;br /&gt;
&lt;br /&gt;
Video that J found!&lt;br /&gt;
http://www.howcast.com/videos/511910-ovarian-hyperstimulation-syndrome-infertility/&lt;br /&gt;
&lt;br /&gt;
==Peer Review==&lt;br /&gt;
&lt;br /&gt;
This wikipage is very well put together. Your choice of headings, subheadings and tables and images is remarkable, it definitely makes the whole page flow very well. I particularly like the hand-drawn image which does a great job at simplifying the process of the pathogenesis of OHSS. &lt;br /&gt;
&lt;br /&gt;
The introduction very concisely explains the contents of the page and I liked how it was finished off with a statement about the aim of the page. I thought it really brought the introduction together nicely. I can’t say much about the content except that it is very engaging and very well written so well done guys! Keep up the good work!&lt;br /&gt;
&lt;br /&gt;
Some suggestions I have that could improve your page include adding more images. It would be nice to have some graphs to complement the statistical date from the epidemiology. Also, in some of the paragraphs e.g. in the last paragraph of ‘Epidemiology’ there isn’t a citation that accounts for the information at the end of the paragraph so that should be fixed. &lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
This page clearly and efficiently explains the topic of choice. It covers all relevant matters well and the text is descriptive and informative. After reading the page, I felt as though I had a greater understanding of the topic. The subheadings used are good, and are placed appropriately in order - providing an element of cohesiveness between the page and the topic in general. Good use of linking statements – connecting all the elements discussed on the page. &lt;br /&gt;
&lt;br /&gt;
There is however an excessive amount of text used. Although the information is relevant and informative, the page is dense and reading all at once is tiresome. Reducing/sifting through the amount of text on the page – and also adding a great deal more media files will help to break up the denseness of the page. There is only 1 image on the whole page – greater attention needs to be paid to alternative media files and sources to help break up the page. Additional media files will also add to increasing the understanding of readers. &lt;br /&gt;
	The diagram drawn is neat and cited correctly. --[[User:Z5015534|Z5015534]] ([[User talk:Z5015534|talk]]) 15:07, 13 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
This Wiki covers the topic well. The content is very well written and easy to understand.  Images and texts are correctly cited and referenced. In some of the sections, eg, ‘Ovulation Induction’, ‘Avoiding hCG during Luteal Phase Support’, more in-text reference will need to be added.&lt;br /&gt;
&lt;br /&gt;
It is a great idea to have some bold texts in lines, which highlight the main points of paragraphs, and help readers to understand when skimming.&lt;br /&gt;
&lt;br /&gt;
The hand-draw diagram of ‘pathogenesis of OHSS’ is excellent. It is well structured, and easy to understand and memorize.  It will be great if more images, diagrams, videos can be added to the other sections.&lt;br /&gt;
&lt;br /&gt;
Overall, the project page is very well developed. Some of the sections need to have more work on though. It would be nice if more graphs and tables can be added to balance the texts.&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
So far your wiki page gives a very good coverage of Ovarian Hyper-Stimulation Syndrome. The progression of your subheadings progresses logically from one topic to another. It's good to see that you've included an excellent hand-drawn image which is well suited to the 'pathophysiology' subheading. The amount of textual information you have under each heading is vast and gives a comprehensive description of OHSS. Furthermore, you have an excellent range of sources to support your discussion.&lt;br /&gt;
&lt;br /&gt;
I feel however that asides from your hand-drawn image, your use of images and other source of media is definitely lacking. As is, your page is largely text with little to no breaks, making it quite difficult to read. The use of images would not only help break up the monotony of the text, but also help reinforce some of your ideas. I feel that the inclusion of images in the 'symptoms' and 'complications' subheadings would be suitable. &lt;br /&gt;
&lt;br /&gt;
It may also be worthwhile to include subheadings concerning current research, to inform readers about contemporary developments regarding OHSS. Furthermore,  'future research' could also be another potential subheading and could illuminate potential areas that are beginning to be or could be investigated in coming years.&lt;br /&gt;
&lt;br /&gt;
Overall, a very impressive page so far, that could be enhanced with the addition of relevant images and other media.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
Great work, it looks like your group has a clear mindset and direction to where your group project is going, even if it is not there yet. Also great introduction! Your entire page's contents were introduced well and simple. However, all Text and no images were included except one image. Not a good look to go through. The information here is good but is also very dense and hard to follow without any images. It would be great if you could break it up a bit with more images, tables, diagrams and hand drawn pictures. This style of writing is very professional and would be perfect for a report or essay; however as a wiki page it is too hard to follow. Breaking up the information into tables and short videos would allow you to guide the reader through your topic.  Well done on the use of bullet points make it easy to follow. Only one hand drawn image as well as one table uploaded onto the page contains adequate information explaining them, which is good. &lt;br /&gt;
&lt;br /&gt;
Well done on use of “Glossary” section. It is indeed necessary and important. &lt;br /&gt;
&lt;br /&gt;
There has clearly been a lot of research and work put into this project and that is very commendable and I do appreciate it. However on a whole as I mentioned, there is too much information without having any interactive techniques such as tables, diagrams and etc. One of my suggestions is to make a table for “Prevention” or “Genetics” section or even both. I also suggest adding another subheading for “current research findings” or “Future research” which requires more time and research. Therefore you can include more journal articles in this section .In this section pictures would also be good to help understand and engage readers. Overall,  well done on your written information for each section. They’re very relevant to the topic and to the project as well.&lt;br /&gt;
&lt;br /&gt;
Some sections like “Effect on the Newborn” or “Animal Models” seem to be untouched. I’m assuming you are still in the process of adding content. Please be aware of the deadline. Moreover, in text citation is crucial which are missing in some paragraphs. Citations should be carried through the entire page to know exactly where you have got your information from. Good job on referencing at the end of the page. All research articles seem to be relevant to all sections.&lt;br /&gt;
&lt;br /&gt;
Overall, it is a really good project with the potential to be excellent because of the amount of effort you have put into the research. Keep up the good work, but just edit and add those things I mentioned to the project and finish the sections you need to. Very well done so far and good luck with finishing the project off.&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_1&amp;diff=205251</id>
		<title>Talk:2015 Group Project 1</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_1&amp;diff=205251"/>
		<updated>2015-10-14T01:24:46Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015discussionheader}}&lt;br /&gt;
&lt;br /&gt;
==Stem cell presentation==&lt;br /&gt;
Hi, I have listed some papers which I am interested in doing because it is highly relevant to my own project. But I am more than happy if you post other papers and topics which interest you and we can work on them together and get ready earlier.&lt;br /&gt;
 &lt;br /&gt;
PMID 26295456&lt;br /&gt;
&lt;br /&gt;
PMID 26439174&lt;br /&gt;
&lt;br /&gt;
PMID 24837661&lt;br /&gt;
&lt;br /&gt;
PMID 26418893&lt;br /&gt;
&lt;br /&gt;
'''PMID 24981862'''&lt;br /&gt;
&lt;br /&gt;
Hey, my pick would be C. Sturgeon et al. Wnt Signaling. purely on ease of doing a review. PMID 24837661. If that suites people. --[[User:Z3292373|Z3292373]] ([[User talk:Z3292373|talk]]) 15:51, 12 October 2015 (AEDT)&lt;br /&gt;
==Useful resources==&lt;br /&gt;
&lt;br /&gt;
Here is a good source for overview and status of 3 Person IVF. http://www.geneticsandsociety.org/article.php?id=6527&lt;br /&gt;
&lt;br /&gt;
==Mitochondria==&lt;br /&gt;
*discovered in muscle by Kölliker in 1857&lt;br /&gt;
*mitochondria are the &amp;quot;powerhouses&amp;quot; of the cell and the location where respiration occurs at the cellular level.&lt;br /&gt;
*mitochondria contain their own DNA (mitochondrial DNA or mtDNA) that has been originally inherited only from the oocyte (maternal inheritance).&lt;br /&gt;
*The spermatozoa (paternal) mitochondria- energy for fertilization motility but are generally destroyed during the first mitotic cell divisions. &lt;br /&gt;
*This pattern of inheritance has important implications for a variety of mitochondrial associated diseases, usually occurring in tissues requiring lots of energy (muscle, brain). &lt;br /&gt;
&lt;br /&gt;
[[File:Mitochondria EM01.jpg|200px|thumb|Electron micrograph of mitochondria.]]&lt;br /&gt;
&lt;br /&gt;
===Eukaryotic mitochondrial genomes===&lt;br /&gt;
*double stranded circular DNA (mitoDNA. mtDNA)&lt;br /&gt;
*1981 complete human sequence (16,569 nucleotides)&lt;br /&gt;
**37 genes&lt;br /&gt;
**encodes 13 polypeptides involved in oxidative phosphorylation&lt;br /&gt;
*remaining genes transfer RNA (tRNA) and ribosomal RNA (rRNA)&lt;br /&gt;
*multiple copies within the matrix&lt;br /&gt;
*maternally inherited&lt;br /&gt;
*remainder encoded by nuclear DNA&lt;br /&gt;
*proteins made in cytosol and imported into mitochondria&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
link to Embryology website  [[Mitochondria]]&lt;br /&gt;
&lt;br /&gt;
==Chat==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:13, 25 September 2015 (AEST) OK so just text on your page to date and not yet a thorough coverage of the topic. Animal models, timeline, images, diseases.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 16:07, 21 August 2015 (AEST) I think you will have 3 students and therefore will exist as a group.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3251292|Z3251292]] ([[User talk:Z3251292|talk]]) 17:29, 21 August 2015 (AEST) hi all,sorry that I still could not make my way to uni today due to illness. I will definitely be back next week. I have added few sub-headings to the points you guys setup, feel free to change them. BTW, would you like to pick one of the 5 topics for now? and start working on it? or there was some good arrangement already? please let me know.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3292373|Z3292373]] ([[User talk:Z3292373|talk]]) 20:51, 24 August 2015 (AEST) Hey, ummm sorry i lead us astray putting up those headings ''female fertility'' had been taken so we have to pick another. I put up the list of ones left. My choice would be three parent ivf. So ill do a bit of research and on that now (add some headings)just 'cuase i got some free time, but by all means if you guys would like to do something else that interests you I'm more then happy to change. &lt;br /&gt;
&lt;br /&gt;
--[[User:Z3251292|Z3251292]] ([[User talk:Z3251292|talk]]) 13:19, 27 August 2015 (AEST) Hi all, I am good with your choice. let's work on 3 person embryo. i have added few papers I find good on this topic.&lt;br /&gt;
&lt;br /&gt;
===General===&lt;br /&gt;
&lt;br /&gt;
Note to self doing history benifits.&lt;br /&gt;
&lt;br /&gt;
===Section===&lt;br /&gt;
&lt;br /&gt;
==Peer Reviews==&lt;br /&gt;
&lt;br /&gt;
===1===&lt;br /&gt;
This wiki page does well in covering a lot of areas relating to the topic, however the website does not outline the information found/used quite clear enough or to the right extent. The page would benefit largely in focusing much more attention to the mechanics of the process itself and how it physically works. There is lots of information regarding other various aspects relating to the topic, however the fundamentals of the topic are not clearly discussed on the page, and it is not clear what goes on in the process. &lt;br /&gt;
&lt;br /&gt;
The page should also fix up some grammatical and syntax errors. Read through the page carefully and ensure all paragraphs make sense ensuring that the quality of the information portrayed is fully appreciated. To also make the page clearer, some thought should be given to rethinking the order of the subheadings. Having a natural cohesion throughout the page as a whole is important – some subheadings do not fit into place correctly and could be moved around a little bit. Also having linking sentences within paragraphs – involving each subheading with others and the topic as a whole – will  make the page much more cohesive. &lt;br /&gt;
&lt;br /&gt;
The page used a good amount of supporting pubmed articles, hwoever more images/media files could be used to break up the concentrated use of text. The video used is relevant and informative – however there is no copyright information.--[[User:Z5015534|Z5015534]] ([[User talk:Z5015534|talk]]) 22:44, 10 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
===2===&lt;br /&gt;
Hi guys! I'll start of by saying that the images and video you have included are excellent and are relevant to your topic of discussion. Also, you have a large number of reliable references which is good to see. However you have yet to include a hand drawn image, which is required for the wiki page. I feel like  you could probably eliminate the typed out 'timeline of mitochondrial donation' and instead use this as an opportunity to use a hand drawn image of the timeline. Furthermore, the timeline under 'cystoplasmic transfer' feels a bit awkward and unnecessary. You could probably include this timeline alongside the 'timeline of mitochondrial donation'. &lt;br /&gt;
&lt;br /&gt;
Under the 'Technical Progression' section it would be best to incorporate human embryo, mouse and human models under a sub-sub heading, as at the moment it feels a bit jumbled.&lt;br /&gt;
&lt;br /&gt;
I would also recommend moving the 'Benefits' heading towards the end of the page. It feels odd reading about the benefits of three person embryos before I gain a proper understanding of how they work. Also it might be worth talking about the disadvantages (if there are any) to three person embryos to balance out the 'benefits' section. As has been previously stated, make sure you sort out the copyright information for your video as it would be a shame to lose marks if it was missing. Also, don't forget to add the 'student template' to the 'Swapping mitochondrial DNA mammalian oocytes' image as it is currently absent.&lt;br /&gt;
&lt;br /&gt;
===3===&lt;br /&gt;
The entire project is presented simplistically and all the content is relevant and easy to understand. Majority of the flaws I found were based around poor grammar and syntax which could be fixed up with some editing. Below is a more detailed breakdown of some of the things you could fix.  &lt;br /&gt;
&lt;br /&gt;
Firstly, I liked that the introduction was brief and concise and gives the reader a basic understanding of the topic of three person embryo. The video was also informative and provided some background information around the topic. I was informed that mitochondrial DNA was the major factor concerning this topic however there was a lack of information about its importance to the body so a short summary could be included along with some examples of diseases it could cause. &lt;br /&gt;
&lt;br /&gt;
Also, the use of a timeline to present the history is a great idea and I think it could be improved and would look more aesthetically pleasing if it were to be placed into a table. I also think the 1990s, 2000s and 2010s label could be removed to make it look less clustered since they aren’t particularly necessary. &lt;br /&gt;
&lt;br /&gt;
Some information under the heading ‘Technical Progression’ has yet to be filled in but from what is there I’d like to suggest exchanging the bullet points for numbering instead for the information under ‘Pronuclear transfer’ and ‘Polar body transfer’ since they sounded like sequence steps as opposed to separate points. &lt;br /&gt;
&lt;br /&gt;
Finally, I found the layout of the table under the heading ‘Legal status’ to be very well put together. There are however some countries placed under the incorrect continents and I found that the order was easily changed and mixed up. I also noticed that several of the countries were linked to the same sources which made the information very unspecific. Instead of just links I think a few sentences explaining the legislation would be more informative.&lt;br /&gt;
&lt;br /&gt;
===4===&lt;br /&gt;
&lt;br /&gt;
I liked how you guys started the introduction and provides partially a brief overview of what your project is about. But I believe it is not enough to allow the audience an insight to your project page. This is something that needs to be worked on and maybe add some images also. However, the choice of short video used in the introduction is great. This is definitely a benefit for your page as it will reinforce the information you have been trying to get across. Like I mentioned, one thing you could work on is adding images and explaining the content in more depth. There is great amount of reference at the end of the page in the reference list which is fantastic!, however there is no in- text referencing in each section such as introduction or in some of the parts of the “Technical Progression” like “Cytoplasmic transfer” or “Spindle-chromosome transfer”.  Having in-text referencing will allow the audience to know exactly where the information was read from and for the interest of the audience can read that specific paper in detail.&lt;br /&gt;
&lt;br /&gt;
I also noticed that there are no information for “Benefits” and “Legal Status” or there is limited information for such headings like “Ethics”. I’m assuming you didn’t get the chance to upload information there or you haven’t had the time. This is something you need to work on so that the audience has some note of what this page is about. Also you need to change the format of the page for example it is to move the 'Benefits' heading towards the end of the page after the audience gained a good level of understanding of the project. You included some great images but be careful with copyright as I didn’t see it. But also consider some more images, tables, diagrams as well as hand drawn images in some sections, to make it more inviting and not overwhelming with just content. I do appreciate that the section of “Technical Progression” is subdivided into “Human Model”, timeline” and etc. But maybe consider adding in the current research, historic research, limitations and disadvantages to ensure that you can get all the marks possible by addressing all the key concepts. The timeline is a great idea that outlines the significant progresses and in turn helps put major events into perspective, making it more effective for students to study and understand.&lt;br /&gt;
&lt;br /&gt;
Well done on making the “Glossary” at the end. This is exactly what I would have expected to see and I used it while I was reading through your page. Also it is great to see the table in the “Prohibited” section but I would suggest you to write some sentences explaining the legislation rather than just pasting the links.&lt;br /&gt;
&lt;br /&gt;
Overall, this project page has room for improvement by giving certain sections of the page the attention they deserve. Images are imperative in allowing a balance between text and the image itself. Diagrams, tables and animations can sometimes be refreshing, and less overwhelming to see them among paragraphs of content. Try and work on time management, or set a group deadline that everyone has to meet so that all the information can be well up before the due date so your group can have time to edit and add images and play around with the page comfortably. Goodluck!&lt;br /&gt;
&lt;br /&gt;
===5===&lt;br /&gt;
&lt;br /&gt;
It would be nice if the history section could start earlier in time e.g. who came up with the idea of 3 person embryos. It kind of feels as though 3 person embryos popped out of nowhere. This is just a small nuance but the first sentence in “Hereditary mitochondrial Disease” doesn't really make sense.  It sounds incomplete. I think you have too many timelines going on in your page and it makes it a bit confusing. There is one under “History” and another timeline in “technical progression”. I understand they may be timelines for different things, but it’s all too much history. Maybe the “technical progression” timeline could be simplified into a paragraph?&lt;br /&gt;
&lt;br /&gt;
Some sections have too many subsections e.g. “technical progression”, and this makes the section messy and hard to read. It is however good for the table of contents though as it makes it easier to specify what you want to read on the page so my suggestion would be to keep some subheading but cut down a bit. You guys are listing papers to read too often. People want to have the information summarized for them on a wiki page, not have to outsource all the information themselves. It’s too time consuming and if they wanted to read a bunch of articles, they would go on PubMed themselves. However, I do like that some articles have been listed but maybe cut it down to one or two great ones instead of 4-5 etc.&lt;br /&gt;
 &lt;br /&gt;
I really like the table under the subheading “prohibited”, however, it would be nice to have a little summary next to the links about what each countries stance is, because again it’s too time consuming to have to read all those links. I also think some sections need a lot more work e.g. “ethics” and “benefits” and some more words could be added to the glossary. For example, a definition of what the word gamete mean would be good as, whilst we may know what it means, other people who view your page may not.&lt;br /&gt;
&lt;br /&gt;
I really likes the images you used in “technical” progression. They were easy to understand and simplified the text a lot. It would be good however to add a few more images, perhaps to “history”. Some hand-drawn ones would be good. You've got a good amount of references in there, just maybe add a few more. This indicates that you have done significant research and they appear to be correctly cited. The key points of your topic are clearly described and I feel as though your intro., whilst short, really opens up the topic well. Your page relates well to the learning aims of embryology. &lt;br /&gt;
&lt;br /&gt;
To conclude, I think you've got a great framework and some really good information in there. Just makes sure your page doesn't look too busy and is easy to read. A little bit more work needs to be done in some of the sections and a bit more technical touch ups and you should be good!&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=205249</id>
		<title>User:Z3416054</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=205249"/>
		<updated>2015-10-14T01:21:46Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Hi there&lt;br /&gt;
Just giving the editor a good old test run.&lt;br /&gt;
[[Test student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:45, 7 August 2015 (AEST)&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:47, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 14:06, 14 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:57, 21 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 12:22, 28 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:20, 4 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:18, 11 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:10, 25 September 2015 (AEST)&lt;br /&gt;
==Picture Tutorial==&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
===Article 1===&lt;br /&gt;
This research article aimed to determine the clinical outcomes following IVF (in vitro fertilisation) and embryo transfer treatments in subjects suffering from the sexually transmitted disease syphilis. The clinical outcomes mentioned are the rates of pregnancy and health of newborns following treatment via IVF. Couples engaged in sexual intercourse over 12 months without the use of contraception and who failed to conceive were deemed as being infertile.&lt;br /&gt;
&lt;br /&gt;
The subjects were divided into two groups based on serology results, a syphilis infected group and a control group, each with 160 individuals, giving a total of 320 subjects. The Syphilis infected group was further divided into three subcategories, a male infected group, a female infected group and a couple (male and female) infected group. Penicillin G20 (an anti-syphilis treatment) was given to the individuals in the syphilis group. IVF treatment commenced one month proceeding the disappearance of clinical syphilis symptoms or if test results gave a negative result for syphilis infection.&lt;br /&gt;
&lt;br /&gt;
The results of this experiment revealed no significant differences in regards to the basal FSH and LH of both the control and syphilis groups. However, the thickness of the endometrium differed greatly, with the syphilis group demonstrating a thicker endometrial wall (16.9±5.4mm) compared to the control group (13.0±4.7mm). Further differences were noted in blastocyst implantation rates, with the syphilis group having less successful implantations compared to the control (24.2% vs. 34.4% respectively).Normal oocyte cleavage differed between the two groups with the syphilis group demonstrating less normal oocyte cleavage compared to the control group  (6.3±4.7 vs. 8.1±4.6). Furthermore, the clinical pregnancy rates of the syphilis group stood at 43.8% compared to 55.6% of the control group.&lt;br /&gt;
&lt;br /&gt;
Syphilis infection appeared to have a significant impact on the success and clinical outcomes of IVF. Syphilis associated pelvic inflammatory disease can lead to an increase in the thickness of the endometrium, which can adversely affect blastocyte implantation and endometrial receptivity. Successful pregnancy rates typically correlate with an endometrial thickness of 7-14mm, with any thickness beyond 14mm often corresponding with decreased clinical pregnancies. Rates of clinical pregnancy and miscarriage rates did not differ between the three syphilis subgroups. Conception involving a male infected partner was associated with a shorter gestational period and decreased offspring birth weight, when compared to the female infected and couple infected subgroups. No explanation for this phenomenon was provided.&lt;br /&gt;
&lt;br /&gt;
PMID 26208116&lt;br /&gt;
&lt;br /&gt;
''Article 1 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4514756&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
===Article 2===&lt;br /&gt;
The effects of oxygen levels on factors such as cleavage, implantation and pregnancy rates in IVF cultured embryos was the primary focus of this article.  Women between the ages of 20-48 who were seeking treatment for infertility were utilised in this experiment.&lt;br /&gt;
Gametes were allocated to be incubated in one of three environments, each with a different oxygen concentration. The first group was placed in an atmosphere with an oxygen concentration of 20%. The second group rested in a 20% oxygen environment for a day before being moved to a 5% oxygen, 5% carbon dioxide and 90% nitrogen atmosphere. The third group consisted of a 5% carbon dioxide, 5% oxygen and 90% nitrogen atmosphere. The gametes (spermatozoa and oocytes) were incubated together in their respective environmental conditions for 4-6 hours after which fertilisation is presumed to have occurred.&lt;br /&gt;
&lt;br /&gt;
Successful embryos were transferred at Day 3 cleavage. A biochemical analysis of HCG validated pregnancy, whilst ultrasound was used to confirm the presence of a heartbeat 28 days following the transfer.&lt;br /&gt;
IVF fertilisation rates were calculated as being the number of fertilised oocytes over the number of oocytes inseminated. Cleavage rates were characterised by the number of blastomeres over the number of fertilised and abortion rate by the amount of miscarriages divided by the number of transfers.&lt;br /&gt;
&lt;br /&gt;
The research article concluded that the embryos from the 5% oxygen group had the highest rates of fertilisation and implantation. The 20% oxygen group had the second highest rates of fertilisation and maintained excellent embryo quality, whilst the 20% to 5% group had the lowest rates overall. Abortion and miscarriage rates did not differ at all between the three groups. The group incubated at 5% oxygen demonstrated higher quality embryos and increased rates of pregnancy when compared to the 20% oxygen group. The article concludes that implantation, pregnancy and embryo quality can be somewhat affected by a set oxygen concentration, but are affected adversely by a shift from one concentration to another. &lt;br /&gt;
Shifting from one oxygen concentration to another appeared to have an adverse effect on the cleavage of the embryo and would likely impact future development and the overall success of the IVF treatment.&lt;br /&gt;
&lt;br /&gt;
PMID 26131222 &lt;br /&gt;
&lt;br /&gt;
''Article 2 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4483955&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These are quite good descriptions of these 2 articles. (5/5)&lt;br /&gt;
==Lab 2 Assessment==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Notch Signalling - Ovulation in Drosphila.jpg|Caption]]&lt;br /&gt;
&lt;br /&gt;
===Image Reference===&lt;br /&gt;
Jianjun Sun, Allan C Spradling Ovulation in Drosophila is controlled by secretory cells of the female reproductive tract. Elife: 2013, 2;e00415 PubMed 23599892&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 23599892&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) Image uploaded and named correctly. All reference, copyright and student image template included. You might have included in the summary box an explanation to the terms that appear in the image as there is no way for the reader to interpret what is shown in each panel. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 3 Assessment==&lt;br /&gt;
===Causes===&lt;br /&gt;
====The Genetics of Infertility: Current Status of the Field====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3885174&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This article attempted to determine the role that genetics plays in female infertility. It was noted that several prominent causes of female infertility such as Galactosemia and Primary Ovarian Failure (POF) were associated with specific genes, with the GALT gene contributing to the former condition and the FMR1 gene contributing to the latter.&lt;br /&gt;
&lt;br /&gt;
====Causes of Sterility in Bosnia-Herzegovina Population====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4499307&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
The study conducted as laid out in this article examined the causes of female sterility in the Bosnia-Herzegovina population. Married participants were arranged into various groups based upon their age. The experiment came to the conclusion that in approximately 42% of infertile married couples, female sterility was the primary cause. The two primary causes of female infertility were tubal deficiencies (31% of cases) and Diminished Ovarian Reserves (38% of cases)&lt;br /&gt;
&lt;br /&gt;
====Epidemiology, diagnosis, and management of polycystic ovary syndrome====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3872139&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This research article examines the causes of polycystic ovary syndrome (POS), a common cause of infertility in women. The article concluded that 50-70% of women suffer from insulin resistance secondary to Type 2 Diabetes and in many cases obseity, which may contribute partially to POS. Furthermore, 85-90% of women with oligomenorrhea also had POS, suggesting that it is an underlying cause. However, the exact pathophysiology of POS was not determined.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These papers relate to your group project, I hope they are useful for the final submission. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 4 Assessment==&lt;br /&gt;
===Quiz===&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
{Primary villi are produced during which stage of development?:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ Week 2&lt;br /&gt;
- Week 1&lt;br /&gt;
- Week 3&lt;br /&gt;
- None of the above&lt;br /&gt;
|| Primary Villi appear during Week 2 of development, whilst secondary villi appear during Week 3 of development.&lt;br /&gt;
&lt;br /&gt;
{Mesoderm is a precursor for all of the following EXCEPT:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Skeletal Muscle Cells&lt;br /&gt;
- Cardiac Muscle Cells&lt;br /&gt;
- Erythrocytes&lt;br /&gt;
+ Epidermal Skin Cells&lt;br /&gt;
- Smooth Muscle&lt;br /&gt;
|| Epidermal skin cells originate from ectoderm. Skeletal, cardiac and smooth muscle along with erythrocytes originate from the mesoderm.&lt;br /&gt;
&lt;br /&gt;
{Which of the following shows the correct developmental pathway of the male gamete:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatogonia &amp;gt; Spermatozoa&lt;br /&gt;
- Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell &amp;gt; Spermatozoa &amp;gt; Spermatid&lt;br /&gt;
- Sertoli Cell &amp;gt; Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatozoa&lt;br /&gt;
- Spermatid &amp;gt; Spermatozoa &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell&lt;br /&gt;
+ Spermatogonia &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatid &amp;gt; Spermatozoa&lt;br /&gt;
|| Spermatogonia represent the beginning of male sex cell development, with spermatozoa being the mature gamete.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) No descriptive title to your questions. Q1 relates to the timing of villi development. These types of questions encourage &amp;quot;student guessing&amp;quot; and you could have given a more detailed explanation and links to resources in your revealed answer e.g. [[Placenta - Villi Development]]. Q2 is a reasonable question, but only requiring the student only to know that Epidermal Skin Cells are from ectoderm. Once again it is your revealed answer that needs more work. Q3 is a little easy, as long as you know Spermatogonia are the diploid start cell you can quickly exclude most options, need more work. (8/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5 Assessment==&lt;br /&gt;
===Gastroschisis and Omphalocele===&lt;br /&gt;
&lt;br /&gt;
Gastroschisis is classified as a full thickness cleft found in the abdominal wall, adjacent to the site of insertion of the umbilical cord. The defining features of this abnormality is the absence of a membranous sac shrouding the intestines. As a result of this the intestines will become eviscerated, thereby protruding out of the abdominal wall and will be on the exterior, rather than the interior of the body. It is believed that disruption to the vascular supply of the right abdominal wall is the primary gass of gastroschisis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2166158&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Omphalocele is an abnormality characterised by the herniation of visceral organs such as the intestines, liver and spleen outside of the abdominal cavity. The visceral organs are enclosed in a membranous sac, into which the umbilical cord is inserted.  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC1355659&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The primary difference between gastroschisis and omphalocele lies in the presence of a membraneous sac and the exact organs herniating from the abdominal wall. Gastroschisis involves the intestines protruding to the outside of the body but are not covered by a membranous sac. Omphalocele however is characterised by the protrusion of multiple visceral organs (liver, spleen etc.) which are enclosed within a membranous. Furthermore, the size of both abnormalities differs greatly, with gastroschisis typically being 2-5 cm in size whilst omphalocele can vary between 2-15cm. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2552910&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) This is an adequate description of the differences between these conditions. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 7 Assessment==&lt;br /&gt;
&lt;br /&gt;
1: This research paper aimed to examine the relationship between fetal adrenal cells and the differentiated adrenal cortex. In particular, research was focussed upon possible pregenitor cells involved in maintenance of the adrenal cortex. It was hypothesised that the the most likely precursor cells of the adult cortex were the 'Glil' expressing cells found in the adrenal capsule. A number of mice adrenal glands were taken, treated with antigen retrieval solution, after which fluorescence microscopy was conducted.&lt;br /&gt;
&lt;br /&gt;
The results of the paper concluded that 'Glil' expressing descendants of fetal adrenal cells are the pregenitors of the differentiated adrenal cortex. Furthermore, it was found that the 'Glil' expressing cells oringinated from 'FAdE-Cre' expressing fetal adrenal cells. Thus the authors of this research article came to the conclusion that 'Glil' expressing cells found in the adrenal cortex play an important role in the development, differentiation and maintenance of the adrenal cortex. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3817941&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
2: A number of embryonic layers and tissues contribute to the development of teeth. The primary contributing layers are mesoderm, ectoderm and neural crest ectomesenchyme. Furthermore, neural crest may contribute through interactions with the ectoderm. Odontoblasts originate from neural crest derived mesenchymal cells and are responsible for forming predentin which calificies to create dentin (which forms the bulk of the tooth). Ameloblasts are responsible for the production of enamel, which provides teeth with the hardness required to engage in mastication. &lt;br /&gt;
&lt;br /&gt;
==Peer Assessment==&lt;br /&gt;
&lt;br /&gt;
===Group 1 Peer Assessment===&lt;br /&gt;
Hi guys! I'll start of by saying that the images and video you have included are excellent and are relevant to your topic of discussion. Also, you have a large number of reliable references which is good to see. However you have yet to include a hand drawn image, which is required for the wiki page. I feel like  you could probably eliminate the typed out 'timeline of mitochondrial donation' and instead use this as an opportunity to use a hand drawn image of the timeline. Furthermore, the timeline under 'cystoplasmic transfer' feels a bit awkward and unnecessary. You could probably include this timeline alongside the 'timeline of mitochondrial donation'. &lt;br /&gt;
&lt;br /&gt;
Under the 'Technical Progression' section it would be best to incorporate human embryo, mouse and human models under a sub-sub heading, as at the moment it feels a bit jumbled.&lt;br /&gt;
&lt;br /&gt;
I would also recommend moving the 'Benefits' heading towards the end of the page. It feels odd reading about the benefits of three person embryos before I gain a proper understanding of how they work. Also it might be worth talking about the disadvantages (if there are any) to three person embryos to balance out the 'benefits' section. As has been previously stated, make sure you sort out the copyright information for your video as it would be a shame to lose marks if it was missing. Also, don't forget to add the 'student template' to the 'Swapping mitochondrial DNA mammalian oocytes' image as it is currently absent.&lt;br /&gt;
&lt;br /&gt;
===Group 2 Peer Assessment===&lt;br /&gt;
So far your wiki page gives a very good coverage of Ovarian Hyper-Stimulation Syndrome. The progression of your subheadings progresses logically from one topic to another. It's good to see that you've included an excellent hand-drawn image which is well suited to the 'pathophysiology' subheading. The amount of textual information you have under each heading is vast and gives a comprehensive description of OHSS. Furthermore, you have an excellent range of sources to support your discussion.&lt;br /&gt;
&lt;br /&gt;
I feel however that asides from your hand-drawn image, your use of images and other source of media is definitely lacking. As is, your page is largely text with little to no breaks, making it quite difficult to read. The use of images would not only help break up the monotony of the text, but also help reinforce some of your ideas. I feel that the inclusion of images in the 'symptoms' and 'complications' subheadings would be suitable. &lt;br /&gt;
&lt;br /&gt;
It may also be worthwhile to include subheadings concerning current research, to inform readers about contemporary developments regarding OHSS. Furthermore,  'future research' could also be another potential subheading and could illuminate potential areas that are beginning to be or could be investigated in coming years.&lt;br /&gt;
&lt;br /&gt;
Overall, a very impressive page so far, that could be enhanced with the addition of relevant images and other media.&lt;br /&gt;
&lt;br /&gt;
===Group 4 Peer Assessment===&lt;br /&gt;
Very impressive work so far guys! Your page covers a comprehensive topic very well, without focussing too much on certain subheadings at the expense of others. Your use of both tables and images is excellent so far. It's good to see that you have also included a video to give some variety to the media on your page. The 'background information' gives context to the issues which you discuss and though it might not be of great use for someone familiar with embryology, it would be a great help to those with no experience in this field and is therefore useful in establishing the topic of male infertility.&lt;br /&gt;
&lt;br /&gt;
The only things that could be changed to improve your wiki page is perhaps altering the location of tables and pictures on your page. For example all pictures are located on the right side of the page, although not a significant issue, becomes slightly monotonous as one progresses through the page. It may be worth alternating pictures between left and right to mix things up a little bit and improve the overall flow of the page. &lt;br /&gt;
It might also be worth including a short video underneath the 'surgical treatments' subheading to give a visual example of some of the techniques discussed.&lt;br /&gt;
&lt;br /&gt;
Furthermore a subheading on future research could possibly be included under the 'treatments' subheading to give the reader information on techniques and therapies which may come to prominence in the near future.&lt;br /&gt;
&lt;br /&gt;
Your wiki page thus far is very impressive! Excellent work so far. &lt;br /&gt;
===Group 5 Peer Assessment===&lt;br /&gt;
Awesome page so far guys! I commend you on your use of various videos to assist in conveying your ideas. Furthermore, the images you have chosen are highly relevant to the topic of discussion and assist the reader in gaining a greater understanding of oncofertility. All copyright information is present for the images you have used which is excellent to see.&lt;br /&gt;
It may be worth including a hand drawn image under the 'radiation' subheading, as we are required to include at least one such image. The current image under the radiation subheading could easily be replicated by hand and could fulfill this portion of the criteria.&lt;br /&gt;
&lt;br /&gt;
I am nitpicking here, but I would also recommend including some kind of media, most likely a picture, underneath the surgery subheading. It might even be worth doing the hand drawn image here if possible. A picture may also be good underneath the 'types of chemotherapy drugs' subheading, just to break up the wall of text and improve the reading experience for the reader.&lt;br /&gt;
It might also be worth restructuring the 'oncofertility limitations' subheading into the form of a table (if possible), as the bullet point format feels quite awkward and out of place compared to the rest of the page.&lt;br /&gt;
The inclusion of a glossary is also recommended, as this page will be accessible by the general public and a glossary will assist those without a background in embryology to understand and appreciate your content.&lt;br /&gt;
&lt;br /&gt;
Keep up the great work guys! Your page is absolutely amazing so far and the effort you have put in is definitely reflected in the high quality of your page.&lt;br /&gt;
===Group 6 Peer Assessment===&lt;br /&gt;
A very snazzy wiki page so far! You have used a wide variety of images to convey the concepts of prenatal genetic diagnosis to those reading your wiki page. Copyright information and student templates were present for all the images which you provided which is great to see. A hand drawn image is absent, which is a requirement for every wiki page. It might be worth including the hand drawn image in the 'history section' as the information here could easily be represented by a hand drawn flow chart.&lt;br /&gt;
&lt;br /&gt;
I commend you on your inclusion of a 'future/current research' subheading as this gives the reader a perspective of where the field of prenatal genetic diagnosis is heading in the distant future.&lt;br /&gt;
&lt;br /&gt;
I see that you have included a table underneath the 'biopsy methods' subheading. It would be great to see you compile the advantages and disadvantages of blastomere biopsy and trophectoderm biopsy into a tabular format as this would make for an easier reading experience. Furthermore, tables may also be incorporated for the disadvantages and advantages of genetic techniques.&lt;br /&gt;
I would recommend the inclusion of other forms of media such as a video or gif to assist in the conveyance of information under certain subheadings. A video/gif would fit nicely underneath the 'biopsy method' subheading, though this is just a suggestion.&lt;br /&gt;
&lt;br /&gt;
Overall your assignment is superb so far. You have successfully covered a vast topic and made successful use of a broad range of sources to support your page. Your inclusion of images has been appropriate, however a hand drawn image is still required. &lt;br /&gt;
Keep up the good work guys! &lt;br /&gt;
Look at this!&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_6&amp;diff=205247</id>
		<title>Talk:2015 Group Project 6</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_6&amp;diff=205247"/>
		<updated>2015-10-14T01:21:36Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015discussionheader}}&lt;br /&gt;
&lt;br /&gt;
[[Science_Student_Projects]]&lt;br /&gt;
&lt;br /&gt;
[[Abnormal Development - Genetic]]&lt;br /&gt;
FISH Image [https://www.genome.gov/images/content/FISH_factsheet.jpg]&lt;br /&gt;
associated copyright [https://www.genome.gov/copyright.cfm]&lt;br /&gt;
fish data - [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1120169/] [http://www.nature.com/scitable/topicpage/fluorescence-in-situ-hybridization-fish-327] [http://www.rarechromo.org/information/Other/FISH%20FTNW.pdf]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:26, 25 September 2015 (AEST) OK this is such an easy project to find resources for, so where are they? Everyone in research, support groups, genetic inheritance are talking about this topic and the techniques. But this is not on your project page.&lt;br /&gt;
 Like my comments for the other project pages, animal models and media, graphics, statistics, graphs to support the project information???? Your project is not ready for peer review.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 16:26, 1 September 2015 (AEST) I would like to see some content (sub-headings) on your project page.&lt;br /&gt;
&lt;br /&gt;
==Peer Reviews==&lt;br /&gt;
&lt;br /&gt;
===1===&lt;br /&gt;
&lt;br /&gt;
I’ll start by saying, you have an extremely extensive list of references.  Well done! It shows you have really done your research and made good use of it. Your citations are consistent throughout the page and most paragraphs have multiple sources. I would suggest to perhaps include a hand-drawn image somewhere on the page as well as a video. Aside from the section “biopsy methods”, the page could use a few more illustrations. From what I can see, the image under the subheadings “FISH” and “future/current research”, does not appear to have been added correctly according to the guidelines Mark gave us a few weeks back. There is no caption for the image like there are for the other images.&lt;br /&gt;
&lt;br /&gt;
I really like, how under the “diagnosis” heading, you have made the table of applicable diseases for PGD an expandable table. It helps keep the page clean and easier to control. Perhaps though add a little blurb below the table describing it. You have a great set of heading and subheadings that all relate back to your topic. Given that, you have addressed all important areas pertaining to your topic. May I suggest, that in the introduction section, which I am assuming is yet to be done, you add some epidemiological information and perhaps a video speaking briefly on the topic as it can be quite complex.&lt;br /&gt;
&lt;br /&gt;
Well done on the section titled “future/current research”. It is really useful for students seeking a higher degree of information on this topic as it goes into great detail. However, some direct references in the text to some papers would be good. I also suggest adding a glossary of words to the bottom of the page to cater to those who read the page, with a lower level of embryology knowledge than you or I. In addition to that, it may be good to try and break-down some of your paragraphs as there is a lot of text and it can be hard to take in for some people. Bullet points and tables are great. The page does however, focus well on embryological learning aims. &lt;br /&gt;
&lt;br /&gt;
Lastly, to conclude, I feel a though the table and image under “biopsy method” is a little cluttered and could be spaced out a bit more. Overall, this is a really good and detailed framework and with a little more work will be a great project.&lt;br /&gt;
&lt;br /&gt;
===2===&lt;br /&gt;
A very snazzy wiki page so far! You have used a wide variety of images to convey the concepts of prenatal genetic diagnosis to those reading your wiki page. Copyright information and student templates were present for all the images which you provided which is great to see. A hand drawn image is absent, which is a requirement for every wiki page. It might be worth including the hand drawn image in the 'history section' as the information here could easily be represented by a hand drawn flow chart.&lt;br /&gt;
&lt;br /&gt;
I commend you on your inclusion of a 'future/current research' subheading as this gives the reader a perspective of where the field of prenatal genetic diagnosis is heading in the distant future.&lt;br /&gt;
&lt;br /&gt;
I see that you have included a table underneath the 'biopsy methods' subheading. It would be great to see you compile the advantages and disadvantages of blastomere biopsy and trophectoderm biopsy into a tabular format as this would make for an easier reading experience. Furthermore, tables may also be incorporated for the disadvantages and advantages of genetic techniques.&lt;br /&gt;
I would recommend the inclusion of other forms of media such as a video or gif to assist in the conveyance of information under certain subheadings. A video/gif would fit nicely underneath the 'biopsy method' subheading, though this is just a suggestion.&lt;br /&gt;
&lt;br /&gt;
Overall your assignment is superb so far. You have successfully covered a vast topic and made successful use of a broad range of sources to support your page. Your inclusion of images has been appropriate, however a hand drawn image is still required. &lt;br /&gt;
Keep up the good work guys! --[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 12:21, 14 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===3===&lt;br /&gt;
&lt;br /&gt;
===4===&lt;br /&gt;
&lt;br /&gt;
===5===&lt;br /&gt;
&lt;br /&gt;
===6===&lt;br /&gt;
&lt;br /&gt;
===7===&lt;br /&gt;
&lt;br /&gt;
==Discussion==&lt;br /&gt;
[[User:Z5088434|Z5088434]]([[User talk:Z5088434|talk]] Would the part you added in indication rather be part of the introduction since it pretty much sums up what the page is about? Maybe go into when PGD and PGS are applied? as for the multiple instances citations: first in text citation has to be like this: &amp;lt;ref name=&amp;quot;PMID...&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;...&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; and the following ones are like this: &amp;lt;ref name=&amp;quot;PMID...&amp;quot;/&amp;gt; (just check for the code in the edit mode, can't figure out how to just show the code without it actually configuring it...)&lt;br /&gt;
==To Do List== &lt;br /&gt;
&lt;br /&gt;
===Week 4=== &lt;br /&gt;
&lt;br /&gt;
*text book summary and some notes&lt;br /&gt;
&lt;br /&gt;
*journal article &lt;br /&gt;
&lt;br /&gt;
*1 relevant media article &lt;br /&gt;
&lt;br /&gt;
*post in this discussion and on your own page under lab 3 assignment &lt;br /&gt;
&lt;br /&gt;
*for links or informal questions please use the facebook Group&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Prenatal Genetic Diagnosis==&lt;br /&gt;
&lt;br /&gt;
===Headings===&lt;br /&gt;
 &lt;br /&gt;
* Polar body&lt;br /&gt;
* Genetic techniques &lt;br /&gt;
* Laws in different countries and states &lt;br /&gt;
* Cell extraction from zygotes, blastomeres, morula&lt;br /&gt;
* How analysis is conducted e.g. PCR&lt;br /&gt;
* Gene Mapping &lt;br /&gt;
* Inheritance patterns &lt;br /&gt;
* Conducted prior to implantation&lt;br /&gt;
&lt;br /&gt;
In order (?): &lt;br /&gt;
* '''Introduction''' (GP)&lt;br /&gt;
* '''History/Development (include transition from post to preimplantation)''' (GP)&lt;br /&gt;
* '''Indications, Inheritance patterns''' (SL)&lt;br /&gt;
** Preimplantation Genetic Diagnosis (PGD) &lt;br /&gt;
** Preimplantation Genetic Screening (PGS)&lt;br /&gt;
* '''Cell Extraction Methods, side effect''' (SK)&lt;br /&gt;
** Polar Body Analysis&lt;br /&gt;
** Blastomere biopsy &lt;br /&gt;
** Trophectoderm biopsy&lt;br /&gt;
* '''Genetic Techniques ''' (GP)&lt;br /&gt;
** Fluorescent In Situ Hybridisation (FISH)&lt;br /&gt;
** PCR&lt;br /&gt;
**Array Comparative Genomic Hybridisation (aCGH)&lt;br /&gt;
PMID 26100406 PMID 24771116&lt;br /&gt;
**Single Nucleotide Polymorphism&lt;br /&gt;
&lt;br /&gt;
history&lt;br /&gt;
explanation&lt;br /&gt;
specific examples&lt;br /&gt;
application&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Next Generation Sequencing&lt;br /&gt;
* '''Diagnosis (table, gene mapping)''' (SL)&lt;br /&gt;
* '''Utilization of Diseased Cell Lines''' (SK) &lt;br /&gt;
* '''Laws/ Legal status''' (SL)&lt;br /&gt;
* '''Future/Current Research'''&lt;br /&gt;
* '''Ethics'''&lt;br /&gt;
&lt;br /&gt;
==Content==&lt;br /&gt;
&lt;br /&gt;
===Legistation for ARTS===&lt;br /&gt;
&lt;br /&gt;
[https://www.nhmrc.gov.au/health-ethics/ethical-issues/assisted-reproductive-technology-art Assisted Reproductive Technology Ethics]&lt;br /&gt;
&lt;br /&gt;
[https://cbhd.org/content/g12-country-regulations-assisted-reproductive-technologies G12 Country Regulations of Assisted Reproductive Technologies]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Cell Extraction Methods==&lt;br /&gt;
Polar bodies: Applying PGD to polar bodies is desired as it can be used before conception. Since genetic testing can be conducted within twenty four hours this makes it possible for the transfer to the mother at the blastomere stage. However this method isn’t commonly used due to the fact that all oocytes must be tested including those that may not progress to mature and only genetic material from the female can be retrieved &amp;lt;ref name=&amp;quot;Coward, K. &amp;amp; Wells, D. (2013). Textbook of Clinical Embryology New York: Cambridge University Press.&amp;quot;&amp;gt;Coward, K. &amp;amp; Wells, D. (2013). Textbook of Clinical Embryology New York: Cambridge University Press.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Cleavage stage: This involves the biopsy of the blastomere (6 to 10 cells) &amp;lt;ref name=&amp;quot;PMID11325751&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11325751&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. It is advantageous to work on blastomeres as they are totipotent, meaning they can give rise to a diverse range of cells. Studies have also shown that there is no increase in congenital abnormality rates caused by the removal of blastomere cells &amp;lt;ref name=&amp;quot;Coward, K. &amp;amp; Wells, D. (2013). Textbook of Clinical Embryology New York: Cambridge University Press.&amp;quot;/&amp;gt;. Contrarily, studies have shown that the standard removal of two blastomeres at one time will decrease its potential to develop into a blastocyst &amp;lt;ref name=&amp;quot;PMID19773223&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19773223&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Along with the fragility of the cells at this stage, highly skilled embryologists are required to minimise poorly performed biopsies which could subsequently lead to impaired growth and a decrease in implantation. Unlike polar bodies both maternal and paternal genes can be tested if PGD is performed at this stage. &amp;lt;ref name=&amp;quot;Coward, K. &amp;amp; Wells, D. (2013). Textbook of Clinical Embryology New York: Cambridge University Press.&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Blastocyst: Performing PGD at this stage is the least common since many patients do not produce embryos healthy enough to reach this stage. Multiple cells can be extracted at this stage for biopsy producing more accurate results. This is possible due to the fact that biopsies have little effect on the development of the embryo. Genetic tests must also be conducted rapidly since implantation is optimal at this stage &amp;lt;ref name=&amp;quot;Coward, K. &amp;amp; Wells, D. (2013). Textbook of Clinical Embryology New York: Cambridge University Press.&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Textbooks==&lt;br /&gt;
&lt;br /&gt;
===The Developing Human 9th Edition: Birth Defects caused by Genetic factors===&lt;br /&gt;
&amp;lt;ref&amp;gt; Moore, K.L., Persaud, T.V.N. &amp;amp; Torchia, M.G. (2011). The developing human: clinically oriented embryology (9th ed.). Philadelphia: Saunders.&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
* Estimated to cause one third of all defects &lt;br /&gt;
* Abnormalities in chromosomes are usually due to structural or numerical changes. These can occur in sex chromosomes or autosomes. &lt;br /&gt;
** Numerical abnormalities are a result of nondisjunction. Nondisjunction is when a pair or chromatids fail to disjoin during meiosis or mitosis. E.g. Turners Syndrome, Trisomy 21 (Down syndrome) and Trisomy 18 (Edward’s Syndrome). &lt;br /&gt;
** Structural abnormalities are usually a result of chromosome breakage followed by reconstitution in an abnormal combination. There are different types of structural abnormalities including translocation and deletion of chromosomes &lt;br /&gt;
* Mutations cause 8% of birth defects. It involves the loss or change in the function of a gene which is permanent and heritable.&lt;br /&gt;
&lt;br /&gt;
===Williams Obstetrics, Twenty-Fourth Edition: Preimplantation Genetic Testing===&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref&amp;gt; Cunningham F, Leveno K.J., Bloom S.L., Spong C.Y., Dashe J.S., Hoffman B.L., Casey B.M., Sheffield J.S. (2013). Prenatal Diagnosis. In Cunningham F, Leveno K.J., Bloom S.L., Spong C.Y., Dashe J.S., Hoffman B.L., Casey B.M., Sheffield J.S.  (Eds), Williams Obstetrics, Twenty-Fourth Edition. Retrieved August 25, 2015 from {http://accessmedicine.mhmedical.com/content.aspx?bookid=1057&amp;amp;Sectionid=59789152.} &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* two categories of preimplantation genetic testing: PGS (-Screening) &amp;amp; PGD (-Diagnosis); different indications&lt;br /&gt;
** PGS: IVF procedure due to infertility without known genetic abnormalities in patients&lt;br /&gt;
** PGD: IVF procedure &amp;amp; genetic testing chosen because of known genetic abnormalities in patients&lt;br /&gt;
* Methods: &lt;br /&gt;
** Polar body analysis: first and second polar body are extruded following completion of meiosis I and meiosis II&lt;br /&gt;
*** Advantages: does not harm embryo, can be used to detect 146 Mendelian disorders, reported 99% accuracy &lt;br /&gt;
*** Disadvantages: paternal genetic contribution is not investigated --&amp;gt; additional procedures &lt;br /&gt;
** Blastomere biopsy: embryo is 3 day old, 6-8 cells stage, most commonly used, hole is made in zona pellucida to retrieve one cell&lt;br /&gt;
*** Disadvantages: 10% pregnancy reduction,&amp;quot;mosaicism of the blastomeres may not reflect the chromosomal complement of the developing embryo&amp;quot;&lt;br /&gt;
** Trophectoderm biopsy: 5-6 day old blastocyst, 5-7 cells are removed&lt;br /&gt;
*** Advantage: no cells removed from embryo&lt;br /&gt;
*** Disadvantage: additional procedures may be necessary because of later stage of developing embryo (cryopreservation, implantation at later IVF-cycle)&lt;br /&gt;
&lt;br /&gt;
===Maternal, Fetal &amp;amp; Neonatal physiology: a Clinical perspective :Prenatal Diagnosis and Maternal, Fetal &amp;amp; Neonatal physiology: a Clinical perspective: Prenatal Diagnosis:=== &lt;br /&gt;
&lt;br /&gt;
Prenatal diagnosis is the screening process that tests an early fetus for overall growth, complications of pregnancy, birth defects and chromosomal or genetic abnormalities within the first 2 trimesters. It aims to provide the parents with as information as possible to help them make an informed decision about the infants quality of life. In 90-95% of the cases negative outcomes occur; confirming the healthy state of the fetus, should a genetic abnormality be present, it provides the parents with the opportunity to  investigate further with other tests, and possible fetal therapeutic treatments available as well  plan and prepare for the disabled infant  or to terminate the pregnancy. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
*Indicators for prenatal screening/ high risk factors include:&lt;br /&gt;
**maternal ages &amp;gt; 35 years&lt;br /&gt;
**paternal ages &amp;gt; 50-55&lt;br /&gt;
**history of 2+ miscarriages&lt;br /&gt;
**previous pregnancy or family history of a preexisting genetic or chromosomal disorder&lt;br /&gt;
**suspected carriers of genetic disorders&lt;br /&gt;
** maternal disease/condition present (high BP, diabetes)&lt;br /&gt;
**abnormal ultrasound or serum test results within the first 2 trimesters&lt;br /&gt;
**family history of neural tube or other birth defects &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
*Ultrasonography:&lt;br /&gt;
**high frequency sound waves are used to generate a image of the fetus &lt;br /&gt;
**relatively non-invasion; its conducted transabdominally or transvaginally ( producing a higher resolution image) &lt;br /&gt;
**It reveals the presence/absence of congenital abnormalities, characteristics of fetal growth and development, uterine development status; amount of **amniotic fluid, placental position, umbilical blood flow and the presence of multiple gestation. &lt;br /&gt;
**(if abnormalities are detected further testing is recommended)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
*Amniotic Fluid Analysis/:&lt;br /&gt;
**samples are obtained through amniocentesis &lt;br /&gt;
**the amniotic fluid is analyzed for its biochemical composition &lt;br /&gt;
**earlier in the pregnancy it can be examined for sex determination and to diagnose genetic or chromosomal disorders present. &lt;br /&gt;
**Later into the pregnancy it provides an indication of fetal maturity and well being&lt;br /&gt;
**Feta; cells recovered from the amniotic fluid can be cultured for specific karyotypes, to test for Chromosomal Abnormalities, and analysed for Alpha- fetoprotein (AFP) a biochemical marker of metabolic disorders and neural tube defects as well as other abnormalities.  &lt;br /&gt;
**Amniocentesis- occurs usually between weeks 14-20 as amniotic fluid has reached the optimal volume (150-250mls) allowing 20-30mls to be removed with a relatively low risk or fetal or maternal complication, and in time for a 2nd trimester abortion.&lt;br /&gt;
**early amniocentesis ( before week 13) increase the risk of fetal loss, leakage of essential amniotic  fluid and talipes equinovarus.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
*Chronic Villus Sampling  (CVS):&lt;br /&gt;
**occurs  roughly 10-13 weeks after last menstrual cycle, ensuing a sufficiently developed chorionic villi but before the chorion laeve forms the definitive placenta. &lt;br /&gt;
**ultrasounds is used to locate the gestational sac and implantation then a transcervial or transabdominal approach is used to aspirate living tropoblast tissue.&lt;br /&gt;
**sample is analyzed for chromosomal abnormalities or with enzyme assay. &lt;br /&gt;
**advantages: earlier diagnosis , decreased waiting period&lt;br /&gt;
**disadvantages: risk of spontaneous abortion, bacterial infection, bleeding, leakage of amniotic fluid, inability to diagnose neural tube defects this early, early cleavage (before wk 10) is associated with increased risk of limb defects (due to insufficiently developed chronic villi) &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
*Umbilical Blood Sampling:&lt;br /&gt;
**can occur as early as 16 weeks &lt;br /&gt;
**using the umbilical cord to obtain fetal blood samples - with real time ultrasound &lt;br /&gt;
**used to diagnose inherited blood disorders, to detect congenital infections, to assess fetal anemia and in treatments such as blood transfusions. &lt;br /&gt;
**disadvantages: risks of infection, preterm labor, thrombosis, bleeding &amp;amp; transient fetal arrhythmia &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
*Fluroscent in Situ Hybridisation (FISH)&lt;br /&gt;
**rapidly detects (within 24 hours of testing )  the presence of Trisomies 21, 13 and 8 and alterations in sex chromosomes in uncultured cells. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
*early diagnosis allows the opportunity for intervention with fetal therapies: &lt;br /&gt;
**surgical intervention urinary tract obstruction ; aiming to reduce prenatal renal damage&lt;br /&gt;
**fetal transfusions ( feta anemia &lt;br /&gt;
**fetal medical treatmetn ( fetal cardiac arrhythmias,impaired thyroid function etc.) treatment occurs   usually through the mother &lt;br /&gt;
** infusions for hematologic conditions &lt;br /&gt;
**stem cell transplantation&lt;br /&gt;
**gene therapy  &lt;br /&gt;
**pharmocolic interventions &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
textbooks used : &lt;br /&gt;
&lt;br /&gt;
*Maternal, Fetal &amp;amp; Neonatal physiology: a Clinical perspective &amp;lt;ref&amp;gt; Blackburn, S.L. (2003) '''Maternal, Fetal &amp;amp; Neonatal physiology: a Clinical perspective''' (2nd ed.). Seattle: Saudners &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Langman's Medical Embryology (12th ed.)Chapter 9, pages 125-129 &amp;lt;ref&amp;gt; Sadler T.W.(2012) '''Langman's Medical Embryology''' (12th ed.) &lt;br /&gt;
Philadelphia: Lipincott, Wiliams &amp;amp; Wilkins, a Wolters Kluwer Business  &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
the following are two articles about a newly available and accessible prenatal non- invasive genetic test- Blood sampling:&lt;br /&gt;
&lt;br /&gt;
*Report on Cutting edge prenatal screening technology to become available in Australia &amp;lt;ref&amp;gt; Carbonell, R. Shinners, A. Amor, D. Mark, D. (2015) '''Report on Cutting edge prenatal screening technology to become available in Australia:''' ''Prepared for ABC news, PM with Mark Colvin.''  Retrieved from {http://www.abc.net.au/pm/content/2015/s4203200.htm} &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Blood Test takes risk out of prenatal testing &amp;lt;ref&amp;gt; Begley, S. (05/07/2015) '''Blood Test takes risk out of prenatal testing'''. ''ABC Science.'' Retrieved from&lt;br /&gt;
{http://www.abc.net.au/science/articles/2012/07/05/3539549.htm} &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* Prenatal screening and Diagnostic Tests Information Pamphlet &amp;lt;ref&amp;gt; Western Australia. Department of Health Genetics Council Prenatal Diagnosis Committee (2011)'''Prenatal screening and Diagnostic Tests'''. Retrieved from {http://www.health.wa.gov.au/docreg/Education/Prevention/Genetics/HP3131_prenatal.pdf} &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Articles==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24810687&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;23773313&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26201722&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26168107&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
''This article reviews the cytogenetic techniques and embryo biopsies required for PGD &amp;amp; PGS and gives an account on the differences in PGD for single gene defects and chromosomal translocations.'' &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;22723007&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
''This article gives relatively recent and detailed information on the three types of biopsy performed on embryos at different stages of development (before conception, after fertilization, and early cleavage or blastocyst stage)''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24515905&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
''This article reviews indications for PGD focusing on single gene disorders.''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;20966459&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
''This article gives detailed laboratory instructions and guidelines for PGD procedures, which might be useful for the methodological part of the website''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
''The following articles are about diseased cells/embryos derived from PGD procedures for further research:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;23242925&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;22735930&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
''Other articles''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;21748341&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26259216&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26258137&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;22404048&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26238130&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26168107&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
IVF and prenatal genetic testing in Australia &lt;br /&gt;
[[http://virtushealth.com.au/australian-first-new-genetic-testing-set-improve-access-and-outcomes-ivf-patients]]&lt;br /&gt;
&lt;br /&gt;
the following are two articles about a newly available and accessible prenatal non- invasive genetic test- Blood sampling:&lt;br /&gt;
[[http://www.abc.net.au/pm/content/2015/s4203200.htm]]&lt;br /&gt;
[[http://www.abc.net.au/science/articles/2012/07/05/3539549.htm]]&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=205239</id>
		<title>User:Z3416054</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=205239"/>
		<updated>2015-10-13T23:44:05Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Hi there&lt;br /&gt;
Just giving the editor a good old test run.&lt;br /&gt;
[[Test student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:45, 7 August 2015 (AEST)&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:47, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 14:06, 14 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:57, 21 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 12:22, 28 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:20, 4 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:18, 11 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:10, 25 September 2015 (AEST)&lt;br /&gt;
==Picture Tutorial==&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
===Article 1===&lt;br /&gt;
This research article aimed to determine the clinical outcomes following IVF (in vitro fertilisation) and embryo transfer treatments in subjects suffering from the sexually transmitted disease syphilis. The clinical outcomes mentioned are the rates of pregnancy and health of newborns following treatment via IVF. Couples engaged in sexual intercourse over 12 months without the use of contraception and who failed to conceive were deemed as being infertile.&lt;br /&gt;
&lt;br /&gt;
The subjects were divided into two groups based on serology results, a syphilis infected group and a control group, each with 160 individuals, giving a total of 320 subjects. The Syphilis infected group was further divided into three subcategories, a male infected group, a female infected group and a couple (male and female) infected group. Penicillin G20 (an anti-syphilis treatment) was given to the individuals in the syphilis group. IVF treatment commenced one month proceeding the disappearance of clinical syphilis symptoms or if test results gave a negative result for syphilis infection.&lt;br /&gt;
&lt;br /&gt;
The results of this experiment revealed no significant differences in regards to the basal FSH and LH of both the control and syphilis groups. However, the thickness of the endometrium differed greatly, with the syphilis group demonstrating a thicker endometrial wall (16.9±5.4mm) compared to the control group (13.0±4.7mm). Further differences were noted in blastocyst implantation rates, with the syphilis group having less successful implantations compared to the control (24.2% vs. 34.4% respectively).Normal oocyte cleavage differed between the two groups with the syphilis group demonstrating less normal oocyte cleavage compared to the control group  (6.3±4.7 vs. 8.1±4.6). Furthermore, the clinical pregnancy rates of the syphilis group stood at 43.8% compared to 55.6% of the control group.&lt;br /&gt;
&lt;br /&gt;
Syphilis infection appeared to have a significant impact on the success and clinical outcomes of IVF. Syphilis associated pelvic inflammatory disease can lead to an increase in the thickness of the endometrium, which can adversely affect blastocyte implantation and endometrial receptivity. Successful pregnancy rates typically correlate with an endometrial thickness of 7-14mm, with any thickness beyond 14mm often corresponding with decreased clinical pregnancies. Rates of clinical pregnancy and miscarriage rates did not differ between the three syphilis subgroups. Conception involving a male infected partner was associated with a shorter gestational period and decreased offspring birth weight, when compared to the female infected and couple infected subgroups. No explanation for this phenomenon was provided.&lt;br /&gt;
&lt;br /&gt;
PMID 26208116&lt;br /&gt;
&lt;br /&gt;
''Article 1 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4514756&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
===Article 2===&lt;br /&gt;
The effects of oxygen levels on factors such as cleavage, implantation and pregnancy rates in IVF cultured embryos was the primary focus of this article.  Women between the ages of 20-48 who were seeking treatment for infertility were utilised in this experiment.&lt;br /&gt;
Gametes were allocated to be incubated in one of three environments, each with a different oxygen concentration. The first group was placed in an atmosphere with an oxygen concentration of 20%. The second group rested in a 20% oxygen environment for a day before being moved to a 5% oxygen, 5% carbon dioxide and 90% nitrogen atmosphere. The third group consisted of a 5% carbon dioxide, 5% oxygen and 90% nitrogen atmosphere. The gametes (spermatozoa and oocytes) were incubated together in their respective environmental conditions for 4-6 hours after which fertilisation is presumed to have occurred.&lt;br /&gt;
&lt;br /&gt;
Successful embryos were transferred at Day 3 cleavage. A biochemical analysis of HCG validated pregnancy, whilst ultrasound was used to confirm the presence of a heartbeat 28 days following the transfer.&lt;br /&gt;
IVF fertilisation rates were calculated as being the number of fertilised oocytes over the number of oocytes inseminated. Cleavage rates were characterised by the number of blastomeres over the number of fertilised and abortion rate by the amount of miscarriages divided by the number of transfers.&lt;br /&gt;
&lt;br /&gt;
The research article concluded that the embryos from the 5% oxygen group had the highest rates of fertilisation and implantation. The 20% oxygen group had the second highest rates of fertilisation and maintained excellent embryo quality, whilst the 20% to 5% group had the lowest rates overall. Abortion and miscarriage rates did not differ at all between the three groups. The group incubated at 5% oxygen demonstrated higher quality embryos and increased rates of pregnancy when compared to the 20% oxygen group. The article concludes that implantation, pregnancy and embryo quality can be somewhat affected by a set oxygen concentration, but are affected adversely by a shift from one concentration to another. &lt;br /&gt;
Shifting from one oxygen concentration to another appeared to have an adverse effect on the cleavage of the embryo and would likely impact future development and the overall success of the IVF treatment.&lt;br /&gt;
&lt;br /&gt;
PMID 26131222 &lt;br /&gt;
&lt;br /&gt;
''Article 2 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4483955&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These are quite good descriptions of these 2 articles. (5/5)&lt;br /&gt;
==Lab 2 Assessment==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Notch Signalling - Ovulation in Drosphila.jpg|Caption]]&lt;br /&gt;
&lt;br /&gt;
===Image Reference===&lt;br /&gt;
Jianjun Sun, Allan C Spradling Ovulation in Drosophila is controlled by secretory cells of the female reproductive tract. Elife: 2013, 2;e00415 PubMed 23599892&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 23599892&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) Image uploaded and named correctly. All reference, copyright and student image template included. You might have included in the summary box an explanation to the terms that appear in the image as there is no way for the reader to interpret what is shown in each panel. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 3 Assessment==&lt;br /&gt;
===Causes===&lt;br /&gt;
====The Genetics of Infertility: Current Status of the Field====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3885174&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This article attempted to determine the role that genetics plays in female infertility. It was noted that several prominent causes of female infertility such as Galactosemia and Primary Ovarian Failure (POF) were associated with specific genes, with the GALT gene contributing to the former condition and the FMR1 gene contributing to the latter.&lt;br /&gt;
&lt;br /&gt;
====Causes of Sterility in Bosnia-Herzegovina Population====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4499307&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
The study conducted as laid out in this article examined the causes of female sterility in the Bosnia-Herzegovina population. Married participants were arranged into various groups based upon their age. The experiment came to the conclusion that in approximately 42% of infertile married couples, female sterility was the primary cause. The two primary causes of female infertility were tubal deficiencies (31% of cases) and Diminished Ovarian Reserves (38% of cases)&lt;br /&gt;
&lt;br /&gt;
====Epidemiology, diagnosis, and management of polycystic ovary syndrome====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3872139&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This research article examines the causes of polycystic ovary syndrome (POS), a common cause of infertility in women. The article concluded that 50-70% of women suffer from insulin resistance secondary to Type 2 Diabetes and in many cases obseity, which may contribute partially to POS. Furthermore, 85-90% of women with oligomenorrhea also had POS, suggesting that it is an underlying cause. However, the exact pathophysiology of POS was not determined.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These papers relate to your group project, I hope they are useful for the final submission. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 4 Assessment==&lt;br /&gt;
===Quiz===&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
{Primary villi are produced during which stage of development?:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ Week 2&lt;br /&gt;
- Week 1&lt;br /&gt;
- Week 3&lt;br /&gt;
- None of the above&lt;br /&gt;
|| Primary Villi appear during Week 2 of development, whilst secondary villi appear during Week 3 of development.&lt;br /&gt;
&lt;br /&gt;
{Mesoderm is a precursor for all of the following EXCEPT:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Skeletal Muscle Cells&lt;br /&gt;
- Cardiac Muscle Cells&lt;br /&gt;
- Erythrocytes&lt;br /&gt;
+ Epidermal Skin Cells&lt;br /&gt;
- Smooth Muscle&lt;br /&gt;
|| Epidermal skin cells originate from ectoderm. Skeletal, cardiac and smooth muscle along with erythrocytes originate from the mesoderm.&lt;br /&gt;
&lt;br /&gt;
{Which of the following shows the correct developmental pathway of the male gamete:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatogonia &amp;gt; Spermatozoa&lt;br /&gt;
- Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell &amp;gt; Spermatozoa &amp;gt; Spermatid&lt;br /&gt;
- Sertoli Cell &amp;gt; Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatozoa&lt;br /&gt;
- Spermatid &amp;gt; Spermatozoa &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell&lt;br /&gt;
+ Spermatogonia &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatid &amp;gt; Spermatozoa&lt;br /&gt;
|| Spermatogonia represent the beginning of male sex cell development, with spermatozoa being the mature gamete.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) No descriptive title to your questions. Q1 relates to the timing of villi development. These types of questions encourage &amp;quot;student guessing&amp;quot; and you could have given a more detailed explanation and links to resources in your revealed answer e.g. [[Placenta - Villi Development]]. Q2 is a reasonable question, but only requiring the student only to know that Epidermal Skin Cells are from ectoderm. Once again it is your revealed answer that needs more work. Q3 is a little easy, as long as you know Spermatogonia are the diploid start cell you can quickly exclude most options, need more work. (8/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5 Assessment==&lt;br /&gt;
===Gastroschisis and Omphalocele===&lt;br /&gt;
&lt;br /&gt;
Gastroschisis is classified as a full thickness cleft found in the abdominal wall, adjacent to the site of insertion of the umbilical cord. The defining features of this abnormality is the absence of a membranous sac shrouding the intestines. As a result of this the intestines will become eviscerated, thereby protruding out of the abdominal wall and will be on the exterior, rather than the interior of the body. It is believed that disruption to the vascular supply of the right abdominal wall is the primary gass of gastroschisis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2166158&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Omphalocele is an abnormality characterised by the herniation of visceral organs such as the intestines, liver and spleen outside of the abdominal cavity. The visceral organs are enclosed in a membranous sac, into which the umbilical cord is inserted.  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC1355659&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The primary difference between gastroschisis and omphalocele lies in the presence of a membraneous sac and the exact organs herniating from the abdominal wall. Gastroschisis involves the intestines protruding to the outside of the body but are not covered by a membranous sac. Omphalocele however is characterised by the protrusion of multiple visceral organs (liver, spleen etc.) which are enclosed within a membranous. Furthermore, the size of both abnormalities differs greatly, with gastroschisis typically being 2-5 cm in size whilst omphalocele can vary between 2-15cm. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2552910&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) This is an adequate description of the differences between these conditions. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 7 Assessment==&lt;br /&gt;
&lt;br /&gt;
1: This research paper aimed to examine the relationship between fetal adrenal cells and the differentiated adrenal cortex. In particular, research was focussed upon possible pregenitor cells involved in maintenance of the adrenal cortex. It was hypothesised that the the most likely precursor cells of the adult cortex were the 'Glil' expressing cells found in the adrenal capsule. A number of mice adrenal glands were taken, treated with antigen retrieval solution, after which fluorescence microscopy was conducted.&lt;br /&gt;
&lt;br /&gt;
The results of the paper concluded that 'Glil' expressing descendants of fetal adrenal cells are the pregenitors of the differentiated adrenal cortex. Furthermore, it was found that the 'Glil' expressing cells oringinated from 'FAdE-Cre' expressing fetal adrenal cells. Thus the authors of this research article came to the conclusion that 'Glil' expressing cells found in the adrenal cortex play an important role in the development, differentiation and maintenance of the adrenal cortex. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3817941&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
2: A number of embryonic layers and tissues contribute to the development of teeth. The primary contributing layers are mesoderm, ectoderm and neural crest ectomesenchyme. Furthermore, neural crest may contribute through interactions with the ectoderm. Odontoblasts originate from neural crest derived mesenchymal cells and are responsible for forming predentin which calificies to create dentin (which forms the bulk of the tooth). Ameloblasts are responsible for the production of enamel, which provides teeth with the hardness required to engage in mastication. &lt;br /&gt;
&lt;br /&gt;
==Peer Assessment==&lt;br /&gt;
&lt;br /&gt;
===Group 1 Peer Assessment===&lt;br /&gt;
Hi guys! I'll start of by saying that the images and video you have included are excellent and are relevant to your topic of discussion. Also, you have a large number of reliable references which is good to see. However you have yet to include a hand drawn image, which is required for the wiki page. I feel like  you could probably eliminate the typed out 'timeline of mitochondrial donation' and instead use this as an opportunity to use a hand drawn image of the timeline. Furthermore, the timeline under 'cystoplasmic transfer' feels a bit awkward and unnecessary. You could probably include this timeline alongside the 'timeline of mitochondrial donation'. &lt;br /&gt;
&lt;br /&gt;
Under the 'Technical Progression' section it would be best to incorporate human embryo, mouse and human models under a sub-sub heading, as at the moment it feels a bit jumbled.&lt;br /&gt;
&lt;br /&gt;
I would also recommend moving the 'Benefits' heading towards the end of the page. It feels odd reading about the benefits of three person embryos before I gain a proper understanding of how they work. Also it might be worth talking about the disadvantages (if there are any) to three person embryos to balance out the 'benefits' section. As has been previously stated, make sure you sort out the copyright information for your video as it would be a shame to lose marks if it was missing. Also, don't forget to add the 'student template' to the 'Swapping mitochondrial DNA mammalian oocytes' image as it is currently absent.&lt;br /&gt;
&lt;br /&gt;
===Group 2 Peer Assessment===&lt;br /&gt;
So far your wiki page gives a very good coverage of Ovarian Hyper-Stimulation Syndrome. The progression of your subheadings progresses logically from one topic to another. It's good to see that you've included an excellent hand-drawn image which is well suited to the 'pathophysiology' subheading. The amount of textual information you have under each heading is vast and gives a comprehensive description of OHSS. Furthermore, you have an excellent range of sources to support your discussion.&lt;br /&gt;
&lt;br /&gt;
I feel however that asides from your hand-drawn image, your use of images and other source of media is definitely lacking. As is, your page is largely text with little to no breaks, making it quite difficult to read. The use of images would not only help break up the monotony of the text, but also help reinforce some of your ideas. I feel that the inclusion of images in the 'symptoms' and 'complications' subheadings would be suitable. &lt;br /&gt;
&lt;br /&gt;
It may also be worthwhile to include subheadings concerning current research, to inform readers about contemporary developments regarding OHSS. Furthermore,  'future research' could also be another potential subheading and could illuminate potential areas that are beginning to be or could be investigated in coming years.&lt;br /&gt;
&lt;br /&gt;
Overall, a very impressive page so far, that could be enhanced with the addition of relevant images and other media.&lt;br /&gt;
&lt;br /&gt;
===Group 4 Peer Assessment===&lt;br /&gt;
Very impressive work so far guys! Your page covers a comprehensive topic very well, without focussing too much on certain subheadings at the expense of others. Your use of both tables and images is excellent so far. It's good to see that you have also included a video to give some variety to the media on your page. The 'background information' gives context to the issues which you discuss and though it might not be of great use for someone familiar with embryology, it would be a great help to those with no experience in this field and is therefore useful in establishing the topic of male infertility.&lt;br /&gt;
&lt;br /&gt;
The only things that could be changed to improve your wiki page is perhaps altering the location of tables and pictures on your page. For example all pictures are located on the right side of the page, although not a significant issue, becomes slightly monotonous as one progresses through the page. It may be worth alternating pictures between left and right to mix things up a little bit and improve the overall flow of the page. &lt;br /&gt;
It might also be worth including a short video underneath the 'surgical treatments' subheading to give a visual example of some of the techniques discussed.&lt;br /&gt;
&lt;br /&gt;
Furthermore a subheading on future research could possibly be included under the 'treatments' subheading to give the reader information on techniques and therapies which may come to prominence in the near future.&lt;br /&gt;
&lt;br /&gt;
Your wiki page thus far is very impressive! Excellent work so far. &lt;br /&gt;
===Group 5 Peer Assessment===&lt;br /&gt;
Awesome page so far guys! I commend you on your use of various videos to assist in conveying your ideas. Furthermore, the images you have chosen are highly relevant to the topic of discussion and assist the reader in gaining a greater understanding of oncofertility. All copyright information is present for the images you have used which is excellent to see.&lt;br /&gt;
It may be worth including a hand drawn image under the 'radiation' subheading, as we are required to include at least one such image. The current image under the radiation subheading could easily be replicated by hand and could fulfill this portion of the criteria.&lt;br /&gt;
&lt;br /&gt;
I am nitpicking here, but I would also recommend including some kind of media, most likely a picture, underneath the surgery subheading. It might even be worth doing the hand drawn image here if possible. A picture may also be good underneath the 'types of chemotherapy drugs' subheading, just to break up the wall of text and improve the reading experience for the reader.&lt;br /&gt;
It might also be worth restructuring the 'oncofertility limitations' subheading into the form of a table (if possible), as the bullet point format feels quite awkward and out of place compared to the rest of the page.&lt;br /&gt;
The inclusion of a glossary is also recommended, as this page will be accessible by the general public and a glossary will assist those without a background in embryology to understand and appreciate your content.&lt;br /&gt;
&lt;br /&gt;
Keep up the great work guys! Your page is absolutely amazing so far and the effort you have put in is definitely reflected in the high quality of your page.&lt;br /&gt;
===Group 6 Peer Assessment===&lt;br /&gt;
&lt;br /&gt;
Look at this!&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_5&amp;diff=205237</id>
		<title>Talk:2015 Group Project 5</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_5&amp;diff=205237"/>
		<updated>2015-10-13T23:43:54Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015discussionheader}}&lt;br /&gt;
&lt;br /&gt;
Hey guys - i tried to upload a video for the how cancer cells work section  - but i have no idea how to do it, tried looking it up but have failed immensely! so i you know how to do it - please explain haha so grateful! thanks --[[User:Z5015534|Z5015534]] ([[User talk:Z5015534|talk]]) 12:42, 4 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:23, 25 September 2015 (AEST) OK, there is so much more that should be on your project page by now. That currently consists of all text, no media, histology, graphics, tables etc. Furthermore no discussion of animal models used in research for this topic. This project page is not ready for peer review.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hi everyone,&lt;br /&gt;
the page is coming together well. &lt;br /&gt;
only thing is while we write up our parts can we focus on all using in text referencing so that we are consistent and can just have a single reference list at the bottom.&lt;br /&gt;
I found out how to use the same reference again and only have it associated with one in text number, so if you are using the same reference and would like me to show you how to do this let me know :)&lt;br /&gt;
--[[User:Z3463667|Z3463667]] ([[User talk:Z3463667|talk]]) 21:40, 14 September 2015 (AEST)&lt;br /&gt;
 &lt;br /&gt;
I have added some of the references + citations but not yet finished as this is only the draft and I might delete some of the parts so there is no point adding the citations/ text referencing now. I will add my part at the end. I'm still waiting for your part to see what to do. http://www.ncbi.nlm.nih.gov/pubmed/15951668&lt;br /&gt;
--[[User:Z3463890|Z3463890]] ([[User talk:Z3463890|talk]]) 08:35, 17 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
=Research/Review articles=&lt;br /&gt;
&lt;br /&gt;
===[Oncofertility and breast cancer: Where have we come from, where are we going?].===&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;25991386&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This article focuses on the current context of national and international recommendations, techniques development to evaluate and preserve fertility and patients' claims, this study aims to make a survey about the management of patients' breast cancer regarding oncofertility. This article concludes that , in order to satisfy patients' requests, several improvements have to be made regarding the patients' information, the health professionals' awareness and care coordination.I don't go through it now but very interesting article to read and useful for our group project.&lt;br /&gt;
&lt;br /&gt;
===Emergency fertility preservation for female patients with cancer: clinical perspectives.===&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26026071&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This article explains about clinical perspectives to explore the new as well as the currently available options and strategies that can be used for emergency fertility preservation of female cancer patients.Such options include emergency ovarian stimulation, embryo freezing, egg freezing, ovarian tissue freezing and autotransplantation, in vitro maturation, and ovarian protection techniques. This article also mentions the advantages and disadvantages of each option as well as a new comprehensive multi-step strategy for these situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Sexual dysfunction and infertility as late effects of cancer treatment===&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26217165&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
As all we know, Sexual dysfunction is the main consequence of cancer treatment. Problems are usually linked to damage to nerves, blood vessels, and hormones that underlie normal sexual function. This article emphasizes on these sexual dysfunction and does in depth. It addresses that innovations in cancer treatment such as robotic surgery or more targeted radiation therapy have not had the anticipated result of reducing sexual dysfunction. Therefore, advances in both technologies and in knowledge about how cancer treatments can damage fertility, offer hope to patients who want children.&lt;br /&gt;
&lt;br /&gt;
===Impact of fertility preservation counseling and treatment on psychological outcomes among women with cancer: A systematic review===&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26264701&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This article explains about psychological outcomes in female cancer patients who undergo fertility preservation counseling/consultation (FPC), with or without fertility preservation (FP).I read through the whole article as I found it really interesting and relevant to our group project. This is another subheadings we can add to those.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3463890|Z3463890]] ([[User talk:Z3463890|talk]]) 11:24, 24 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
I DID THE SAME :) &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Variability in the practice of fertility preservation for patients with cancer.===&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26010087&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This is an interesting article on how reproductive endocrinologists counselled cancer patients on fertility preservation. This is relevant to our group projects because it gives us an idea of what techniques and services are currently being utilised to help women. &lt;br /&gt;
&lt;br /&gt;
===Strategies for fertility preservation in young patients with cancer: a comprehensive approach.===&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24669162&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This article recognises that as cancer treatment improves the life span of patients, with it comes the treat to fertility. It is a great article as it clearly states what methods are currently available for addressing fertility preservation in males and females. &lt;br /&gt;
&lt;br /&gt;
===Clinical guide to fertility preservation in hematopoietic cell transplant recipients.===&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24419521&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This article focuses specifically on patients suffering infertility due to hematopoietic cell transplantation. It lists the options available to the patients whether female or male, which are applicable to patients who underwent other treatments and also lists the barriers to fertility preservation.&lt;br /&gt;
&lt;br /&gt;
===Fertility preservation in patients with haematological disorders: a retrospective cohort study.===&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24140311&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This article addresses fertility treatment in patients with haematological disorders specifically. However, is it a really good article as it is a cohort study comparing patients at various stages in their cancer journey, such as those who have had prior chemotherapy, those who pursued ovarian stimulation and those who did not pursue fertility treatment at all.&lt;br /&gt;
&lt;br /&gt;
just moving my articles here for reference while i edit the project page. &lt;br /&gt;
--[[User:Z3463667|Z3463667]] ([[User talk:Z3463667|talk]]) 11:39, 14 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
Hi&lt;br /&gt;
I have added some points to the page but i will add more info soon. In terms of references and accurate citation, I have written down all the references and I will add those at the end as I might edit/delete some of them. I will explain those fertility drugs too. just added the names and do them over weekend.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3463890|Z3463890]] ([[User talk:Z3463890|talk]]) 08:58, 11 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hi everyone, &lt;br /&gt;
&lt;br /&gt;
yes, I agree we have to assign everyone a certain section to write about, I'm happy to do Infertility causing cancers ( I already found those related articles from pubmed) and Oncofertility timeline. so if everyone is happy I can start it :)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3463890|Z3463890]] ([[User talk:Z3463890|talk]]) 08:05, 27 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hi People, &lt;br /&gt;
&lt;br /&gt;
Does anyone know how to reference a non pubmed source? I'm not sure how to reference the general information that we want to put on our page? &lt;br /&gt;
I definitely think also that we should assign everyone a certain section to cover - so that were not all just editing and adding stuff in chaos - Ive started editing the chemotherapy section of the page - i hope this is alright if i take that on- i found some good info! dont worry the stuff i have up now is no where near finished.. just having a play around with general stuff and trying to get the hang of editing etc... (literally no nothing about IT...) But at the end it obviously will be all sorted and good :) &lt;br /&gt;
&lt;br /&gt;
Thanks&lt;br /&gt;
&lt;br /&gt;
--[[User:Z5015534|Z5015534]] ([[User talk:Z5015534|talk]]) 16:18, 26 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hey everyone, &lt;br /&gt;
&lt;br /&gt;
As discussed we will be researching oncofertility as our topic for this week, and depending on how successful our research is we will decide on whether we stick to the topic or not. &lt;br /&gt;
I have added some potential subheadings to help guide our research, feel free to change them and add more. &lt;br /&gt;
We need to pick a subheading each and find research articles related to it for this weeks individual lab assessment. &lt;br /&gt;
https://oncofertility.northwestern.edu/patients/fertility-preservation-options-nu --&amp;gt; this is a good website to trigger ideas to research. &lt;br /&gt;
--[[User:Z3463667|Z3463667]] ([[User talk:Z3463667|talk]]) 17:12, 23 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
==Peer Review===&lt;br /&gt;
&lt;br /&gt;
===1===&lt;br /&gt;
&lt;br /&gt;
Let me start off by commending this group on a fantastic page! It is incredibly thorough, detailed and long. You can immediately see that a lot of work and research has gone into it. You have a great list of references and they appear to be cited correctly throughout the page. However, some sections which appear to be incomplete and lack some citations e.g. “fertility preservation”. &lt;br /&gt;
&lt;br /&gt;
One suggestion I will make, is it would be good to see the addition of some hand-drawn images, perhaps one under either of the first 3 headings. Some more images could be used under the heading “surgery”. The videos used on this page are great. Really informative, relevant and easy to watch. I also think the “what are cancer cells” section should be higher up on the page as it is part of the basis of what the whole page is about. It also cuts between the two sections “chemotherapy” and “how does chemotherapy work?” which should be one after another. On the topic of formatting, you have a heading in there called “oncofertility timeline”, I think it would be better placed at the beginning of the page where it is more relevant. &lt;br /&gt;
&lt;br /&gt;
I also think there is just too much text in some areas e.g.  “Fertility preservation in women” and “surgery”. It makes that part of the page look clustered and difficult to read. Perhaps simplifying it more into bullet points, as you have done in other areas of the page, would be good. Conversely though, I think areas such as “targeted drugs” and “bone marrow or stem cells transplant” could use more work, however, it is possible you still intend to work on those areas anyway. &lt;br /&gt;
&lt;br /&gt;
I would suggest adding a glossary to the bottom of your page to assist in those who view your page with a lower level of scientific knowledge. You have covered an expansive range of topics pertaining to your topic, all of which are relevant and link well with each other. The page has a great focus on the learning aims of embryology. I think with some formatting corrections and some simplification of the text, this will be a really wonderful page.&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
Awesome page so far guys! I commend you on your use of various videos to assist in conveying your ideas. Furthermore, the images you have chosen are highly relevant to the topic of discussion and assist the reader in gaining a greater understanding of oncofertility. All copyright information is present for the images you have used which is excellent to see.&lt;br /&gt;
It may be worth including a hand drawn image under the 'radiation' subheading, as we are required to include at least one such image. The current image under the radiation subheading could easily be replicated by hand and could fulfill this portion of the criteria.&lt;br /&gt;
&lt;br /&gt;
I am nitpicking here, but I would also recommend including some kind of media, most likely a picture, underneath the surgery subheading. It might even be worth doing the hand drawn image here if possible. A picture may also be good underneath the 'types of chemotherapy drugs' subheading, just to break up the wall of text and improve the reading experience for the reader.&lt;br /&gt;
It might also be worth restructuring the 'oncofertility limitations' subheading into the form of a table (if possible), as the bullet point format feels quite awkward and out of place compared to the rest of the page.&lt;br /&gt;
The inclusion of a glossary is also recommended, as this page will be accessible by the general public and a glossary will assist those without a background in embryology to understand and appreciate your content.&lt;br /&gt;
&lt;br /&gt;
Keep up the great work guys! Your page is absolutely amazing so far and the effort you have put in is definitely reflected in the high quality of your page.&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 10:43, 14 October 2015 (AEDT)&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_5&amp;diff=205235</id>
		<title>Talk:2015 Group Project 5</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_5&amp;diff=205235"/>
		<updated>2015-10-13T23:42:35Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015discussionheader}}&lt;br /&gt;
&lt;br /&gt;
Hey guys - i tried to upload a video for the how cancer cells work section  - but i have no idea how to do it, tried looking it up but have failed immensely! so i you know how to do it - please explain haha so grateful! thanks --[[User:Z5015534|Z5015534]] ([[User talk:Z5015534|talk]]) 12:42, 4 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:23, 25 September 2015 (AEST) OK, there is so much more that should be on your project page by now. That currently consists of all text, no media, histology, graphics, tables etc. Furthermore no discussion of animal models used in research for this topic. This project page is not ready for peer review.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hi everyone,&lt;br /&gt;
the page is coming together well. &lt;br /&gt;
only thing is while we write up our parts can we focus on all using in text referencing so that we are consistent and can just have a single reference list at the bottom.&lt;br /&gt;
I found out how to use the same reference again and only have it associated with one in text number, so if you are using the same reference and would like me to show you how to do this let me know :)&lt;br /&gt;
--[[User:Z3463667|Z3463667]] ([[User talk:Z3463667|talk]]) 21:40, 14 September 2015 (AEST)&lt;br /&gt;
 &lt;br /&gt;
I have added some of the references + citations but not yet finished as this is only the draft and I might delete some of the parts so there is no point adding the citations/ text referencing now. I will add my part at the end. I'm still waiting for your part to see what to do. http://www.ncbi.nlm.nih.gov/pubmed/15951668&lt;br /&gt;
--[[User:Z3463890|Z3463890]] ([[User talk:Z3463890|talk]]) 08:35, 17 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
=Research/Review articles=&lt;br /&gt;
&lt;br /&gt;
===[Oncofertility and breast cancer: Where have we come from, where are we going?].===&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;25991386&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This article focuses on the current context of national and international recommendations, techniques development to evaluate and preserve fertility and patients' claims, this study aims to make a survey about the management of patients' breast cancer regarding oncofertility. This article concludes that , in order to satisfy patients' requests, several improvements have to be made regarding the patients' information, the health professionals' awareness and care coordination.I don't go through it now but very interesting article to read and useful for our group project.&lt;br /&gt;
&lt;br /&gt;
===Emergency fertility preservation for female patients with cancer: clinical perspectives.===&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26026071&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This article explains about clinical perspectives to explore the new as well as the currently available options and strategies that can be used for emergency fertility preservation of female cancer patients.Such options include emergency ovarian stimulation, embryo freezing, egg freezing, ovarian tissue freezing and autotransplantation, in vitro maturation, and ovarian protection techniques. This article also mentions the advantages and disadvantages of each option as well as a new comprehensive multi-step strategy for these situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Sexual dysfunction and infertility as late effects of cancer treatment===&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26217165&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
As all we know, Sexual dysfunction is the main consequence of cancer treatment. Problems are usually linked to damage to nerves, blood vessels, and hormones that underlie normal sexual function. This article emphasizes on these sexual dysfunction and does in depth. It addresses that innovations in cancer treatment such as robotic surgery or more targeted radiation therapy have not had the anticipated result of reducing sexual dysfunction. Therefore, advances in both technologies and in knowledge about how cancer treatments can damage fertility, offer hope to patients who want children.&lt;br /&gt;
&lt;br /&gt;
===Impact of fertility preservation counseling and treatment on psychological outcomes among women with cancer: A systematic review===&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26264701&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This article explains about psychological outcomes in female cancer patients who undergo fertility preservation counseling/consultation (FPC), with or without fertility preservation (FP).I read through the whole article as I found it really interesting and relevant to our group project. This is another subheadings we can add to those.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3463890|Z3463890]] ([[User talk:Z3463890|talk]]) 11:24, 24 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
I DID THE SAME :) &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Variability in the practice of fertility preservation for patients with cancer.===&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26010087&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This is an interesting article on how reproductive endocrinologists counselled cancer patients on fertility preservation. This is relevant to our group projects because it gives us an idea of what techniques and services are currently being utilised to help women. &lt;br /&gt;
&lt;br /&gt;
===Strategies for fertility preservation in young patients with cancer: a comprehensive approach.===&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24669162&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This article recognises that as cancer treatment improves the life span of patients, with it comes the treat to fertility. It is a great article as it clearly states what methods are currently available for addressing fertility preservation in males and females. &lt;br /&gt;
&lt;br /&gt;
===Clinical guide to fertility preservation in hematopoietic cell transplant recipients.===&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24419521&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This article focuses specifically on patients suffering infertility due to hematopoietic cell transplantation. It lists the options available to the patients whether female or male, which are applicable to patients who underwent other treatments and also lists the barriers to fertility preservation.&lt;br /&gt;
&lt;br /&gt;
===Fertility preservation in patients with haematological disorders: a retrospective cohort study.===&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24140311&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This article addresses fertility treatment in patients with haematological disorders specifically. However, is it a really good article as it is a cohort study comparing patients at various stages in their cancer journey, such as those who have had prior chemotherapy, those who pursued ovarian stimulation and those who did not pursue fertility treatment at all.&lt;br /&gt;
&lt;br /&gt;
just moving my articles here for reference while i edit the project page. &lt;br /&gt;
--[[User:Z3463667|Z3463667]] ([[User talk:Z3463667|talk]]) 11:39, 14 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
Hi&lt;br /&gt;
I have added some points to the page but i will add more info soon. In terms of references and accurate citation, I have written down all the references and I will add those at the end as I might edit/delete some of them. I will explain those fertility drugs too. just added the names and do them over weekend.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3463890|Z3463890]] ([[User talk:Z3463890|talk]]) 08:58, 11 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hi everyone, &lt;br /&gt;
&lt;br /&gt;
yes, I agree we have to assign everyone a certain section to write about, I'm happy to do Infertility causing cancers ( I already found those related articles from pubmed) and Oncofertility timeline. so if everyone is happy I can start it :)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3463890|Z3463890]] ([[User talk:Z3463890|talk]]) 08:05, 27 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hi People, &lt;br /&gt;
&lt;br /&gt;
Does anyone know how to reference a non pubmed source? I'm not sure how to reference the general information that we want to put on our page? &lt;br /&gt;
I definitely think also that we should assign everyone a certain section to cover - so that were not all just editing and adding stuff in chaos - Ive started editing the chemotherapy section of the page - i hope this is alright if i take that on- i found some good info! dont worry the stuff i have up now is no where near finished.. just having a play around with general stuff and trying to get the hang of editing etc... (literally no nothing about IT...) But at the end it obviously will be all sorted and good :) &lt;br /&gt;
&lt;br /&gt;
Thanks&lt;br /&gt;
&lt;br /&gt;
--[[User:Z5015534|Z5015534]] ([[User talk:Z5015534|talk]]) 16:18, 26 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hey everyone, &lt;br /&gt;
&lt;br /&gt;
As discussed we will be researching oncofertility as our topic for this week, and depending on how successful our research is we will decide on whether we stick to the topic or not. &lt;br /&gt;
I have added some potential subheadings to help guide our research, feel free to change them and add more. &lt;br /&gt;
We need to pick a subheading each and find research articles related to it for this weeks individual lab assessment. &lt;br /&gt;
https://oncofertility.northwestern.edu/patients/fertility-preservation-options-nu --&amp;gt; this is a good website to trigger ideas to research. &lt;br /&gt;
--[[User:Z3463667|Z3463667]] ([[User talk:Z3463667|talk]]) 17:12, 23 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
==Peer Review===&lt;br /&gt;
&lt;br /&gt;
===1===&lt;br /&gt;
&lt;br /&gt;
Let me start off by commending this group on a fantastic page! It is incredibly thorough, detailed and long. You can immediately see that a lot of work and research has gone into it. You have a great list of references and they appear to be cited correctly throughout the page. However, some sections which appear to be incomplete and lack some citations e.g. “fertility preservation”. &lt;br /&gt;
&lt;br /&gt;
One suggestion I will make, is it would be good to see the addition of some hand-drawn images, perhaps one under either of the first 3 headings. Some more images could be used under the heading “surgery”. The videos used on this page are great. Really informative, relevant and easy to watch. I also think the “what are cancer cells” section should be higher up on the page as it is part of the basis of what the whole page is about. It also cuts between the two sections “chemotherapy” and “how does chemotherapy work?” which should be one after another. On the topic of formatting, you have a heading in there called “oncofertility timeline”, I think it would be better placed at the beginning of the page where it is more relevant. &lt;br /&gt;
&lt;br /&gt;
I also think there is just too much text in some areas e.g.  “Fertility preservation in women” and “surgery”. It makes that part of the page look clustered and difficult to read. Perhaps simplifying it more into bullet points, as you have done in other areas of the page, would be good. Conversely though, I think areas such as “targeted drugs” and “bone marrow or stem cells transplant” could use more work, however, it is possible you still intend to work on those areas anyway. &lt;br /&gt;
&lt;br /&gt;
I would suggest adding a glossary to the bottom of your page to assist in those who view your page with a lower level of scientific knowledge. You have covered an expansive range of topics pertaining to your topic, all of which are relevant and link well with each other. The page has a great focus on the learning aims of embryology. I think with some formatting corrections and some simplification of the text, this will be a really wonderful page.&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
Awesome page so far guys! I commend you on your use of various videos to assist in conveying your ideas. Furthermore, the images you have chosen are highly relevant to the topic of discussion and assist the reader in gaining a greater understanding of oncofertility. All copyright information is present for the images you have used which is excellent to see.&lt;br /&gt;
It may be worth including a hand drawn image under the 'radiation' subheading, as we are required to include at least one such image. The current image under the radiation subheading could easily be replicated by hand and could fulfill this portion of the criteria.&lt;br /&gt;
&lt;br /&gt;
I am nitpicking here, but I would also recommend including some kind of media, most likely a picture, underneath the surgery subheading. It might even be worth doing the hand drawn image here if possible. A picture may also be good underneath the 'types of chemotherapy drugs' subheading, just to break up the wall of text and improve the reading experience for the reader.&lt;br /&gt;
It might also be worth restructuring the 'oncofertility limitations' subheading into the form of a table (if possible), as the bullet point format feels quite awkward and out of place compared to the rest of the page.&lt;br /&gt;
The inclusion of a glossary is also recommended, as this page will be accessible by the general public and a glossary will assist those without a background in embryology to understand and appreciate your content.&lt;br /&gt;
&lt;br /&gt;
Keep up the great work guys! Your page is absolutely amazing so far and the effort you have put in is definitely reflected in the high quality of your page.&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_4&amp;diff=205209</id>
		<title>Talk:2015 Group Project 4</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_4&amp;diff=205209"/>
		<updated>2015-10-13T06:53:40Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015discussionheader}}&lt;br /&gt;
&lt;br /&gt;
==Discussion==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:20, 25 September 2015 (AEST) OK I discussed this with your group in last week's lab. you have not shown animal models, graphics, histology, media etc to really build your project page. The introduction does not give me a clear idea of the scope of the project. Not ready for peer review.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hey guys, I have just had a really quick look on PubMed and I found a good starting article. Its a review article (I'm pretty sure) so I'm not sure if we can use it, but it discusses some interesting genetic causes of male infertility and also references a lot of primary articles. &lt;br /&gt;
&lt;br /&gt;
PMID 26178295 &lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:38, 25 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
I can't seem to view anything but the first page of the article but the introduction gives a good idea on what male infertility is and how it arises. At the moment I have found 2 research articles that address factors that can increase male fertility. Although they do not address male infertility conditions specifically, in the discussion they imply that these methods can be applied to men who have them such as oligospermia and azoospermia. I feel as though we can use these articles when discussing alternative therapies for successful conception. Please have a read and share your opinions! &lt;br /&gt;
&lt;br /&gt;
PMID 22958644 - note that you can only view the condensed version of this article&lt;br /&gt;
&lt;br /&gt;
PMID 26097523 - you can view the whole article on biomed (subheadings in the discussion particularly addresses male infertility)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462297|Z3462297]] ([[User talk:Z3462297|talk]]) 14:17, 25 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hey guys, it was pretty hard finding research articles from Pubmed regarding the epidemiology of male infertility.  For now, I have found an article about sperm extraction which I thought could be an alternative for treatments.  However I can't view the full article without paying, but the abstract from Pubmed seems to sum it up.&lt;br /&gt;
So, I came across a research article addressing the epidemiology and aetiology of male infertility, through Pubmed it doesn't have a direct link to the full PDF article however I linked it you guys on Facebook so have a read!&lt;br /&gt;
&lt;br /&gt;
PMID 22128297&lt;br /&gt;
&lt;br /&gt;
PMID 9663768&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3463514|Z3463514]] ([[User talk:Z3463514|talk]]) 11:59, 26 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hello everyone! To get started, I just added a few headings on the page where you can add your research/review articles. Feel free to add more subheadings or change the wording of the titles - I'm sure we will need to as we research more. From looking at other groups' pages, I think it is also important we add a bit of 'Background Information&amp;quot; regarding the process of spermatogenesis and how any abnormalities can cause infertility so we can all look for articles as we go. Remember we are targeting this towards students like us, so a bit of key background info is essential. &lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462297|Z3462297]] ([[User talk:Z3462297|talk]]) 00:06, 27 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
I just posted the articles that I found on male infertility. It was kind of hard to find ones because I stuck to studies in humans- but i found some good ones that were studies on rats (not sure if we can use them) and also some good secondary or review articles that we could use as background information maybe? So I'll just post the PMID's here..&lt;br /&gt;
* PMID 26303086&lt;br /&gt;
* PMID 23725463 &lt;br /&gt;
* PMID 25160621&lt;br /&gt;
* PMID 25142466&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 09:59, 27 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Not sure if we are review articles are any good, but I thought that it's also important to talk about &amp;quot;detecting abnormalities&amp;quot;.  I came across this review article which talks about the &amp;quot;male genital tract - colour dopple ultrasound&amp;quot; is a useful tool to detect impaired reproductive health.&lt;br /&gt;
&lt;br /&gt;
PMID 25038770 &lt;br /&gt;
&lt;br /&gt;
--[[User:Z3463514|Z3463514]] ([[User talk:Z3463514|talk]]) 19:59, 27 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Good thinking! If anyone comes across more articles regarding this, please post them up! I'll add a 'diagnosis' sub-heading to the page &lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462297|Z3462297]] ([[User talk:Z3462297|talk]]) 22:23, 27 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hey guys, found a couple of articles describing different methods of ARTs for male infertility:&lt;br /&gt;
&lt;br /&gt;
These 2 talk about Intrauterine Insemination (IUI)&lt;br /&gt;
PMID 26294874&lt;br /&gt;
PMID 26288981&lt;br /&gt;
&lt;br /&gt;
Also, another potential sub-heading to research might be the risks involved different ARTs&lt;br /&gt;
E.g. the following article about the prevalence of birth defects after a number of different male-related ARTs&lt;br /&gt;
PMID 26265143&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462833|Z3462833]] ([[User talk:Z3462833|talk]]) 23:38, 27 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
That sounds good. I think mentioning risks are important to show what is successful and what isnt. Feel free to add it under the &amp;quot;ART&amp;quot; heading (as a sub-heading)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462297|Z3462297]] ([[User talk:Z3462297|talk]]) 23:06, 31 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hey I found this article that discusses some ARTs for infertile men. Its not a bad read and has info on two different methods, Intracytoplasmic morphologically selected sperm injection (IMSI) and conventional intracytoplasmic sperm injection (cICSI). You can read the full text on biomod &lt;br /&gt;
&lt;br /&gt;
PMID 26307050&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462297|Z3462297]] ([[User talk:Z3462297|talk]]) 17:27, 1 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
LOOK! &lt;br /&gt;
This is a really good review article that talks about causes, diagnosis AND treatments. I recommend everyone to read it!  &lt;br /&gt;
&lt;br /&gt;
PMID 21243017 &lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462297|Z3462297]] ([[User talk:Z3462297|talk]]) 11:09, 2 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
==Peer Assessment==&lt;br /&gt;
&lt;br /&gt;
===1===&lt;br /&gt;
&lt;br /&gt;
To start, I think some of your subheadings are a bit unnecessary, for example, you could get away without having the subheading “background information” and just having the sub-subheadings as subheadings below your intro. Whilst some subheadings are good as it helps break down the info in the table of contents, it makes the actual page difficult to read and follow. &lt;br /&gt;
&lt;br /&gt;
Great use of images on the page. There are many, without it cluttering the page and they are simple and relevant. However, the pictures you have used under “background information” appear to be a bit lifeless and complex. Perhaps using more simplified images with some colours would help liven up the section as well as allow people who use this page, with less scientific knowledge than you, to understand what they are seeing. They are important images as they set the basis for the rest of the page. It would also be good to see a hand-drawn image on the page. &lt;br /&gt;
&lt;br /&gt;
Your use of tables is also great, it really helps to break down the information. I would suggest however, you include a little more information and references under the section “male infertility disorders”. It is a big vague and there are no citations.  Your list of references is incredible and you should be commended on that. It shows a great deal of research has gone into this page. Your citations appear to be correctly done throughout the page. Your “Causes of fertility” section is done really well and is very thorough. The video accompanying it is good to as it is easy to understand and explanatory. Your “risk factors and prevention” heading could use more work. I would suggest actually splitting them up into two separate headings and really delving more into prevention and how to handle infertility. &lt;br /&gt;
&lt;br /&gt;
Your “treatment” section is really well done and thorough. I would suggest however, to make it easier to read, that you simplify some of your paragraphs into bullet points. A glossary section may also be useful for people reading this page with a lesser degree of embryology knowledge than you or I. I will say, this page has covered its chosen topic well and has attacked it from an embryologically focused angle. Lastly I would suggest including a section on animal models and the literature for the more advanced student.&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
Very impressive work so far guys! Your page covers a comprehensive topic very well, without focussing too much on certain subheadings at the expense of others. Your use of both tables and images is excellent so far. All necessary copyright information seems to be present for the images that you have uploaded. It's good to see that you have also included a video to give some variety to the media on your page. The 'background information' gives context to the issues which you discuss and though it might not be of great use for someone familiar with embryology, it would be a great help to those with no experience in this field and is therefore useful in establishing the topic of male infertility.&lt;br /&gt;
&lt;br /&gt;
The only things that could be changed to improve your wiki page is perhaps altering the location of tables and pictures on your page. For example all pictures are located on the right side of the page, although not a significant issue, becomes slightly monotonous as one progresses through the page. It may be worth alternating pictures between left and right to mix things up a little bit and improve the overall flow of the page. &lt;br /&gt;
It might also be worth including a short video underneath the 'surgical treatments' subheading to give a visual example of some of the techniques discussed.&lt;br /&gt;
&lt;br /&gt;
Furthermore a subheading on future research could possibly be included under the 'treatments' subheading to give the reader information on techniques and therapies which may come to prominence in the near future.&lt;br /&gt;
&lt;br /&gt;
Your wiki page thus far is very impressive! Excellent work so far. --[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 17:18, 13 October 2015 (AEDT)&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=205207</id>
		<title>User:Z3416054</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=205207"/>
		<updated>2015-10-13T06:19:17Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Hi there&lt;br /&gt;
Just giving the editor a good old test run.&lt;br /&gt;
[[Test student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:45, 7 August 2015 (AEST)&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:47, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 14:06, 14 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:57, 21 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 12:22, 28 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:20, 4 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:18, 11 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:10, 25 September 2015 (AEST)&lt;br /&gt;
==Picture Tutorial==&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
===Article 1===&lt;br /&gt;
This research article aimed to determine the clinical outcomes following IVF (in vitro fertilisation) and embryo transfer treatments in subjects suffering from the sexually transmitted disease syphilis. The clinical outcomes mentioned are the rates of pregnancy and health of newborns following treatment via IVF. Couples engaged in sexual intercourse over 12 months without the use of contraception and who failed to conceive were deemed as being infertile.&lt;br /&gt;
&lt;br /&gt;
The subjects were divided into two groups based on serology results, a syphilis infected group and a control group, each with 160 individuals, giving a total of 320 subjects. The Syphilis infected group was further divided into three subcategories, a male infected group, a female infected group and a couple (male and female) infected group. Penicillin G20 (an anti-syphilis treatment) was given to the individuals in the syphilis group. IVF treatment commenced one month proceeding the disappearance of clinical syphilis symptoms or if test results gave a negative result for syphilis infection.&lt;br /&gt;
&lt;br /&gt;
The results of this experiment revealed no significant differences in regards to the basal FSH and LH of both the control and syphilis groups. However, the thickness of the endometrium differed greatly, with the syphilis group demonstrating a thicker endometrial wall (16.9±5.4mm) compared to the control group (13.0±4.7mm). Further differences were noted in blastocyst implantation rates, with the syphilis group having less successful implantations compared to the control (24.2% vs. 34.4% respectively).Normal oocyte cleavage differed between the two groups with the syphilis group demonstrating less normal oocyte cleavage compared to the control group  (6.3±4.7 vs. 8.1±4.6). Furthermore, the clinical pregnancy rates of the syphilis group stood at 43.8% compared to 55.6% of the control group.&lt;br /&gt;
&lt;br /&gt;
Syphilis infection appeared to have a significant impact on the success and clinical outcomes of IVF. Syphilis associated pelvic inflammatory disease can lead to an increase in the thickness of the endometrium, which can adversely affect blastocyte implantation and endometrial receptivity. Successful pregnancy rates typically correlate with an endometrial thickness of 7-14mm, with any thickness beyond 14mm often corresponding with decreased clinical pregnancies. Rates of clinical pregnancy and miscarriage rates did not differ between the three syphilis subgroups. Conception involving a male infected partner was associated with a shorter gestational period and decreased offspring birth weight, when compared to the female infected and couple infected subgroups. No explanation for this phenomenon was provided.&lt;br /&gt;
&lt;br /&gt;
PMID 26208116&lt;br /&gt;
&lt;br /&gt;
''Article 1 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4514756&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
===Article 2===&lt;br /&gt;
The effects of oxygen levels on factors such as cleavage, implantation and pregnancy rates in IVF cultured embryos was the primary focus of this article.  Women between the ages of 20-48 who were seeking treatment for infertility were utilised in this experiment.&lt;br /&gt;
Gametes were allocated to be incubated in one of three environments, each with a different oxygen concentration. The first group was placed in an atmosphere with an oxygen concentration of 20%. The second group rested in a 20% oxygen environment for a day before being moved to a 5% oxygen, 5% carbon dioxide and 90% nitrogen atmosphere. The third group consisted of a 5% carbon dioxide, 5% oxygen and 90% nitrogen atmosphere. The gametes (spermatozoa and oocytes) were incubated together in their respective environmental conditions for 4-6 hours after which fertilisation is presumed to have occurred.&lt;br /&gt;
&lt;br /&gt;
Successful embryos were transferred at Day 3 cleavage. A biochemical analysis of HCG validated pregnancy, whilst ultrasound was used to confirm the presence of a heartbeat 28 days following the transfer.&lt;br /&gt;
IVF fertilisation rates were calculated as being the number of fertilised oocytes over the number of oocytes inseminated. Cleavage rates were characterised by the number of blastomeres over the number of fertilised and abortion rate by the amount of miscarriages divided by the number of transfers.&lt;br /&gt;
&lt;br /&gt;
The research article concluded that the embryos from the 5% oxygen group had the highest rates of fertilisation and implantation. The 20% oxygen group had the second highest rates of fertilisation and maintained excellent embryo quality, whilst the 20% to 5% group had the lowest rates overall. Abortion and miscarriage rates did not differ at all between the three groups. The group incubated at 5% oxygen demonstrated higher quality embryos and increased rates of pregnancy when compared to the 20% oxygen group. The article concludes that implantation, pregnancy and embryo quality can be somewhat affected by a set oxygen concentration, but are affected adversely by a shift from one concentration to another. &lt;br /&gt;
Shifting from one oxygen concentration to another appeared to have an adverse effect on the cleavage of the embryo and would likely impact future development and the overall success of the IVF treatment.&lt;br /&gt;
&lt;br /&gt;
PMID 26131222 &lt;br /&gt;
&lt;br /&gt;
''Article 2 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4483955&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These are quite good descriptions of these 2 articles. (5/5)&lt;br /&gt;
==Lab 2 Assessment==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Notch Signalling - Ovulation in Drosphila.jpg|Caption]]&lt;br /&gt;
&lt;br /&gt;
===Image Reference===&lt;br /&gt;
Jianjun Sun, Allan C Spradling Ovulation in Drosophila is controlled by secretory cells of the female reproductive tract. Elife: 2013, 2;e00415 PubMed 23599892&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 23599892&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) Image uploaded and named correctly. All reference, copyright and student image template included. You might have included in the summary box an explanation to the terms that appear in the image as there is no way for the reader to interpret what is shown in each panel. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 3 Assessment==&lt;br /&gt;
===Causes===&lt;br /&gt;
====The Genetics of Infertility: Current Status of the Field====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3885174&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This article attempted to determine the role that genetics plays in female infertility. It was noted that several prominent causes of female infertility such as Galactosemia and Primary Ovarian Failure (POF) were associated with specific genes, with the GALT gene contributing to the former condition and the FMR1 gene contributing to the latter.&lt;br /&gt;
&lt;br /&gt;
====Causes of Sterility in Bosnia-Herzegovina Population====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4499307&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
The study conducted as laid out in this article examined the causes of female sterility in the Bosnia-Herzegovina population. Married participants were arranged into various groups based upon their age. The experiment came to the conclusion that in approximately 42% of infertile married couples, female sterility was the primary cause. The two primary causes of female infertility were tubal deficiencies (31% of cases) and Diminished Ovarian Reserves (38% of cases)&lt;br /&gt;
&lt;br /&gt;
====Epidemiology, diagnosis, and management of polycystic ovary syndrome====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3872139&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This research article examines the causes of polycystic ovary syndrome (POS), a common cause of infertility in women. The article concluded that 50-70% of women suffer from insulin resistance secondary to Type 2 Diabetes and in many cases obseity, which may contribute partially to POS. Furthermore, 85-90% of women with oligomenorrhea also had POS, suggesting that it is an underlying cause. However, the exact pathophysiology of POS was not determined.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These papers relate to your group project, I hope they are useful for the final submission. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 4 Assessment==&lt;br /&gt;
===Quiz===&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
{Primary villi are produced during which stage of development?:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ Week 2&lt;br /&gt;
- Week 1&lt;br /&gt;
- Week 3&lt;br /&gt;
- None of the above&lt;br /&gt;
|| Primary Villi appear during Week 2 of development, whilst secondary villi appear during Week 3 of development.&lt;br /&gt;
&lt;br /&gt;
{Mesoderm is a precursor for all of the following EXCEPT:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Skeletal Muscle Cells&lt;br /&gt;
- Cardiac Muscle Cells&lt;br /&gt;
- Erythrocytes&lt;br /&gt;
+ Epidermal Skin Cells&lt;br /&gt;
- Smooth Muscle&lt;br /&gt;
|| Epidermal skin cells originate from ectoderm. Skeletal, cardiac and smooth muscle along with erythrocytes originate from the mesoderm.&lt;br /&gt;
&lt;br /&gt;
{Which of the following shows the correct developmental pathway of the male gamete:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatogonia &amp;gt; Spermatozoa&lt;br /&gt;
- Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell &amp;gt; Spermatozoa &amp;gt; Spermatid&lt;br /&gt;
- Sertoli Cell &amp;gt; Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatozoa&lt;br /&gt;
- Spermatid &amp;gt; Spermatozoa &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell&lt;br /&gt;
+ Spermatogonia &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatid &amp;gt; Spermatozoa&lt;br /&gt;
|| Spermatogonia represent the beginning of male sex cell development, with spermatozoa being the mature gamete.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) No descriptive title to your questions. Q1 relates to the timing of villi development. These types of questions encourage &amp;quot;student guessing&amp;quot; and you could have given a more detailed explanation and links to resources in your revealed answer e.g. [[Placenta - Villi Development]]. Q2 is a reasonable question, but only requiring the student only to know that Epidermal Skin Cells are from ectoderm. Once again it is your revealed answer that needs more work. Q3 is a little easy, as long as you know Spermatogonia are the diploid start cell you can quickly exclude most options, need more work. (8/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5 Assessment==&lt;br /&gt;
===Gastroschisis and Omphalocele===&lt;br /&gt;
&lt;br /&gt;
Gastroschisis is classified as a full thickness cleft found in the abdominal wall, adjacent to the site of insertion of the umbilical cord. The defining features of this abnormality is the absence of a membranous sac shrouding the intestines. As a result of this the intestines will become eviscerated, thereby protruding out of the abdominal wall and will be on the exterior, rather than the interior of the body. It is believed that disruption to the vascular supply of the right abdominal wall is the primary gass of gastroschisis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2166158&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Omphalocele is an abnormality characterised by the herniation of visceral organs such as the intestines, liver and spleen outside of the abdominal cavity. The visceral organs are enclosed in a membranous sac, into which the umbilical cord is inserted.  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC1355659&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The primary difference between gastroschisis and omphalocele lies in the presence of a membraneous sac and the exact organs herniating from the abdominal wall. Gastroschisis involves the intestines protruding to the outside of the body but are not covered by a membranous sac. Omphalocele however is characterised by the protrusion of multiple visceral organs (liver, spleen etc.) which are enclosed within a membranous. Furthermore, the size of both abnormalities differs greatly, with gastroschisis typically being 2-5 cm in size whilst omphalocele can vary between 2-15cm. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2552910&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) This is an adequate description of the differences between these conditions. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 7 Assessment==&lt;br /&gt;
&lt;br /&gt;
1: This research paper aimed to examine the relationship between fetal adrenal cells and the differentiated adrenal cortex. In particular, research was focussed upon possible pregenitor cells involved in maintenance of the adrenal cortex. It was hypothesised that the the most likely precursor cells of the adult cortex were the 'Glil' expressing cells found in the adrenal capsule. A number of mice adrenal glands were taken, treated with antigen retrieval solution, after which fluorescence microscopy was conducted.&lt;br /&gt;
&lt;br /&gt;
The results of the paper concluded that 'Glil' expressing descendants of fetal adrenal cells are the pregenitors of the differentiated adrenal cortex. Furthermore, it was found that the 'Glil' expressing cells oringinated from 'FAdE-Cre' expressing fetal adrenal cells. Thus the authors of this research article came to the conclusion that 'Glil' expressing cells found in the adrenal cortex play an important role in the development, differentiation and maintenance of the adrenal cortex. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3817941&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
2: A number of embryonic layers and tissues contribute to the development of teeth. The primary contributing layers are mesoderm, ectoderm and neural crest ectomesenchyme. Furthermore, neural crest may contribute through interactions with the ectoderm. Odontoblasts originate from neural crest derived mesenchymal cells and are responsible for forming predentin which calificies to create dentin (which forms the bulk of the tooth). Ameloblasts are responsible for the production of enamel, which provides teeth with the hardness required to engage in mastication. &lt;br /&gt;
&lt;br /&gt;
==Peer Assessment==&lt;br /&gt;
&lt;br /&gt;
===Group 1 Peer Assessment===&lt;br /&gt;
Hi guys! I'll start of by saying that the images and video you have included are excellent and are relevant to your topic of discussion. Also, you have a large number of reliable references which is good to see. However you have yet to include a hand drawn image, which is required for the wiki page. I feel like  you could probably eliminate the typed out 'timeline of mitochondrial donation' and instead use this as an opportunity to use a hand drawn image of the timeline. Furthermore, the timeline under 'cystoplasmic transfer' feels a bit awkward and unnecessary. You could probably include this timeline alongside the 'timeline of mitochondrial donation'. &lt;br /&gt;
&lt;br /&gt;
Under the 'Technical Progression' section it would be best to incorporate human embryo, mouse and human models under a sub-sub heading, as at the moment it feels a bit jumbled.&lt;br /&gt;
&lt;br /&gt;
I would also recommend moving the 'Benefits' heading towards the end of the page. It feels odd reading about the benefits of three person embryos before I gain a proper understanding of how they work. Also it might be worth talking about the disadvantages (if there are any) to three person embryos to balance out the 'benefits' section. As has been previously stated, make sure you sort out the copyright information for your video as it would be a shame to lose marks if it was missing. Also, don't forget to add the 'student template' to the 'Swapping mitochondrial DNA mammalian oocytes' image as it is currently absent.&lt;br /&gt;
&lt;br /&gt;
===Group 2 Peer Assessment===&lt;br /&gt;
So far your wiki page gives a very good coverage of Ovarian Hyper-Stimulation Syndrome. The progression of your subheadings progresses logically from one topic to another. It's good to see that you've included an excellent hand-drawn image which is well suited to the 'pathophysiology' subheading. The amount of textual information you have under each heading is vast and gives a comprehensive description of OHSS. Furthermore, you have an excellent range of sources to support your discussion.&lt;br /&gt;
&lt;br /&gt;
I feel however that asides from your hand-drawn image, your use of images and other source of media is definitely lacking. As is, your page is largely text with little to no breaks, making it quite difficult to read. The use of images would not only help break up the monotony of the text, but also help reinforce some of your ideas. I feel that the inclusion of images in the 'symptoms' and 'complications' subheadings would be suitable. &lt;br /&gt;
&lt;br /&gt;
It may also be worthwhile to include subheadings concerning current research, to inform readers about contemporary developments regarding OHSS. Furthermore,  'future research' could also be another potential subheading and could illuminate potential areas that are beginning to be or could be investigated in coming years.&lt;br /&gt;
&lt;br /&gt;
Overall, a very impressive page so far, that could be enhanced with the addition of relevant images and other media.&lt;br /&gt;
&lt;br /&gt;
===Group 4 Peer Assessment===&lt;br /&gt;
Very impressive work so far guys! Your page covers a comprehensive topic very well, without focussing too much on certain subheadings at the expense of others. Your use of both tables and images is excellent so far. It's good to see that you have also included a video to give some variety to the media on your page. The 'background information' gives context to the issues which you discuss and though it might not be of great use for someone familiar with embryology, it would be a great help to those with no experience in this field and is therefore useful in establishing the topic of male infertility.&lt;br /&gt;
&lt;br /&gt;
The only things that could be changed to improve your wiki page is perhaps altering the location of tables and pictures on your page. For example all pictures are located on the right side of the page, although not a significant issue, becomes slightly monotonous as one progresses through the page. It may be worth alternating pictures between left and right to mix things up a little bit and improve the overall flow of the page. &lt;br /&gt;
It might also be worth including a short video underneath the 'surgical treatments' subheading to give a visual example of some of the techniques discussed.&lt;br /&gt;
&lt;br /&gt;
Furthermore a subheading on future research could possibly be included under the 'treatments' subheading to give the reader information on techniques and therapies which may come to prominence in the near future.&lt;br /&gt;
&lt;br /&gt;
Your wiki page thus far is very impressive! Excellent work so far. &lt;br /&gt;
===Group 5 Peer Assessment===&lt;br /&gt;
&lt;br /&gt;
===Group 6 Peer Assessment===&lt;br /&gt;
&lt;br /&gt;
Look at this!&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_4&amp;diff=205205</id>
		<title>Talk:2015 Group Project 4</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_4&amp;diff=205205"/>
		<updated>2015-10-13T06:18:58Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015discussionheader}}&lt;br /&gt;
&lt;br /&gt;
==Discussion==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:20, 25 September 2015 (AEST) OK I discussed this with your group in last week's lab. you have not shown animal models, graphics, histology, media etc to really build your project page. The introduction does not give me a clear idea of the scope of the project. Not ready for peer review.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hey guys, I have just had a really quick look on PubMed and I found a good starting article. Its a review article (I'm pretty sure) so I'm not sure if we can use it, but it discusses some interesting genetic causes of male infertility and also references a lot of primary articles. &lt;br /&gt;
&lt;br /&gt;
PMID 26178295 &lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:38, 25 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
I can't seem to view anything but the first page of the article but the introduction gives a good idea on what male infertility is and how it arises. At the moment I have found 2 research articles that address factors that can increase male fertility. Although they do not address male infertility conditions specifically, in the discussion they imply that these methods can be applied to men who have them such as oligospermia and azoospermia. I feel as though we can use these articles when discussing alternative therapies for successful conception. Please have a read and share your opinions! &lt;br /&gt;
&lt;br /&gt;
PMID 22958644 - note that you can only view the condensed version of this article&lt;br /&gt;
&lt;br /&gt;
PMID 26097523 - you can view the whole article on biomed (subheadings in the discussion particularly addresses male infertility)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462297|Z3462297]] ([[User talk:Z3462297|talk]]) 14:17, 25 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hey guys, it was pretty hard finding research articles from Pubmed regarding the epidemiology of male infertility.  For now, I have found an article about sperm extraction which I thought could be an alternative for treatments.  However I can't view the full article without paying, but the abstract from Pubmed seems to sum it up.&lt;br /&gt;
So, I came across a research article addressing the epidemiology and aetiology of male infertility, through Pubmed it doesn't have a direct link to the full PDF article however I linked it you guys on Facebook so have a read!&lt;br /&gt;
&lt;br /&gt;
PMID 22128297&lt;br /&gt;
&lt;br /&gt;
PMID 9663768&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3463514|Z3463514]] ([[User talk:Z3463514|talk]]) 11:59, 26 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hello everyone! To get started, I just added a few headings on the page where you can add your research/review articles. Feel free to add more subheadings or change the wording of the titles - I'm sure we will need to as we research more. From looking at other groups' pages, I think it is also important we add a bit of 'Background Information&amp;quot; regarding the process of spermatogenesis and how any abnormalities can cause infertility so we can all look for articles as we go. Remember we are targeting this towards students like us, so a bit of key background info is essential. &lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462297|Z3462297]] ([[User talk:Z3462297|talk]]) 00:06, 27 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
I just posted the articles that I found on male infertility. It was kind of hard to find ones because I stuck to studies in humans- but i found some good ones that were studies on rats (not sure if we can use them) and also some good secondary or review articles that we could use as background information maybe? So I'll just post the PMID's here..&lt;br /&gt;
* PMID 26303086&lt;br /&gt;
* PMID 23725463 &lt;br /&gt;
* PMID 25160621&lt;br /&gt;
* PMID 25142466&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 09:59, 27 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Not sure if we are review articles are any good, but I thought that it's also important to talk about &amp;quot;detecting abnormalities&amp;quot;.  I came across this review article which talks about the &amp;quot;male genital tract - colour dopple ultrasound&amp;quot; is a useful tool to detect impaired reproductive health.&lt;br /&gt;
&lt;br /&gt;
PMID 25038770 &lt;br /&gt;
&lt;br /&gt;
--[[User:Z3463514|Z3463514]] ([[User talk:Z3463514|talk]]) 19:59, 27 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Good thinking! If anyone comes across more articles regarding this, please post them up! I'll add a 'diagnosis' sub-heading to the page &lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462297|Z3462297]] ([[User talk:Z3462297|talk]]) 22:23, 27 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hey guys, found a couple of articles describing different methods of ARTs for male infertility:&lt;br /&gt;
&lt;br /&gt;
These 2 talk about Intrauterine Insemination (IUI)&lt;br /&gt;
PMID 26294874&lt;br /&gt;
PMID 26288981&lt;br /&gt;
&lt;br /&gt;
Also, another potential sub-heading to research might be the risks involved different ARTs&lt;br /&gt;
E.g. the following article about the prevalence of birth defects after a number of different male-related ARTs&lt;br /&gt;
PMID 26265143&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462833|Z3462833]] ([[User talk:Z3462833|talk]]) 23:38, 27 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
That sounds good. I think mentioning risks are important to show what is successful and what isnt. Feel free to add it under the &amp;quot;ART&amp;quot; heading (as a sub-heading)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462297|Z3462297]] ([[User talk:Z3462297|talk]]) 23:06, 31 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hey I found this article that discusses some ARTs for infertile men. Its not a bad read and has info on two different methods, Intracytoplasmic morphologically selected sperm injection (IMSI) and conventional intracytoplasmic sperm injection (cICSI). You can read the full text on biomod &lt;br /&gt;
&lt;br /&gt;
PMID 26307050&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462297|Z3462297]] ([[User talk:Z3462297|talk]]) 17:27, 1 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
LOOK! &lt;br /&gt;
This is a really good review article that talks about causes, diagnosis AND treatments. I recommend everyone to read it!  &lt;br /&gt;
&lt;br /&gt;
PMID 21243017 &lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462297|Z3462297]] ([[User talk:Z3462297|talk]]) 11:09, 2 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
==Peer Assessment==&lt;br /&gt;
&lt;br /&gt;
===1===&lt;br /&gt;
&lt;br /&gt;
To start, I think some of your subheadings are a bit unnecessary, for example, you could get away without having the subheading “background information” and just having the sub-subheadings as subheadings below your intro. Whilst some subheadings are good as it helps break down the info in the table of contents, it makes the actual page difficult to read and follow. &lt;br /&gt;
&lt;br /&gt;
Great use of images on the page. There are many, without it cluttering the page and they are simple and relevant. However, the pictures you have used under “background information” appear to be a bit lifeless and complex. Perhaps using more simplified images with some colours would help liven up the section as well as allow people who use this page, with less scientific knowledge than you, to understand what they are seeing. They are important images as they set the basis for the rest of the page. It would also be good to see a hand-drawn image on the page. &lt;br /&gt;
&lt;br /&gt;
Your use of tables is also great, it really helps to break down the information. I would suggest however, you include a little more information and references under the section “male infertility disorders”. It is a big vague and there are no citations.  Your list of references is incredible and you should be commended on that. It shows a great deal of research has gone into this page. Your citations appear to be correctly done throughout the page. Your “Causes of fertility” section is done really well and is very thorough. The video accompanying it is good to as it is easy to understand and explanatory. Your “risk factors and prevention” heading could use more work. I would suggest actually splitting them up into two separate headings and really delving more into prevention and how to handle infertility. &lt;br /&gt;
&lt;br /&gt;
Your “treatment” section is really well done and thorough. I would suggest however, to make it easier to read, that you simplify some of your paragraphs into bullet points. A glossary section may also be useful for people reading this page with a lesser degree of embryology knowledge than you or I. I will say, this page has covered its chosen topic well and has attacked it from an embryologically focused angle. Lastly I would suggest including a section on animal models and the literature for the more advanced student.&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
Very impressive work so far guys! Your page covers a comprehensive topic very well, without focussing too much on certain subheadings at the expense of others. Your use of both tables and images is excellent so far. It's good to see that you have also included a video to give some variety to the media on your page. The 'background information' gives context to the issues which you discuss and though it might not be of great use for someone familiar with embryology, it would be a great help to those with no experience in this field and is therefore useful in establishing the topic of male infertility.&lt;br /&gt;
&lt;br /&gt;
The only things that could be changed to improve your wiki page is perhaps altering the location of tables and pictures on your page. For example all pictures are located on the right side of the page, although not a significant issue, becomes slightly monotonous as one progresses through the page. It may be worth alternating pictures between left and right to mix things up a little bit and improve the overall flow of the page. &lt;br /&gt;
It might also be worth including a short video underneath the 'surgical treatments' subheading to give a visual example of some of the techniques discussed.&lt;br /&gt;
&lt;br /&gt;
Furthermore a subheading on future research could possibly be included under the 'treatments' subheading to give the reader information on techniques and therapies which may come to prominence in the near future.&lt;br /&gt;
&lt;br /&gt;
Your wiki page thus far is very impressive! Excellent work so far. --[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 17:18, 13 October 2015 (AEDT)&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=205191</id>
		<title>User:Z3416054</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=205191"/>
		<updated>2015-10-13T05:19:05Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Hi there&lt;br /&gt;
Just giving the editor a good old test run.&lt;br /&gt;
[[Test student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:45, 7 August 2015 (AEST)&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:47, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 14:06, 14 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:57, 21 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 12:22, 28 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:20, 4 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:18, 11 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:10, 25 September 2015 (AEST)&lt;br /&gt;
==Picture Tutorial==&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
===Article 1===&lt;br /&gt;
This research article aimed to determine the clinical outcomes following IVF (in vitro fertilisation) and embryo transfer treatments in subjects suffering from the sexually transmitted disease syphilis. The clinical outcomes mentioned are the rates of pregnancy and health of newborns following treatment via IVF. Couples engaged in sexual intercourse over 12 months without the use of contraception and who failed to conceive were deemed as being infertile.&lt;br /&gt;
&lt;br /&gt;
The subjects were divided into two groups based on serology results, a syphilis infected group and a control group, each with 160 individuals, giving a total of 320 subjects. The Syphilis infected group was further divided into three subcategories, a male infected group, a female infected group and a couple (male and female) infected group. Penicillin G20 (an anti-syphilis treatment) was given to the individuals in the syphilis group. IVF treatment commenced one month proceeding the disappearance of clinical syphilis symptoms or if test results gave a negative result for syphilis infection.&lt;br /&gt;
&lt;br /&gt;
The results of this experiment revealed no significant differences in regards to the basal FSH and LH of both the control and syphilis groups. However, the thickness of the endometrium differed greatly, with the syphilis group demonstrating a thicker endometrial wall (16.9±5.4mm) compared to the control group (13.0±4.7mm). Further differences were noted in blastocyst implantation rates, with the syphilis group having less successful implantations compared to the control (24.2% vs. 34.4% respectively).Normal oocyte cleavage differed between the two groups with the syphilis group demonstrating less normal oocyte cleavage compared to the control group  (6.3±4.7 vs. 8.1±4.6). Furthermore, the clinical pregnancy rates of the syphilis group stood at 43.8% compared to 55.6% of the control group.&lt;br /&gt;
&lt;br /&gt;
Syphilis infection appeared to have a significant impact on the success and clinical outcomes of IVF. Syphilis associated pelvic inflammatory disease can lead to an increase in the thickness of the endometrium, which can adversely affect blastocyte implantation and endometrial receptivity. Successful pregnancy rates typically correlate with an endometrial thickness of 7-14mm, with any thickness beyond 14mm often corresponding with decreased clinical pregnancies. Rates of clinical pregnancy and miscarriage rates did not differ between the three syphilis subgroups. Conception involving a male infected partner was associated with a shorter gestational period and decreased offspring birth weight, when compared to the female infected and couple infected subgroups. No explanation for this phenomenon was provided.&lt;br /&gt;
&lt;br /&gt;
PMID 26208116&lt;br /&gt;
&lt;br /&gt;
''Article 1 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4514756&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
===Article 2===&lt;br /&gt;
The effects of oxygen levels on factors such as cleavage, implantation and pregnancy rates in IVF cultured embryos was the primary focus of this article.  Women between the ages of 20-48 who were seeking treatment for infertility were utilised in this experiment.&lt;br /&gt;
Gametes were allocated to be incubated in one of three environments, each with a different oxygen concentration. The first group was placed in an atmosphere with an oxygen concentration of 20%. The second group rested in a 20% oxygen environment for a day before being moved to a 5% oxygen, 5% carbon dioxide and 90% nitrogen atmosphere. The third group consisted of a 5% carbon dioxide, 5% oxygen and 90% nitrogen atmosphere. The gametes (spermatozoa and oocytes) were incubated together in their respective environmental conditions for 4-6 hours after which fertilisation is presumed to have occurred.&lt;br /&gt;
&lt;br /&gt;
Successful embryos were transferred at Day 3 cleavage. A biochemical analysis of HCG validated pregnancy, whilst ultrasound was used to confirm the presence of a heartbeat 28 days following the transfer.&lt;br /&gt;
IVF fertilisation rates were calculated as being the number of fertilised oocytes over the number of oocytes inseminated. Cleavage rates were characterised by the number of blastomeres over the number of fertilised and abortion rate by the amount of miscarriages divided by the number of transfers.&lt;br /&gt;
&lt;br /&gt;
The research article concluded that the embryos from the 5% oxygen group had the highest rates of fertilisation and implantation. The 20% oxygen group had the second highest rates of fertilisation and maintained excellent embryo quality, whilst the 20% to 5% group had the lowest rates overall. Abortion and miscarriage rates did not differ at all between the three groups. The group incubated at 5% oxygen demonstrated higher quality embryos and increased rates of pregnancy when compared to the 20% oxygen group. The article concludes that implantation, pregnancy and embryo quality can be somewhat affected by a set oxygen concentration, but are affected adversely by a shift from one concentration to another. &lt;br /&gt;
Shifting from one oxygen concentration to another appeared to have an adverse effect on the cleavage of the embryo and would likely impact future development and the overall success of the IVF treatment.&lt;br /&gt;
&lt;br /&gt;
PMID 26131222 &lt;br /&gt;
&lt;br /&gt;
''Article 2 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4483955&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These are quite good descriptions of these 2 articles. (5/5)&lt;br /&gt;
==Lab 2 Assessment==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Notch Signalling - Ovulation in Drosphila.jpg|Caption]]&lt;br /&gt;
&lt;br /&gt;
===Image Reference===&lt;br /&gt;
Jianjun Sun, Allan C Spradling Ovulation in Drosophila is controlled by secretory cells of the female reproductive tract. Elife: 2013, 2;e00415 PubMed 23599892&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 23599892&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) Image uploaded and named correctly. All reference, copyright and student image template included. You might have included in the summary box an explanation to the terms that appear in the image as there is no way for the reader to interpret what is shown in each panel. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 3 Assessment==&lt;br /&gt;
===Causes===&lt;br /&gt;
====The Genetics of Infertility: Current Status of the Field====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3885174&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This article attempted to determine the role that genetics plays in female infertility. It was noted that several prominent causes of female infertility such as Galactosemia and Primary Ovarian Failure (POF) were associated with specific genes, with the GALT gene contributing to the former condition and the FMR1 gene contributing to the latter.&lt;br /&gt;
&lt;br /&gt;
====Causes of Sterility in Bosnia-Herzegovina Population====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4499307&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
The study conducted as laid out in this article examined the causes of female sterility in the Bosnia-Herzegovina population. Married participants were arranged into various groups based upon their age. The experiment came to the conclusion that in approximately 42% of infertile married couples, female sterility was the primary cause. The two primary causes of female infertility were tubal deficiencies (31% of cases) and Diminished Ovarian Reserves (38% of cases)&lt;br /&gt;
&lt;br /&gt;
====Epidemiology, diagnosis, and management of polycystic ovary syndrome====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3872139&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This research article examines the causes of polycystic ovary syndrome (POS), a common cause of infertility in women. The article concluded that 50-70% of women suffer from insulin resistance secondary to Type 2 Diabetes and in many cases obseity, which may contribute partially to POS. Furthermore, 85-90% of women with oligomenorrhea also had POS, suggesting that it is an underlying cause. However, the exact pathophysiology of POS was not determined.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These papers relate to your group project, I hope they are useful for the final submission. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 4 Assessment==&lt;br /&gt;
===Quiz===&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
{Primary villi are produced during which stage of development?:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ Week 2&lt;br /&gt;
- Week 1&lt;br /&gt;
- Week 3&lt;br /&gt;
- None of the above&lt;br /&gt;
|| Primary Villi appear during Week 2 of development, whilst secondary villi appear during Week 3 of development.&lt;br /&gt;
&lt;br /&gt;
{Mesoderm is a precursor for all of the following EXCEPT:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Skeletal Muscle Cells&lt;br /&gt;
- Cardiac Muscle Cells&lt;br /&gt;
- Erythrocytes&lt;br /&gt;
+ Epidermal Skin Cells&lt;br /&gt;
- Smooth Muscle&lt;br /&gt;
|| Epidermal skin cells originate from ectoderm. Skeletal, cardiac and smooth muscle along with erythrocytes originate from the mesoderm.&lt;br /&gt;
&lt;br /&gt;
{Which of the following shows the correct developmental pathway of the male gamete:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatogonia &amp;gt; Spermatozoa&lt;br /&gt;
- Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell &amp;gt; Spermatozoa &amp;gt; Spermatid&lt;br /&gt;
- Sertoli Cell &amp;gt; Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatozoa&lt;br /&gt;
- Spermatid &amp;gt; Spermatozoa &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell&lt;br /&gt;
+ Spermatogonia &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatid &amp;gt; Spermatozoa&lt;br /&gt;
|| Spermatogonia represent the beginning of male sex cell development, with spermatozoa being the mature gamete.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) No descriptive title to your questions. Q1 relates to the timing of villi development. These types of questions encourage &amp;quot;student guessing&amp;quot; and you could have given a more detailed explanation and links to resources in your revealed answer e.g. [[Placenta - Villi Development]]. Q2 is a reasonable question, but only requiring the student only to know that Epidermal Skin Cells are from ectoderm. Once again it is your revealed answer that needs more work. Q3 is a little easy, as long as you know Spermatogonia are the diploid start cell you can quickly exclude most options, need more work. (8/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5 Assessment==&lt;br /&gt;
===Gastroschisis and Omphalocele===&lt;br /&gt;
&lt;br /&gt;
Gastroschisis is classified as a full thickness cleft found in the abdominal wall, adjacent to the site of insertion of the umbilical cord. The defining features of this abnormality is the absence of a membranous sac shrouding the intestines. As a result of this the intestines will become eviscerated, thereby protruding out of the abdominal wall and will be on the exterior, rather than the interior of the body. It is believed that disruption to the vascular supply of the right abdominal wall is the primary gass of gastroschisis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2166158&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Omphalocele is an abnormality characterised by the herniation of visceral organs such as the intestines, liver and spleen outside of the abdominal cavity. The visceral organs are enclosed in a membranous sac, into which the umbilical cord is inserted.  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC1355659&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The primary difference between gastroschisis and omphalocele lies in the presence of a membraneous sac and the exact organs herniating from the abdominal wall. Gastroschisis involves the intestines protruding to the outside of the body but are not covered by a membranous sac. Omphalocele however is characterised by the protrusion of multiple visceral organs (liver, spleen etc.) which are enclosed within a membranous. Furthermore, the size of both abnormalities differs greatly, with gastroschisis typically being 2-5 cm in size whilst omphalocele can vary between 2-15cm. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2552910&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) This is an adequate description of the differences between these conditions. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 7 Assessment==&lt;br /&gt;
&lt;br /&gt;
1: This research paper aimed to examine the relationship between fetal adrenal cells and the differentiated adrenal cortex. In particular, research was focussed upon possible pregenitor cells involved in maintenance of the adrenal cortex. It was hypothesised that the the most likely precursor cells of the adult cortex were the 'Glil' expressing cells found in the adrenal capsule. A number of mice adrenal glands were taken, treated with antigen retrieval solution, after which fluorescence microscopy was conducted.&lt;br /&gt;
&lt;br /&gt;
The results of the paper concluded that 'Glil' expressing descendants of fetal adrenal cells are the pregenitors of the differentiated adrenal cortex. Furthermore, it was found that the 'Glil' expressing cells oringinated from 'FAdE-Cre' expressing fetal adrenal cells. Thus the authors of this research article came to the conclusion that 'Glil' expressing cells found in the adrenal cortex play an important role in the development, differentiation and maintenance of the adrenal cortex. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3817941&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
2: A number of embryonic layers and tissues contribute to the development of teeth. The primary contributing layers are mesoderm, ectoderm and neural crest ectomesenchyme. Furthermore, neural crest may contribute through interactions with the ectoderm. Odontoblasts originate from neural crest derived mesenchymal cells and are responsible for forming predentin which calificies to create dentin (which forms the bulk of the tooth). Ameloblasts are responsible for the production of enamel, which provides teeth with the hardness required to engage in mastication. &lt;br /&gt;
&lt;br /&gt;
==Peer Assessment==&lt;br /&gt;
&lt;br /&gt;
===Group 1 Peer Assessment===&lt;br /&gt;
Hi guys! I'll start of by saying that the images and video you have included are excellent and are relevant to your topic of discussion. Also, you have a large number of reliable references which is good to see. However you have yet to include a hand drawn image, which is required for the wiki page. I feel like  you could probably eliminate the typed out 'timeline of mitochondrial donation' and instead use this as an opportunity to use a hand drawn image of the timeline. Furthermore, the timeline under 'cystoplasmic transfer' feels a bit awkward and unnecessary. You could probably include this timeline alongside the 'timeline of mitochondrial donation'. &lt;br /&gt;
&lt;br /&gt;
Under the 'Technical Progression' section it would be best to incorporate human embryo, mouse and human models under a sub-sub heading, as at the moment it feels a bit jumbled.&lt;br /&gt;
&lt;br /&gt;
I would also recommend moving the 'Benefits' heading towards the end of the page. It feels odd reading about the benefits of three person embryos before I gain a proper understanding of how they work. Also it might be worth talking about the disadvantages (if there are any) to three person embryos to balance out the 'benefits' section. As has been previously stated, make sure you sort out the copyright information for your video as it would be a shame to lose marks if it was missing. Also, don't forget to add the 'student template' to the 'Swapping mitochondrial DNA mammalian oocytes' image as it is currently absent.&lt;br /&gt;
&lt;br /&gt;
===Group 2 Peer Assessment===&lt;br /&gt;
So far your wiki page gives a very good coverage of Ovarian Hyper-Stimulation Syndrome. The progression of your subheadings progresses logically from one topic to another. It's good to see that you've included an excellent hand-drawn image which is well suited to the 'pathophysiology' subheading. The amount of textual information you have under each heading is vast and gives a comprehensive description of OHSS. Furthermore, you have an excellent range of sources to support your discussion.&lt;br /&gt;
&lt;br /&gt;
I feel however that asides from your hand-drawn image, your use of images and other source of media is definitely lacking. As is, your page is largely text with little to no breaks, making it quite difficult to read. The use of images would not only help break up the monotony of the text, but also help reinforce some of your ideas. I feel that the inclusion of images in the 'symptoms' and 'complications' subheadings would be suitable. &lt;br /&gt;
&lt;br /&gt;
It may also be worthwhile to include subheadings concerning current research, to inform readers about contemporary developments regarding OHSS. Furthermore,  'future research' could also be another potential subheading and could illuminate potential areas that are beginning to be or could be investigated in coming years.&lt;br /&gt;
&lt;br /&gt;
Overall, a very impressive page so far, that could be enhanced with the addition of relevant images and other media.&lt;br /&gt;
&lt;br /&gt;
===Group 4 Peer Assessment===&lt;br /&gt;
&lt;br /&gt;
===Group 5 Peer Assessment===&lt;br /&gt;
&lt;br /&gt;
===Group 6 Peer Assessment===&lt;br /&gt;
&lt;br /&gt;
Look at this!&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_2&amp;diff=205189</id>
		<title>Talk:2015 Group Project 2</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_2&amp;diff=205189"/>
		<updated>2015-10-13T05:18:45Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015discussionheader}}&lt;br /&gt;
&lt;br /&gt;
--[[User:Z5016784|Z5016784]] ([[User talk:Z5016784|talk]]) 14:42, 13 October 2015 (AEDT) Just regarding the peer reviewing of other group projects, do we have to be assessing all 5 other projects?&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:16, 25 September 2015 (AEST) Hmm still a little thin. There should be some animal model info, histology images, physiological data, drug info, and genetic information.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3374116|Z3374116]] ([[User talk:Z3374116|talk]]) 17:15, 18 August 2015 (AEST) Hello there&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3415911|Z3415911]] ([[User talk:Z3415911|talk]]) 16:12, 24 August 2015 (AEST) Hey guys! So I've gone and added a few subheadings that may be useful to start researching. For this weeks assessment we need to choose one each and find 3 articles to go with it etc. So if we all choose one and start researching it, that would be good :)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3415911|Z3415911]] ([[User talk:Z3415911|talk]]) 11:02, 26 August 2015 (AEST) Good article for treatment http://humupd.oxfordjournals.org/content/16/5/459.abstract?etoc&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3374116|Z3374116]] ([[User talk:Z3374116|talk]]) 19:20, 26 August 2015 (AEST) Sweet, Thanks for putting up those headings to get things going. Lets all put up related documents by Thursday so we have can discuss things at the Lab this Friday!&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3374116|Z3374116]] ([[User talk:Z3374116|talk]]) 19:29, 26 August 2015 (AEST) I've put up some interesting pubmed documents on our main page, Have a read through them (I haven't read them all yet)&lt;br /&gt;
&lt;br /&gt;
=== &amp;lt;span style=&amp;quot;font-size:75%&amp;quot;&amp;gt;'''Classifications of Ovarian Hyper-stimulation Syndrome'''&amp;lt;/span&amp;gt; ===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Classification'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;650px&amp;quot;| '''Symptoms'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Mild''' &lt;br /&gt;
|style=&amp;quot;height: 75px; background: #CCEEEE;&amp;quot;| '''Grade 1''' - Abdominal distention and discomfort&lt;br /&gt;
'''Grade 2''' - Abdominal distention, discomfort with nausea, vomiting and/or diarrhea and ovarian enlargement from 5~12cm&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Moderate'''&lt;br /&gt;
|style=&amp;quot;height: 75px; background: #EEEEEE;&amp;quot;| '''Grade 3''' - All features of Mild OHSS with ultrasonographic evidence of ascites&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Severe''' &lt;br /&gt;
|style=&amp;quot;height: 75px; background: #CCEEEE;&amp;quot;| '''Grade 4''' - All features of Moderate OHSS with the addition of clinical evidence of ascites and breathing difficulties present&lt;br /&gt;
'''Grade 5''' - All of the above symptoms along with a change in the blood volume, increased blood viscosity due to coagulation and diminished renal function&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3374116|Z3374116]] ([[User talk:Z3374116|talk]]) 11:40, 28 August 2015 (AEST) I wont be able to make it to uni today for the lab and the meetup after it. Got to take my cousin to the ER&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3374116|Z3374116]] ([[User talk:Z3374116|talk]]) 12:07, 28 August 2015 (AEST) I was thinking to include the risk factors in the 'causative' subheading&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3374116|Z3374116]] ([[User talk:Z3374116|talk]]) 13:22, 28 August 2015 (AEST) So basically in the Causative subheading, I was planning&lt;br /&gt;
1) Identify the different causes (including primary and secondary risk factors)&lt;br /&gt;
2) What difference occurs from a normal cycle (e.g. level of hCG normally)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3415911|Z3415911]] ([[User talk:Z3415911|talk]]) 13:36, 28 August 2015 (AEST) No problem! I hope your cousin is okay. Whoever added a sub heading called: Tests and Diagnosis, there already is the same kind of subheading, Symptoms and Diagnosis so we need to merge the two. It also needs to be in chronological order&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3372824|Z3372824]] ([[User talk:Z3372824|talk]]) 13:46, 28 August 2015 (AEST)Hope he gets well! Talking about sections, I'll try and work on Prevention, and get the research summaries done for that section by next week.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3372824|Z3372824]] ([[User talk:Z3372824|talk]]) 14:00, 28 August 2015 (AEST) J and I had a little discussion about how we're going to go about completing this. We can all work on each others sections and collaborate that way. Let's focus on finding research articles, collating them, referencing them i.e. get to the meat of the matter. Once we've done that we can cut to the point and make it more easy-to-read/user-friendly. We also think that our 1 wiki page reference should be the OHSS Wiki page. Also, when writing about your section, always compare/refer to the Controlled Ovarian Stimulation case. Bring those picture/youtube suggestions in!&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3374116|Z3374116]] ([[User talk:Z3374116|talk]]) 00:12, 29 August 2015 (AEST) Sweet, thanks for the info. Will be on the lookout for youtube clips and pictures. Is the OHSS wikipage you are referring to https://en.wikipedia.org/wiki/Ovarian_hyperstimulation_syndrome&lt;br /&gt;
this one?? And I agree on helping each other with respective sections and then cutting it down to the fine details&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3415911|Z3415911]] ([[User talk:Z3415911|talk]]) 21:49, 1 September 2015 (AEST) Yes, that's the wiki page :) I have already started taking down information from it in each section so when you see '''[OHSS Wiki]''', that's where the information is from. I just don't know how to reference something that is not pubmed yet haha&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3415911|Z3415911]] ([[User talk:Z3415911|talk]]) 22:11, 1 September 2015 (AEST) Also guys please note, I have not used any info. from wiki in regards to TREATMENT and PREVENTION as it appears someone is already working on those subheadings and I don't want to interfere, so yea, that info. is still out there for you guys to use.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3415911|Z3415911]] ([[User talk:Z3415911|talk]]) 11:51, 13 September 2015 (AEST) Hey guys, can everyone please send me an email with your full names so I can add you on fb and make  group. I feel like we need a better way of communicating. Thanks, z3415911@student.unsw.edu.au.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Video that J found!&lt;br /&gt;
http://www.howcast.com/videos/511910-ovarian-hyperstimulation-syndrome-infertility/&lt;br /&gt;
&lt;br /&gt;
==Peer Review==&lt;br /&gt;
&lt;br /&gt;
This wikipage is very well put together. Your choice of headings, subheadings and tables and images is remarkable, it definitely makes the whole page flow very well. I particularly like the hand-drawn image which does a great job at simplifying the process of the pathogenesis of OHSS. &lt;br /&gt;
&lt;br /&gt;
The introduction very concisely explains the contents of the page and I liked how it was finished off with a statement about the aim of the page. I thought it really brought the introduction together nicely. I can’t say much about the content except that it is very engaging and very well written so well done guys! Keep up the good work!&lt;br /&gt;
&lt;br /&gt;
Some suggestions I have that could improve your page include adding more images. It would be nice to have some graphs to complement the statistical date from the epidemiology. Also, in some of the paragraphs e.g. in the last paragraph of ‘Epidemiology’ there isn’t a citation that accounts for the information at the end of the paragraph so that should be fixed. &lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
This page clearly and efficiently explains the topic of choice. It covers all relevant matters well and the text is descriptive and informative. After reading the page, I felt as though I had a greater understanding of the topic. The subheadings used are good, and are placed appropriately in order - providing an element of cohesiveness between the page and the topic in general. Good use of linking statements – connecting all the elements discussed on the page. &lt;br /&gt;
&lt;br /&gt;
There is however an excessive amount of text used. Although the information is relevant and informative, the page is dense and reading all at once is tiresome. Reducing/sifting through the amount of text on the page – and also adding a great deal more media files will help to break up the denseness of the page. There is only 1 image on the whole page – greater attention needs to be paid to alternative media files and sources to help break up the page. Additional media files will also add to increasing the understanding of readers. &lt;br /&gt;
	The diagram drawn is neat and cited correctly. --[[User:Z5015534|Z5015534]] ([[User talk:Z5015534|talk]]) 15:07, 13 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
This Wiki covers the topic well. The content is very well written and easy to understand.  Images and texts are correctly cited and referenced. In some of the sections, eg, ‘Ovulation Induction’, ‘Avoiding hCG during Luteal Phase Support’, more in-text reference will need to be added.&lt;br /&gt;
It is a great idea to have some bold texts in lines, which highlight the main points of paragraphs, and help readers to understand when skimming.&lt;br /&gt;
The hand-draw diagram of ‘pathogenesis of OHSS’ is excellent. It is well structured, and easy to understand and memorize.  It will be great if more images, diagrams, videos can be added to the other sections.&lt;br /&gt;
Overall, the project page is very well developed. Some of the sections need to have more work on though. It would nice if more graphs and tables can be added to balance the texts.&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
So far your wiki page gives a very good coverage of Ovarian Hyper-Stimulation Syndrome. The progression of your subheadings progresses logically from one topic to another. It's good to see that you've included an excellent hand-drawn image which is well suited to the 'pathophysiology' subheading. The amount of textual information you have under each heading is vast and gives a comprehensive description of OHSS. Furthermore, you have an excellent range of sources to support your discussion.&lt;br /&gt;
&lt;br /&gt;
I feel however that asides from your hand-drawn image, your use of images and other source of media is definitely lacking. As is, your page is largely text with little to no breaks, making it quite difficult to read. The use of images would not only help break up the monotony of the text, but also help reinforce some of your ideas. I feel that the inclusion of images in the 'symptoms' and 'complications' subheadings would be suitable. &lt;br /&gt;
&lt;br /&gt;
It may also be worthwhile to include subheadings concerning current research, to inform readers about contemporary developments regarding OHSS. Furthermore,  'future research' could also be another potential subheading and could illuminate potential areas that are beginning to be or could be investigated in coming years.&lt;br /&gt;
&lt;br /&gt;
Overall, a very impressive page so far, that could be enhanced with the addition of relevant images and other media.&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 16:18, 13 October 2015 (AEDT)&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=204997</id>
		<title>User:Z3416054</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=204997"/>
		<updated>2015-10-12T00:15:12Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Hi there&lt;br /&gt;
Just giving the editor a good old test run.&lt;br /&gt;
[[Test student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:45, 7 August 2015 (AEST)&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:47, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 14:06, 14 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:57, 21 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 12:22, 28 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:20, 4 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:18, 11 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:10, 25 September 2015 (AEST)&lt;br /&gt;
==Picture Tutorial==&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
===Article 1===&lt;br /&gt;
This research article aimed to determine the clinical outcomes following IVF (in vitro fertilisation) and embryo transfer treatments in subjects suffering from the sexually transmitted disease syphilis. The clinical outcomes mentioned are the rates of pregnancy and health of newborns following treatment via IVF. Couples engaged in sexual intercourse over 12 months without the use of contraception and who failed to conceive were deemed as being infertile.&lt;br /&gt;
&lt;br /&gt;
The subjects were divided into two groups based on serology results, a syphilis infected group and a control group, each with 160 individuals, giving a total of 320 subjects. The Syphilis infected group was further divided into three subcategories, a male infected group, a female infected group and a couple (male and female) infected group. Penicillin G20 (an anti-syphilis treatment) was given to the individuals in the syphilis group. IVF treatment commenced one month proceeding the disappearance of clinical syphilis symptoms or if test results gave a negative result for syphilis infection.&lt;br /&gt;
&lt;br /&gt;
The results of this experiment revealed no significant differences in regards to the basal FSH and LH of both the control and syphilis groups. However, the thickness of the endometrium differed greatly, with the syphilis group demonstrating a thicker endometrial wall (16.9±5.4mm) compared to the control group (13.0±4.7mm). Further differences were noted in blastocyst implantation rates, with the syphilis group having less successful implantations compared to the control (24.2% vs. 34.4% respectively).Normal oocyte cleavage differed between the two groups with the syphilis group demonstrating less normal oocyte cleavage compared to the control group  (6.3±4.7 vs. 8.1±4.6). Furthermore, the clinical pregnancy rates of the syphilis group stood at 43.8% compared to 55.6% of the control group.&lt;br /&gt;
&lt;br /&gt;
Syphilis infection appeared to have a significant impact on the success and clinical outcomes of IVF. Syphilis associated pelvic inflammatory disease can lead to an increase in the thickness of the endometrium, which can adversely affect blastocyte implantation and endometrial receptivity. Successful pregnancy rates typically correlate with an endometrial thickness of 7-14mm, with any thickness beyond 14mm often corresponding with decreased clinical pregnancies. Rates of clinical pregnancy and miscarriage rates did not differ between the three syphilis subgroups. Conception involving a male infected partner was associated with a shorter gestational period and decreased offspring birth weight, when compared to the female infected and couple infected subgroups. No explanation for this phenomenon was provided.&lt;br /&gt;
&lt;br /&gt;
PMID 26208116&lt;br /&gt;
&lt;br /&gt;
''Article 1 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4514756&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
===Article 2===&lt;br /&gt;
The effects of oxygen levels on factors such as cleavage, implantation and pregnancy rates in IVF cultured embryos was the primary focus of this article.  Women between the ages of 20-48 who were seeking treatment for infertility were utilised in this experiment.&lt;br /&gt;
Gametes were allocated to be incubated in one of three environments, each with a different oxygen concentration. The first group was placed in an atmosphere with an oxygen concentration of 20%. The second group rested in a 20% oxygen environment for a day before being moved to a 5% oxygen, 5% carbon dioxide and 90% nitrogen atmosphere. The third group consisted of a 5% carbon dioxide, 5% oxygen and 90% nitrogen atmosphere. The gametes (spermatozoa and oocytes) were incubated together in their respective environmental conditions for 4-6 hours after which fertilisation is presumed to have occurred.&lt;br /&gt;
&lt;br /&gt;
Successful embryos were transferred at Day 3 cleavage. A biochemical analysis of HCG validated pregnancy, whilst ultrasound was used to confirm the presence of a heartbeat 28 days following the transfer.&lt;br /&gt;
IVF fertilisation rates were calculated as being the number of fertilised oocytes over the number of oocytes inseminated. Cleavage rates were characterised by the number of blastomeres over the number of fertilised and abortion rate by the amount of miscarriages divided by the number of transfers.&lt;br /&gt;
&lt;br /&gt;
The research article concluded that the embryos from the 5% oxygen group had the highest rates of fertilisation and implantation. The 20% oxygen group had the second highest rates of fertilisation and maintained excellent embryo quality, whilst the 20% to 5% group had the lowest rates overall. Abortion and miscarriage rates did not differ at all between the three groups. The group incubated at 5% oxygen demonstrated higher quality embryos and increased rates of pregnancy when compared to the 20% oxygen group. The article concludes that implantation, pregnancy and embryo quality can be somewhat affected by a set oxygen concentration, but are affected adversely by a shift from one concentration to another. &lt;br /&gt;
Shifting from one oxygen concentration to another appeared to have an adverse effect on the cleavage of the embryo and would likely impact future development and the overall success of the IVF treatment.&lt;br /&gt;
&lt;br /&gt;
PMID 26131222 &lt;br /&gt;
&lt;br /&gt;
''Article 2 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4483955&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These are quite good descriptions of these 2 articles. (5/5)&lt;br /&gt;
==Lab 2 Assessment==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Notch Signalling - Ovulation in Drosphila.jpg|Caption]]&lt;br /&gt;
&lt;br /&gt;
===Image Reference===&lt;br /&gt;
Jianjun Sun, Allan C Spradling Ovulation in Drosophila is controlled by secretory cells of the female reproductive tract. Elife: 2013, 2;e00415 PubMed 23599892&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 23599892&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) Image uploaded and named correctly. All reference, copyright and student image template included. You might have included in the summary box an explanation to the terms that appear in the image as there is no way for the reader to interpret what is shown in each panel. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 3 Assessment==&lt;br /&gt;
===Causes===&lt;br /&gt;
====The Genetics of Infertility: Current Status of the Field====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3885174&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This article attempted to determine the role that genetics plays in female infertility. It was noted that several prominent causes of female infertility such as Galactosemia and Primary Ovarian Failure (POF) were associated with specific genes, with the GALT gene contributing to the former condition and the FMR1 gene contributing to the latter.&lt;br /&gt;
&lt;br /&gt;
====Causes of Sterility in Bosnia-Herzegovina Population====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4499307&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
The study conducted as laid out in this article examined the causes of female sterility in the Bosnia-Herzegovina population. Married participants were arranged into various groups based upon their age. The experiment came to the conclusion that in approximately 42% of infertile married couples, female sterility was the primary cause. The two primary causes of female infertility were tubal deficiencies (31% of cases) and Diminished Ovarian Reserves (38% of cases)&lt;br /&gt;
&lt;br /&gt;
====Epidemiology, diagnosis, and management of polycystic ovary syndrome====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3872139&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This research article examines the causes of polycystic ovary syndrome (POS), a common cause of infertility in women. The article concluded that 50-70% of women suffer from insulin resistance secondary to Type 2 Diabetes and in many cases obseity, which may contribute partially to POS. Furthermore, 85-90% of women with oligomenorrhea also had POS, suggesting that it is an underlying cause. However, the exact pathophysiology of POS was not determined.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These papers relate to your group project, I hope they are useful for the final submission. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 4 Assessment==&lt;br /&gt;
===Quiz===&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
{Primary villi are produced during which stage of development?:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ Week 2&lt;br /&gt;
- Week 1&lt;br /&gt;
- Week 3&lt;br /&gt;
- None of the above&lt;br /&gt;
|| Primary Villi appear during Week 2 of development, whilst secondary villi appear during Week 3 of development.&lt;br /&gt;
&lt;br /&gt;
{Mesoderm is a precursor for all of the following EXCEPT:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Skeletal Muscle Cells&lt;br /&gt;
- Cardiac Muscle Cells&lt;br /&gt;
- Erythrocytes&lt;br /&gt;
+ Epidermal Skin Cells&lt;br /&gt;
- Smooth Muscle&lt;br /&gt;
|| Epidermal skin cells originate from ectoderm. Skeletal, cardiac and smooth muscle along with erythrocytes originate from the mesoderm.&lt;br /&gt;
&lt;br /&gt;
{Which of the following shows the correct developmental pathway of the male gamete:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatogonia &amp;gt; Spermatozoa&lt;br /&gt;
- Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell &amp;gt; Spermatozoa &amp;gt; Spermatid&lt;br /&gt;
- Sertoli Cell &amp;gt; Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatozoa&lt;br /&gt;
- Spermatid &amp;gt; Spermatozoa &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell&lt;br /&gt;
+ Spermatogonia &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatid &amp;gt; Spermatozoa&lt;br /&gt;
|| Spermatogonia represent the beginning of male sex cell development, with spermatozoa being the mature gamete.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) No descriptive title to your questions. Q1 relates to the timing of villi development. These types of questions encourage &amp;quot;student guessing&amp;quot; and you could have given a more detailed explanation and links to resources in your revealed answer e.g. [[Placenta - Villi Development]]. Q2 is a reasonable question, but only requiring the student only to know that Epidermal Skin Cells are from ectoderm. Once again it is your revealed answer that needs more work. Q3 is a little easy, as long as you know Spermatogonia are the diploid start cell you can quickly exclude most options, need more work. (8/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5 Assessment==&lt;br /&gt;
===Gastroschisis and Omphalocele===&lt;br /&gt;
&lt;br /&gt;
Gastroschisis is classified as a full thickness cleft found in the abdominal wall, adjacent to the site of insertion of the umbilical cord. The defining features of this abnormality is the absence of a membranous sac shrouding the intestines. As a result of this the intestines will become eviscerated, thereby protruding out of the abdominal wall and will be on the exterior, rather than the interior of the body. It is believed that disruption to the vascular supply of the right abdominal wall is the primary gass of gastroschisis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2166158&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Omphalocele is an abnormality characterised by the herniation of visceral organs such as the intestines, liver and spleen outside of the abdominal cavity. The visceral organs are enclosed in a membranous sac, into which the umbilical cord is inserted.  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC1355659&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The primary difference between gastroschisis and omphalocele lies in the presence of a membraneous sac and the exact organs herniating from the abdominal wall. Gastroschisis involves the intestines protruding to the outside of the body but are not covered by a membranous sac. Omphalocele however is characterised by the protrusion of multiple visceral organs (liver, spleen etc.) which are enclosed within a membranous. Furthermore, the size of both abnormalities differs greatly, with gastroschisis typically being 2-5 cm in size whilst omphalocele can vary between 2-15cm. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2552910&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) This is an adequate description of the differences between these conditions. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 7 Assessment==&lt;br /&gt;
&lt;br /&gt;
1: This research paper aimed to examine the relationship between fetal adrenal cells and the differentiated adrenal cortex. In particular, research was focussed upon possible pregenitor cells involved in maintenance of the adrenal cortex. It was hypothesised that the the most likely precursor cells of the adult cortex were the 'Glil' expressing cells found in the adrenal capsule. A number of mice adrenal glands were taken, treated with antigen retrieval solution, after which fluorescence microscopy was conducted.&lt;br /&gt;
&lt;br /&gt;
The results of the paper concluded that 'Glil' expressing descendants of fetal adrenal cells are the pregenitors of the differentiated adrenal cortex. Furthermore, it was found that the 'Glil' expressing cells oringinated from 'FAdE-Cre' expressing fetal adrenal cells. Thus the authors of this research article came to the conclusion that 'Glil' expressing cells found in the adrenal cortex play an important role in the development, differentiation and maintenance of the adrenal cortex. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3817941&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
2: A number of embryonic layers and tissues contribute to the development of teeth. The primary contributing layers are mesoderm, ectoderm and neural crest ectomesenchyme. Furthermore, neural crest may contribute through interactions with the ectoderm. Odontoblasts originate from neural crest derived mesenchymal cells and are responsible for forming predentin which calificies to create dentin (which forms the bulk of the tooth). Ameloblasts are responsible for the production of enamel, which provides teeth with the hardness required to engage in mastication. &lt;br /&gt;
&lt;br /&gt;
==Peer Assessment==&lt;br /&gt;
&lt;br /&gt;
===Group 1 Peer Assessment===&lt;br /&gt;
Hi guys! I'll start of by saying that the images and video you have included are excellent and are relevant to your topic of discussion. Also, you have a large number of reliable references which is good to see. However you have yet to include a hand drawn image, which is required for the wiki page. I feel like  you could probably eliminate the typed out 'timeline of mitochondrial donation' and instead use this as an opportunity to use a hand drawn image of the timeline. Furthermore, the timeline under 'cystoplasmic transfer' feels a bit awkward and unnecessary. You could probably include this timeline alongside the 'timeline of mitochondrial donation'. &lt;br /&gt;
&lt;br /&gt;
Under the 'Technical Progression' section it would be best to incorporate human embryo, mouse and human models under a sub-sub heading, as at the moment it feels a bit jumbled.&lt;br /&gt;
&lt;br /&gt;
I would also recommend moving the 'Benefits' heading towards the end of the page. It feels odd reading about the benefits of three person embryos before I gain a proper understanding of how they work. Also it might be worth talking about the disadvantages (if there are any) to three person embryos to balance out the 'benefits' section. As has been previously stated, make sure you sort out the copyright information for your video as it would be a shame to lose marks if it was missing. Also, don't forget to add the 'student template' to the 'Swapping mitochondrial DNA mammalian oocytes' image as it is currently absent.&lt;br /&gt;
&lt;br /&gt;
===Group 2 Peer Assessment===&lt;br /&gt;
&lt;br /&gt;
===Group 4 Peer Assessment===&lt;br /&gt;
&lt;br /&gt;
===Group 5 Peer Assessment===&lt;br /&gt;
&lt;br /&gt;
===Group 6 Peer Assessment===&lt;br /&gt;
&lt;br /&gt;
Look at this!&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=204995</id>
		<title>User:Z3416054</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=204995"/>
		<updated>2015-10-12T00:13:02Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Hi there&lt;br /&gt;
Just giving the editor a good old test run.&lt;br /&gt;
[[Test student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:45, 7 August 2015 (AEST)&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:47, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 14:06, 14 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:57, 21 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 12:22, 28 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:20, 4 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:18, 11 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:10, 25 September 2015 (AEST)&lt;br /&gt;
==Picture Tutorial==&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
===Article 1===&lt;br /&gt;
This research article aimed to determine the clinical outcomes following IVF (in vitro fertilisation) and embryo transfer treatments in subjects suffering from the sexually transmitted disease syphilis. The clinical outcomes mentioned are the rates of pregnancy and health of newborns following treatment via IVF. Couples engaged in sexual intercourse over 12 months without the use of contraception and who failed to conceive were deemed as being infertile.&lt;br /&gt;
&lt;br /&gt;
The subjects were divided into two groups based on serology results, a syphilis infected group and a control group, each with 160 individuals, giving a total of 320 subjects. The Syphilis infected group was further divided into three subcategories, a male infected group, a female infected group and a couple (male and female) infected group. Penicillin G20 (an anti-syphilis treatment) was given to the individuals in the syphilis group. IVF treatment commenced one month proceeding the disappearance of clinical syphilis symptoms or if test results gave a negative result for syphilis infection.&lt;br /&gt;
&lt;br /&gt;
The results of this experiment revealed no significant differences in regards to the basal FSH and LH of both the control and syphilis groups. However, the thickness of the endometrium differed greatly, with the syphilis group demonstrating a thicker endometrial wall (16.9±5.4mm) compared to the control group (13.0±4.7mm). Further differences were noted in blastocyst implantation rates, with the syphilis group having less successful implantations compared to the control (24.2% vs. 34.4% respectively).Normal oocyte cleavage differed between the two groups with the syphilis group demonstrating less normal oocyte cleavage compared to the control group  (6.3±4.7 vs. 8.1±4.6). Furthermore, the clinical pregnancy rates of the syphilis group stood at 43.8% compared to 55.6% of the control group.&lt;br /&gt;
&lt;br /&gt;
Syphilis infection appeared to have a significant impact on the success and clinical outcomes of IVF. Syphilis associated pelvic inflammatory disease can lead to an increase in the thickness of the endometrium, which can adversely affect blastocyte implantation and endometrial receptivity. Successful pregnancy rates typically correlate with an endometrial thickness of 7-14mm, with any thickness beyond 14mm often corresponding with decreased clinical pregnancies. Rates of clinical pregnancy and miscarriage rates did not differ between the three syphilis subgroups. Conception involving a male infected partner was associated with a shorter gestational period and decreased offspring birth weight, when compared to the female infected and couple infected subgroups. No explanation for this phenomenon was provided.&lt;br /&gt;
&lt;br /&gt;
PMID 26208116&lt;br /&gt;
&lt;br /&gt;
''Article 1 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4514756&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
===Article 2===&lt;br /&gt;
The effects of oxygen levels on factors such as cleavage, implantation and pregnancy rates in IVF cultured embryos was the primary focus of this article.  Women between the ages of 20-48 who were seeking treatment for infertility were utilised in this experiment.&lt;br /&gt;
Gametes were allocated to be incubated in one of three environments, each with a different oxygen concentration. The first group was placed in an atmosphere with an oxygen concentration of 20%. The second group rested in a 20% oxygen environment for a day before being moved to a 5% oxygen, 5% carbon dioxide and 90% nitrogen atmosphere. The third group consisted of a 5% carbon dioxide, 5% oxygen and 90% nitrogen atmosphere. The gametes (spermatozoa and oocytes) were incubated together in their respective environmental conditions for 4-6 hours after which fertilisation is presumed to have occurred.&lt;br /&gt;
&lt;br /&gt;
Successful embryos were transferred at Day 3 cleavage. A biochemical analysis of HCG validated pregnancy, whilst ultrasound was used to confirm the presence of a heartbeat 28 days following the transfer.&lt;br /&gt;
IVF fertilisation rates were calculated as being the number of fertilised oocytes over the number of oocytes inseminated. Cleavage rates were characterised by the number of blastomeres over the number of fertilised and abortion rate by the amount of miscarriages divided by the number of transfers.&lt;br /&gt;
&lt;br /&gt;
The research article concluded that the embryos from the 5% oxygen group had the highest rates of fertilisation and implantation. The 20% oxygen group had the second highest rates of fertilisation and maintained excellent embryo quality, whilst the 20% to 5% group had the lowest rates overall. Abortion and miscarriage rates did not differ at all between the three groups. The group incubated at 5% oxygen demonstrated higher quality embryos and increased rates of pregnancy when compared to the 20% oxygen group. The article concludes that implantation, pregnancy and embryo quality can be somewhat affected by a set oxygen concentration, but are affected adversely by a shift from one concentration to another. &lt;br /&gt;
Shifting from one oxygen concentration to another appeared to have an adverse effect on the cleavage of the embryo and would likely impact future development and the overall success of the IVF treatment.&lt;br /&gt;
&lt;br /&gt;
PMID 26131222 &lt;br /&gt;
&lt;br /&gt;
''Article 2 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4483955&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These are quite good descriptions of these 2 articles. (5/5)&lt;br /&gt;
==Lab 2 Assessment==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Notch Signalling - Ovulation in Drosphila.jpg|Caption]]&lt;br /&gt;
&lt;br /&gt;
===Image Reference===&lt;br /&gt;
Jianjun Sun, Allan C Spradling Ovulation in Drosophila is controlled by secretory cells of the female reproductive tract. Elife: 2013, 2;e00415 PubMed 23599892&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 23599892&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) Image uploaded and named correctly. All reference, copyright and student image template included. You might have included in the summary box an explanation to the terms that appear in the image as there is no way for the reader to interpret what is shown in each panel. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 3 Assessment==&lt;br /&gt;
===Causes===&lt;br /&gt;
====The Genetics of Infertility: Current Status of the Field====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3885174&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This article attempted to determine the role that genetics plays in female infertility. It was noted that several prominent causes of female infertility such as Galactosemia and Primary Ovarian Failure (POF) were associated with specific genes, with the GALT gene contributing to the former condition and the FMR1 gene contributing to the latter.&lt;br /&gt;
&lt;br /&gt;
====Causes of Sterility in Bosnia-Herzegovina Population====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4499307&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
The study conducted as laid out in this article examined the causes of female sterility in the Bosnia-Herzegovina population. Married participants were arranged into various groups based upon their age. The experiment came to the conclusion that in approximately 42% of infertile married couples, female sterility was the primary cause. The two primary causes of female infertility were tubal deficiencies (31% of cases) and Diminished Ovarian Reserves (38% of cases)&lt;br /&gt;
&lt;br /&gt;
====Epidemiology, diagnosis, and management of polycystic ovary syndrome====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3872139&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This research article examines the causes of polycystic ovary syndrome (POS), a common cause of infertility in women. The article concluded that 50-70% of women suffer from insulin resistance secondary to Type 2 Diabetes and in many cases obseity, which may contribute partially to POS. Furthermore, 85-90% of women with oligomenorrhea also had POS, suggesting that it is an underlying cause. However, the exact pathophysiology of POS was not determined.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These papers relate to your group project, I hope they are useful for the final submission. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 4 Assessment==&lt;br /&gt;
===Quiz===&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
{Primary villi are produced during which stage of development?:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ Week 2&lt;br /&gt;
- Week 1&lt;br /&gt;
- Week 3&lt;br /&gt;
- None of the above&lt;br /&gt;
|| Primary Villi appear during Week 2 of development, whilst secondary villi appear during Week 3 of development.&lt;br /&gt;
&lt;br /&gt;
{Mesoderm is a precursor for all of the following EXCEPT:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Skeletal Muscle Cells&lt;br /&gt;
- Cardiac Muscle Cells&lt;br /&gt;
- Erythrocytes&lt;br /&gt;
+ Epidermal Skin Cells&lt;br /&gt;
- Smooth Muscle&lt;br /&gt;
|| Epidermal skin cells originate from ectoderm. Skeletal, cardiac and smooth muscle along with erythrocytes originate from the mesoderm.&lt;br /&gt;
&lt;br /&gt;
{Which of the following shows the correct developmental pathway of the male gamete:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatogonia &amp;gt; Spermatozoa&lt;br /&gt;
- Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell &amp;gt; Spermatozoa &amp;gt; Spermatid&lt;br /&gt;
- Sertoli Cell &amp;gt; Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatozoa&lt;br /&gt;
- Spermatid &amp;gt; Spermatozoa &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell&lt;br /&gt;
+ Spermatogonia &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatid &amp;gt; Spermatozoa&lt;br /&gt;
|| Spermatogonia represent the beginning of male sex cell development, with spermatozoa being the mature gamete.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) No descriptive title to your questions. Q1 relates to the timing of villi development. These types of questions encourage &amp;quot;student guessing&amp;quot; and you could have given a more detailed explanation and links to resources in your revealed answer e.g. [[Placenta - Villi Development]]. Q2 is a reasonable question, but only requiring the student only to know that Epidermal Skin Cells are from ectoderm. Once again it is your revealed answer that needs more work. Q3 is a little easy, as long as you know Spermatogonia are the diploid start cell you can quickly exclude most options, need more work. (8/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5 Assessment==&lt;br /&gt;
===Gastroschisis and Omphalocele===&lt;br /&gt;
&lt;br /&gt;
Gastroschisis is classified as a full thickness cleft found in the abdominal wall, adjacent to the site of insertion of the umbilical cord. The defining features of this abnormality is the absence of a membranous sac shrouding the intestines. As a result of this the intestines will become eviscerated, thereby protruding out of the abdominal wall and will be on the exterior, rather than the interior of the body. It is believed that disruption to the vascular supply of the right abdominal wall is the primary gass of gastroschisis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2166158&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Omphalocele is an abnormality characterised by the herniation of visceral organs such as the intestines, liver and spleen outside of the abdominal cavity. The visceral organs are enclosed in a membranous sac, into which the umbilical cord is inserted.  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC1355659&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The primary difference between gastroschisis and omphalocele lies in the presence of a membraneous sac and the exact organs herniating from the abdominal wall. Gastroschisis involves the intestines protruding to the outside of the body but are not covered by a membranous sac. Omphalocele however is characterised by the protrusion of multiple visceral organs (liver, spleen etc.) which are enclosed within a membranous. Furthermore, the size of both abnormalities differs greatly, with gastroschisis typically being 2-5 cm in size whilst omphalocele can vary between 2-15cm. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2552910&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) This is an adequate description of the differences between these conditions. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 7 Assessment==&lt;br /&gt;
&lt;br /&gt;
1: This research paper aimed to examine the relationship between fetal adrenal cells and the differentiated adrenal cortex. In particular, research was focussed upon possible pregenitor cells involved in maintenance of the adrenal cortex. It was hypothesised that the the most likely precursor cells of the adult cortex were the 'Glil' expressing cells found in the adrenal capsule. A number of mice adrenal glands were taken, treated with antigen retrieval solution, after which fluorescence microscopy was conducted.&lt;br /&gt;
&lt;br /&gt;
The results of the paper concluded that 'Glil' expressing descendants of fetal adrenal cells are the pregenitors of the differentiated adrenal cortex. Furthermore, it was found that the 'Glil' expressing cells oringinated from 'FAdE-Cre' expressing fetal adrenal cells. Thus the authors of this research article came to the conclusion that 'Glil' expressing cells found in the adrenal cortex play an important role in the development, differentiation and maintenance of the adrenal cortex. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3817941&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
2: A number of embryonic layers and tissues contribute to the development of teeth. The primary contributing layers are mesoderm, ectoderm and neural crest ectomesenchyme. Furthermore, neural crest may contribute through interactions with the ectoderm. Odontoblasts originate from neural crest derived mesenchymal cells and are responsible for forming predentin which calificies to create dentin (which forms the bulk of the tooth). Ameloblasts are responsible for the production of enamel, which provides teeth with the hardness required to engage in mastication. &lt;br /&gt;
&lt;br /&gt;
==Peer Assessment==&lt;br /&gt;
&lt;br /&gt;
===Group 1 Peer Assessment===&lt;br /&gt;
Hi guys! I'll start of by saying that the images and video you have included are excellent and are relevant to your topic of discussion. Also, you have a large number of reliable references which is good to see. However you have yet to include a hand drawn image, which is required for the wiki page. I feel like  you could probably eliminate the typed out 'timeline of mitochondrial donation' and instead use this as an opportunity to use a hand drawn image of the timeline. Furthermore, the timeline under 'cystoplasmic transfer' feels a bit awkward and unnecessary. You could probably include this timeline alongside the 'timeline of mitochondrial donation'. &lt;br /&gt;
&lt;br /&gt;
Under the 'Technical Progression' section it would be best to incorporate human embryo, mouse and human models under a sub-sub heading, as at the moment it feels a bit jumbled.&lt;br /&gt;
&lt;br /&gt;
I would also recommend moving the 'Benefits' heading towards the end of the page. It feels odd reading about the benefits of three person embryos before I gain a proper understanding of how they work. Also it might be worth talking about the disadvantages (if there are any) to three person embryos to balance out the 'benefits' section. As has been previously stated, make sure you sort out the copyright information for your video as it would be a shame to lose marks if it was missing. Also, don't forget to add the 'student template' to the 'Swapping mitochondrial DNA mammalian oocytes' image as it is currently absent.&lt;br /&gt;
&lt;br /&gt;
Look at this!&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_1&amp;diff=204991</id>
		<title>Talk:2015 Group Project 1</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_1&amp;diff=204991"/>
		<updated>2015-10-12T00:12:20Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015discussionheader}}&lt;br /&gt;
&lt;br /&gt;
==Stem cell presentation==&lt;br /&gt;
Hi, I have listed some papers which I am interested in doing because it is highly relevant to my own project. But I am more than happy if you post other papers and topics which interest you and we can work on them together and get ready earlier.&lt;br /&gt;
 &lt;br /&gt;
PMID 26295456&lt;br /&gt;
&lt;br /&gt;
PMID 26439174&lt;br /&gt;
&lt;br /&gt;
PMID 24837661&lt;br /&gt;
&lt;br /&gt;
PMID 26418893&lt;br /&gt;
&lt;br /&gt;
'''PMID 24981862'''&lt;br /&gt;
&lt;br /&gt;
==Useful resources==&lt;br /&gt;
&lt;br /&gt;
Here is a good source for overview and status of 3 Person IVF. http://www.geneticsandsociety.org/article.php?id=6527&lt;br /&gt;
&lt;br /&gt;
==Mitochondria==&lt;br /&gt;
*discovered in muscle by Kölliker in 1857&lt;br /&gt;
*mitochondria are the &amp;quot;powerhouses&amp;quot; of the cell and the location where respiration occurs at the cellular level.&lt;br /&gt;
*mitochondria contain their own DNA (mitochondrial DNA or mtDNA) that has been originally inherited only from the oocyte (maternal inheritance).&lt;br /&gt;
*The spermatozoa (paternal) mitochondria- energy for fertilization motility but are generally destroyed during the first mitotic cell divisions. &lt;br /&gt;
*This pattern of inheritance has important implications for a variety of mitochondrial associated diseases, usually occurring in tissues requiring lots of energy (muscle, brain). &lt;br /&gt;
&lt;br /&gt;
[[File:Mitochondria EM01.jpg|200px|thumb|Electron micrograph of mitochondria.]]&lt;br /&gt;
&lt;br /&gt;
===Eukaryotic mitochondrial genomes===&lt;br /&gt;
*double stranded circular DNA (mitoDNA. mtDNA)&lt;br /&gt;
*1981 complete human sequence (16,569 nucleotides)&lt;br /&gt;
**37 genes&lt;br /&gt;
**encodes 13 polypeptides involved in oxidative phosphorylation&lt;br /&gt;
*remaining genes transfer RNA (tRNA) and ribosomal RNA (rRNA)&lt;br /&gt;
*multiple copies within the matrix&lt;br /&gt;
*maternally inherited&lt;br /&gt;
*remainder encoded by nuclear DNA&lt;br /&gt;
*proteins made in cytosol and imported into mitochondria&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
link to Embryology website  [[Mitochondria]]&lt;br /&gt;
&lt;br /&gt;
==Chat==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:13, 25 September 2015 (AEST) OK so just text on your page to date and not yet a thorough coverage of the topic. Animal models, timeline, images, diseases.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 16:07, 21 August 2015 (AEST) I think you will have 3 students and therefore will exist as a group.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3251292|Z3251292]] ([[User talk:Z3251292|talk]]) 17:29, 21 August 2015 (AEST) hi all,sorry that I still could not make my way to uni today due to illness. I will definitely be back next week. I have added few sub-headings to the points you guys setup, feel free to change them. BTW, would you like to pick one of the 5 topics for now? and start working on it? or there was some good arrangement already? please let me know.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3292373|Z3292373]] ([[User talk:Z3292373|talk]]) 20:51, 24 August 2015 (AEST) Hey, ummm sorry i lead us astray putting up those headings ''female fertility'' had been taken so we have to pick another. I put up the list of ones left. My choice would be three parent ivf. So ill do a bit of research and on that now (add some headings)just 'cuase i got some free time, but by all means if you guys would like to do something else that interests you I'm more then happy to change. &lt;br /&gt;
&lt;br /&gt;
--[[User:Z3251292|Z3251292]] ([[User talk:Z3251292|talk]]) 13:19, 27 August 2015 (AEST) Hi all, I am good with your choice. let's work on 3 person embryo. i have added few papers I find good on this topic.&lt;br /&gt;
&lt;br /&gt;
===General===&lt;br /&gt;
&lt;br /&gt;
Note to self doing history benifits.&lt;br /&gt;
&lt;br /&gt;
===Section===&lt;br /&gt;
&lt;br /&gt;
==Peer Reviews==&lt;br /&gt;
&lt;br /&gt;
This wiki page does well in covering a lot of areas relating to the topic, however the website does not outline the information found/used quite clear enough or to the right extent. The page would benefit largely in focusing much more attention to the mechanics of the process itself and how it physically works. There is lots of information regarding other various aspects relating to the topic, however the fundamentals of the topic are not clearly discussed on the page, and it is not clear what goes on in the process. &lt;br /&gt;
&lt;br /&gt;
The page should also fix up some grammatical and syntax errors. Read through the page carefully and ensure all paragraphs make sense ensuring that the quality of the information portrayed is fully appreciated. To also make the page clearer, some thought should be given to rethinking the order of the subheadings. Having a natural cohesion throughout the page as a whole is important – some subheadings do not fit into place correctly and could be moved around a little bit. Also having linking sentences within paragraphs – involving each subheading with others and the topic as a whole – will  make the page much more cohesive. &lt;br /&gt;
&lt;br /&gt;
The page used a good amount of supporting pubmed articles, hwoever more images/media files could be used to break up the concentrated use of text. The video used is relevant and informative – however there is no copyright information.--[[User:Z5015534|Z5015534]] ([[User talk:Z5015534|talk]]) 22:44, 10 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 11:12, 12 October 2015 (AEDT)Hi guys! I'll start of by saying that the images and video you have included are excellent and are relevant to your topic of discussion. Also, you have a large number of reliable references which is good to see. However you have yet to include a hand drawn image, which is required for the wiki page. I feel like  you could probably eliminate the typed out 'timeline of mitochondrial donation' and instead use this as an opportunity to use a hand drawn image of the timeline. Furthermore, the timeline under 'cystoplasmic transfer' feels a bit awkward and unnecessary. You could probably include this timeline alongside the 'timeline of mitochondrial donation'. &lt;br /&gt;
&lt;br /&gt;
Under the 'Technical Progression' section it would be best to incorporate human embryo, mouse and human models under a sub-sub heading, as at the moment it feels a bit jumbled.&lt;br /&gt;
&lt;br /&gt;
I would also recommend moving the 'Benefits' heading towards the end of the page. It feels odd reading about the benefits of three person embryos before I gain a proper understanding of how they work. Also it might be worth talking about the disadvantages (if there are any) to three person embryos to balance out the 'benefits' section. As has been previously stated, make sure you sort out the copyright information for your video as it would be a shame to lose marks if it was missing. Also, don't forget to add the 'student template' to the 'Swapping mitochondrial DNA mammalian oocytes' image as it is currently absent.&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_1&amp;diff=204989</id>
		<title>Talk:2015 Group Project 1</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_1&amp;diff=204989"/>
		<updated>2015-10-12T00:12:04Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015discussionheader}}&lt;br /&gt;
&lt;br /&gt;
==Stem cell presentation==&lt;br /&gt;
Hi, I have listed some papers which I am interested in doing because it is highly relevant to my own project. But I am more than happy if you post other papers and topics which interest you and we can work on them together and get ready earlier.&lt;br /&gt;
 &lt;br /&gt;
PMID 26295456&lt;br /&gt;
&lt;br /&gt;
PMID 26439174&lt;br /&gt;
&lt;br /&gt;
PMID 24837661&lt;br /&gt;
&lt;br /&gt;
PMID 26418893&lt;br /&gt;
&lt;br /&gt;
'''PMID 24981862'''&lt;br /&gt;
&lt;br /&gt;
==Useful resources==&lt;br /&gt;
&lt;br /&gt;
Here is a good source for overview and status of 3 Person IVF. http://www.geneticsandsociety.org/article.php?id=6527&lt;br /&gt;
&lt;br /&gt;
==Mitochondria==&lt;br /&gt;
*discovered in muscle by Kölliker in 1857&lt;br /&gt;
*mitochondria are the &amp;quot;powerhouses&amp;quot; of the cell and the location where respiration occurs at the cellular level.&lt;br /&gt;
*mitochondria contain their own DNA (mitochondrial DNA or mtDNA) that has been originally inherited only from the oocyte (maternal inheritance).&lt;br /&gt;
*The spermatozoa (paternal) mitochondria- energy for fertilization motility but are generally destroyed during the first mitotic cell divisions. &lt;br /&gt;
*This pattern of inheritance has important implications for a variety of mitochondrial associated diseases, usually occurring in tissues requiring lots of energy (muscle, brain). &lt;br /&gt;
&lt;br /&gt;
[[File:Mitochondria EM01.jpg|200px|thumb|Electron micrograph of mitochondria.]]&lt;br /&gt;
&lt;br /&gt;
===Eukaryotic mitochondrial genomes===&lt;br /&gt;
*double stranded circular DNA (mitoDNA. mtDNA)&lt;br /&gt;
*1981 complete human sequence (16,569 nucleotides)&lt;br /&gt;
**37 genes&lt;br /&gt;
**encodes 13 polypeptides involved in oxidative phosphorylation&lt;br /&gt;
*remaining genes transfer RNA (tRNA) and ribosomal RNA (rRNA)&lt;br /&gt;
*multiple copies within the matrix&lt;br /&gt;
*maternally inherited&lt;br /&gt;
*remainder encoded by nuclear DNA&lt;br /&gt;
*proteins made in cytosol and imported into mitochondria&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
link to Embryology website  [[Mitochondria]]&lt;br /&gt;
&lt;br /&gt;
==Chat==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:13, 25 September 2015 (AEST) OK so just text on your page to date and not yet a thorough coverage of the topic. Animal models, timeline, images, diseases.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 16:07, 21 August 2015 (AEST) I think you will have 3 students and therefore will exist as a group.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3251292|Z3251292]] ([[User talk:Z3251292|talk]]) 17:29, 21 August 2015 (AEST) hi all,sorry that I still could not make my way to uni today due to illness. I will definitely be back next week. I have added few sub-headings to the points you guys setup, feel free to change them. BTW, would you like to pick one of the 5 topics for now? and start working on it? or there was some good arrangement already? please let me know.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3292373|Z3292373]] ([[User talk:Z3292373|talk]]) 20:51, 24 August 2015 (AEST) Hey, ummm sorry i lead us astray putting up those headings ''female fertility'' had been taken so we have to pick another. I put up the list of ones left. My choice would be three parent ivf. So ill do a bit of research and on that now (add some headings)just 'cuase i got some free time, but by all means if you guys would like to do something else that interests you I'm more then happy to change. &lt;br /&gt;
&lt;br /&gt;
--[[User:Z3251292|Z3251292]] ([[User talk:Z3251292|talk]]) 13:19, 27 August 2015 (AEST) Hi all, I am good with your choice. let's work on 3 person embryo. i have added few papers I find good on this topic.&lt;br /&gt;
&lt;br /&gt;
===General===&lt;br /&gt;
&lt;br /&gt;
Note to self doing history benifits.&lt;br /&gt;
&lt;br /&gt;
===Section===&lt;br /&gt;
&lt;br /&gt;
==Peer Reviews==&lt;br /&gt;
&lt;br /&gt;
This wiki page does well in covering a lot of areas relating to the topic, however the website does not outline the information found/used quite clear enough or to the right extent. The page would benefit largely in focusing much more attention to the mechanics of the process itself and how it physically works. There is lots of information regarding other various aspects relating to the topic, however the fundamentals of the topic are not clearly discussed on the page, and it is not clear what goes on in the process. &lt;br /&gt;
&lt;br /&gt;
The page should also fix up some grammatical and syntax errors. Read through the page carefully and ensure all paragraphs make sense ensuring that the quality of the information portrayed is fully appreciated. To also make the page clearer, some thought should be given to rethinking the order of the subheadings. Having a natural cohesion throughout the page as a whole is important – some subheadings do not fit into place correctly and could be moved around a little bit. Also having linking sentences within paragraphs – involving each subheading with others and the topic as a whole – will  make the page much more cohesive. &lt;br /&gt;
&lt;br /&gt;
The page used a good amount of supporting pubmed articles, hwoever more images/media files could be used to break up the concentrated use of text. The video used is relevant and informative – however there is no copyright information.--[[User:Z5015534|Z5015534]] ([[User talk:Z5015534|talk]]) 22:44, 10 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 11:12, 12 October 2015 (AEDT)Hi guys! I'll start of by saying that the images and video you have included are excellent and are relevant to your topic of discussion. Also, you have a large number of reliable references which is good to see. However you have yet to include a hand drawn image, which is required for the wiki page. I feel like  you could probably eliminate the typed out 'timeline of mitochondrial donation' and instead use this as an opportunity to use a hand drawn image of the timeline. Furthermore, the timeline under 'cystoplasmic transfer' feels a bit awkward and unnecessary. You could probably include this timeline alongside the 'timeline of mitochondrial donation'. &lt;br /&gt;
&lt;br /&gt;
Under the 'Technical Progression' section it would be best to incorporate human embryo, mouse and human models under a sub-sub heading, as at the moment it feels a bit jumbled.&lt;br /&gt;
&lt;br /&gt;
I would also recommend moving the 'Benefits' heading towards the end of the page. It feels odd reading about the benefits of three person embryos before I gain a proper understanding of how they work. Also it might be worth talking about the disadvantages (if there are any) to three person embryos to balance out the 'benefits' section. As has been previously stated, make sure you sort out the copyright information for your video as it would be a shame to lose marks if it was missing. Also, don't forget to add the 'student template' to the 'Swapping mitochondrial DNA mammalian oocytes' image as it is currently absent.--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 11:11, 12 October 2015 (AEDT)&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_1&amp;diff=204987</id>
		<title>Talk:2015 Group Project 1</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_1&amp;diff=204987"/>
		<updated>2015-10-12T00:11:39Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015discussionheader}}&lt;br /&gt;
&lt;br /&gt;
==Stem cell presentation==&lt;br /&gt;
Hi, I have listed some papers which I am interested in doing because it is highly relevant to my own project. But I am more than happy if you post other papers and topics which interest you and we can work on them together and get ready earlier.&lt;br /&gt;
 &lt;br /&gt;
PMID 26295456&lt;br /&gt;
&lt;br /&gt;
PMID 26439174&lt;br /&gt;
&lt;br /&gt;
PMID 24837661&lt;br /&gt;
&lt;br /&gt;
PMID 26418893&lt;br /&gt;
&lt;br /&gt;
'''PMID 24981862'''&lt;br /&gt;
&lt;br /&gt;
==Useful resources==&lt;br /&gt;
&lt;br /&gt;
Here is a good source for overview and status of 3 Person IVF. http://www.geneticsandsociety.org/article.php?id=6527&lt;br /&gt;
&lt;br /&gt;
==Mitochondria==&lt;br /&gt;
*discovered in muscle by Kölliker in 1857&lt;br /&gt;
*mitochondria are the &amp;quot;powerhouses&amp;quot; of the cell and the location where respiration occurs at the cellular level.&lt;br /&gt;
*mitochondria contain their own DNA (mitochondrial DNA or mtDNA) that has been originally inherited only from the oocyte (maternal inheritance).&lt;br /&gt;
*The spermatozoa (paternal) mitochondria- energy for fertilization motility but are generally destroyed during the first mitotic cell divisions. &lt;br /&gt;
*This pattern of inheritance has important implications for a variety of mitochondrial associated diseases, usually occurring in tissues requiring lots of energy (muscle, brain). &lt;br /&gt;
&lt;br /&gt;
[[File:Mitochondria EM01.jpg|200px|thumb|Electron micrograph of mitochondria.]]&lt;br /&gt;
&lt;br /&gt;
===Eukaryotic mitochondrial genomes===&lt;br /&gt;
*double stranded circular DNA (mitoDNA. mtDNA)&lt;br /&gt;
*1981 complete human sequence (16,569 nucleotides)&lt;br /&gt;
**37 genes&lt;br /&gt;
**encodes 13 polypeptides involved in oxidative phosphorylation&lt;br /&gt;
*remaining genes transfer RNA (tRNA) and ribosomal RNA (rRNA)&lt;br /&gt;
*multiple copies within the matrix&lt;br /&gt;
*maternally inherited&lt;br /&gt;
*remainder encoded by nuclear DNA&lt;br /&gt;
*proteins made in cytosol and imported into mitochondria&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
link to Embryology website  [[Mitochondria]]&lt;br /&gt;
&lt;br /&gt;
==Chat==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:13, 25 September 2015 (AEST) OK so just text on your page to date and not yet a thorough coverage of the topic. Animal models, timeline, images, diseases.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 16:07, 21 August 2015 (AEST) I think you will have 3 students and therefore will exist as a group.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3251292|Z3251292]] ([[User talk:Z3251292|talk]]) 17:29, 21 August 2015 (AEST) hi all,sorry that I still could not make my way to uni today due to illness. I will definitely be back next week. I have added few sub-headings to the points you guys setup, feel free to change them. BTW, would you like to pick one of the 5 topics for now? and start working on it? or there was some good arrangement already? please let me know.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3292373|Z3292373]] ([[User talk:Z3292373|talk]]) 20:51, 24 August 2015 (AEST) Hey, ummm sorry i lead us astray putting up those headings ''female fertility'' had been taken so we have to pick another. I put up the list of ones left. My choice would be three parent ivf. So ill do a bit of research and on that now (add some headings)just 'cuase i got some free time, but by all means if you guys would like to do something else that interests you I'm more then happy to change. &lt;br /&gt;
&lt;br /&gt;
--[[User:Z3251292|Z3251292]] ([[User talk:Z3251292|talk]]) 13:19, 27 August 2015 (AEST) Hi all, I am good with your choice. let's work on 3 person embryo. i have added few papers I find good on this topic.&lt;br /&gt;
&lt;br /&gt;
===General===&lt;br /&gt;
&lt;br /&gt;
Note to self doing history benifits.&lt;br /&gt;
&lt;br /&gt;
===Section===&lt;br /&gt;
&lt;br /&gt;
==Peer Reviews==&lt;br /&gt;
&lt;br /&gt;
This wiki page does well in covering a lot of areas relating to the topic, however the website does not outline the information found/used quite clear enough or to the right extent. The page would benefit largely in focusing much more attention to the mechanics of the process itself and how it physically works. There is lots of information regarding other various aspects relating to the topic, however the fundamentals of the topic are not clearly discussed on the page, and it is not clear what goes on in the process. &lt;br /&gt;
&lt;br /&gt;
The page should also fix up some grammatical and syntax errors. Read through the page carefully and ensure all paragraphs make sense ensuring that the quality of the information portrayed is fully appreciated. To also make the page clearer, some thought should be given to rethinking the order of the subheadings. Having a natural cohesion throughout the page as a whole is important – some subheadings do not fit into place correctly and could be moved around a little bit. Also having linking sentences within paragraphs – involving each subheading with others and the topic as a whole – will  make the page much more cohesive. &lt;br /&gt;
&lt;br /&gt;
The page used a good amount of supporting pubmed articles, hwoever more images/media files could be used to break up the concentrated use of text. The video used is relevant and informative – however there is no copyright information.--[[User:Z5015534|Z5015534]] ([[User talk:Z5015534|talk]]) 22:44, 10 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
Hi guys! I'll start of by saying that the images and video you have included are excellent and are relevant to your topic of discussion. Also, you have a large number of reliable references which is good to see. However you have yet to include a hand drawn image, which is required for the wiki page. I feel like  you could probably eliminate the typed out 'timeline of mitochondrial donation' and instead use this as an opportunity to use a hand drawn image of the timeline. Furthermore, the timeline under 'cystoplasmic transfer' feels a bit awkward and unnecessary. You could probably include this timeline alongside the 'timeline of mitochondrial donation'. &lt;br /&gt;
&lt;br /&gt;
Under the 'Technical Progression' section it would be best to incorporate human embryo, mouse and human models under a sub-sub heading, as at the moment it feels a bit jumbled.&lt;br /&gt;
&lt;br /&gt;
I would also recommend moving the 'Benefits' heading towards the end of the page. It feels odd reading about the benefits of three person embryos before I gain a proper understanding of how they work. Also it might be worth talking about the disadvantages (if there are any) to three person embryos to balance out the 'benefits' section. As has been previously stated, make sure you sort out the copyright information for your video as it would be a shame to lose marks if it was missing. Also, don't forget to add the 'student template' to the 'Swapping mitochondrial DNA mammalian oocytes' image as it is currently absent.--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 11:11, 12 October 2015 (AEDT)&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_1&amp;diff=204983</id>
		<title>Talk:2015 Group Project 1</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_1&amp;diff=204983"/>
		<updated>2015-10-11T23:56:54Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015discussionheader}}&lt;br /&gt;
&lt;br /&gt;
==Stem cell presentation==&lt;br /&gt;
Hi, I have listed some papers which I am interested in doing because it is highly relevant to my own project. But I am more than happy if you post other papers and topics which interest you and we can work on them together and get ready earlier.&lt;br /&gt;
 &lt;br /&gt;
PMID 26295456&lt;br /&gt;
&lt;br /&gt;
PMID 26439174&lt;br /&gt;
&lt;br /&gt;
PMID 24837661&lt;br /&gt;
&lt;br /&gt;
PMID 26418893&lt;br /&gt;
&lt;br /&gt;
'''PMID 24981862'''&lt;br /&gt;
&lt;br /&gt;
==Useful resources==&lt;br /&gt;
&lt;br /&gt;
Here is a good source for overview and status of 3 Person IVF. http://www.geneticsandsociety.org/article.php?id=6527&lt;br /&gt;
&lt;br /&gt;
==Mitochondria==&lt;br /&gt;
*discovered in muscle by Kölliker in 1857&lt;br /&gt;
*mitochondria are the &amp;quot;powerhouses&amp;quot; of the cell and the location where respiration occurs at the cellular level.&lt;br /&gt;
*mitochondria contain their own DNA (mitochondrial DNA or mtDNA) that has been originally inherited only from the oocyte (maternal inheritance).&lt;br /&gt;
*The spermatozoa (paternal) mitochondria- energy for fertilization motility but are generally destroyed during the first mitotic cell divisions. &lt;br /&gt;
*This pattern of inheritance has important implications for a variety of mitochondrial associated diseases, usually occurring in tissues requiring lots of energy (muscle, brain). &lt;br /&gt;
&lt;br /&gt;
[[File:Mitochondria EM01.jpg|200px|thumb|Electron micrograph of mitochondria.]]&lt;br /&gt;
&lt;br /&gt;
===Eukaryotic mitochondrial genomes===&lt;br /&gt;
*double stranded circular DNA (mitoDNA. mtDNA)&lt;br /&gt;
*1981 complete human sequence (16,569 nucleotides)&lt;br /&gt;
**37 genes&lt;br /&gt;
**encodes 13 polypeptides involved in oxidative phosphorylation&lt;br /&gt;
*remaining genes transfer RNA (tRNA) and ribosomal RNA (rRNA)&lt;br /&gt;
*multiple copies within the matrix&lt;br /&gt;
*maternally inherited&lt;br /&gt;
*remainder encoded by nuclear DNA&lt;br /&gt;
*proteins made in cytosol and imported into mitochondria&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
link to Embryology website  [[Mitochondria]]&lt;br /&gt;
&lt;br /&gt;
==Chat==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:13, 25 September 2015 (AEST) OK so just text on your page to date and not yet a thorough coverage of the topic. Animal models, timeline, images, diseases.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 16:07, 21 August 2015 (AEST) I think you will have 3 students and therefore will exist as a group.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3251292|Z3251292]] ([[User talk:Z3251292|talk]]) 17:29, 21 August 2015 (AEST) hi all,sorry that I still could not make my way to uni today due to illness. I will definitely be back next week. I have added few sub-headings to the points you guys setup, feel free to change them. BTW, would you like to pick one of the 5 topics for now? and start working on it? or there was some good arrangement already? please let me know.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3292373|Z3292373]] ([[User talk:Z3292373|talk]]) 20:51, 24 August 2015 (AEST) Hey, ummm sorry i lead us astray putting up those headings ''female fertility'' had been taken so we have to pick another. I put up the list of ones left. My choice would be three parent ivf. So ill do a bit of research and on that now (add some headings)just 'cuase i got some free time, but by all means if you guys would like to do something else that interests you I'm more then happy to change. &lt;br /&gt;
&lt;br /&gt;
--[[User:Z3251292|Z3251292]] ([[User talk:Z3251292|talk]]) 13:19, 27 August 2015 (AEST) Hi all, I am good with your choice. let's work on 3 person embryo. i have added few papers I find good on this topic.&lt;br /&gt;
&lt;br /&gt;
===General===&lt;br /&gt;
&lt;br /&gt;
Note to self doing history benifits.&lt;br /&gt;
&lt;br /&gt;
===Section===&lt;br /&gt;
&lt;br /&gt;
==Peer Reviews==&lt;br /&gt;
&lt;br /&gt;
This wiki page does well in covering a lot of areas relating to the topic, however the website does not outline the information found/used quite clear enough or to the right extent. The page would benefit largely in focusing much more attention to the mechanics of the process itself and how it physically works. There is lots of information regarding other various aspects relating to the topic, however the fundamentals of the topic are not clearly discussed on the page, and it is not clear what goes on in the process. &lt;br /&gt;
&lt;br /&gt;
The page should also fix up some grammatical and syntax errors. Read through the page carefully and ensure all paragraphs make sense ensuring that the quality of the information portrayed is fully appreciated. To also make the page clearer, some thought should be given to rethinking the order of the subheadings. Having a natural cohesion throughout the page as a whole is important – some subheadings do not fit into place correctly and could be moved around a little bit. Also having linking sentences within paragraphs – involving each subheading with others and the topic as a whole – will  make the page much more cohesive. &lt;br /&gt;
&lt;br /&gt;
The page used a good amount of supporting pubmed articles, hwoever more images/media files could be used to break up the concentrated use of text. The video used is relevant and informative – however there is no copyright information.--[[User:Z5015534|Z5015534]] ([[User talk:Z5015534|talk]]) 22:44, 10 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
Hi guys! I'll start of by saying that the images and video you have included are excellent and are relevant to your topic of discussion. However you have yet to include a hand drawn image, which is required for the wiki page. I feel like  you could probably eliminate the typed out 'timeline of mitochondrial donation' and instead use this as an opportunity to use a hand drawn image of the timeline.&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=204621</id>
		<title>User:Z3416054</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3416054&amp;diff=204621"/>
		<updated>2015-10-09T02:19:44Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Hi there&lt;br /&gt;
Just giving the editor a good old test run.&lt;br /&gt;
[[Test student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:45, 7 August 2015 (AEST)&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:47, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 14:06, 14 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:57, 21 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 12:22, 28 August 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:20, 4 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:18, 11 September 2015 (AEST)&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 13:10, 25 September 2015 (AEST)&lt;br /&gt;
==Picture Tutorial==&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
===Article 1===&lt;br /&gt;
This research article aimed to determine the clinical outcomes following IVF (in vitro fertilisation) and embryo transfer treatments in subjects suffering from the sexually transmitted disease syphilis. The clinical outcomes mentioned are the rates of pregnancy and health of newborns following treatment via IVF. Couples engaged in sexual intercourse over 12 months without the use of contraception and who failed to conceive were deemed as being infertile.&lt;br /&gt;
&lt;br /&gt;
The subjects were divided into two groups based on serology results, a syphilis infected group and a control group, each with 160 individuals, giving a total of 320 subjects. The Syphilis infected group was further divided into three subcategories, a male infected group, a female infected group and a couple (male and female) infected group. Penicillin G20 (an anti-syphilis treatment) was given to the individuals in the syphilis group. IVF treatment commenced one month proceeding the disappearance of clinical syphilis symptoms or if test results gave a negative result for syphilis infection.&lt;br /&gt;
&lt;br /&gt;
The results of this experiment revealed no significant differences in regards to the basal FSH and LH of both the control and syphilis groups. However, the thickness of the endometrium differed greatly, with the syphilis group demonstrating a thicker endometrial wall (16.9±5.4mm) compared to the control group (13.0±4.7mm). Further differences were noted in blastocyst implantation rates, with the syphilis group having less successful implantations compared to the control (24.2% vs. 34.4% respectively).Normal oocyte cleavage differed between the two groups with the syphilis group demonstrating less normal oocyte cleavage compared to the control group  (6.3±4.7 vs. 8.1±4.6). Furthermore, the clinical pregnancy rates of the syphilis group stood at 43.8% compared to 55.6% of the control group.&lt;br /&gt;
&lt;br /&gt;
Syphilis infection appeared to have a significant impact on the success and clinical outcomes of IVF. Syphilis associated pelvic inflammatory disease can lead to an increase in the thickness of the endometrium, which can adversely affect blastocyte implantation and endometrial receptivity. Successful pregnancy rates typically correlate with an endometrial thickness of 7-14mm, with any thickness beyond 14mm often corresponding with decreased clinical pregnancies. Rates of clinical pregnancy and miscarriage rates did not differ between the three syphilis subgroups. Conception involving a male infected partner was associated with a shorter gestational period and decreased offspring birth weight, when compared to the female infected and couple infected subgroups. No explanation for this phenomenon was provided.&lt;br /&gt;
&lt;br /&gt;
PMID 26208116&lt;br /&gt;
&lt;br /&gt;
''Article 1 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4514756&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
===Article 2===&lt;br /&gt;
The effects of oxygen levels on factors such as cleavage, implantation and pregnancy rates in IVF cultured embryos was the primary focus of this article.  Women between the ages of 20-48 who were seeking treatment for infertility were utilised in this experiment.&lt;br /&gt;
Gametes were allocated to be incubated in one of three environments, each with a different oxygen concentration. The first group was placed in an atmosphere with an oxygen concentration of 20%. The second group rested in a 20% oxygen environment for a day before being moved to a 5% oxygen, 5% carbon dioxide and 90% nitrogen atmosphere. The third group consisted of a 5% carbon dioxide, 5% oxygen and 90% nitrogen atmosphere. The gametes (spermatozoa and oocytes) were incubated together in their respective environmental conditions for 4-6 hours after which fertilisation is presumed to have occurred.&lt;br /&gt;
&lt;br /&gt;
Successful embryos were transferred at Day 3 cleavage. A biochemical analysis of HCG validated pregnancy, whilst ultrasound was used to confirm the presence of a heartbeat 28 days following the transfer.&lt;br /&gt;
IVF fertilisation rates were calculated as being the number of fertilised oocytes over the number of oocytes inseminated. Cleavage rates were characterised by the number of blastomeres over the number of fertilised and abortion rate by the amount of miscarriages divided by the number of transfers.&lt;br /&gt;
&lt;br /&gt;
The research article concluded that the embryos from the 5% oxygen group had the highest rates of fertilisation and implantation. The 20% oxygen group had the second highest rates of fertilisation and maintained excellent embryo quality, whilst the 20% to 5% group had the lowest rates overall. Abortion and miscarriage rates did not differ at all between the three groups. The group incubated at 5% oxygen demonstrated higher quality embryos and increased rates of pregnancy when compared to the 20% oxygen group. The article concludes that implantation, pregnancy and embryo quality can be somewhat affected by a set oxygen concentration, but are affected adversely by a shift from one concentration to another. &lt;br /&gt;
Shifting from one oxygen concentration to another appeared to have an adverse effect on the cleavage of the embryo and would likely impact future development and the overall success of the IVF treatment.&lt;br /&gt;
&lt;br /&gt;
PMID 26131222 &lt;br /&gt;
&lt;br /&gt;
''Article 2 Reference:''&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4483955&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These are quite good descriptions of these 2 articles. (5/5)&lt;br /&gt;
==Lab 2 Assessment==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:Notch Signalling - Ovulation in Drosphila.jpg|Caption]]&lt;br /&gt;
&lt;br /&gt;
===Image Reference===&lt;br /&gt;
Jianjun Sun, Allan C Spradling Ovulation in Drosophila is controlled by secretory cells of the female reproductive tract. Elife: 2013, 2;e00415 PubMed 23599892&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 23599892&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) Image uploaded and named correctly. All reference, copyright and student image template included. You might have included in the summary box an explanation to the terms that appear in the image as there is no way for the reader to interpret what is shown in each panel. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 3 Assessment==&lt;br /&gt;
===Causes===&lt;br /&gt;
====The Genetics of Infertility: Current Status of the Field====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3885174&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This article attempted to determine the role that genetics plays in female infertility. It was noted that several prominent causes of female infertility such as Galactosemia and Primary Ovarian Failure (POF) were associated with specific genes, with the GALT gene contributing to the former condition and the FMR1 gene contributing to the latter.&lt;br /&gt;
&lt;br /&gt;
====Causes of Sterility in Bosnia-Herzegovina Population====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC4499307&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
The study conducted as laid out in this article examined the causes of female sterility in the Bosnia-Herzegovina population. Married participants were arranged into various groups based upon their age. The experiment came to the conclusion that in approximately 42% of infertile married couples, female sterility was the primary cause. The two primary causes of female infertility were tubal deficiencies (31% of cases) and Diminished Ovarian Reserves (38% of cases)&lt;br /&gt;
&lt;br /&gt;
====Epidemiology, diagnosis, and management of polycystic ovary syndrome====&lt;br /&gt;
&amp;lt;pubmed&amp;gt;PMC3872139&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This research article examines the causes of polycystic ovary syndrome (POS), a common cause of infertility in women. The article concluded that 50-70% of women suffer from insulin resistance secondary to Type 2 Diabetes and in many cases obseity, which may contribute partially to POS. Furthermore, 85-90% of women with oligomenorrhea also had POS, suggesting that it is an underlying cause. However, the exact pathophysiology of POS was not determined.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:40, 17 September 2015 (AEST) These papers relate to your group project, I hope they are useful for the final submission. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 4 Assessment==&lt;br /&gt;
===Quiz===&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
{Primary villi are produced during which stage of development?:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ Week 2&lt;br /&gt;
- Week 1&lt;br /&gt;
- Week 3&lt;br /&gt;
- None of the above&lt;br /&gt;
|| Primary Villi appear during Week 2 of development, whilst secondary villi appear during Week 3 of development.&lt;br /&gt;
&lt;br /&gt;
{Mesoderm is a precursor for all of the following EXCEPT:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Skeletal Muscle Cells&lt;br /&gt;
- Cardiac Muscle Cells&lt;br /&gt;
- Erythrocytes&lt;br /&gt;
+ Epidermal Skin Cells&lt;br /&gt;
- Smooth Muscle&lt;br /&gt;
|| Epidermal skin cells originate from ectoderm. Skeletal, cardiac and smooth muscle along with erythrocytes originate from the mesoderm.&lt;br /&gt;
&lt;br /&gt;
{Which of the following shows the correct developmental pathway of the male gamete:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatogonia &amp;gt; Spermatozoa&lt;br /&gt;
- Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell &amp;gt; Spermatozoa &amp;gt; Spermatid&lt;br /&gt;
- Sertoli Cell &amp;gt; Spermatid &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatozoa&lt;br /&gt;
- Spermatid &amp;gt; Spermatozoa &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Leydig Cell&lt;br /&gt;
+ Spermatogonia &amp;gt; Primary Spermatocyte &amp;gt; Secondary Spermatocyte &amp;gt; Spermatid &amp;gt; Spermatozoa&lt;br /&gt;
|| Spermatogonia represent the beginning of male sex cell development, with spermatozoa being the mature gamete.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) No descriptive title to your questions. Q1 relates to the timing of villi development. These types of questions encourage &amp;quot;student guessing&amp;quot; and you could have given a more detailed explanation and links to resources in your revealed answer e.g. [[Placenta - Villi Development]]. Q2 is a reasonable question, but only requiring the student only to know that Epidermal Skin Cells are from ectoderm. Once again it is your revealed answer that needs more work. Q3 is a little easy, as long as you know Spermatogonia are the diploid start cell you can quickly exclude most options, need more work. (8/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5 Assessment==&lt;br /&gt;
===Gastroschisis and Omphalocele===&lt;br /&gt;
&lt;br /&gt;
Gastroschisis is classified as a full thickness cleft found in the abdominal wall, adjacent to the site of insertion of the umbilical cord. The defining features of this abnormality is the absence of a membranous sac shrouding the intestines. As a result of this the intestines will become eviscerated, thereby protruding out of the abdominal wall and will be on the exterior, rather than the interior of the body. It is believed that disruption to the vascular supply of the right abdominal wall is the primary gass of gastroschisis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2166158&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Omphalocele is an abnormality characterised by the herniation of visceral organs such as the intestines, liver and spleen outside of the abdominal cavity. The visceral organs are enclosed in a membranous sac, into which the umbilical cord is inserted.  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC1355659&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The primary difference between gastroschisis and omphalocele lies in the presence of a membraneous sac and the exact organs herniating from the abdominal wall. Gastroschisis involves the intestines protruding to the outside of the body but are not covered by a membranous sac. Omphalocele however is characterised by the protrusion of multiple visceral organs (liver, spleen etc.) which are enclosed within a membranous. Furthermore, the size of both abnormalities differs greatly, with gastroschisis typically being 2-5 cm in size whilst omphalocele can vary between 2-15cm. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC2552910&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:50, 17 September 2015 (AEST) This is an adequate description of the differences between these conditions. (5/5)&lt;br /&gt;
&lt;br /&gt;
==Lab 7 Assessment==&lt;br /&gt;
&lt;br /&gt;
1: This research paper aimed to examine the relationship between fetal adrenal cells and the differentiated adrenal cortex. In particular, research was focussed upon possible pregenitor cells involved in maintenance of the adrenal cortex. It was hypothesised that the the most likely precursor cells of the adult cortex were the 'Glil' expressing cells found in the adrenal capsule. A number of mice adrenal glands were taken, treated with antigen retrieval solution, after which fluorescence microscopy was conducted.&lt;br /&gt;
&lt;br /&gt;
The results of the paper concluded that 'Glil' expressing descendants of fetal adrenal cells are the pregenitors of the differentiated adrenal cortex. Furthermore, it was found that the 'Glil' expressing cells oringinated from 'FAdE-Cre' expressing fetal adrenal cells. Thus the authors of this research article came to the conclusion that 'Glil' expressing cells found in the adrenal cortex play an important role in the development, differentiation and maintenance of the adrenal cortex. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3817941&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
2: A number of embryonic layers and tissues contribute to the development of teeth. The primary contributing layers are mesoderm, ectoderm and neural crest ectomesenchyme. Furthermore, neural crest may contribute through interactions with the ectoderm. Odontoblasts originate from neural crest derived mesenchymal cells and are responsible for forming predentin which calificies to create dentin (which forms the bulk of the tooth). Ameloblasts are responsible for the production of enamel, which provides teeth with the hardness required to engage in mastication. &lt;br /&gt;
&lt;br /&gt;
==Peer Assessment==&lt;br /&gt;
&lt;br /&gt;
Look at this!&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_3&amp;diff=204619</id>
		<title>Talk:2015 Group Project 3</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_3&amp;diff=204619"/>
		<updated>2015-10-09T02:18:43Z</updated>

		<summary type="html">&lt;p&gt;Z3416054: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015discussionheader}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:19, 25 September 2015 (AEST) OK so this is far from ready for peer assessment. This is a very large topic with many possible sub-headings (missing from your project page) as well as animal models and environmental/genetic information. I cannot see any illustrations, images, media, resources added to the project page to illustrate the topic and give a balance to the content.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 02:07, 27 September 2015 (AEST) Hey guys, where do you think we should include animal models? Also I think it'd be a pretty snazzy idea to have a cartoon/photograph of polycystic ovaries in the intro and then for causes/pathogenesis have a flow chart or something similar&lt;br /&gt;
&lt;br /&gt;
----[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 16:20, 27 September 2015 (AEST) Hey guys, I've found some pretty snazzy images of polycystic ovaries, but do you know if we have to find the copy right information to be able to use the images? Most of the images come from google-image linked sites and don't really give much information on usage&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3459224|Z3459224]] ([[User talk:Z3459224|talk]]) 14:40, 29 September 2015 (AEST) Yeah I'm pretty sure we have to find the copy right information for all our images. I think it would be best if we try to find images on Pubmed first. If not we can use other journal databases. &lt;br /&gt;
&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 16:51, 30 September 2015 (AEST) Agreed, I'll get rid of the one I put up as I couldn't really find any copyright information for it. I'll have another browse of pubmed and see what I can find&lt;br /&gt;
&lt;br /&gt;
----[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 17:35, 30 September 2015 (AEST) I uploaded a new image/flowchart with some proper referencing. I'm thinking that my discussion of pathogenesis will largely be on insulin resistance and hyperandrogenemia&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3459224|Z3459224]] ([[User talk:Z3459224|talk]]) 12:24, 2 October 2015 (AEST) That sounds good! If you need any articles, let me know. I came across a few articles on pathogenesis. &lt;br /&gt;
&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 14:03, 6 October 2015 (AEDT) Howdy guys! I added an image of some polycysts present on the polycystic ovaries of a rat. It's nothing too amazing, but if you think it's not necessary/appropriate for the section let me know and I can find another pic&lt;br /&gt;
'''Sub-headings'''&lt;br /&gt;
]&lt;br /&gt;
&lt;br /&gt;
Introduction- Krithika &lt;br /&gt;
&lt;br /&gt;
Causes&lt;br /&gt;
- Pathophysiology - Miller, Krithika &lt;br /&gt;
- Risk Factors- Hyolie, Krithika &lt;br /&gt;
&lt;br /&gt;
Diagnosis - Hyolie&lt;br /&gt;
&lt;br /&gt;
Treatment - Niousha&lt;br /&gt;
&lt;br /&gt;
==Peer Asssessment==&lt;/div&gt;</summary>
		<author><name>Z3416054</name></author>
	</entry>
</feed>